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Abstract 
Dendritic cells (DC) are specialised antigen presenting cells, which induce 
and control the adaptive irm11une response. DC mediate a wide range of immune 
responses including generation of T helper cells, development of cytotoxic T cell 
responses to viral infection and induction of tolerance. However, DC studies in vivo 
have been hindered by the small numbers of cells available. Various culture systems 
have been established to overcome this issue. In this lab, a splenic longterm culture 
(L TC) was established that produces distinct dendritic-like cells (L TC-DC) 
continuously in the absence of added growth factors or cytokines. Previous studies in 
this lab identified an in vivo equivalent of L TC-DC in mvrine spleen. This thesis 
further characterises this novel dendritic-like subset (L-DC). The relationship 
between L-DC and other known dendritic and 1nyeloid subsets has also been 
investigated through phenotypic, morphological and functional studies, by 
comparing gene expression, and by analysis of cell development in mutant mouse 
models. In order to identify L-DC, it was necessary to redefine splenic dendritic and 
n1yeloid subsets. 
L-DC have now been characterised with the CDl lb11iCD1 lc10MHCirLy6C-
Ly6G-CD43+CX3CR1 +Siglec-F- phenotype. CD43 expression, lack of MHCII 
expression, and a low level of CD 11 c expression best differentiate L-DC fro1n 
conventional DC (cDC). Like CD8+ cDC, L-DC have high capacity for receptor-
n1edicated endocytosis and induce activation and proliferation of CD8+ T cells, 
although not CD4+ T cells. L-DC also show capacity to induce an in vivo cytotoxic T 
lymphocyte response equivalent to that induced by CD8+ cDC. L-DC are 
distinguishable fron1 neutrophils by the absence of Ly6G and 7/4 expression, and 
fron1 eosinophils by lack of Siglec-F expression. L-DC can be distinguished from 
monocytes by their lack Ly6C expression. Morphological studies revealed L-DC to 
b_e mononuclear cells with vacuoles in the cytoplasm, and distinct from other 
I 
n1yeloid cell types. All of these findings have identified L-DC as a novel antigen 
presenting cell subset, distinct from other known dendritic and myeloid subsets in 
murine spleen. 
l V 
In this study, resident monocytes were initially analysed according to 
protocols described in the literature. This led instead to the identification of 
eosinophils. Resident monocytes are described in literature as CD 11 bhiCD 11 c-
Ly6C+Ly6G-CD43 hi cells. However, since this subset showed low expression of 
CX3CR1, and expressed high levels of Siglec-F, they were found to be clearly 
eosinophils. Their morphology was also shown to be consistent with eosinophils, 
having amulti-lobate nucleus and orange cytoplasmic granules. Resident monocytes 
were found instead to reside within the CD1 lb11iCDl lc10Ly6C+Ly6G-subset, verified 
by high expression of CX3CR1 , CD43 and CDl 15 , and an absence of Siglec-F 
expression. The CD 11 c10 resident 1nonocyte subset shows 1norphology similar to 
inflanunatory 1nonocytes, with a bi-lo bate nucleus and cytoplasm devoid of granules. 
Both inflarmnatory 1nonocytes and neutrophils were gated as CD 11 b11 iCD 11 c-
Ly6C11iLy6G-CX3CR1 1°CD43 10 and CDl 1 b11iCD1 lc-Ly6C+Ly6G+CX3CR1-CD4310 
cells, as described in the literature. Their identity was also verified morphologically. 
Splenic macrophages were distinguished in this study as CDl 1 b +CDl lc-Ly6C+/-
Ly6G- cells which stained for specific 1nacrophage markers including MOMA-1 , 
SIGNRl and CD6S. 
Atten1pts have been n1ade to understand the lineage relationship between L-
DC and the other splenic dendritic and n1yeloid subsets, and to identify new markers 
for easier delineation of L-DC. RNA was extracted fro1n L-DC, inflarmnatory 
monocytes, resident 1nonocytes, eosinophils, CDS+ cDC and CDS- cDC. This was 
prepared for transcriptome analysis employing Mouse Gene I.OST genechips 
(Affy1netrix). The L-DC gene expression profile was found to be distinct fron1 that of 
cDC, and L-DC expressed genes related to 1nyeloid cells like Itgam , Csflr, En1r4 and 
Krt80. However, the L-DC gene expression profile was also found to be distinct from 
that of resident monocytes and inflan1matory monocytes. L-DC specifically 
expressed genes like Siglec-e, Igsj2, CD300ld, CD300e and CD9. Overall, gene 
expression analysis showed that L-DC rese1nbled a myeloid lineage cell having 
I 
dendritic-like characteristics and function in antigen presentation. 
Mouse strains carrying 1nutations which affect the development of dendritic 
and myeloid cell types were investigated for changes in L-DC development 1n 
V 
spleen. Antibody staining was used to identify the propo1iion of dendritic and 
myeloid cell subsets in mutant versus wild type mice. cDC numbers were found to be 
significantly reduced in Flt3L_1_ and Trif1- mice. This indicated that cDC development 
was dependent on FL T3L and TRIP signalling. In addition, CD8+ cDC numbers were 
significantly reduced in Batf 3_1_ 1nice. However, L-DC numbers were not altered in 
any of the mutant mice, suggesting that L-DC represent a lineage of cells distinct 
fron1 cDC. Both resident monocyte and inflammatory monocytes developed in lower 
numbers in Flt3L_1_ and GM-CSF1- mice, although L-DC were not affected. Resident 
monocyte numbers were also reduced in Trif1- and Trif/MyD88_1_ mice, while 
infla1mnatory monocytes were found to be reduced in Batf3_1_ mice. However, L-DC 
nw11bers were not affected in any of these mice, confirming that L-DC is a distinct 
lineage of cells separate from the monocyte lineage and also the cDC lineage. 
The representation of DC and myeloid subsets was also investigated in 
spleens of Booreana mice which carry a non-lethal mutation in c-Myb (c-MybE308°) . 
c-My b is known to be essential for the development of hematopoietic progenitors in 
bone marrow. Since L-DC development was not affected in __ Booreana mice, L-DC 
n1ay not arise from a bone marrow progenitor. The possibility that L-DC arise from a 
yolk sac-derived progenitor laid down in spleen during development is now 
considered. Taken together, these findings indicate that L-DC development occurs 
independently of Flt3L , Gn1-csf, Batf3 , c-Myb and toll-like receptor (TLR) signaling, 
so distinguishing the subset fro1n known dendritic and n1yeloid subsets in spleen. 
This study has revealed a novel dendritic-like cell type distinct from known 
dendritic and myeloid subsets in spleen, and having specialised function in cross-
prin1ing CD8+ T cells. The findings presented here predict an important role for L-
DC in the inunune response against blood-borne antigens which enter the splenic 
microenvironment. 
Vl 
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CHAPTER 1 
1.1 The development of myeloid cell lineages in the mouse model 
Myelopoiesis is a regulated process of cell development leading to multiple 
cell types which contribute to both innate and adaptive immunity. A common 
myeloid progenitor (CMP) 1n adult bone . marrow gives nse to 
monocytes/macrophages, dendritic cells (DC), granulocytes and mast cells (Akashi 
et al. , 2000). The granulocyte lineage gives rise to neutrophils, eosinophils, and 
basophils, each of which provides specific innate immune functions (Ueda et al. , 
2005). Classification of the monocyte and granulocyte lineages is less well advanced 
than the DC lineage. While many DC subsets are well defined and can be clearly 
isolated, the monocyte and granulocyte populations are only partially defined and 
likely to be heterogeneous. 
During embryogenesis, hematopoietic stem cells (HSC) seed fetal liver 
driving myelopoiesis beginning with the formation of a CMP equivalent (Traver et 
al. , 2001). This gives rise to cells resen1bling monocytes and granulocytes. Fetal liver 
and bone marrow precursors have been shown to be similar on the basis of their gene 
expression profiles (Traver et al. , 2001 ). However, progenitors laid down during 
embryogenesis can also undergo extramedullary myelopoiesis leading to tissue-
specific subsets. There is now an increasing number of reports in the literature of 
tissue-specific hematopoiesis. For example, microglia are known to self-renew and to 
proliferate independently of bone marrow-derived precursors (Ajami et al. , 2007; 
Ginhoux et al. , 2010). Similarly, Langerhans cells are maintained and replenished by 
progenitors in skin in the steady-state, and by blood-borne precursors during 
inflan1mation (Merad et al. , 2002). In addition, a dendritic-like cell type in spleen has 
been described which derives from endogenous splenic precursors (Tan and O'Neill, 
2012; Tan et al. , 2011). A recent study has also identified a lineage of yolk sac-
derived macrophages present in kidney, pancreas, skin, lungs and spleen tissues 
(Schulz et al. , 2012). These cells appear to develop from progenitors laid down in 
these tissues during ontogeny. 
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1.1.1 Hierarchy of hematopoietic cell development 
Hematopoietic stem cells were first described by the work of Till and 
McCulloch (Becker et al., 1963; Siminovitch et al., 1963; Till and McCulloch, 1961; 
Wu et al., 1968). They observed regeneration of the blood system after 
transplantation of syngeneic bone marrow cells into recipient mice, along with 
colony formation in recipient mouse spleen. Further analysis of splenic colonies led 
to the identification of a small subset of donor cells possessing two distinct 
properties including the ability to self-renew, and the ability to produce erythrocytes 
and multiple lineages of hematopoietic cells (Becker et al., 1963; Siminovitch et al. , 
1963; Till and McCulloch, 1961 ). These two properties are now considered the 
defining characteristics of a sten1 cell. Hematopoietic stem cells are the only cells 
with hematopoietic potential that can differentiate to produce all blood cell types and 
also divide to give rise to daughter cells without undergoing differentiation. 
Hematopoiesis occurs primarily in bone marrow where hematopoietic 
steni/progenitor cells (HSPC) have been classified as three distinct populations of 
--
longtenn HSC, shortterm HSC and multipotent progenitors (MPP) (Morrison and 
Weiss1nan, 1994; Seita and Weissman, 2010; Smith et al., 1991). Initially, HSC were 
isolated from bone 1na1Tow as c-kit+Lin-Sca-1 + (KLS) cells, although this population 
is now known to be heterogeneous (Seita and Weissman, 2010). Longterm HSC have 
recently been defined as CD34-CD38-CD135-CD150+ KLS cells, while shortterm 
HSC are CD34+CD38+CD135-CD150+ KLS cells. MPP are distinct fro1n longtenn 
and shortterm HSC, since they express CD135 , but lack CD150 expression. While 
both longtenn and sho1iten11 HSC have ability to self-renew as well as differentiate 
into all other lineages, MPP have lost some self-renewal ability (Morrison and 
Weissman, 1994). The current hierarchial model for hematopoietic cell development 
now prescribes that MPP differentiate to give lineage progenitors termed co1nmon 
lymphoid progenitors (CLP) (Karsunky et al. , 2008; Kondo et al. , 1997; Serwold et 
al. , 2009) and corm11on 1nyeloid progenitors (CMP) (Akashi et al. , 2000). CLP then 
give rise to a range of cells including natural killer (NK) cells, Pro-T and Pro-B cells 
that further differentiate in thyn1us and spleen respectively, to give T and B cells 
(Kawamoto et al., 1997). 
2 
CHAPTER 1 
Further differentiation of CMP gives rise to three distinct progenitors 
including megakaryocyte/erythrocyte progenitors (MEP), granulocyte/inacrophage 
progenitors (GMP), and the recently described, but disputed macrophage/dendritic 
cell progenitors (MDP) (Akashi et al., 2000; Diao et al., 2004; Fogg et al. , 2006; Liu 
et al. , 2009; Nakorn et al., 2003; Sathe et al. , 2014). MEP differentiate further to 
give platelets and erythrocytes, while GMP differentiate to give granulocytes and 
n1acrophages. GMP generate precursors of neutrophils, eosinophils and basophils 
(Seita and Weissn1an, 2010), although the nature of the precursor of each granulocyte 
lineage ren1ains to be investigated. 
It has been repo1ied that MD P differentiate to give monocytes and co nun on 
dendritic progenitors (CDP) (Fogg et al., 2006; Liu et al., 2009; Naik et al., 2013; 
Varol et al. , 2009), generating both cDC and monocytes, with the latter 
differentiating to give tissue 1nacrophages. Recent evidence now questions the nature 
of the MDP subset (Sathe et al., 2014), although a downstream CDP is known to 
exclusively generate conventional DC ( cDC) and plasmacytoid DC (pDC) (Liu et al. , 
2009; Onai et al. , 2013; Varol et al. , 2007). A monocyte and macrophage committed 
progenitor downstrea1n of the MDP has now been identified (Hettinger et al., 2013 ). 
This common n1onocyte progenitor (CMoP) gives rise to Ly6C11 i monocytes and not 
DC (Hettinger et al. , 2013). However, there is still so1ne uncertainty over the 
relationship between CDP, CMP and MDP. MDP were originally described as 
progenitors of cDC since they could replenish splenic DC without the fonnation of a 
n1onocytic intermediate (Varol et al. , 2007). However, those experiments utilised 
bone man·ow chin1eras generated by reconstitution of lethally irradiated wild type 
1nice with bone ma1Tow fron1 CD 11 c-diphtheria toxin (DTx) mice (Varol et al. , 
2007). Irradiation depleted MDP fron1 the host, while DTx treatment depleted 
1nacrophages and DC developing from donor bone marrow. However, it is still 
questionable whether the replenisht11ent of splenic DC occurs from host monocytes 
under the inflanunatory state induced by irradiation of these mice. A recent study 
now shows that MDP can differentiate to give multiple cell types like DC, 
macrophages and granulocytes (Sathe et al. , 2014). However, DC generated from 
MDP display the characteristics of monocyte-derived DC (mo-DC) instead of steady-
state DC (Sathe et al. , 2014). Atte1npts to identify a bi-potential MDP that give rises 
to monocytes and steady-state DC were unsuccessful (Sathe at al. , 2014). In general, 
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the development of 1nonocytes and mo-DC 1s less well characterised than the 
development of cDC or pDC lineages. 
While monocytes are 1nature when they exit bone marrow and enter blood, 
cDC precursors (pre-cDC) exit bone marrow, circulating through blood to the spleen 
and other ly1nphoid tissues for further differentiation and division (Naik et al. , 2006). 
Early evidence showed CDl lc +MHCirLy6C+B220+ dendritic precursors in bone 
n1arrow which give rise to pDC on adoptive transfer (Diao et al. , 2004). The B220-
variant of this CDl lc +MHCirLy6C+ precursor also gives rise to CD8a- cDC (Diao et 
al. , 2006). Pre-cDC can now be identified in spleen, blood and bone marrow based 
on a CD 11 c +CD43+SIRP-a + phenotype, as well as differentiative potential for cDC 
(Liu et al. , 2009; Naik et al. , 2006). Pre-cDC are clearly distinct fron1 monocytes on 
the basis of their phenotype, morphology and i1m11une function as 
CDl lcinterCDl 1 b1°F4/8010SIRP-ainter cells, while monocytes can be differentiated as 
CDl lc-CDl 1 b11 iF4/8011iSIRP-ainter cells (Naik et al. , 2006). Pre-cDC also differ from 
n1onocytes in that the latter can differentiate in response to M-CSF in culture (Naik 
et al. , 2006). Plasmacytoid DC are now known to develop fro1n CD 11 c10B220+ 
circulating iimnediate precursors (p-preDC) in blood that lodge in spleen under 
infla1m11atory conditions to produce pDC (Saunders et al. , 1996). Despite these 
studies, there are still n1any aspects of dendritic and n1yeloid cell development which 
are not well understood. 
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1.2 The dendritic cell lineage 
Dendritic cells are the most efficient antigen presenting cells (APC) in the 
inunune system, with unique ability to activate nai:ve T cells. They are closely 
aligned with monocytes/macrophages which can also function as APC. Multiple 
subsets of DC have been identified in both humans and mice (Heath et al. , 2004; 
Naik, 2008), all capable of antigen uptake, processing and presentation for T cell 
activation. They represent a heterogeneous class of cells with subtypes differing in 
tissue location, migratory pathway, cell surface marker expression, immunological 
function and dependence on infection or infla1mnatory stimulus for their generation 
(Heath et al. , 2004). They are widely distributed throughout the body with distinct 
subsets present in spleen, 1nucosa, intestine and epide1mis (Heath et al., 2004). S01ne 
DC have been classified as migratory, and these cells survey the enviro1unent by 
constant uptake of tissue antigens. In the presence of pathogen-related ' danger 
signals ', these DC mature and migrate to lymph nodes where they present antigens to 
nearby T cells (Sho1iman and Naik, 2007). In contrast, lymphoid tissue-resident DC 
do not 1nigrate, but take up and present inco1ning antigen to T cells (Sho1iman and 
Naik, 2007). 
1.2.1 Dendritic cell subsets in spleen 
Conventional DC ( cDC) represent the main DC subset in spleen and have 
been further classified as functionally distinct CD8a + and CD8a- subsets in mice. 
CD8a + cDC are distinct as CD 11c11iCD11 b-CD8a +MHCII+ cells, while CD8a- cDC 
have a CD1lc11 iCD1 1 b +CD8a-MHCII+ phenotype (Vremec et al. , 2000) . These 
subsets differ in immune function, including cytokine production and ability to cross-
present antigen (Hochrein et al. , 2001 ). It has been proposed that CD8a + cDC play a 
role in the n1aintenance of tolerance to self-antigens, consistent with their close 
proximity to T cells in the resting state, and their notable capability for cross-
presentation (De S1nedt et al. , 1996; Stei1unan et al. , 1997). CD8a + cDC are also the 
predo1ninant producer of interleukin (IL)-12, a factor iinportant for CD8+ T cell 
proliferation (Heath et al. , 2004). In contrast, CD8a- cDC have weaker cross-priming 
ability and are localised mainly in the 1narginal zone of spleen (De Smedt et al. , 
1996). Upon stimulation with lipopolysaccharide (LPS), CD8a- cDC migrate to T 
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cell areas and secrete inflammatory chemokines (De Smedt et al. , 1996). 
The pDC is another common DC subset described in spleen (Isaacs and 
Lindenmann, 1957), existing as a plas1nacytoid preDC (p-preDC) in the steady-state. 
These are non-myeloid cells which are long-lived and circulating, producing high 
levels of type I interferon after stimulation with viral or other microbial agents 
(Pelayo et al. , 2005). Inflammatory stimuli initiate the conversion of p-preDC into 
pDC with the production of type I interferons which enhance the function of NK 
cells, B cells, T cells and DC during antiviral responses. Subsequently, pDC 
differentiate to give the CD8a +CD205- DC subset, which is distinct from CD8a + 
cDC and which also regulates T cell function (O'Keeffe et al. , 2002). Plas1nacytoid 
DC can be distinguished from other DC subsets and 1nyeloid cells by their 
CD1lc1°CD11 b-B220+ phenotype, and their high production of type I interferons 
(Shortn1an and Naik, 2007). In contrast to other DC that produce type I interferons 
only upon viral infection, pDC produce type I interferons in response to stimuli that 
bind Toll-like receptors (Asselin-Paturel et al. , 2001; Diebold et al. , 2003). 
Apart fro1n the clearly defined cDC and pDC subsets, spleen also contains 
another less well described class of DC tenned 'n1yeloid DC' . This is an umbrella 
tern1 describing cells with both dendritic and 1nyeloid cell characteristics. During the 
resting state, myeloid DC comprise mainly tolerogenic DC (TolDC) also known as 
regulatory DC, which are capable of inducing a tolerogenic T cell response 
(Stei1u11an et al. , 2003). They are phenotypically characterised by expression of 
SLAM ( signalling lyn1phocyte activation n1olecule ), PD-L 1 (prograrm11ed cell death 
ligand-I), DEC-205 and ILT3/ILT4 (irmnunoglobin-like transcripts 3 and 4) 
(Maldonado and von Andrian, 201 O; Rutella et al. , 2006). In addition, TolDC are 
characterised by constitutive low expression of MHC molecules and co-stin1ulatory 
n1olecules (Morelli and Thomson, 2007). In tern1s of function, TolDC are capable of 
pro1noting the conversion of nai've CD4+ T cells into naturally-occurring 
CD4+CD25+Foxp3+ regulatory T cells (Tregs), the induction of Tregl cells in vitro in 
the presence of cytokines, and the expansion of existing Treg populations (Schmidt 
et al. , 2012; Stei11111an et al. , 2003). Another feature of TolDC is their secretion of 
indolean1ine 2,3-dioxygenase and the suppressive cytokine IL-10 (Morelli and 
Thomson, 2007; Rutella et al. , 2006; Tho1nson, 2010). TolDC also dowmegulate the 
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production of IL-12, a factor essential for effector T cell proliferation and 
cliff erentiation (Morelli and Thomson, 2007). 
Under inflammatory conditions, n1yeloid DC in spleen can also include 1no-
DC. Inflarmnatory stin1uli appear to recruit circulating CD 115+Ly6ChiCCR2+ 
infla1nmatory 1nonocytes from blood into spleen where they differentiate to become 
1no-DC (Geissmann et al., 2008; Leon et al., 2005, 2007). Different subsets of mo-
DC have been observed in different disease models. One example is the TNF /iNOS-
producing DC (TipDC) described in Listeria 1nonocytogenes infected mice (Serbina 
et al. , 2003). Inflammatory monocytes recruited from blood to L. 1nonocytogenes 
infected spleens, differentiate to beco1ne TipDC. These are distinguishable from 
steady-state cDC on the basis of their umque phenotype as 
CD 11 b11 iCD 11 cinterMAC3+MHCII+ cells, and their production of high levels of TNF-
a and nitric oxide (NO) which induce clearance of n1icrobes fro1n tissue (Serbina et 
al. , 2003). In addition, a 1no-DC subset of similar phenotype has been described in 
the draining lymph nodes of Leish1nania nrzajor infected mice (Leon et al., 2007). The 
importance of prostaglandin E in the migration of mo-DC from tissues to T cell 
zones within lyn1ph nodes has been described (Scandella et al., 2002). Prostaglandin 
E stimulates expression of CCR 7 on 1no-DC which binds to CCL 19 and CCL2 l 
expressed by ly1nph node cells (Scandella et al. , 2002). 
1.2.2 Defining characteristic of dendritic cells 
Mw·ine splenic DC were first repo1ied by Steinman in 1973. However, it took 
a decade to establish that DC were novel cells with functions distinct fro1n 
macrophages. Delineating characteristics of DC are their ability to induce a stronger 
n1ixed leukocyte reaction than B cells and n1acrophages (Steinman and Witmer, 
1978), and their ability to cross-prin1e CDS+ T cells. With advances in technology 
allowing isolation of the rare DC, their phenotypic and functional abilities have been 
studied in detail. Phenotypically, DC can be distinguished fro1n myeloid cells on the 
basis of their high expression of CD 11 c and MHCII. 
In line with their high endocytic ability, DC are often located at tissue sites 
that are constantly exposed to antigen. Exogenous antigens are phagocytosed or 
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pinocytosed by DC. When phagosomes carrying exogenous antigens fuse with 
lysosomes containing proteolytic enzymes, antigens are cleaved to give peptides. 
Newly synthesised MHCII molecules are delivered by vesicular transport to 
phagolysosomes which contain peptides. Peptides are then loaded on to MHCII 
molecules for delivery to the cell meinbrane for subsequent presentation as 
MHCII/peptide complexes to CD4+ T cells (Groothuis and Neefjes, 2005). Once 
activated, CD4 + T cells differentiate to becon1e effector T cells that produce 
cytokines and can activate monocytes for control of infection. In contrast, antigens 
produced endogenously by infected cells, or defective ribosomal proteins, become 
tagged with ubiquitin for destruction in the cytoplasm (Sigal et al., 1999). 
Ubiquitinated proteins are proteolytically cleaved in the cytoplasm to give peptides. 
The transporter associated with antigen processing selectively allows peptides to 
enter the endoplasmic reticulum where they are loaded on to MHCI molecules 
(Groothuis and Neefjes, 2005). The MHCI/peptide complex is then transported to the 
cell inembrane within vesicles for antigen presentation to CD8+ cytotoxic T cells. 
Dendritic cells can function in the presentation of antigens of both exogenous and 
endogenous origin. 
Some DC subsets can 'cross-present' exogenous antigens acquired from dead 
or dying cells like tumor cells or virally infected cells on to MHCI molecules for 
presentation to CD8+ T cells (Huang et al. , 1996; Sigal et al. , 1999). Cross-
presentation is a function largely restricted to CD8a + cDC (Bedoui et al. , 2009; Den 
Haan et al., 2000; Dudziak et al. , 2007; Pooley et al. , 2001; Schulz and Reis E Sousa, 
2002). The exact inechanisin by which exogenous antigens gain access to newly 
synthesised MHCI n1olecules, however, remains under investigation. One model 
involves ER-phagosome fusion whereby the ER dislocon, a protein transporter, 
participates in cross-presentation at the phagosoinal membrane by allowing 
translocation of peptides froin phagosomes into the cytosol (Gagnon, 2002). Another 
model involves peptides leaking from phagosomes into the cytoplasm, or peptides 
escaping into cytoplasm through the rupture of the phagosoinal membrane, and 
subsequently being loaded on to MHCI n1olecules outside the ER (Vyas et al. , 2008). 
While other cell types like neutrophils (Beauvillain et al. , 2007) and 
monocytes/macrophages (Ran1irez and Sigal, 2002; Randolph et al. , 2008) are 
thought to function in cross-presentation, these earlier reports remain 
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unsubstantiated. Indeed definitive infonnation on antigen presenting function is still 
very dependent on clear and reproducible subset definition and the isolation of pure 
subsets of cells. 
1.2.3 Tissue-specific dendritic cells 
Apa1i fron1 spleen, there are multiple secondary lymphoid sites where DC 
reside. DC play an important role in balancing the induction of tolerance against self 
antigen during the steady-state with the initiation of an immune response against a 
pathogen during an inflammatory state. DC can also play different roles in different 
tissue sites. 
1.2.3.1 Epidermal DC 
Skin DC have been extensively characterised. At least five populations of DC 
can be identified in the skin, distinguishable on the basis of CD 103, CD207 and 
EpCAM expression (Henri et al. , 2010; Nagao et al. , 2009). The most prominent 
subset co1nprises Langerhans cells located in the epidermal layer and identifiable as 
CDllbinterCD103-CD207 11iEpCAM11iMHCII 11i cells (Henri et al. , 2010; Nagao et al. , 
2009). The re1naining four DC subsets are located within the dermal layer. One 
subset has been identified as a dern1al Langerhans cell on the basis of phenotype. 
The ren1aining tlu·ee de1mal DC subsets can be distinguished fro1n Langerhans cells 
by the absence of EpCAM expression (Nagao et al. , 2009). These can be further 
differentiated into CD11b1°CD103+CD207\ CD1lb+CD103-CD207- and CD11b-
CD103-CD207- subsets (Henri et al. , 2010). 
Langerhans cells have long been described as the pivotal APC within skin. 
They capture local antigen and migrate to cutaneous lymph nodes to present antigen 
directly to T cells. They can also transfer antigen to lymph node resident DC, so 
inducing an adaptive immw1e response against the captured antigen. However, recent 
studies have challenged the role of Langerhans cells, suggesting that 
CD11b1°CD103+CD207+ dern1al DC are the true cross-pruning subset (Nagao et al. , 
2009; Seneschal et al. , 2014; Stoecklinger et al. , 2011 ). Both Langerhans cells and 
CD207+ dern1al DC are capable of cross-presenting OVA to CDS+ T cells 
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(Azukizawa et al., 2003; Waithman et al., 2007) . However, others have described the 
CD103+CD207+ dermal DC as the main cross-presenting cell type (Bedoui et al., 
2009; Henri et al., 2010). One possible explanation for this difference could be 
contamination of Langerhans cells with dermal DC since cells were not delineated on 
the basis of CD103 expression (Waithman et al., 2007). 
Recent studies have suggested a tolerogenic role for Langerhans cells, 
whereby Langerhans cells suppress contact hypersensitivity responses through 
secretion of IL-10 and cognate interaction with CD4+ T helper cells (Igyarto et al. , 
2009). In a suppo1iing study, Fukunaga et al. (2008) identified Langerin- dermal DC, 
and not Langerhans cells, as the 1nain DC subset that induces a contact 
hypersensitivity response through proliferation of CD4+ T helper cells (Fukunaga et 
al. , 2008). In a parasite study, conditional deletion of Langerhans cells led to 
enhanced protective irmnunity against Leishniania niajor infection (Kautz-Neu et al. , 
2011). This study implicated Langerhans cells as the main subset that suppressed the 
anti-Leishniania iimnune response through recruitment and expansion of Treg via 
secretion of IL-10 (Kautz- eu et al. , 2011 ). In general, Langerhans cells represent 
--
tissue-resident DC that paiiicipate in immunosuppressive responses , \\rhile 
CD 103+CD207+ dennal DC represent a migratory DC subset that participates in 
adaptive ii111nune responses. 
1.2.3.2 Gut 111ucosal D·C 
The gut contaii1s multiple subsets of DC distinguishable by their location, 
function and phenotype (Johansson and Kelsall, 2005). Within the gut, DC can be 
first differentiated on the basis of location, namely in Peyer's patches, mesenteric 
ly1nph nodes or lamina propria (Johansson and Kelsall, 2005). Peyer's patches and 
n1esenteric lyn1ph nodes ai·e prin1ary sites for the induction of imn1une responses, 
while lamina propria are the primary site for development of effector T cells. DC 
located \\rithin these sites ha, e distinct functions , and DC v1ithin Peyer's patches and 
mesenteric I mph nodes include the CDllb+CD8a-, CDllb-CD8o.+ and CD11b-
CD8a.- subsets (Iwasaki and Kelsall, 2001 ). Both CD1 lb+CD8a- and CDI lb-CD8a.-
DC ai·e migratory cells while CDl 1 b-CD8a + DC are restricted to the T cell zone 
within lymph nodes (Johansson and Kelsall 2005). Apart from differences in 
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location and phenotype, these subsets also have distinct functions. CD 11 b +CD8a-
and CD 11 b-CD8a- DC are highly endocytic and induce Th2 responses, while CD 11 b-
CD8a + DC are primarily involved in the induction of Thl responses and the cross-
priming of CD8+ T cells to confer tolerance against self-antigens (Johansson and 
Kelsall, 2005). 
Lamina propna are the main site for DC contact with food antigen, 
cormnensal bacteria and pathogenic bacteria. Hence, DC in lamina propria have 
distinct function to cope with the envirorunent. They can be distinguished as two 
1nain populations of CD103+ and CD103- DC (Scott et al., 2011) which induce two 
distinct T effector cell types. CD103+CX3CR1- DC are the main subset that migrates 
, 
from lamina propria to n1esenteric lymph node to prime naYve T cells. Conversely, 
CD103-CX3CR1 + DC lack ability to prin1e naYve T cells. CD103+CX3CR1- DC 
differentiate fron1 CDP and/or pre-cDC and are dependent on granulocyte/ 
macrophage colony-stin1ulating factor (GM-CSF) and Fms-like tyrosine kinase 3 
ligand (Flt3L) for develop1nent (Bogunovic et al. , 2009; Scott et al. , 2011; Varol et 
al., 2009). In contrast, CD103-CX3CR1 + DC arise from Ly6C 11 i inflammatory 
--
n1onocytes which differentiate in the presence of Flt3L and M-CSF (Bogunovic et 
al. , 2009; Scott et al. , 2011; Varol et al., 2009). Hence, CD103- DC are thought to be 
macrophages. Recent studies have shown that CD 103+ DC possess ability to induce 
expression of the gut-hon1ing markers CCR9 and a4~7 on naYve T and B cells in 
mesenteric lyn1ph nodes which aid migration of these cells to lamina propria 
(Johansson-Lindbon1 and Agace, 2007; Johansson-Lindbom et al. , 2005). In addition, 
CD 103 + DC induce the differentiation of CD4 + T cells to Tregs via production of IL-
10 and TGF-~ (Siddiqui and Powrie, 2008; Sun et al. , 2007). Tregs are crucial for the 
n1aintenance of tolerance towards food and self antigens in the gut. These studies 
suggest a tolerogenic role for CD103+ DC, while CD103- DC prime T cells towards a 
pro-inflarmnatory response (Atarashi et al. , 2008; Denning et al. , 2007). 
1.2.3.3 Thyn1ic DC 
T cells develop in thymus where developing thymocytes undergo positive and 
negative selection before maturing as antigen-specific T cells (Nitta et al. , 2008). 
Most self-reactive thyn1ocytes are removed in thymus via negative selection, a 
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process crucial for establishment and maintenance of central tolerance (Nitta et al. , 
2008). Thymic DC are crucial to negative selection, and present self antigens to 
developing thymocytes causing deletion of T cells which have high self affinity. 
Three subsets of DC have been described in the thymus: pDC, CD810Sirpahi cDC and 
CD811 iSirpa10 cDC (Li et al. , 2009; Proietto et al. , 2008). CD811 iSirpa10 cDC develop 
from early T cell progenitors and are highly efficient at inducing functional Tregs in 
vitro (Proietto et al. , 2008). They display a more mature phenotype in terms of 
expression of MHCII and co-stimulatory molecules compared with other thy1nic DC 
subsets (Proietto et al. , 2008). In addition, CD8hiSirpa10 cDC express high levels of 
CCL 17 and CCL22 which attract CD4+ thy1nocytes (Proietto et al. , 2008). Recent 
studies suggest that both pDC and CD810Sirpa11 i cDC originate extrathymically and 
continuously 1nigrate into the thyn1us (Li et al. , 2009). CD810Sirpahi cDC can present 
both self and non-self antigens on MHC molecules. They induce negative selection 
of thy1nocytes that strongly bind organ-specific antigens, and positively select T cells 
for Treg development (Proietto et al. , 2008). 
Multiple subsets of DC can be identified in different tissue sites, and each DC 
subset has a specialised role in tissues. This reflects compart1nentalisation and a 
1nechanisn1 to regulate the immune response efficiently. 
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1.3 Myeloid subsets in spleen 
Dendritic cells are located mainly within the white pulp region of spleen 
where itnmune responses against blood-borne antigens and pathogens are initiated, 
while n1yeloid cells are primarily located within the red pulp region. White pulp 
co1nprises three regions: the periarteriolar lymphoid sheath (PALS) which is the T-
cell zone, B cell follicles, and the n1arginal zone (Cesta, 2006). The PALS can be 
further divided to give the inner PALS which comprises mainly CD4 + T cells, some 
CD8+ T cells, interdigitating DC and migrating B cells, while the outer PALS 
contains 1nacrophages (Mebius and Kraal, 2005). The marginal zone is strategically 
situated at the interface of the red pulp and PALS for screening blood-borne antigens 
and pathogens. It contains a large reservoir of resident 1nyeloid cells as APC that 
participate in 1nounting an irmnune response against blood-bo1ne antigens. 
1.3.1 Splenic macrophages 
Four subsets of 1nacrophages have been described for spleen. Two of these 
--
are located within the 1narginal zone, namely marginal zone metallophilic 
1nacrophages and 1narginal zone macrophages (Mebius and Kraal, 2005). Marginal 
zone 1netallophilic macrophages can be visualised by staining with the MOMA-1 
n1onoclonal antibody and are located near the PALS and B cell follicles (Mebius and 
Kraal, 2005). Recent studies have described 1narginal zone 1netallophilic 
n1acrophages as essential for induction of cytotoxic T cell responses against blood-
borne antigens (Backer et al. , 2010). Marginal zone metallophilic macrophages 
concentrate antigens in the n1arginal zone via SIGLEC 1 which interacts with sialic 
acid residues on pathogens (Mebius and Kraal, 2005). Subsequently, marginal zone 
1netallophilic n1acrophages phagocytose pathogens and transfer antigens to CD8+ 
cDC which then mount a cytotoxic T cell response against the pathogen. They can 
also induce tolerance against self antigens (Backer et al. , 2010; Ravishankar et al. , 
2014). In addition, there is increased production of CCL22 in marginal zone 
1netallophilic macrophages following adn1inistration of apoptotic cells (Ravishankar 
et al. , 2014). CCL22 can recruit and activate Tregs to suppress inflammatory 
responses elicited by apoptotic cells (Ravishankar et al. , 2014). 
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Marginal zone macrophages are located closer to the red pulp and are 
characterised by SIGNRl expression (Mebius and Kraal, 2005). These 1nacrophages 
express a number of pattern recognition receptors like Toll-like receptor (TLR) type 
1 scavenger receptor MARCO, and the C-type lectin SIGNRl. They play an 
important role in the clearance of microorganisms (Kang et al. , 2003). SIGNRl 
efficiently binds polysaccharide antigen on several 1nicroorganis1ns like 
Mycobacterium tuberculosis (Kang et al. , 2003), and can bind antigens expressed on 
viruses (Oehen et al. , 2002). In addition, marginal zone macrophages have been 
reported to play a role in the retention and activation of 1narginal zone B cells 
(Karlsson et al. , 2003). 
, 
The third subset is the tangible body n1acrophages within the white pulp of 
spleen. These can be distinguished fron1 other 1nacrophages by their phenotype as 
CDl 1 b-F4/80-CD68+ cells (Noel et al. , 2007) and their involvement in the 
phagocytosis of apoptotic B cells generated during genninal center reactions. A final 
subset is the red pulp n1acrophages. These are distinct by F 4/80 expression 
(CDl 1 b +F4/80+CD68+) which distinguishes then1 from 1narginal zone metallophilic 
--
1nacrophages, n1arginal zone 1nacrophages and tangible body 1nacrophages, all of 
which are F4/80- (Noel et al. , 2007). Red pulp n1acrophages are involved mainly in 
the clearance of old or da1naged red blood cells and the recycling of hen1e groups. 
1.3.2 Splenic monocytes 
Monocytes are thought to develop in bone 1na1Tow from a con1mon 
myeloid/dendritic cell progenitor (MDP) which exists only in bone ma1Tow (Liu et 
al. , 2009; Yona et al. , 2013). MDP progeny continuously 1nigrate into blood via a 
CCR2-dependent 1nechanis1n (Geissmann et al. , 2008) . When monocytes enter 
tissues they tenninally differentiate to give 1nacrophages. Monocyte-derived DC 1nay 
also develop in lymphoid sites in response to pathogen invasion and infla1nmatory 
sti1nuli (Randolph et al. , 1998). 
In general, two subsets of monocytes have been identified in blood: the 
CX3CRl 10Ly6C11 i inflammatory monocytes, and the CX3CR1 hiLy6C- resident 
n1onocytes (Geissmann et al. , 2008; Yona et al. , 2013). Inflarmnatory n1onocytes 
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home to sites of infection where they differentiate to give TipDC (Geissmann et al. , 
2003), while resident monocytes home to non-inflammatory sites and are thought to 
be precursors of macrophages resident in normal tissues, e.g. liver and spleen 
(Geiss1nann et al. , 2003). However, infonnation on the function of resident 
monocytes, and whether or not they differentiate to give macrophages within tissues, 
is still debatable. Contradictory evidence suggests that tissue-specific macrophages, 
e.g. Kupffer cells in liver, lung alveolar macrophages and splenic macrophages, are 
maintained through adulthood without replenishment fro1n blood monocytes (Davies 
et al. , 2013 ; Hashi1noto et al. , 2013; Schulz et al., 2012). This raises questions about 
the function of resident monocytes and whether all tissue-specific macrophages are 
monocyte-derived. Indeed evidence for a yolk sac-derived lineage of macrophages 
argues for develop1nent of tissue-specific 1nacrophages from progenitors endogenous 
to tissues (Schulz et al. , 2012). 
A reservoir of undifferentiated n1onocytes resident in spleen was recently 
identified (Swirski et al. , 2009). Phenotypically, morphologically and 
transcripto1nically these were shown to resemble blood monocytes. Under 
infla1nmatory conditions, both inflanunatory monocytes and resident monocytes are 
selectively n1obilised fron1 spleen to the site of inflammation. Splenic inflarmnatory 
monocytes were found to clear damaged tissues, while splenic resident monocytes 
promoted wound healing (Swirski et al. , 2009). In addition, spleen was found to 
deploy large nu1nbers of n1onocytes to injury sites faster than fro1n bone marrow. 
Deployment of a reservoir of splenic monocytes was hypothesised as a mechanism 
for faster initiation of an immune response. The potential role of spleen in 
1nyelopoiesis was therefore predicted from this study. 
1.3.3 Yolk sac-derived macrophages 
Tissue n1acrophages can develop fro1n either bone marrow-derived or yolk 
sac-derived progenitors. During primitive hematopoiesis, yolk sac-derived 
progenitors give rise to hematopoietic cells including erythrocytes and macrophages 
(Palis and Yoder, 2001 ). Yolk sac-derived macrophages then migrate to and colonise 
other fetal organs. Several studies have highlighted how tissue-specific macrophages 
appear to have a yolk sac origin (Ginhoux et al. , 2010; Hashi1noto et al. , 2013 ; 
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Schulz et al., 2012). In particular, lineage tracing studies using 
RunxlCrelwt:Rosa26R26R-eYFP mice have confirmed that adult microglial cells derive 
from yolk sac precursors (Ginhoux et al. , 2010). A similar tracing study using 
Runxl Crelwt:Rosa26R26R-eYFP mice identified yolk sac-derived macrophages as 
CD 11 b1°F 4/8011 i cells, while bone marrow-derived macrophages were CD 11 b11 iF 4/8010 
cells (Schulz et al. , 2012). Unlike bone man·ow-derived 1nacrophages, yolk sac-
derived macrophages develop independently of the c-Myb transcription factor and 
the Flt3L growth factor (Schulz et al. , 2012). Their development is instead dependent 
on the transcription factor PU.1 (Schulz et al. , 2012). A recent study suggests a third 
possible origin for tissue 1nacrophages from fetal monocytes. Parabiosis studies and 
BrdU labelling experiments showed that circulating monocytes contribute n1inin1ally 
to alveolar 1nacrophage development (Guilliams et al. , 2013). Instead, adoptive 
transfer experin1ents showed that alveolar 1nacrophages derive from fetal monocytes 
(Guilliams et al. , 2013). Similarly, Langerhans cells have been shown to derive fro1n 
both yolk sac-derived n1acrophages and fetal 1nonocytes (Hoeffel et al. , 2012). 
1.3.4 Splenic granulocytes 
Granulocytes in spleen are n1ainly localised in the red pulp region with some 
evident in transition tlu·ough the marginal zone as blood-borne cells flowing into red 
pulp (Nolte et al. , 2000). In general, granulocytes comprise neutrophils, eosinophils, 
basophils and n1ast cells, although neutrophils are the major subset within spleen 
(Nolte et al. , 2000). Neutrophils are key con1ponents of the infla1mnatory response, 
recruiting APC, transporting antigen, and controlling T-cell expansion and 
differentiation (Beauvillain et al. , 2007). They can be distinguished from other 
leukocytes on the basis of their phenotype as CD1 lb11 iCD1 lc-Ly6G+F4/80-MHCir 
cells (Abadie et al. , 2005 ; Beauvillain et al. , 2007). Recently, it was shown that 
neutrophils from inflanunatory peritoneal exudates could cross-prime CD8+ T-cells 
both in vivo and in vitro (Beauvillain et al. , 2007; Tvinnereim et al. , 2004). While 
these studies demonstrated cross-priming capability, this response occurred only 
under inflanunatory stitnulus, and so n1ay not be reflective of neutrophils in steady-
state spleen. 
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Other granulocyte subsets can also be detected in blood and tissues, although 
in lower frequency. Eosinophils are indicative of parasitic infections, allergies and 
some rare diseases (Stone et al. , 2010). They are distinguishable from other 
granulocytes on the basis of their unique morphology with a bi-lo bate nucleus and 
highly condensed chromatin, as well as the presence of orange-stained granules in 
the cytoplasn1 (Muniz et al. , 2012; Walsh, 2013). In terms of cell surface markers, 
eosinophils express a range of markers including CD32, CD89, CR3 , CD88, CCRl , 
CCR3 , Siglec-F, IL-3R, IL-SR, GM-CSFR and multiple TLR (Stone et al. , 2010). 
Upon activation, eosinophils release proinflammatory granules containing cationic 
proteins and cytokines. At least three types of cationic proteins are present in 
eosinophilic granules which can disrupt cell me1nbranes. They also possess RNAse 
activity to target parasites and virus infections (Stone et al. , 2010; Walsh, 2013), and 
can catalyse the oxidation of NO and halides into products which are toxic for 
parasites and host cells (Stone et al. , 2010; Walsh, 2013). 
As with eosinophils, mast cells are detected mainly in tissues. Mast cells 
develop fro1n CD34+ progenitors in bone man·ow and then circulate into tissues sites 
where they 1nature to fonn functional mast cells (Metcalfe, 2008; Stone et al. , 2010). 
They are distinguishable from other granulocytes on the basis of ckit, Fcc:Rl and 
FcyRIIa expression (Stone et al. , 2010). In particular tissue sites, mast cells may 
upregulate other n1arkers like FcyRI, prostaglandin receptor EP2, complement C3a 
and C5a receptors, as ,;vell as various interleukin, chen1okine and toll-like receptors 
(Metcalfe, 2008 ; Stone et al. , 2010). Upon activation, mast cells release granules 
containing mediators like histanune, proteases and proteoglycans as well as 
cytokines. Histamine plays an iinpo1iant role in inflammatory and allergic responses, 
and recruits leukocytes to sites of inflammation, as well as regulating mucous 
secretion and smooth muscle contraction (Jutel et al. , 2006; Metcalfe, 2008). 
Proteases break down ligands like fibrinogen, fibronectm, and the complement C3 
molecule (Stone et al. , 2010). They can also activate fibroblasts , encourage 
accwnulation of inflamn1atory cells, and potentiate histamine-induced airway 
bronchoconstriction (Stone et al. , 2010). Lastly, mast cells secrete a range of 
cytokines like twnour necrosis factor (TNF)-a IL-3 , IL-5 , IL-6, IL-10, IL-13 and 
GM-CSF Vlhich can regulate the immune response (Metcalfe, 2008). IL-3 , IL-5 and 
GM-CSF are crucial for eosinophil de elopment. 
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Basophils share many traits with mast cells including expression of Fcc:Rl , 
secretion of T helper 2 cytokines, and the release of histamine upon activation 
(Karasuyama et al., 2011; Stone et al. , 2010). However, basophils can be 
distinguished from n1ast cells by their rapid and large secretion of IL-4 and IL-13 
(Karasuyama et al. , 2011). In addition, basophils mature in bone n1arrow and remain 
within the circulatory system, rather than in tissue sites (Karasuyama et al. , 2011 ). 
Due to their low numbers and their similarity with mast cells, basophils have been 
neglected and considered redundant in irmnune responses. Recent studies have 
highlighted the unique role of basophils in the regulation of i1nmunity. Basophils act 
as initiators in the developn1ent of IgE-mediated chronic allergic inflammation in the 
skin, unlike n1ast cells that act as effectors in the inflan1matory response 
(Karasuya1na et al., 2009; Mukai et al. , 2005). Basophils also help drive the Th2 
response against allergens via IL-4 secretion (Hida et al. , 2005; Oh et al. , 2007). 
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1.4 Dendritic cell development in spleen 
1.4.1 Dendritic cell culture systems 
Since DC are a rare cell type, in vitro culture syste1ns have been developed to 
generate large nu1nbers of cells for studies of function. There have been two n1ain 
culture systems developed for the generation of DC, each giving cells with distinct 
function (Randolph et al. , 2008). The first utilises a cytokine cocktail of GM-CSF, 
TNF-a and IL-4, which sti1nulates 1nyeloid precursors and n1onocytes to give mo-DC 
(Sallusto and Lanzavecchia, 1994; Xu et al., 2007). The second method utilises Flt3L 
which stimulates proliferation and differentiation of bone 1narrow derived pre-DC to 
give cDC and pDC (Brawand et al., 2002; Naik et al., 2005; Xu et al., 2007). The 
GM-CSF/IL-4 culture syste1n is an attractive 1nodel for generating large numbers of 
DC. However, it produces only mo-DC expressing CDl lc and MHC-II, which have 
properties reflective of DC generated under inflarmnatory conditions. These cells do 
not reflect steady-state or immature DC. Evidence has shown that GM-CSF levels 
are low in resting mice but increase dran1atically during inflanm1ation, consistent 
with evidence that cDC and pDC are present at normal levels in spleens of GM-CSF-
/-1nice (Vren1ec et al. , 1997). 
Flt3L is a known proliferative factor for DC (Brasel et al., 2000), and a 
growth factor for hen1atopoietic progenitors. It also n1obilises he1natopoietic 
progenitors and sten1 cells in vivo (Merad and Manz, 2009). Flt3L_1_ n1utant mice 
have lower nun1bers of DC in spleen, thyn1us and lymph nodes, emphasising the 
overall i1nportance of Flt3L in DC develop1nent (McKenna et al. , 2000). It was 
recently shown that in vitro grown Flt3 L-induced cDC resen1ble the in vivo subsets 
of CD8a + cDC and CD8a- cDC in spleen (Naik et al. , 2005). Cell phenotypes of 
CD2411 iCD 11 b1°CD 172a10 and CD241°CD 11 b11 iCD 172a11 i reflect the CD8a + cDC and 
CD8a- cDC subsets described in n1urine spleen respectively (Brawand et al. , 2002; 
Naik et al. , 2006). 
The Flt3L culture system is distinct fro1n the GM-CSF/IL-4 culture system in 
that it generates steady-state and not inflarmnatory DC. GM-CSP-induced DC and 
Flt3L-induced DC appear to derive fro1n distinct precursors (Xu et al. , 2007). When 
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the CD 11 bhiLy6C+Ly6G- infla1mnatory monocyte population from bone marrow was 
cultured with GM-CSF, cells produced resembled a TipDC as a 
CDI I bhiCDl lc10Mac-3+MHC-II+ cell subset (Geissmann et al., 2003). No cDC 
production was induced upon culture of inflammatory monocytes with Flt3L. 
Inflammatory monocytes in bone n1arrow appears to be GM-CSP-responsive DC 
precursors, and these appear to be the in vitro counterpart of TipDC (Auffray et al. , 
2009). 
1.4.2 Longterm splenic cultures produce dendritic-like cells 
Another 1nethod for DC production in vitro involves splenic longtenn 
cultures (LTC) which produce a distinct dendritic-like cell type (O'Neill et al. , 2004). 
These 'LTC-DC' arise from spleen-derived progenitors maintained over long periods 
in contact with n1urine splenic stromal cells (Wilson and O'Neill, 2004; Wilson et al. , 
2000). Splenic stron1a maintained within L TC supports continuous but restricted 
developn1ent of only this cell type, without the addition of cytokines like GM-CSF, 
TNF-a, IL-4 or Flt3L to cultures. The continuous production of cells within L TC is 
-
consistent with the n1aintenance of self-renewing progenitors or stem cells within the 
stro1nal layer (Wilson and O'Neill, 2004). Recent studies have confinned that 
progenitors are n1aintained in L TC by endothelial-like stro1nal cells unique to spleen 
(Despars and O'Neill, 2006). He1natopoietic cells fonn foci of proliferating cells 
above the stron1a, and continuously shed dendritic-like cells into the medium. 
1.4.3 Further characterisation of L TC-DC 
Non-adherent cells collected fron1 L TC co1nprise a minor population of small 
precursors/progenitors, and a n1ajor population of large cells reflecting iinmature 
splenic DC (Quah et al. , 2004). The non-adherent small cells represent a 
heterogeneous population expressing markers of he1natopoietic progenitors like cKit, 
Sea-I and Thy-I , with subsets of large-sized cells expressing CDI I b, CDI le, 
CDI 17 and CD80 having weak endocytic ability (Quah et al. , 2004). LTC-DC 
production was achieved when a sorted small cell population was cultured over the 
splenic stro1nal cell line STX3 , derived fro1n a LTC that had lost hematopoietic cells 
with passage over tin1e (Wilson and O'Neill, 2004). This study confirmed the 
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presence of self-renewing progenitors within the small cell population produced in 
L TC (Wilson and O'Neill, 2004 ). In contrast, the large, non-adherent cells produced 
reflected L TC-DC, a subset of immature myeloid dendritic-like cells. They had the 
cell surface phenotype of CD 11 bhiCD 11 c1°CD8a-MHCirCD80+CD86+ cells (Quah et 
al. , 2004). The absence of MHCII and CD40 expression distinguished LTC-DC from 
DC derived by culture of precursors with inflanunatory cytokines. Hence, LTC-DC 
differ fro1n mo-DC generated in the GM-CSP /IL-4 culture system (Sallusto and 
Lanzavecchia, 1994; Xu et al. , 2007), and from cDC or pDC generated in the Flt3L 
culture system (Brawand et al. , 2002; Naik et al. , 2005; Xu et al. , 2007). 
A notable characteristic of LTC-DC is their ability to cross-prime CD8+ T 
cells (Tan and O'Neill, 2010). LTC-DC demonstrated superior ability to cross-prime 
CD8+ T cells when compared with freshly isolated CD 11 c + splenic DC. However, 
LTC-DC lack ability to activate CD4+ T cells, consistent with their MHCir 
phenotype. L TC-DC are therefore distinct from other splenic DC subsets or DC 
derived in other in vitro culture systems which activate CD4+ T cells. 
1.4.4 Identification of an in vivo equivalent of L-DC 
An in vivo equivalent of LTC-DC, namely 'L-DC', has been identified in 
murine spleen based on an equivalent phenotype, cross-priming capability, and 
inability to activate CD4+ T cells (Tan and O'Neill, 2010). Like LTC-DC, L-DC are 
large cells, which express the same CD 11 bhiCD 11 c1°CD8-MHCir phenotype. The in 
vitro cross-priming capability of L-DC was found to be comparable with that of 
CD8+ cDC (Heath et al. , 2004; Tan and O'Neill, 2010). While the cross-presentation 
capacity of CD8+ cDC increases further after LPS activation, L-DC were found to be 
strong activators of CD8+ T cells assessed in vitro, only with LPS activation (Tan 
and O'Neill, 2010). Evidence for an in vivo cell type equivalent to LTC-DC, gives 
physiological relevance to the in vitro derived cell type named L TC-DC. The 
possibility that spleen produces an endogenous APC with function specific to the 
splenic environment, and to blood-borne pathogens and antigens, is under further 
consideration. 
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Preliminary studies have shown that L-DC are well positioned compared with 
other splenic 1nyeloid and DC subsets for uptake of blood-bo1ne antigens (Tan and 
O'Neill, 2010). In vh o antigen prirning prior to isolation of APC subsets followed 
by in 1 itro assays of T cell activation, showed that L-DC were superior to CD8+ cDC 
and n1onocytes in uptake and presentation of antigen (Tan and O'Neill, 2010). L-DC 
have also been shov.,rn to be capable of cross-priming CD8+ T cells in adoptive 
transfer experirnents (Tan and O'Neill 2010), and may therefore represent an 
in1po1tant cross-presenting subset in spleen, especially under inflanu11atory 
conditions. To date, they have been identified as FSChi cells vvithir1 the 
CD·l 1 b11 iCD 11 c1°CD8-1vfHCir splenic subset. Hovvever, this subset is heterogeneous 
and further characterisation is needed to delineate L-DC more specifically. 
1.4.5 Other splenic stroma-based culture systems 
Several other groups have also repo1ted production of dendritic-like cells in 
spleen stron1a culture systen1s. One group described the differentiation of bone 
n1aiTO\N-derived DC to give CD 11 b11iCD 11 c1°CD8-CD8011 iCD4011 i:NG-ICII10 DC ( diff 
DC) in cultw·es o er spleen-derived stron1a (Tang et al. 2006· Zhang et al. , 2004). In 
addition this group also identified an in 1 71 o counterpart of diff DC on the basis of 
cell swface phenotype. Both in 1 itro and in 1 71 o diff DC , -ere sho~rn to secrete nitric 
oxide ai1d to inhibit CD4+ T cells so fui1ctionally resen1blir1g regulatory DC (Tang et 
al. , 2006· Zhang et al. 2004). In addition, in 1 itro generated diff DC have been 
sho,"m to induce apoptosis in CD4+ T cells , ia Fas ligand induced IFN-y and IO 
production u et al. , 2012). In 1 itro generated diff DC also reprogrammed CD4+ T 
111emory cells to give inu11w1osuppressive T 1ne1nory cells ,;vhich suppress CD4+ T 
cell acti, ation and proliferation , ia IL-10 secretion (Xu et al. , 2011 ). Lastly, in 1 itro 
generated diff DC also induced differentiation of splenic B cells to gi, e regulator) B 
cells , ia IF -~ secretion and CD40 ligand signalling (Qian et al. , _012) . The 
relation hip between regulator) DC and L-DC is not kno,"rn, and is ret to be 
identified. 
Another group generated IL-10 producing DC ,~1ith a 
CDl 1 b11 iCDl lc1°CD45RB+ phenot) pe b) culturing CD 11 7+Lin- bone n1arro,;v 
progenitors over splenic stro1na comprising mainly fibroblastic cells (S, ensson and 
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Kaye, 2006; Svensson et al. , 2006). These CD 11 c1°CD45RB+ DC display regulatory 
functions including suppression of mixed leukocyte reactions, differentiation of 
CD4+ Th cells into IL-10 producing Treg cells, as well as antigen-specific tolerance 
following adoptive transfer (Svensson and Kaye, 2006). These CD 11 c1°CD45RB+ 
DC rese1nbled the regulatory CD 11 c1°CD45RB 11 i DC described by Wakkach et al. 
(2003) in terms of their phenotype and secretion of IL-10. However, in Wakkach et 
al. (2003), a GM-CSF and TNF-a culture systen1 was used to generate DC from bone 
marrow progenitors, which then further differentiated to give regulatory DC 
(CD1 lc1°CD45RB 11 i) upon addition of IL-10 (Wakkach et al. , 2003). Currently, the 
development and role of regulatory DC is not well understood, and more than one 
pathway for development appears to be possible. 
1.4.6 Spleen as a site for hematopoiesis 
While hematopoiesis occurs 1nainly in the bone marrow in adults, spleen can 
act as a secondary site for hematopoiesis (Wolber et al. , 2002). Extramedullary 
hematopoiesis has also been described in the yolk sac, liver and spleen during fetal 
development before bone marrow forn1ation (Lux et al. , 2008; Palis and Yoder, 
2001; Tavassoli, 1991; \Volber et al. , 2002). In response to pathogens, HSC in spleen 
can differentiate to give increased nun1bers of APC and phagocytes (Morita et al. , 
2011 ; Shat1-y and Levy, 2004). The capacity of spleen stroma to support 
hematopoiesis, and particularly n1yelopoiesis, in the absence of additional growth 
factors or cytokines was first described by Ni and O'Neill (1997). Subsequent studies 
have identified and isolated stromal cell lines that support extramedullary 
he1natopoiesis in vitro with production of dendritic-like cells (O'Neill et al. , 2014; 
Periasamy and O'Neill, 2013 ; Periasamy et al. , 2013). Early in vitro studies are now 
suppo1ied by the identification of an in vivo equivalent of LTC-DC (Tan and O'Neill, 
2010). All of these studies support a model whereby spleen stroma supports HSPC 
differentiation to give a specific dendritic-like cell type. This appears to be unique to 
spleen and to display distinct functional capacity in activation of CD8+ but not CD4+ 
T cells. 
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1.5 Hypothesis and Aims 
Progress in identification and characterisation of an in vivo equivalent of 
L TC-DC has led to the identification of a putative subset of L-DC (Tan et al. , 2011 ). 
However this subset is heterogeneous and requires further delineation. Given the 
availability of new 1narkers which delineate splenic dendritic and myeloid cell 
subsets and the availability of mouse strains 1nutated for specific genes, it is now 
possible; 1) to further delineate and characterise L-DC in relation to other cell 
lineages both phenotypically and genotypically, 2) to investigate the functional 
relationship between L-DC and other splenic dendritic and myeloid subsets, and 3) to 
assess the lineage origin of L-DC in terms of requirement for cytokines and growth 
factors during developn1ent. 
The following hypothesis is therefore investigated: L-DC reflect a lineage of 
dendritic-like cells distinct from known subsets of dendritic and myeloid cells 
present in spleen in terms of phenotype, gene expression and function in T cell 
activation. 
Specific ain1s: 
1. To distinguish a L-DC candidate subset fro1n splenic subsets of resident 
monocytes, infla1nmatory n1onocytes, eosinophils, neutrophils, cDC and pDC, on the 
basis of cell surface marker expression. 
2. To investigate the function of a putative L-DC subset in terms of ability to activate 
CD8+ and CD4+ T cells, and to cross-present antigen in co1nparison with other well 
defined APC subsets in spleen. 
3. To investigate the developn1ent of L-DC in spleens of 1nouse strains mutated for 
genes which regulate the development and function of other known subsets of 
dendritic and n1yeloid cells. 
4. To profile gene expression in a candidate L-DC subset purified from spleen, and to 
identify genes specifically expressed in L-DC which could encode new markers for 
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cell identification. The relationship of L-DC with known DC and 1nonocyte subsets 
in spleen will be assessed on the basis of gene expression profiles. 
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Materials and Methods 
CHAPTER2 
2.1 Murine cell development 
2.1.1 Animals 
Mice were obtained from several different sources. Specific pathogen-free 
C57BL/6J, C57BL/6.Tg(TcraTcrb)l 100Mjb (OT-I), C57BL/6.SJL/J.OT-II.CD45.1 
(OT-II), C57BL/6-Tg(CAG-OVA)916Jen:WehiAnu (Act-mOVA), C57BL/6-
MyD88_1_ (MyD88_1_) and C57BL/6-TRIF1- (TRIF1-) mice were obtained from the 
John Curtin School of Medical Research (JCSMR, Australian National University 
(ANU), and used at 4-6 weeks of age. C57BL/6-Flt3L1mllmx (Flt3L_1_) mice (Taconic 
Fanns Inc. , NY, USA) were purchased from the Biomedical Research Facility, 
University of Western Australia (Perth, Australia), while B6. l29P(Cg)-
Ptprc0Cx3Cr J11111Dtt/LittJ ( Cx3Cr 1-GFP) and C57BL/6-MyD88-1-TRIF1- (MyD88_1_ 
TRIF1-) 1nice were purchased from the Walter and Eliza Hall Institute (WEHI: 
Parkville, Victoria, Australia). C57BL/6-Csj211111Ard (GM-CSF1-) mice were obtained 
from the Ludwig Institute for Cancer Research (Melbourne, Australia). Lastly, 
C57BL/6-c-MybE30BG (Booreana) and C57BL/6-l29S-Batj1111 ·1Kmm (Batf-3_1_) mice 
were provided through the courtesy of Peter Papathanasiou (JCSMR, ANU) and Ian 
Cockburn (JCSMR, ANU), respectively. Mice were housed and handled according to 
protocols approved by the Animal Experimentation Ethics Co1nmittee at the ANU, 
and sacrificed by cervical dislocation. 
2.1.2 Isolation and culture of cells 
Cells were cultured in Dulbecco ' s Modified Eagle Medium (DMEM) 
supplen1ented with 22.2mM D-glucose, 13µM folic acid, 27µM L-asparagine, 
5.5mM L-arganine HCL, 10% heat inactivated Fetal Calf Seru1n (FCS) (JRH 
Biosciences: Lenexa, Kansas, USA), l0mM Hepes (JRH Biosciences), 2mM L-
glutamine (JRH Biosciences), 17.1 µM streptomycin (JCSMR), 1 00U penicillin and 
50µM 2-mercaptoethanol (BDH Ltd.: Poole, England) per litre of medium. This is 
referred to as supplemented DMEM (sDMEM). Cells were 1naintained in 5% CO2 in 
air with 97% humidity at 37°C. 
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To prepare a suspension of ly1nphoid cells, dissected spleen or thymus was 
pressed through a fine mesh sieve. Cells were resuspended into 5mL red blood cell 
(RBC) lysis buffer (140mM NH4Cl, 17mM Tris base) for 5 minutes at 20°C. Cells 
were then washed twice in sDMEM by centrifugation (5 minutes, 300g), and counted 
after the final wash. For preparation of bone 1narrow (BM), the fe1nur and tibia of a 
C57BL/6J 1nouse were dissected and the marrow flushed out by injection of sDMEM 
using a syringe and 26G needle. Cells were dissociated, cleared of RBC, washed and 
resuspended as for splenocytes. For T cell activation studies, cells were isolated from 
spleen, and e1u·iched for T cells by depletion of myeloid and B cells. 
For counting, cells were stained with 0.4% Trypan blue/saline (Gibco BRL: 
Grand Island, NY, USA). Unstained cells were counted using a hae1nocytometer to 
detennine the number of live cells/mL for adjustment of cell concentration. 
2.1.3 Fractionation of cells 
2.1.3.1 Depletion of T and B cells from spleen 
Dendritic and 1nyeloid cells were enriched from dissociated whole spleen via 
negative depletion of T and B cells using 1nagnetic bead separation and MACS® 
teclu1ology (Miltenyi Biotec: Auburn, California, USA). T and B cell depletion was 
perfonned by exposing cells to specific antibody: 0.2µg biotinylated anti-Thy l.2 
antibody/108 cells (T cells) and 0.25µg biotinylated anti-CD19 antibody/108 cells (B 
cells) in 1 n1L. Cells were pelleted ( 4°C, 5 minutes,300g) and the supernatant 
aspirated. They were then resuspended at 108 cellshnL of MACS labelling buffer 
(21nM EDTA/0.5% Bovine Serun1 Albumin (BSA) in Phosphate-Buffered Saline 
(PBS)) and incubated on ice for 25 n1inutes. After incubation, cells were washed 
twice with 51nL of MACS labelling buffer, with centrifugation ( 4 °C, 5 1ninutes, 
300g) between each wash. Cells were resuspended in MACS labelling buffer (108 
cells/mL), followed by addition of 20µ1 of anti-biotin 1nicrobeads/ l 08 cells 
(Miltenyi) and incubation for 25 n1inutes on ice. The washing step was repeated 
once, and cells were resuspended in 500µ1 of MACS labelling buffer. T and B cells 
were depleted by running cells through LS colu1nns (Miltenyi) in a SuperMACS II 
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Separation Unit (Miltenyi), washing thrice with 3mL of MACS buffer, and collecting 
unbound cells as flow-through. 
2.1.3.2 Isolation of CDllc + cells from spleen 
CDl lc is a surface marker expressed by 1nany DC subsets. To isolate 
CD 11 c + DC, splenocytes ( 108 cells/mL) were incubated for 25 minutes on ice with 
20µL of anti-CD 11 c magnetic micro beads (Miltenyi)/108 cells and washed once with 
5mL MACS labelling buffer. Cells were resuspended in 500µL MACS labelling 
buffer. Columns were placed in the SuperMacs II magnet and pre-conditioned by 
washing with MACS labelling buffer using 500µL for MS colu1nns and 3mL for LS 
, 
columns, with discard of effluent. For positive selection of CDl lc + cells, the cell 
suspension was loaded on to the column and unlabelled cells collected as the 
effluent. To collect CD 11 c + labelled cells, the column was washed thrice with 
MACS labelling buffer and the effluent discarded. Labelled cells were eluted with 
ln1L MACS labelling buffer for MS columns, and 5mL for LS columns, either 
allowing elution by gravity, or by using a column plunger to apply pressure. Cells 
were then sedi1nented at 3 00g and counted. 
2.1.3.3 Purification of T cells 
For em·ichment of CD4+ and/or CD8+ T cells from OT-I or OT-II mice, 
spleen or mesenteric lymph nodes (MLN) were aseptically removed and processed as 
described in Section 2.2. Cells were pelleted ( 4°C, 5 minutes, 300g), and then 
resuspended in hybridoma culture supernatant (CSN) containing antibody to deplete 
macrophages, B cells and MHCII+ antigen presenting cells (APC). The CSN 
antibody cocktail was prepared by addition of 50µL anti-CD 11 b ( clone: Ml /70), 
anti-B220 (RA3-6B3) and anti-IAb/k (TIB120) per 107 cells. For depletion of CD4+ or 
CD8+ T cells, 50µL of anti-CD4 (GKl.5) or anti-CDS (53-6.7) CSN per 107 cells 
was included in the antibody cocktail. Cells were incubated with antibodies for 25 
minutes on ice and washed twice with MACS labelling buffer. Cells were then 
incubated with sheep anti-rat lg Dynabeads® (Invitrogen Dynal: AS, Oslo, Norway) 
(50uL beads/107cells) at 4°C for 25 minutes with rotation prior to placing cells in a 
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1nagnetic particle separator (Dynal®) for 2 minutes. Supernatant containing unbound 
T cell subsets was transferred into a new tube. 
An alternative 1nethod was used for isolation of CD4+ and/or CD8+ T cells 
fron1 OT-I or OT-II mice. Splenocytes were prepared as described in Section 2.2, 
then enriched for T cells via depletion of B cells as described in Section 2.3 .1. 
Enriched splenocytes were then stained with specific antibodies against Thy 1.2, Va2, 
and CD4 (for OT-I isolation) or CD8 (OT-II isolation), as described in Section 2.4.2. 
The population of interest was isolated by sorting following flow cytometeric 
analysis of fluorochro1ne-labelled antibody binding to cells as described in Section 
2.4.6. 
2.1.4 Flow Cytometry 
2.1.4.1 Antibodies 
Antibodies were purchased as affinity purified, flurochrome or biotin 
conjugates. These are listed in Table 2.1. Isotype control antibodies and secondary 
fluorescent conjugates are shown in Table 2.2. All antibodies were titrated before use 
on splenocytes or BM cells to detennine the concentration giving 1ninin1un1 
saturation binding to cells. 
2.1.4.2 Cell staining procedure 
For single colour analysis, 5xl05 - lxl06 cells were sedi1nented into the wells 
of a 96-well polystyrene n1icrotitre plate (Corning: New York, USA) using 
centrifugation ( 4°C, 10 n1inutes, 300g). Supernatant was discarded by flicking the 
plate, and cells resuspended in anti-CD16/32 (FcBlock: Biolegend, USA) at 5µg/n1L 
with incubation on ice for 15 1ninutes. The plate was centrifuged ( 4°C, 5 n1inutes, 
300g), and supen1atant aspirated. Cells were resuspended in 25 µL /106 cells of diluted 
primary antibody, and incubated on ice for 25 minutes. Cells were washed twice 
using l 50µL/ l 06 cells F ACS (Fluorescence-activated cell sorting) buffer (1 % FSC, 
0.1 % sodiu1n azide in DMEM) with centrifugation (5 minutes, 300g) between each 
wash. If necessary, cells were then resuspended in 25 µL /106 cells of diluted 
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Table 2.1. Primary antibodies used in flow cytometry 
Specificity Conjugation a Clone of Isotype Final Sourceb 
.. Concentration ongm 
(mg/mL) 
7/4 Biotin 7/4 Rat IgG2a 0.1 2 
CD115 PE AFS98 Rag IgG2a,K 0.5 5 
CDI lb Biotin Ml/70 Rat IgG2b,K 0.5 5 
CDI lb FITC Ml/70 Rat IgG2b.K 1.25 5 
CDllb Pe-Cy7 Ml/70 Rat IgG2b,K 0.2 5 
CDI le APC N418 Hamster IgG 0.2 5 
CD16/32 - 93 Rat IgG2a 0.5 5 
(FcBlock) 
, 
CD172a FITC P84 Rat IgG 1 0.5 3 
(SIRPa) 
CD19 Biotin eBiolD3 Rat IgG2a,K 0.5 4 
CD24 PE Ml/69 Rat IgG2b,K 0.5 4 
CD4 FITC GKI .5 Rat IgG2b 0.5 5 
CD40 FITC HM40-3 Hamster 0.5 5 
IgM,K 
-
CD43 Alexa488 IBII Rat IgG2a 1.25 4 
CD43 APC-Cy7 IBII Rat IgG2a 0.5 4 
CD68 Biotin FA-11 Rat IgG2a 0.1 2 
CD69 PE-Cy7 Hl.2F3 Armenian 0.1 5 
Hamster IgG 
CD8a FITC 53-6.7 Rat IgG2aK 1.25 3 
CD8a PE 53-6.7 Rat IgG28_K 0.2 5 
CD8a Alexa 700 53-6.7 Rat IgG2a,K 0.5 4 
cKit (CDI 17) PE 2B8 Rat IgG2a.K 0.2 5 
F4/80 Biotin CI:A3-l Rat IgG2b 1.25 4 
Foxp3 PE MF-14 Mouse IgG 1.K 0.2 4 
IAb MHCII Biotin 25-9-17 Mouse IgG2a,K 0.5 3 
IAb MHCII FITC AF6-120.l Mouse IgG2a,K 0.5 3 
Ly6C FITC AL-21 Rat IgMK 0.25 3 
Ly6C Pacific Blue HKI.4 Rat IgMK 0.5 4 
Ly6G Biotin 1A8 Rat IgG2aK 1.25 4 
Ly6G PE 1A8 Rat IgG2a,K 0.2 
Mac3 PE M3/84 Rat IgG 1,K 0.5 
Mannose FITC MR5D3 Rat igG2a 0.1 
receptor 
MOMA-1 Biotin MOMA-1 Rat IgG2a 0.4 
Siglec F PE E50-2440 Rat IgG2a,K 0.2 
SIGN-Rl Biotin ER-TR9 Rat IgM 0.1 
TCR-Va2 APC B20.l Rat IgG2a 0.2 
Ter119 Biotin TER-119 Rat IgG2b_K 0.5 
Thyl.2 Biotin 30-Hl2 Rat IgG2b,K 0.5 
IAb MHCII Pacific Blue M5/l 14.15.2 Rat IgG2b,K 0.5 
a APC, allophycocyanin ; Alexa488, Alexa Fluor ® 488; Alexa700, Alexa Fluor ® 700; FITC, 
fluorescein isothiocyanate; PE, phycoerythrin; PE-Cy7, phycoerythrin-Cy7 
3 
5 
2 
1 
3 
2 
5 
4 
5 
4 
b 1: Abeam (Cambridge, Massachusetts, USA), 2:AbD Serotec (Oxford, UK), 3: BD Pharmingen , 4: 
Bio legend (San Diego,CA,USA), 5 :eBioscience (Parkville, VIC, Australia) 
Table 2.2. Isotype antibodies and secondary reagents used in flow cytometry 
Specificity Conjugation a Clone of origin Isotype Source b 
Hamster IgG APC eBio299Arm Hamster IgG 5 
Mouse lgG 2a Biotin eBM2a Mouse IgG2a 5 
Rat IgG 1 PE RTK2071 Rat IgG 1 4 
Rat IgG2a PE, FITC R35-95 Rat IgG2a 3 
Rat IgG2b PE-Cy7, FITC eB149/10H5 Rat IgG2b 5 
Rat IgG2b PE RTK4530 Rat IgG2b 4 
Rat IgM Biotin RTK2118 Rat IgM 4 
Secondary Reagent 
Specificity Conjugation a Final Concentration Sourceb 
(ug/mL) 
Streptavidin APC-Cy7 0.2 5 
Streptavidin FITC 25 5 
-
Streptavidin PE 0.5 3 
a APC, allophycocyanin ; APC-Cy7, allophycocyanin-Cy7; FITC, fluorescein isothiocyanate; PE, 
phycoerythrin ; PE-Cy7, phycoerythrin-Cy7 
b 1: Abeam (Cambridge, Massachusetts, USA), 2:AbD Serotec (Oxford , UK), 3: BD Pharmingen, 
4: Biolegend (San Diego,CA,USA), 5:eBioscience (Parkville, VIC, Australia) 
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secondary antibody and incubated for 25 minutes on ice. The washing procedure was 
repeated after staining, and cells resuspended in 50µL FACS buffer before transfer to 
a FACS tube (Corning) for flow cytometric analysis using a LSRII or Fortessa flow 
cytometer (Becton Dickinson: Franklin Lakes, New Jersey, USA). Prior to analysis, 
propidiun1 iodide (PI: 1 µghnL) was added for dead cell discrin1ination. PI was not 
used in single colour staining controls, or when permeablised cells were stained with 
antibody. 
For 1nulticolour analysis, cells were aliquoted and incubated with FcBlock as 
described above. Cells were then resuspended in a mixture of n prin1ary antibodies 
where antibodies were used at n times the concentration used in single colour 
, 
staining. The same staining procedure was used as described for single colour 
staining. Fluorochro1nes were selected to avoid interference in terms of emission 
wavelengths. 
2.1.4.3 Intracellular staining 
Cells were washed with lmL cold PBS and then resupended into 0.25% 
parafon11aldehyde/cold PBS, with incubation on ice for an hour. Cells were then 
sedin1ented ( 4°C, 5 1ninutes, 300g), resuspended into hnL 0.2% Tween20, incubated 
at 3 7 °C for 15 1ninutes, and then pelleted by centrifugation ( 4 °C, 5 minutes, 3 00g). 
Cells were washed with ln1L of cold PBS, and then incubated with 25ul of 1 µg/mL 
PE-conjugated anti-Mac3 antibody on ice for 30 minutes. After incubation, cells 
were washed twice with 1 mL 0 .1 % Tween20 with centrifugation (3 00g, 5 1ninutes) 
between each wash. Cells were then resuspended in 50µ1 of FACS buffer and 
transferred to F ACS tubes for flow cyton1etric analysis. 
2.1.4.4 CFSE labelling of cells 
Cells were stained with 5-(and 6-) carboxyfluorescein diacetate succinimidyl 
ester (CFSE: Molecular Probes: Eugene, Oregon, USA) for quantitation of 
proliferation in ten11s of the dilution of stain with each cell division measured flow 
cytometrically as a decrease in fluorescence. To stain cells, enriched T cell 
suspensions were washed and resuspended in 1mL/10 7 cells CFSE labelling buffer 
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(PBS/0.1 %BSA). CFSE was added at a final concentration of 2.5 µM and vortexed 
immediately upon addition to ensure uniform cell labelling. Cells were incubated at 
3 7°C for 10 1ninutes followed by addition of 5 volumes of cold complete medium 
with incubation on ice for 5 1ninutes to quench labelling. Cells were pelleted ( 4 °c, 5 
1ninutes, 3 00g), and washed twice with complete n1edium. 
2.1.4.5 Marker expression analysis using flow cytometry 
Flow cyto1netry was used to identify cell surface marker expression on cells 
by 1neasuring the binding of fluorescent-labelled antibodies. In each experiment, cell 
labelling involved multiple (1nulticolour) antibodies specific for markers of interest. 
Compensation was perforn1ed on single colour san1ples ( stained with one antibody) 
to avoid the en1ission of one fluorochrome interfering with the detection of another. 
In addition, voltage para1neter and event counts were also set before sa1nple 
acquisition. Background binding was 1nonitored using isotype control antibodies 
con·esponding to each fluorochron1e-conjugated antibody used. Fluorescence Minus 
One Controls (FMOC) were used to set gates for analysis of positively stained cells. 
Live cells were detected by exclusion of propidium iodide (PI, 1 µg/inL ), which 
intercalates in the DNA of dead or dying cells. Analysis was perfon11ed using 
FACSDiva Software (Becton Dickson) and Flow Jo software (Tristar: Phoenix, 
Arizona, USA). Between 5x104 and lx106 cells were analysed for each sample, and 
data was collected for each flw·oclu·on1e used, along with forward scatter (FSC) and 
side scatter (SSC) data. 
2.1.4.6 Cell sorting 
Cell populations ,vere isolated by so1iing following flow cytometric analysis 
of fluorochron1e-labelled antibody binding. Cells were prepared as described in 
Section 2.4.1 and all incubation and washing steps were performed in sodiu1n azide-
free FACS buffer. After a final ,vash prior to so1iing, cells were filtered through a 
70µm nylon cell strainer (Becton Dickinson) into a 5mL polystyrene tube (Becton 
Dickinson) for removal of cell clumps. So1ied populations were collected in 
con1plete 1nediw11 for cell cultw·e and functional assays. 
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2.2 Murine cell function 
2.2.1 Endocytosis 
The capacity of cells to take up antigen was assessed by in vivo measurement 
of endocytosis. Ovalbumin conjugated to FITC (OVA-FITC) was delivered 
intravenously to mice at 1 mg/mouse according to a time course. Mice were 
sacrificed and their spleens harvested at the end of the timed study. Splenocytes were 
RBC lysed and emiched via T and B cell depletion as described in Section 2.2 and 
2.3 .1. After depletion, cells were collected for antibody staining and flow cyton1etric 
analysis. 
2.2.2 Activation of CDS+ T cells 
The cross-presentation capacity of isolated DC and APC subsets was 
n1easured by the ability of antigen-pulsed cells to induce proliferation in purified 
CD8+ T cells isolated from OT-I T cell receptor-transgenic (TCR-Tg) mice specific 
for ovalbumin (OVA2s7-264/H-2Kb). Freshly isolated splenic CDllc+ DC were 
prepared as control APC as described in Section 2.3 .2. DC and APC were plated in 
96 well culture plates in 107/mL of sDMEM, pulsed with l0µg/mL of OVA or HEL 
(Hen Egg Lysozyme) overnight (8-12 hrs), then washed by centrifugation (300g, 5 
n1inutes) twice. Some DC or APC were activated via addition of lipopolysaccharide 
(LPS, 1 0µg/inL) for 8-12 hrs. 
An alten1ative source of DC or APC were subsets isolated from transgenic 
Actm-OV A mice, which constitutively express OVA on the cell membrane via the 
actin promoter. In Actm-OV A mice, APC express OVA antigen in the context of 
MHCI via the cross-presentation pathway after uptake and clearance of dead cells. 
CD8+ T cells were purified from spleens of OT-I mice as described in Section 
2.3.3 , and labeled with CFSE to measure proliferation flow cytometrically as 
described in Section 2.4.4. CFSE-labelled CD8+ T cells were added to DC and APC 
at various ratios (104-105cells/well) in a total volume of 200µL. Cells were collected 
after 4 days, stained with anti-CDS antibody, and proliferation determined flow 
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cytometrically in terms of CFSE dilution and blastogenesis of cells, i.e increase in 
size. 
2.2.3 Activation of CD4+ T cells 
The ability of isolated DC and APC subsets to process and present antigen to 
CD4+ T cells was assessed in terms of the proliferation of CD4+ T cells isolated froin 
OT-II TCR-Tg mice specific for ovalbumin (OVA323_339/l-Ab). DC and APC subsets 
were isolated froin Actm-OV A mice. 
CD4+ T cells were soiied fron1 spleens of OT-II mice as described in Section 
2.4.6, and CFSE labelled for flow cytometric measurement of proliferation as 
described in Section 2.4.4. CFSE-labelled CD4+ T cells were added to OVA-
expressing DC and APC at various ratios ( 104 - 105 cells/well) in a total volume of 
200µL. Cells were collected after 4 days and proliferation determined flow 
cytoinetrically in terms of CFSE dilution and blastogenesis of cells, i.e increase in 
. 
size. 
2.2.4 Effector function of CDS+ T cells 
The ability of APC to induce a cytotoxic T lymphocyte (CTL) response was 
investigated via lysis of target cells. Targeted cell lysis was measured using a 
fluorescent target an·ay (PTA) developed by Ben Quah (JCSMR, ANU). 
On Day 0, CD8+ and CD4+ T cells were isolated froin OT-I and OT-II TCR-
Tg mice respectively, as described in Section 2.3.3. Equal numbers of CD8+ and 
CD4+ T cells were delivered into individual host n1ice (C57BL/6J) via intravenous 
injection (3.5 x 106 cells/mouse). At one hour after delivery of T cells, various APC 
subsets sorted from Actin-OV A mice were also delivered into host mice. Three 
concentrations of APC were used: 90,000, 9000 or 900 cells. The effector function of 
activated CD8+ T cells was n1easured on Day 7 via lysis of peptide-pulsed target 
cells adoptively transferred intravenously on Day 6. Target cells were isolated from 
B6.SJL spleen as described in Section 2.3.1 and labelled with CFSE, Cell Trace 
Violet (CTV) (both from Molecular Probes, Invitrogen) and Cell Proliferation Dye 
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(CPD) (eBioscience). Splenocytes were resuspended at 0.5-2 x 108 cells/mL in 20°C 
sDMEM and labelled with a final concentration of 0, 400, 2250 and 12,500nM of 
each dye. Labelled splenocytes were pulsed with SIINFEKL (SIIN), SIINKL (N6), 
SIIGFEKL (G4) and EIINFEKL (El) respectively, for an hour at 37°C. All peptides 
were synthesised at the Biomolecular Research Facility (JCSMR, ANU). Pulsed 
target cells (2.5 x 10 7) were delivered intravenously into host mice one day prior to 
harvesting host splenocytes for FACS analysis of target cells. Specific killing of 
target cells was determined by the following formula. 
% specific killing = 1-
Targets+~ept~'de primed 
T t 
+nil 
arge $primed 
Targets+p_epti½e 
naive 
T t 
+nil 
arge 8 naive 
X 100 
2.2.5 Immunohistochemistry 
2.2.5.1 Giemsa staining 
Cell staining with Giemsa was employed for morphological delineation of 
cells within so1ied cell populations. Cells (103 - 106 in 200µL) were pelleted on to a 
glass slide using a cytospin centrifuge (900rpm, 5 1ninutes ). Cells were fixed in 
1nethanol for five seconds, then stained in a two-step procedure with CliniPure 
staining solution 1 (0 .25% Eosin YO/Soresen buffer, pH 6.8) followed by CliniPure 
staining solution 2 (0.25% methylene blue polychrone /Soresen buffer, pH 6.8) (HD 
Scientfic; NSW, Australia) for five seconds at each step. Excess staining solution 
was rinsed off under running water, and slides dried before mounting. A non-
aqueous 1nounting agent (Depex, Fluka Analytical: Buchs, Switzerland) was used to 
prevent leaching of dye from stained cells. Photographs were taken with a LEICA 
DFC digital can1era co1u1ected to a LEICA brightfield inverted microscope (LEICA 
Microsystems, Wetzlar, Gern1any). 
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2.3 Gene expression analysis 
Mouse Gene 1.0ST genechips (Affymetrix, Santa Clara, CA, USA) were used 
for transcriptome analysis of gene expression in splenic myeloid and DC subsets. 
The ain1 of the experiment was to determine differentially expressed genes between 
the subsets, to better delineate L-DC, and to better characterise this subset in terms of 
lineage, function and cell surf ace phenotype. 
2.3.1 Preparation of RNA 
Splenic myeloid and DC subsets were isolated and sorted fron1 C57BL/6J 
1nice as described in Sections 2.3 .1 and 2.4.6. Sorted subsets were washed thrice with 
PBS to ren1ove any trace of sorting medium. 
RNA was extracted fron1 sorted cell subsets usmg an RNeasy mini kit 
(Qiagen: Clifton Hill. VIC, Australia). The cell pellet was resuspended in 350µL of 
RL T buffer containing 3.5µL of ~-mercaptoethanol and vortexed for 5 minutes to 
lyse cells. 350µL of 70% ethanol was added to the cell lysate which was transfen·ed 
into the RNeasy column, avoiding any cell debris. The RNeasy column with 
collection tube was centrifuged in a Microfuge 18 centrifuge (Beckman Coulter) for 
15 seconds at 9200g, and the flowthrough discarded. 700µL of RWl buffer was 
added to the column and the colunm centrifuged for 15 seconds at 9200g. The 
flowthrough and collection colu1nn were discarded after the spin. The RN easy 
column was fitted with a new collection tube. 500µL of RPE buffer was added to the 
RN easy column, and centrifuged for 15 seconds at 9200g. The flovrthrough was 
discarded and the column washed with another 5 00 µL of RPE followed by a 2 
nunute spin at 9200g. The flowthrough and collection tube were discarded at the 
fmal spin. The RNeasy colunm was placed in a new collection tube and 30µL of 
RNAse free water added. The column was allowed to stand for 5 minutes before 
centrifugation at 9200g for 1 minute. RNA was collected as flowthrough and stored 
at -20°C. 
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2.3.2 RNA quality and yield 
A preliminary assessment of RNA quality and yield was determined 
spectrophotometrically using an ND-100 spectrophotometer (Nanodrop: 
Wilmington, DE, USA). MilliQ water was used to calibrate the spectrophotometer at 
absorbance of 260nm and 280run. The yield of RNA was determined by reading 
A260nm, such that a reading of 1.0 at A260nm indicates a concentration of 40µg/inL 
of RNA. The quality of RNA was determined by the ratio of A260/ A28o, with value of 
1.8 to 2.1 reflecting high purity. A lower ratio indicates protein contamination, while 
a higher ratio indicates degradation of RNA. 
A 1nore sensitive method of determining RNA quality and yield employed the 
RNA 6000 Pico Chip (Aglient Technologies: Waldbronn, Germany) followed by 
analysis on an Agilent 2100 Bioanalyser. The chip was loaded with a gel and dye 
n1ixture followed by a conditioning solution. An indicator was added to all wells, 
prior to addition of samples and the n1olecular weight ladder. Readout from the 
bioanalyser gives RNA purity, quality and concentration. 
2.3.3 Microarray analysis of gene expression 
RNA was prepared fron1 so1ied myeloid and DC subsets, labelled and 
hybridised on to Mouse Gene 1.0ST genechips (Affymetrix) by Kaiman Peng 
(Biomolecular Resource Facility, JCSMR: ANU, Canberra, Australia) according to 
the Applause WT-Amp ST and WT-Amp Plus ST RNA Amplification Systems 
protocol published online by the NuGEN technologies (San Carlos, CA, USA): 
(http://www.nugeninc.com/nugen/index.cfm/products/apl/applause-ma-
amplification-syste1nsO. Initially, first stand cDNA was generated from the RNA 
sample using a unique first strand DNA/RNA chimeric primer mix and reverse 
transcriptase (RT). The DNA portion of the priiner hybridises either to the 5' end of 
the poly A sequence or randomly across the transcript. RT extends the 3' end of each 
primer generating first strand cDNA. The resulting cDNA/RNA hybrid molecule 
contains a unique RNA sequence at the 5' end of the cDNA strand. Subsequently 
RNA within the cDNA strand was fragmented to allow DNA polymerase to 
synthesise a second strand of DNA that co1nplements the 5' unique sequences from 
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the first strand pnmer. Amplification of cDNA was performed with the SPIA 
amplification kit developed by NuGEN technologies. The cDNA samples were 
fragmented and labelled according to the FL-Ovation™ cDNA Biotin Module V2 
protocol (NuGEN technologies), followed by hybridisation on to the genechip. The 
genechip was washed and stained using the fluidics station (Affymetrix), prior to 
scanning and analysis using a GeneArray® Scanner (Affymetrix). 
2.3.4 Analysis of microarray data 
Scam1ed images of genechips were processed using Partek (St. Louis, 
Missouri, USA). Data files were prepared containing probeset numbers, gene 
descriptions, signal values and p-values in text file format. Data files were 
subsequently exported into Excel (Microsoft: Redmond, WA, USA) for further 
processing. The annotation of probesets was performed using the Gene Ontology 
caterogies of 'Biological Process', 'Cellular Component' and 'Molecular Function', 
available on the Affymetrix website (www.Affymetrix.com). Further Analysis of 
data involved selection of datasets using Excel on the basis of defined analysis 
criteria, for exan1ple, identification of genes specific to subsets, and identification of 
genes cormnon to subsets. In addition, dendrogran1s, bivariate plots, and heatmaps 
were prepared using R project (http://www.r-project.org/). 
Hierarchical clustering analysis en1ployed a set of dissimilarities for 
clustering gene expression a1nongst dendritic and myeloid subsets. Initially, each 
subset was assigned to its own cluster of gene expression and then the algorithm 
proceeded iteratively, at each stage joining the two most similar subsets, and 
continuing until all subsets were clustered on the basis of their gene expression. At 
each stage, distances between subsets were recomputed by the Lance-Williams 
dissi1nilarity update forn1ula (Sibson, 1973). Hierarchical clustering analysis is 
presented as dendrograms, someti1ne on heatmaps. 
Pairwise comparison of total gene expression by subsets was presented as 
bagplots which are a generalisation of the 1 dimensional box plot (Rousseeuw et al. , 
1999). The inner polygon is called the bag and contains approxi1nately 50% of the 
observations. Outliers are defined as points lying outside the polygon formed by 
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inflating the bag by a factor of 3, which is called the fence (not drawn in the 
bagplot). The outer depicted polygon is called the loop and is the convex hull of all 
points which are not outliers. 
2.4 Statistical analysis 
Data have been presented as mean ± standard en·or for sample size n. For 
sa1nple size n < 5, where normal distribution cannot be assumed, the Wilcoxon Rank 
Sun1 test was used to test significant (p < 0.01 or 0.05). Where a non11al distribution 
could be assun1ed, Students ' t-test was used to determine significance (p < 0.01 or 
0.05). 
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Identification of in vivo equivalent of 
longterm culture dendritic-like cells 
i . 
CHAPTER3 
3.1 Introduction 
Dendritic cells (DC) are a rare cell type, making up only ,..., 1 % percent of the 
total spleen cell population. Studies on DC have been very much limited by their low 
cell nu1nber. To counter this problem, many groups have established in vitro culture 
systems that generate DC from bone marrow progenitors under the influence of 
growth factors like Flt3 ligand (Flt3L) and granulocyte/macrophage colony 
stimulating factor (GM-CSP) (Kingston et al., 2009). In contrast, O'Neill et al. 
(2004, 2011) have established a stroma-dependent culture system from spleen that 
produces dendritic-like cells continuously without the addition of growth factors or 
cytokines. This culture system is termed a longterm culture (L TC), and the dendritic-
like cells produced have been called 'LTC-DC' (O'Neill et al., 2004). 
Production of L TC-DC is dependent on the presence of splenic stromal cells. 
The stromal layer within L TC produces all growth factors and cytokines needed to 
induce L TC-DC production from precursors/progenitors continuously for at least a 
year (O'Neill et al., 2004; Wilson and O'Neill, 2003). Isolation of stroma from LTC 
has led to the establishment of the STX3 splenic stromal cell line, comprising a 
mixture of both fibroblastic-like cells and stromal cells with n1ore endothelial-like 
1norphology (Despars and O'Neill, 2006; O'Neill et al. , 2004). The LTC system 
represents a model stromal niche which supports restricted hematopoiesis. It is 
hypothesised that splenic stroma in L TC maintains hematopoietic stem/progenitor 
cells (HSPC) and produces factors that induce differentiation and production of 
LTC-DC. 
Phenotypic and functional characterisation of cells produced in L TC has led 
to the identification of LTC-DC as FSC11iCD1 lb11 iCD1 lc1°CD8-MHCir cells with 
strong ability to endocytose antigen and to cross-pri1ne CD8+ T cells (O'Neill et al., 
2004; Quah et al. , 2004). However, LTC-DC are distinct from other ' described ' DC 
in that they lack ability to activate CD4+ T cells. On the basis of cell phenotype and 
function, LTC-DC rese1nble immature, myeloid DC. Many studies have been 
conducted to establish their relationship with known subsets of DC present in murine 
spleen but they remain a novel, unrelated cell type (O'Neill et al., 2004; Periasan1y et 
al. , 2009; Petvises and O'Neill, 2014; Tan and O'Neill, 2010, 2012). An in vivo 
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equivalent population has been partially defined, and distinguished both 
phenotypically and functionally from known DC subsets (Tan and O'Neill, 2012). 
This chapter describes L TC-DC produced in vitro and demonstrates their 
functional potential. Further investigation of an in vivo counterpart cell has been 
conducted, based on the properties of LTC-DC. This study involves initial analysis 
of ' L-DC ' as a novel subset in spleen in relation to other known splenic dendritic and 
myeloid subsets. 
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3.2 Results 
3.2.1 Phenotypic identification of LTC-DC 
L TC were established from whole dissociated spleens of C57BL/6J mice. 
Cultures were maintained for at least 6 weeks before analysis of cell production. At 
this time, established LTC were characterised by se1ni-adherent small progenitor 
cells, adherent fibroblastic-like cells and other stroma, and large non-adherent 
dendritic-like cells (Figure 3 .1 A). Non-adherent cells were collected from the 
supernatant of L TC and stained with antibodies for flow cytometric analysis of cell 
surface markers. Large L TC-DC were first delineated on the basis of size as a FSC11i 
and sscmid population (Figure 3.1 B). This population was further delineated on the 
basis of CD 11 b and CD 11 c expression as a uniform population of CD 11 b11iCD 11 c10 
cells. Further staining of this gated population revealed cells with a MHCir CD8-
B220- phenotype. In addition, cells produced in L TC were negative for Ly6C and 
Ly6G expression. In summary, LTC-DC reflect a population of 
FSC11 isscmidCD 11 bhiCD 11 c1°CD8-MHCirLy6C-Ly6G-B220- cells with dendritic-
like morphology and phenotype. 
3.2.2 Identification of an in vivo equivalent subset of LTC-DC 
The phenotype of L TC-DC was used in identification of an in vivo 'L-DC ' 
subset. Splenocytes were depleted of T and B cells using 111agnetic bead technology 
and then stained with a cocktail of labelled antibodies as described above. For flow 
cyto1netry, cells were stained with propidiun1 iodide (PI) for initial gating of Pr live 
cells. Cells were then gated on the basis of CD 11 b and CD 11 c expression to 
delineate L-DC candidates, conventional DC ( cDC) and myeloid cells. Conventional 
DC were initially gated as CD 11 b +/-CD 11 c11 i cells, and then fu1iher delineated on the 
basis of CD8 and MHCII expression (Figure 3 .2). In line with the literature, CD8+ 
cDC are CDl 1 b-CDl lc11 iCD8+MHCII+ cells (26.7%), while CD8- cDC are 
CDllb+CDllc11iCD8-MHCII+ cells (61.1%) (Short1nan and Liu, 2002). Myeloid 
cells were gated as CD 11 b11iCD 11 c- cells. In general, the myeloid population 
comprises granulocytes, 111onocytes and activated macrophages (Iwasaki and Akashi, 
2007). All of these cell types except macrophages have been described as MHCir 
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Figure 3.1 Phenotypic characterisation of longterm culture (L TC)-derived cells. 
A splenic L TC syste1n has been established that continuously produces a don1inant cell 
type resen1bling DC. A) The LTC co1nprises adherent fibroblastic-like and other 
stron1al cells, s1nall progenitor cells and L TC-DC. The adherent stron1al cells provide a 
niche that supports the develop1nent of L TC-DC fron1 hen1atopoietic . progenitors in 
spleen. B) Phenotypic characterisation of LTC-DC. Non-adherent cells were collected 
fro1n culture and stained with 2 cocktails of antibodies. The first included antibodies 
specific for CDI lb (Ml/70, PE-Cy7), CDI lc (N418, APC), MHC-II (25-9-17, Biotin), 
CD8 (53-6.7, PE) and B220 (RA3 -6B2, FITC). The second included antibodies specific 
for CDllb (Ml /70, PE-Cy7), CDJ le (N418 , APC), MHC-II (25 -9-17, Biotin), Ly6C 
(Al-21, FITC) and Ly6G (1A8, PE). Prior to analysis, cells were stained with propidium 
iodide (PI, 1 µg/n1l) for gating live (Pr) cells. Large cells were gated by forward scatter 
(FSC) versus side scatter (SSC) analysis. LTC-DC were gated as 
CD 11 b17 iCD 11 c10MHCir cells for further analysis. Independent control stainings of 
splenocytes were used to confirm antibody specificity and activity ( data not shown). 
Gates were set based on isotype controls and nun1bers in gates represent % specific 
binding. 
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Figure 3.2 Identification of the in vivo equivalent subset of LTC-DC. 
Splenocytes were prepared from C57BL/6J 1nice. Red blood cells were lysed and T and 
B cells depleted using magnetic bead technology. Cells were stained with antibodies 
specific for CDllb (Ml /70, PE-Cy7), CDllc (N418, APC), CD8 (53 -6.7, Alexa 700) , 
MHCII (MS/114.15.2, Biotin), Ly6C (Al-21 , FITC) and Ly6G (1A8 , PE). Prior to flow 
cyto1netric analysis, cells were stained with propidium iodide (PI , 1 µghnl) for gating 
live (Pr) cells. Cells were gated based on the known phenotype of LTC-DC, as a 
CDl 1 b11 iCDl lc10MHCirCD8- subset and labelled 'L-DC ' . Myeloid cells were gated as 
CDl 1 b17 iCDl lc-MHCirCD8- cells. Both L-DC and 111yeloid cells were further 
delineated by Ly6C and Ly6G expression. Conventional DC were gated as CD 11 b +/-
CD 11 c17 iLy6C-Ly6G- cells, and further delineated on the basis CD8 and MHCII 
expression to give CD8+ cDC and CD8- cDC. Gates were set based on fluorescence 
1ninus one controls and nu1nbers in gates represent % specific binding. 
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cells, and 95.7% of cells were gated as CD8-MHCir to eliminate DC, activated 
macrophages and B cells from the L-DC gating (Figure 3.2). Ly6C and Ly6G 
staining revealed 3 major subsets amongst myeloid cells. These have been described 
in the literature as Ly6ChiLy6G- infla1nmatory monocytes, Ly6C10Ly6G- resident 
n1onocytes and Ly6C+Ly6G+ granulocytes present in blood (Auffray et al. , 2009; 
Fle1ning et al. , 1993; Galli et al. , 2011 ). 
L TC-DC are CD 11 b11iCD 11 c10 cells. In order to delineate an in vzvo 
equivalent population of L-DC, 1nyeloid and cDC subsets were used as biological 
controls. Fluorescence minus one controls were used to delineate background 
staining. Initially, L-DC were gated as CD 11 b11iCD 11 c10 cells, and a large proportion 
(50.9%) of cells within this gate were found to be CD8-MHCir (Figure 3.2). This 
population of 'L-DC' candidate was found to be heterogeneous with respect to Ly6C 
and Ly6G staining, with the Ly6C-Ly6G- subset being the largest sub-population 
(58.4%) (Figure 3.2). 
Further analysis of 1narker expression on gated cell populations was 
conducted, for co1nparison with L TC-DC. L-DC candidates display a similar 
phenotype to L TC-DC (Table 3 .1 ). In contrast with L TC-DC, L-DC candidates 
express CD24 and Mac3. Conventional DC are distinguished fron1 L-DC and L TC-
DC by expression of CD40 and MHCII (Table 3.1). In addition, both LTC-DC and 
L-DC subsets express F4/80. Both CD8+ cDC and CD8- cDC show similar 
phenotypic profiles, except that CD g- cDC express the n1yeloid 1narkers CD 11 b and 
F4/80 (Table 3.1). The gated CDl 1 b11iCD1 lc-MHCirCD8- myeloid cells express a 
range of n1yeloid markers including CDl 1 b, CD24, F4/80, Ly6C, Ly6G and Mac3 
(Table 3.1 ), consistent with the heterogeneous nature of the 'L-DC candidate ' 
population. 
3.2.3 Functional ability of LTC-DC 
One clear property of LTC-DC is their ability to cross-pri1ne CD8+ T cells 
(Quah et al. , 2004). In this respect, LTC-DC rese1nble cDC and particularly CD8+ 
cDC (Joffre et al. , 2012). To den1onstrate their ability to cross-present antigen, LTC-
DC were collected from L TC and stained as described in Figure 3 .1 for F ACS 
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Table 3.1 Comparison of marker expression on LTC-DC and ex vivo isolated splenic dendritic and myeloid subsets. 
Marker LTC-DC L-DC CD8+cDC CD8-cDC Myeloid cells 
CDllb +++ +++ - + +++ 
CDllc + + +++ +++ -
CD8 - - + - -
CD24 - ++ + + ++ 
CD40 - - + + -
F4/80 ++ ++ +/- ++ +++ 
Ly6C - +/- - - +/-
Ly6G - - - - +/-
Mac3 - + - - ++ 
' 
MHCII I ++ ++ - - -
NKI.1 - - - - +/-
Expression of n1arkers was determined by antibody staining and flow cyto1netry. 
+++, 75-100% cell staining;++, 50-75% cell staining;+, 25-50% cell staining;+/-, 5-25% cell staining; -, < 5% cell staining. 
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sorting. Isolated LTC-DC were then pulsed with ovalbumin (OVA) as specific 
antigen or with the control antigen, hen egg lysozyme (HEL ), in the presence or 
absence of lipopolysaccharide (LPS) added as an activator. Antigen-plused LTC-DC 
were co-cultured with labelled CDS+ T cells. Freshly isolated splenic CD 11 c + cells 
were used as control antigen presenting cells (APC) in the assay. Diluting numbers 
of antigen-pulsed LTC-DC or control CDl lc+ splenic DC, were co-cultured with 
CFSE-labelled OT-I (TCR-tg; anti-OVA/Kb) CDS+ T cells, or OT-II (TCR-tg; anti-
OV A/IAb) CD4+ T cells. After 4 days, T cells were collected, stained for CD4 or 
CDS as well as TCR-V a2, and assessed for reduction in CFSE staining as cells 
proliferated. 
LTC-DC demonstrated strong ability to cross-pnme CD8+ T cells in 
comparison with CDl lc+ cells, in both the presence and absence of LPS (Figure 3.3). 
In contrast, L TC-DC showed no ability to present antigen to CD4 + T cells, while 
splenic CD 11 c + DC were strong activators (Figure 3 .3 ). In all cases of T cell 
activation, responses were antigen specific for OVA, and were significantly greater 
in the presence ofLPS (p < 0.05, Student's t-test). 
3.2.4 Identification of L-DC on the basis of function 
The cross-prin1ing ability of LTC-DC was used as a further criterion for 
delineation of the in vivo equivalent L-DC subset. Both the CD 11 b11iCD 11 c1°CD8-
MHCir candidate L-DC and the CD 11b-ll°CD11 c11 iCD8+1-MHCII+ cDC populations 
were so1ied as described in Figure 3 .2. Freshly isolated CD 11 c + spleen DC were 
prepared as a positive control. Cells were then pulsed with specific antigen OVA, or 
control antigen HEL, in the presence and absence of LPS (Figure 3.4). The cDC 
populations served as controls for cross-priming OT-I (TCR-tg) CD8+ T cells. In 
line with previous findings, both CD8+ cDC and CD8- cDC were able to cross-prime 
CD8+ T cells (Guennonprez et al. , 2002). CDl 1 b11 iCD1 lc1°CD8-MHCir L-DC 
showed weaker ability to cross-prime, although responses were antigen-specific, and 
stronger in the presence of LPS (Figure 3.4). The low representation of cells in 
spleen li1nited the number of DC available for experimentation, but this initial test 
confi1med the presence of cross-presenting DC within the L-DC candidate subset. 
43 
Figure 3.3 Antigen presenting ability of LTC-DC. 
Non-adherent cells were collected fron1 LTC and stained with antibodies specific for CDllb (Ml /70, PE-Cy7), CDllc (N418, APC), MHC:-II (25-9-
17, Biotin) and CD8 (53-6.7,PE). LTC-DC were sorted as a CDl 1 b11 iCD1 lc10MHCirCD8- subset. CDl lc + cells freshly isolated fron1 spleen using 
MACS 1nagnetic bead teclmology were prepared as a positive control population. Diluting nu1nbers of APC in triplicate were plated and pulsed with 
antigen (OVA, or HEL as a control) (1 0µghnl) overnight, with or without lipopolysaccharide (LPS) (1 0~tghnl). After pulsing, cells were washed in situ 
prior to addition of 105 CFSE-labelled OT-I (TCR-tg) CD8+ T cells or OT-II (TCR-tg) CD4+ T cells. These were purified fro1n mouse spleen by 
depletion of B cells, DC and n1yeloid cells using Dynabead and MACS 1nagnetic bead protocols. Cells were co-cultured at T:APC ratios of 2: 1, 10: 1 
and 100: 1. After 4 days, T cells were collected and stained with antibodies and propidium iodide (PI, 1 ug/ml) for gating live (Pr) cells. Pr CD 11 b-
Thy 1.2+v a2+ cells vvere gated and proliferation assessed in terms of CFSE dilution. The percentage of proliferated T cells was estimated · as a n1easure 
of APC capacity. Data are shown as the mean ± S.E of 3 replicates. This experi1nent was perforn1ed by Pravin Periasa1ny (Periasa1ny and O'Neill, 
2013). 
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Figure 3.4 Cross-priming ability of cDC versus L-DC. 
Splenocytes were prepared and depleted of T and B cells as described in the legend to Figure 3 .2. Cells were then stained with antibodies specific for 
CDI 1 b (Ml /70, PE-Cy7), CDl le (N418, APC), MHC-II (25-9-17, Biotin) and CD8 (53-6.7, PE), along with propidium iodide (PI, lµg/n1l) to 
delineate live (Pr) cells. CD8+ cDC were sorted as CDl 1 b-CDl lc11 iCD8+MHCII+ cells, while CD8- cDC were sorted as CDl 1 b +CDl lc
11 iCD8-MHCII+ 
cells. L-DC were sorted on the basis of L TC-DC phenotype, as CD 11 b
11 iCD 11 c10MHCirCD8- cells. Freshly isolated CD 11 c + cells were prepared fro1n 
spleen using MACS n1agnetic bead technology for use as control APC. Diluting concentrations of APC were plated and pulsed with antigen (OVA, or 
HEL as control) (1 0µg/n1l) overnight, with or without lipopolysaccharide (LPS) (1 0µg/n1l). After pulsing, cells were washed in situ prior to addition of 
8xl 04 CF SE-labelled OT-I (TCR-tg) CD8+ T cells. OT-I cells were purified fron1 spleen as described in Figure 3 .3. Where possible, cells were co-
cultured in T:APC ratios of 4: 1 and 10: 1. After 4 days, CD8+ T cells were gated as Pr CD 11 b-Thy l.2+V a2+ cells. The nu1nber of proliferated T cells 
was assessed in tern1s of CFSE dilution, and graphed in relation to activating APC. 
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3.2.5 Gene profiling to further investigate the L-DC subset 
Transcripto1ne analysis was undertaken to question the relationship between 
the candidate L-DC subset, the cDC subsets and the 1nyeloid subsets of inflammatory 
1nonocytes and granulocytes. In this initial investigation, the broad subset of 
CDl 1 b11iCD1 lc10MHCir cells, which reputedly contains 'L-DC' , was sorted from 
spleen for transcriptional analysis and co1nparison with the 1nore clearly defined 
subsets of cog+ cDC (CD 11 b-CD 11 c11iMHCII+cog+), cog- cDC 
(CD1 lb1°CD1 lc11iMHCII+CDg-), inflammatory n1onocytes (SSC1°CD1 lb+CDl lc-
MHCirGr-1-) and neutrophils (SSCmidCD 11 b +CD 11 c-MHCirGr-1 +) as delineated in 
Table 3.2 and Figure 3.5. High purity RNA was extracted fron1 sorted L-DC, 
granulocytes, inflanu11atory 1nonocytes and cDC subsets, using the RN easy minikit 
as described in Section 2. 7 .1. RNA of high purity and low degradation was converted 
to cDNA and then biotin-labelled and hybridised to Murine Gene STl .0 genechips 
(Affymetrix: Santa Clara, CA, USA). Due to low cell nu1nbers achieved through 
sorting, only single genechips were analysed in this initial study ain1ed at assessing 
the association between the novel L-DC subset and the myeJ.9id and DC lineages. 
Scanned in1ages were analysed using Partek (St. Louis, Missouri, USA) to give 
signal values and p values. Data analysis involved selection of genes up- or down-
regulated by > 3 fold in pairwise co1nparisons of subsets. Data 1nining was also used 
to assess the expression of genes linked to known functions in development, or 
associated with distinct lineages. 
Differences in overall gene expression between the subsets were revealed by 
Principal Co1nponent Analysis (PCA). This showed close grouping between 
monocytes, cog+ cDC and cog- cDC in the first principal component, but 
separation of all but cog+ cDC and cog- cDC in the second principal component 
(Figure 3.6). This confirmed sin1ilarity between the cog+ cDC and cog- cDC 
subsets, and identified the distinctiveness of the granulocyte, inflarmnatory monocyte 
and L-DC subsets, both fron1 each other and fron1 cDC. 
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Figure 3.5 Cell sorting strategy for subset isolation for gene profiling. 
Splenocytes were harvested fron1 C57BL/6J n1ice and red blood cells lysed prior to T 
and B cell depletion. Cells were stained with antibodies specific for CD 11 b (Ml/70, 
PE-Cy7), CDl lc (N41S, APC), CDS (53 -6.7, PE), MHCII (MS/114.15.2, FITC) and 
Gr-1 (RB6-SC5 , Biotin). Prior to analysis, cells were stained with propidium iodide (PI, 
1 µghnl) for gating live (Pr) cells. (A) cDC were gated as CD 11 c11 iMHCII+ cells and 
fu1iher delineated on the basis of CDS and CD 11 b expression. CDS+ cDC were gated as 
CD 11 b-CDS+ cells, while CDS- cDC were gated as CD 11 b +CDS- cells. (B) The 
CD 11 b +CD 11 c10MHCir subset was identified and sorted as 'L-DC'. Myeloid cells were 
gated as CD 11 b +CD 11 c-MHCir cells and further delineated by Gr-1 expression and 
side scatter (SSC). Monocytes (Mono) were gated as SSC 11 iGr-1 - cells, while 
infla1nmatory 111onocytes (Infl 1110110) were gated as S SC10Gr- i- cells. Lastly, 
granulocytes (Granu) were gated as SSCmidGr-1 + cells. Gates were set based on isotype 
controls and numbers in gates represent % specific binding. 
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Table 3.2 Phenotype of subsets isolated. 
Subset isolated 
CD8+ cDC 
CD8- cDC 
L-DC 
N eutrophils 
Inflailllnatory 
1nonocytes 
Phenotype 
CDl 1 b-CD1 lc 11 iMHCII+CD8+ 
CD 11 b1°CD 11 c11 iMHCII+CD8-
FSC 11iCD11 b +CD1 lc10MHCir 
FSC10SSC111 idCDl 1 b +CDl lc-MHCirGr-1 + 
FSC10SSC1°CD11 b +CDl lc-MHCirGr-1-
Figure 3.6 Variability in gene expression amongst dendritic and myeloid subsets. 
Transcriptome analysis was perfonned on sorted murine dendritic and myeloid subsets from spleen as described in Figure 3.5. RNA was extracted and 
labelled for hybridisation to Mtu-ine Gene STl .0 genechips (Affymetrix). Following data collection, Principal Component Analysis (PCA) was used to 
detennine variability in gene expression between the subsets. Two principal con1ponents are shown in the diagran1. 
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3.2.6 Investigation of gene expression 
Initially, subsets were investigated by data mining, comparing the expression 
of known genes in the functional categories of 'DC and APC' , 'Chemokines ', 'Cell 
surface 1narkers' and 'Infla1mnatory cytokines' . Signal values were collected for sets 
of 84 genes utilised by SABiosciences (Frederick, MD, USA) in their PCR arrays. 
Data are shown as heatmaps, comparing expression in the five subsets under study 
for only those genes deemed to be expressed by at least one subset (Figure 3. 7). 
Across all data mining analyses, similarity in gene expression was seen for the CD8+ 
cDC and CD8- cDC subsets as shown by dendrogran1s (Figure 3.7 A-D), consistent 
with PCA analysis which closely grouped the two cDC subsets (Figure 3.6). Notably 
these two subsets were reflective of the DC lineage by their common high expression 
of genes encoding cell surface 1narkers including Cd74, Cd83 , Cd86, Cd40, Klrdl , 
Pecaml , St6gall and Vcan1l (Figure 3.7 A) (Edwards et al., 2003; Lechn1ann et al. , 
2002; Prazma et al., 2007). CD8+ cDC showed high gene expression of Cd22 and 
Cd72 which are also known n1arkers of CD8+ cDC (Edwards et al. , 2003 ; Santos et 
al. , 2008). 
In terms of gene expression related to DC/ APC, both cDC subsets showed 
high specific expression of Cd] di , Cd86, Cd209a, Flt3 , Ican1l and Relb, genes 
which encode known markers of the cDC lineage (Figure 3.7 B) (Can1inschi et al. , 
2001; Edwards et al. , 2003; Naik et al., 2006; Vren1ec et al. , 2000). As previously 
described, CD8+ cDC specifically expressed Cd8a, Cd36, Cle4b2 and Il-12b (Miller 
et al. , 2012), while CD8- cDC showed specific expression of Ter 1 and Cd4 (Miller et 
al. , 2012). In tenns of chemokine-related gene expression, both cDC subsets 
expressed Ccr7 and Cxcll 6 encoding che1nokine and chemokine receptors known to 
be expressed by cDC (Jang et al. , 2006; Riol-Blanco et al. , 2005 ; Sanchez-Sanchez et 
al. , 2006; Van Der V 001i et al. , 2010). CD8+ cDC were uniquely identified by 
expression of Xcr 1 as reported previously (Bachem et al. , 201 0; Kroczek and Henn, 
2012; Ya1nazaki et al. , 2013), as well as expression of Cxcl9, Ccr9, and Ccl22 for 
chen1okines (Rosenblum et al. , 2010). These data and their concordance with 
descriptions of cDC gene expression in the literature, confirm the efficiency of our 
sorting and gene profiling protocols. In tern1s of expression of genes for 
inflammatory cytokines, it was notable that the cDC subsets were more closely 
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Figure 3. 7 Gene expression relative to functional capacity 
Cell subsets were sorted as described in Figure 3 .5 and RNA used to probe Murine 
Gene l .0ST genechips (Affyn1etrix). Data 1nining was used to extract signal values for 
sets of genes in functional groupings as used by SAS Bioscience in their PCR arrays. 
Heat n1aps were drawn using R/Bioconductor Software, and show those genes which 
have signal values > 100 for any one subset. Genes were ordered by level of expression 
in CD8+ cDC. The line cha1i (blue) overlaid on heat maps indicates signal intensity 
changes about the n1ean · ( dashed line). Genes were clustered by their level of 
expression, as shown by row dendrogran1s. In addition, dendritic and 1nyeloid cell 
subsets were clustered by gene expression as shown by colunm dendrogran1s. Granu: 
granulocytes; Infl 1nono: inflan1111atory 111onocytes. A) Cell surface markers; B) 
Dendritic and antigen presenting cells, C) Che1nokines and D) Inflanunatory cytokines. 
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related, in terms of clustering, with the inflarmnatory monocyte subset than with 
either L-DC or granulocytes. This could be a reflection of the activation status of 
cells rather than their lineage origin. 
The two subsets of granulocytes and 'L-DC candidates ' showed high 
similarity in gene expression across groups of functionally related genes, with 
inflanunatory n1onocytes as the next related subset. This relationship is shown by 
dendrogra1ns in Figure 3.7 A-C. Inflan1matory monocytes could be identified by 
specific expression of genes like Fcgr 1, C,nKlr 1, Lrpl , and Ccr2 , as reported 
previously by others (Gordon and Taylor, 2005; Grage-Griebenow et al. , 2001 ; 
Maniecki et al. , 2006; Staudt et al. , 2013). The L-DC subset showed consistent gene 
expression in cormnon with granulocytes, suggesting possible overlap or cross 
conta1nination between these subsets. In relation to subset contamination, L-DC did 
show specific high expression of Ccr 3, and low but specific expression of IL-5ra, 
both of which encode n1olecules specific to eosinophils (Humbles et al. , 2002; 
Takatsu and Nakajima, 2008). Contamination with these cells is therefore also a 
possibility. 
Genes co1runonly expressed at high levels across the three 1nyeloid subsets 
included IL-6ra , Ccl6, Tlr2 , ltga,n , ltgb2, Cxcr4, C1ntn16, Csfi'" 1, Cd44, Cd33 and 
SJ 00a8 (Figure 3.7 A-D). Myeloid cells expressing IL-6R can respond to IL-6 
production associated with inflanunatory responses in multiple diseases, and along 
with TGF-~, induce differentiation of Thl 7 cells (Grohmam1 et al. , 2001 ; Kopf et al. , 
1994; Zhou et al. , 2007). ITGAM, also known as CD 11 b, is a subunit of the 
heterodin1eric integrin MAC-1 , expressed by myeloid cells. CD 11 b mediates the 
infla1runatory response by regulating myeloid cell adhesion and 1nigration to sites of 
infection (Alnaout et al. , 1983; Solovjov et al. , 2005). CD 11 b has also been found to 
pa1iicipate in the phagocytosis of apoptotic cells (Chen et al. , 2008). The migration 
of cells involving ITGAM requires ITGB2, a co-factor also co1ru11only expressed by 
these subsets (Solovjov et al. , 2005). Like CD 11 b, CD44 also plays a role in cell-cell 
interaction, cell adhesion and migration (Goodison et al. , 1999; Marhaba and Zoller, 
2004). Similarly, CSFlR and CD33 have been described as n1yeloid lineage markers 
(Gordon and Taylor, 2005 ; He1nandez-Caselles et al. , 2006). All three subsets 
expressed high levels of S 100a8, a molecule which regulates 1nyeloid cell 1naturation 
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and function, and particularly macrophage activation (Donato, 1999; Lagasse and 
Clerc, 1988; Vogl et al., 2012; Zwadlo et al., 1988). Indeed, all data support the 
myeloid lineage relationship of L-DC, with a functional relationship rather than a 
lineage relationship with the cDC subsets. 
The L-DC candidate shows a gene profile n1ore in com1non with 
inflan1matory monocytes and granulocytes than with cDC. Further analysis was 
therefore ain1ed at identifying genes specifically upregulated in L-DC and not other 
subsets, with a view to identification of specific markers and functions which could 
be used to better delineate the L-DC subset for further characterisation of its 
developn1ent and function as an APC subset in spleen. 
3.2. 7 Identification of genes specifically expressed in the L-DC candidate 
subset 
Datasets were extracted containing genes upregulated at least 3 fold in 
pairwise comparisons of all subsets. The number of genes in ~ach dataset is shown 
by a Venn diagram which indicates similarity between subsets (Figure 3.8). Amongst 
the DC subset comparison, lowest variability was found between the CD8+ cDC and 
CD8- cDC subsets. Much greater variability was seen between L-DC and each of the 
cDC subsets. A total of 44 genes were identified which were differentially expressed 
> 3 fold across all 3 subsets (Figure 3.8 A). Amongst the myeloid subset 
co1nparisons, inflanu11atory n1onocytes and granulocytes were the 1nost distinct, 
while L-DC and granulocytes were closely related (Figure 3.8 B). Only 10 genes 
were found to be co1m11only up- or down- regulated > 3 fold in all 3 myeloid subsets. 
These outcon1es are also consistent with a close subset relationship as shown by data 
1nining in Figure 3.7. 
Genes which were upregulated in one but not two other subsets were then 
identified. In the comparison of L-DC with the two cDC subsets, upregulated genes 
could be identified for all three subsets (Table 3.3). CD8+ cDC subset were 
identifiable by specific upregulation of the Cd8a, Clec9a, and Cd3 6 genes reported 
previously (Belz et al. , 2002; Caminschi et al. , 2008) (Table 3.3). Expression of 
CLEC9a is restricted to CD8+ cDC and pDC, and has been found to play a role in the 
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Figure 3.8 Numbers of differentially expressed genes. 
Diagrams show dataset size for genes upregulated > 3 fold in one of two subsets assessed in pairwise con1parison. Granu: Granulocytes; Infl mono: 
Inflammatory monocytes. 
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Table 3.3 Genes upregulated in only one of three DC subsets. 
Subset 
CD8+ cDC 
CD8- cDC 
L-DC 
Genes upregulated + 
Cd8a, Xcr 1, Clec9a, Cd36, Tlr 11 , Tlr3 , Serpinb9, Fndc 7, Serpinb6b , Plekha5, D330017320, 
Apol7c 
Dscam, 9530009G21 , Ptpn3 , Ube2e2 , Stk32c, Cd4, Centdl , Spns3 , H-2Eb2 , Sashl , 1300002K09, 
Ctnnd2, IL2 l r 
Igsj2, Itgam, Sirp/J, Siglec e, Mmp9, 4732429D16, Slc2a3 , Pygl, Rtp4, Praml , 1810033Bl 7, 
ljitml , Cass4, Emb, Bstl 
+ Genes were identified which showed > 3 fold upregulation in signal value in one subset but not the other two, assessed in . . . pauw1se con1panson. 
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uptake of apoptotic cells via binding to the exposed actin filament of damaged cells 
(Caminschi et al., 2008; Zhang et al. , 2012). Similarly, CD36 expression has been 
associated with CD8+ cDC, and participates in the uptake of apoptotic cells (Albert et 
al. , 1998; Belz et al. , 2002; Urban et al. , 2001 ). CD8+ cDC were also shown to 
specifically express Xcr 1, and XCRl binds to XCLl secreted by T cells. XCRl aids 
the migration of DC to T cell areas within the spleen (Kroczek and Henn, 2012), 
which is thought to pron1ote cross-pri1ning of CD8+ T cells and the development of a 
cytotoxic T cell response (Dorner et al. , 2009). Both Serpinb9 and Serpinb6b were 
also expressed uniquely by CD8+ cDC. These genes encode 1nolecules belonging to 
the serine protease inhibitor fa1nily which participates in many cellular processes 
including apoptosis and co1nplement fixation. A recent study showed that DC 
express both SERPINB9 and SERPINB6b, which confer protection against cell death 
from newly activated cytotoxic T lymphocytes (Bots et al. , 2007). Tlr 3 and Tlr 11 
gene expression was upregulated in CD8+ cDC (Table 3.3). TLR3 recognises double-
stranded RNA, while TLRl 1 recognises bacteria flagellin (Bauer and Ha1imam1, 
2004 ), consistent with the ability of CD8+ cDC to act as APC for viruses and bacteria 
for induction of cytotoxic T ly1nphocyte responses (Bauer qi:_id Hartmann, 2004 ). 
Several other genes upregulated in CD8+ cDC included Fndc 7, Plekha5 and Apol7c 
which have not previously been associated with this subset. 
Known genes upregulated by CD8- cDC included Dsca,n, Cd4 and H-2Eb2, 
confin11ing the identify and purity of the so1ied population (Miller et al. , 2012). In 
addition, Il-2lr gene expression was upregulated in CDS- cDC. IL-21 has been 
reported to induce apoptosis amongst cDC via ST AT3 and BIM signalling (Wan et 
al. , 2013). Indeed, signalling through the IL-21 receptor could provide a mechanism 
for regulating cDC nu1nbers. CD8- cDC also showed high expression of Sash] which 
encodes a signal adaptor protein that participates in cell adhesion and TLR4 
signalling (Dauphinee et al. , 2013 ; Martini et al. , 2011). While several other known 
genes were found to be uniquely expressed by CD8- cDC, none has previously been 
reported as involved in CD8- cDC function. 
Fifteen genes were shown to be specifically upregulated in L-DC over the 
cDC subsets. These included Igsj2 encoding a known marker of human den11al DC 
which regulates T cell activity (Bagot et al. , 1997; Bouloc et al. , 2000a). L-DC also 
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expressed Sirp/J which is also expressed by cog- cDC, albeit in lower level, but not 
by CD8+ cDC (Lahoud et al., 2006). Similarly, L-DC specifically expressed ltgam 
which encodes a known marker of cog- cDC and myeloid cells (Amaout et al. , 
1983; Solovjov et al. , 2005). Higher levels of Siglec e gene expression were also 
observed for L-DC in comparison with the cDC subsets. The SIGLEC E n1olecule on 
DC has been found to play an inhibitory role in the activation of CD4+ and CD8+ T 
cells. Antigen taken up via SIGLEC E is rapidly internalised within DC and 
transported to early endosomes and lysosomes. Presentation of antigen to T cells is 
di1ninished (Bax et al. , 201 O; Boyd et al. , 2009; Zhang et al. , 2004 ), leading to 
lin1ited CD4+ and CD8+ T cell proliferation (Bax et al., 201 O; Boyd et al. , 2009; 
Zhang et al. , 2004). L-DC also expressed high levels of Jfitml , known to be 
expressed by DC by 24 hours after their activation (Jin et al., 2010; Yang et al. , 
2007). IFITMl displays anti-proliferative activity towards interferon-y, so regulating 
the nun1ber of T cells (Yang et al., 2007). Lastly, Pra1nl which encodes an adaptor 
protein involved in T cell receptor-n1ediated signalling, was also upregulated in L-
DC compared with the cDC subsets (Clen1ens et al., 2004; Moog-Lutz et al. , 2001). 
None of the other L-DC expressed genes listed in Table 3.3. _has previously been 
reported as expressed by DC or APC. Overall, genes upregulated in L-DC reflect 
functions related to DC, as well as a role for L-DC in the regulation of T effector cell 
functions. 
Further analysis was ai1ned at identifying genes upregulated in either of L-
DC, inflanm1atory n1onocytes or granulocytes. However, only inflan1matory 
1nonocytes showed upregulated genes (Table 3 .4 ). Such a result can be interpreted if 
granulocytes are a subset of sorted L-DC, and L-DC also contain a subset of 
inflanm1atory n1onocytes. This result confin11s our original premise that the L-DC 
candidate subset is quite heterogeneous, and only pa1iially characterised by the 
phenotype used here to sort this subset. The close relationship between L-DC and 
granulocytes, and then with infla1mnatory n1onocytes, was identified in initial data 
mining experin1ents (Figure 3. 7). 
Genes specifically upregulated in inflammatory monocytes, included F 10 and 
Fl Jal which encode coagulation factors (Muszbek et al. , 1996; Uprichard and Perry, 
2002) (Table 3.4). The F13Al n1olecule is also an alte111ative activation n1arker 
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Table 3.4 Genes upregulated in only one of three myeloid subsets. 
Subset 
Inflammatory 
monocytes 
Granulocytes 
L-DC 
Genes upregulated + 
FJO, EG640268, Fl Jal , Rftnl , Cyp27al, Ehd4, Scpepl, Fyn, Cyp2abl, Zfyve9 
nil 
nil 
+ Genes were identified which showed > 3 fold upregulation in signal value in one subset but not the other two assessed in . . . pauw1se con1panson. 
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expressed by macrophages (Martinez et al. , 2006). Infla1nmatory monocytes showed 
upregulation of Cyp2 7al and Cyp2abl which encode cytochrome P450 oxidase 
(Nelson et al., 2004). CYP27 Al is expressed by macrophages and generates 27-
hydroxycholesterol which inhibits production of inflammatory factors (Quinn et al. , 
2005). Lastly, Fyn and Zfyve which encode signalling molecules were also 
upregulated in inflammatory 1nonocytes. FYN is involved in the integrin signalling 
pathway which activates RAS (Wary et al. , 1998), and participates in a wide range of 
cellular pathways including T and B cell receptor signalling, and cytokine receptor 
signalling (Godfrey et al. , 2000; Osterhout et al. , 1999; Van Oers et al. , 1996). 
Zfyve9 encodes an anchor protein involved in TGF-~ signalling (Lin et al. , 2004). 
Overall, genes specifically upregulated in inflammatory monocytes, reflect the 
n1onocyte/inacrophage lineage. 
Further investigation of the relationship between L-DC and either 
inflanunatory 1nonocytes or granulocytes, involved a search for genes upregulated in 
expression between 2 subsets only (Table 3.5). Granulocytes showed no specific 
gene expression over L-DC, consistent with the interpretation that granulocytes are a 
subset of the L-DC candidate. In contrast, L-DC showed 144 genes upregulated over 
granulocytes. A subset of these is shown in Table 3.5. L-DC showed 265 genes 
upregulated > 3 fold over infla1mnatory monocytes, while inflammatory monocytes 
showed 49 genes upregulated over L-DC. A subset of the most highly upregulated 
genes is shown in Table 3.5. 
Genes upregulated in L-DC over granulocytes reflect n1yeloid cells in terms 
of lineage, but DC in tenns of functions. For exa1nple, Ada,ndecl encodes a myeloid 
DC n1arker which becomes upregulated during CD40- or LPS-induced maturation of 
DC (Fritsche et al. , 2003). Another gene of interest is Cd300e, known to be 
expressed by monocytes and myeloid DC (Brckalo et al. , 201 O; Clark et al. , 2009). 
Upregulation of CD300E in 1nyeloid DC acts as a survival signal (Brckalo et al. , 
2010), and CD300E the increases production of infla1nmatory cytokines and the 
upregulation of costimulatory 1nolecules which regulate T cell activation (Brckalo et 
al. , 2010). Genes associated with cell function and upregulated in L-DC over 
granulocytes included Ace, Plxnb2 and Zfyve9. ACE, also known as CD143 , is 
highly upregulated in 1nonocytes and myeloid DC (Danilov et al. , 2003), and 
so 
Table 3.5 Genes upregulated between L-DC and Inflammatory monocytes or Granulocytes. 
L :,C' 
Subset 
L-DC 
Granulocytes 
' 
.. 
L-DC 
Inflamn1atory 
monocytes 
No. 
144 
0 
265 
49 
Genes upregulated+ 
Ace, LOC100047162, Plxnb2, Cd300e , Zfyve9, Adamdecl , EG434025 
nil 
. ·i .~f. 
: 'i;~;~t':' 
---'-'-'-'"--'-~'-""--"-~'!:'.;.'- >h - "------ir~-'- -~~>-~ _:..ft 
Jgsj2 , Ens, Steap4, Arg2, Ptgs2, Ccrl , 1Llj9, Asprvl , Slc 7al 1, DhrS9 
Ncr 1, NKg7, Gzma, Klra8, Sestdl , Fam] 29b, Vwa5a, Vcan, Pros] 
+ Genes were identified which showed > 3 fold upregulation in sigi;ial value in one subset btlt not the other two assessed in 
' pairwise comparison. Only 10 of the most highly upregulated genes are shown. 
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participates in the presentation of viral antigens to T cells through hydrolysis of 
peptides (Danilov et al. , 2003). PLXNB2 is upregulated in myeloid DC and pDC 
(Holl et al., 2012), and its primary function is in cell migration and axon guidance 
(Holl et al. , 2012). A recent knockout study showed that Plxnb2-1- cells constitutively 
express IL-12/IL-23p40, suggesting that PLXNB2 negatively regulates production of 
IL-12 and IL-23 , factors which induce Thl and Thl 7 responses, respectively (Holl et 
al. , 2012). Lastly, L-DC were shown to express Zfyve9 which encodes an anchor 
protein involved in TGF-~ signalling (Derynck and Zhang, 2003; Shi, 2000; 
Tsukazaki et al. , 1998), and can induce either a pro-inflam1natory or tolerogenic 
response under different conditions (Wakefield and Roberts, 2002). All of these 
genes could be regulators of L-DC function as APC which regulate T cell activation 
and function. 
In the co1nparison of L-DC with infla1nmatory monocytes, genes with known 
DC function including Igsj2 , Ptgs2, DhrS9 and IL-JF9 were found to be upregulated 
by L-DC (Table 3 .3 ). PTGS2 inhibits T cell and DC function via production of 
prostaglandin E2 (Harizi et al. , 2002; Pockaj et al. , 2004; StoliJJa et al. , 2000). This 
supports the activation of DC but suppresses DC ability to attract nai:ve and effector 
T cells (Muthuswan1y et al. , 2010). In addition, prostaglandin E2 also selectively 
suppresses Thl and cytotoxic T lyn1phocyte-1nediated iinmunity, but pro1notes Thl 7 
and regulatory T cell responses (Kalinski, 2012). DhrS9 encodes 3-alpha-
hydroxysteroid dehydrogenase which is involved in the biosynthesis of retinoic acid 
(Chetyrkin et al. , 2001 ; Soref et al. , 2001), which participates in imn1une tolerance 
by enhancing the induction of TGF-~-dependent regulatory T cells, and suppressing 
the development of Thl 7 cells (Xiao et al. , 2008). Lastly, IL-I F9 also known as IL-
3 fry , binds to a receptor on DC and CD4 + T cells and induces the production of 
proinfla1n1natory cytokines (Vigne et al. , 2011) which recruit neutrophils, 
n1onocytes, DC and 1nacrophages to sites of infection and induce their activation 
(Miyaji1na et al. , 1992). Again genes specific to L-DC reflect functions of DC and 
their interaction with T cells in various ways. 
Genes found to be upregulated in inflanunatory 1nonocytes over L-DC 
included Ncr 1, Nkg7, Gzn1a and Klra8, which are also expressed by natural killer 
cells. Gzma encodes granzyn1e A expressed by mature natural killer cells and 
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cytotoxic T lymphocytes (Hameed et al. , 1988; Masson et al. , 1986). The expression 
of these genes supports possible contamination of the inflammatory 1nonocyte subset 
with natural killer cells. However, Pros] expressed by inflammatory monocytes 
reflects a previously reported function of inflammatory monocytes. It encodes an 
extracellular 1natrix proteoglycan, upregulated in inflamn1atory monocytes, which is 
a key factor in inflammation by interaction with chemokines and adhesion molecules 
expressed through inflammatory leukocytes (Hirose et al. , 2001 ; Wight, 2002). It 
also participates in cell migration and proliferation (Wight, 2002). Gene expression 
analysis between the 3 myeloid subsets confirms suspected subset contamination, 
and reaffinns the need to define subsets of the myeloid lineage more fully in order to 
define the L-DC subset in spleen with precision. 
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3.3 Discussion 
On the basis of phenotype and function, a candidate in vivo equivalent subset 
of L TC-DC was identified in spleen. This subset has been named 'L-DC', and 
represents a CD 11 b11iCD 11 c1°CD8-MHCir subset, containing cells with distinct 
ability to cross-prime CD8+ T cells. Gene profiling studies have confirmed that the 
antibody staining and so1iing strategies used here have accurately identified CD8+ 
cDC and CD8- cDC, since their gene profiles reflect cells described in the published 
literature. However, in te1ms of identification of myeloid subsets in spleen, the study 
has been less successful. While sorted granulocytes and inflammatory 1nonocytes 
displayed 1narkers of the known n1yeloid subsets, the so1ied infla1nmatory monocyte 
subset appears to contain some natural killer cells. The sorted L-DC candidate subset 
expresses both myeloid and DC markers suggesting it is a heterogeneous population. 
This subset was also shown to contain granulocytes, as well as a subset of cells 
present in the inflanunatory n1onocyte population. This evidence emphasises how the 
ability to fractionate subsets is very much dependent on knowledge of the cell 
surface phenotype of the different cell types. Despite these li;pitations, this initial 
gene profiling experiment has been used to advantage to investigate the lineage 
relationship and function of L-DC with a view to improving our understanding of 
this novel subset. 
L-DC were identified initially on the basis of phenotypic similarity with 
L TC-DC. Ho~rever, phenotype alone did not confinn that the CD 11 b11iCD 11 c1°CD8-
MHCir population contained an in vivo equivalent of LTC-DC. Functional assays 
however, verified the presence of cells with ability to present exogenous antigen for 
T cell activation. As with L TC-DC, gated L-DC de1nonstrated strong ability to cross-
prune CD8+ T cells in both the presence and absence of LPS. 
In te1ms of gene profiling of subsets isolated from spleen, PCA analysis 
confinned that CD8+ cDC and CD8- cDC were closely related but quite distinct from 
the L-DC candidate subset. Both cDC subsets displayed very similar expression 
profiles across a list of commonly known genes expressed by DC and APC (Figure 
3.7 A-D). Both CDS+ cDC and CDS- cDC showed upregulated gene expression of 
Flt3 , Cd86, Relb and Cd209. CD209 also known as DC-SIGN is a marker which 
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3.3 Discussion 
On the basis of phenotype and function, a candidate in vivo equivalent subset 
of L TC-DC was identified in spleen. This subset has been named 'L-DC' , and 
represents a CD 11 b11iCD 11 c1°CD8-MHCir subset, containing cells with distinct 
ability to cross-prin1e CD8+ T cells. Gene profiling studies have confinned that the 
antibody staining and sorting strategies used here have accurately identified CD8+ 
cDC and CD8- cDC, since their gene profiles reflect cells described in the published 
literature. However, in terms of identification of myeloid subsets in spleen, the study 
has been less successful. While sorted granulocytes and inflammatory monocytes 
displayed markers of the known myeloid subsets, the sorted inflammatory monocyte 
subset appears to contain some natural killer cells. The sorted L-DC candidate subset 
expresses both 1nyeloid and DC markers suggesting it is a heterogeneous population. 
This subset was also shown to contain granulocytes, as well as a subset of cells 
present in the inflam1natory n1onocyte population. This evidence emphasises how the 
ability to fractionate subsets is very much dependent on knowledge of the cell 
surface phenotype of the different cell types. Despite these li1p.itations, this initial 
gene profiling experiment has been used to advantage to investigate the lineage 
relationship and function of L-DC with a view to improving our understanding of 
this novel subset. 
L-DC were identified initially on the basis of phenotypic similarity with 
L TC-DC. However, phenotype alone did not confinn that the CD 11 b11 iCD 11 c1°CD8-
MHCir population contained an in vivo equivalent of LTC-DC. Functional assays 
however, verified the presence of cells with ability to present exogenous antigen for 
T cell activation. As with LTC-DC, gated L-DC demonstrated strong ability to cross-
priine CD8+ T cells in both the presence and absence of LPS. 
In terms of gene profiling of subsets isolated fro1n spleen, PCA analysis 
confirmed that CD8+ cDC and CD8- cDC were closely related but quite distinct from 
the L-DC candidate subset. Both cDC subsets displayed very si1nilar expression 
profiles across a list of co1mnonly known genes expressed by DC and APC (Figure 
3.7 A-D). Both CD8+ cDC and CD8- cDC showed upregulated gene expression of 
Flt3 , Cd86, Relb and Cd209. CD209 also known as DC-SIGN is a 1narker which 
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identifies DC which are monocyte-derived (Cheong et al., 2010) and is expressed by 
some human macrophages (Rappocciolo et al., 2006). Relb encodes a transcription 
factor expressed by human DC and monocytes (Platzer et al., 2004) which regulates 
DC activation via NF-kB signalling (Shih et al., 2012). Flt3 encodes a receptor for 
FL T3 ligand, an essential growth factor for DC development from common dendritic 
progenitors and pre-cDC (Karsunky et al., 2003; Kingston et al. , 2009). Cd86 
encodes a 1narker which is upregulated upon DC activation, and both CD86 and 
CD80 work as co-receptors on DC for activation of T cells (Caux et al. , 1994). These 
data highlight how the so1ied cDC subsets studied here express genes and have 
properties consistent with the reported literature. 
The L-DC gene profile was co1npared with that of CD8+ cDC and CD8- cDC 
in order to assess any lineage or functional relationship with DC and to identify 
genes specifically upregulated in L-DC. Sirp/J and Itgan1, previously described as 
expressed by cog- cDC and myeloid cells, were also found to be upregulated in L-
DC. In addition, Igsj2 expressed by human dermal DC and Langerhans cells 
(Bouloc et al. , 2000b; Grassi et al., 1998) showed upregulated -~xpression in L-DC. 
L-DC also showed upregulation of genes related to T cell inhibitory roles. Both 
Siglec e arid Igsj2 have been reported to play a role in T cell inhibition. SIGLEC E 
restricts the presentation of antigen by DC to CD4+ and CD8+ T cells (Bax et al. , 
201 0; Boyd et al. , 2009; Zhang et al. , 2004 ), while IGSF2 inhibits T cell proliferation 
via IL-10 production (Bouloc et al. , 2000a). Expression of these genes could reflect 
regulatory functions of L-DC for T cells. L-DC showed expression of genes conunon 
to the DC lineage, and also genes important in antigen presentation or T cell 
interaction. L-DC therefore reflect DC and APC in tenns of gene expression, as well 
as function in T cell activation. Further gene expression analysis however showed 
greater similarity between L-DC and 1nyeloid rather than dendritic type cells. 
Data n11n1ng for expression of genes related to DC and APC function 
revealed high similarity between L-DC and the n1yeloid subsets of granulocytes and 
infla1mnatory n1onocytes. Genes included the DC n1arkers Ada,ndecl and Cd300e 
(Brckalo et al. , 201 0; Clark et al. , 2009; Fritsche et al. , 2003). They also included 
genes associated with inhibition of T cell function including Plxnb2 and Zfyve 9 (Holl 
et al. , 2012; Liu et al. , 2008), and genes related to tolerance induction including 
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Ptgs2, DhrS9 and Il-lj9 (Muthuswamy et al. , 2010; Vigne et al. , 2011; Xiao et al. , 
2008). 
The inflammatory monocyte subset sorted here appears to be conta1ninated 
with natural killer cells, evidence by upregulated expression of Ncr 1, Nkg7, Gzn1a 
and Klra8 (Hameed et al., 1988; Lee et al., 2001; Liebennan, 2003; Masson et al. , 
1986; Orr et al. , 2009). Natural killer cells are a CD 11 b11iCD27+Ly6C+1-NK1.1 + 
subset of cells (Bezman et al., 2012; Michel et al., 2012; Ryan et al. , 1992), and 
could be contained within the gated inflarmnatory monocyte subset of 
CD 11b11 iCD11 c10Gr-1-MHCirSSC 10 cells. A more stringent phenotypic profile 
involving 1nore antibodies will be needed to define inflarmnatory n1onocytes more 
fully. 
In su1nn1ary, the gene profile of the splenic L-DC candidate defined as a 
CD 11 b 11iCD 11 c10MHCir CD8- subset bears resemblance with myeloid DC, with 
antigen presenting cells and with cells capable of activating or inhibiting T cells. 
While this is consistent with evidence for their antigen presenting function, the L-DC 
candidate subset appears to represent a heterogeneous population resembling L TC-
DC, yet showing characteristics of both dendritic and 1nyeloid cells. It is clearly 
distinct from the known cDC subsets and has greater similarity with myeloid subsets. 
Further phenotypic characterisation of the L-DC subset has therefore been conducted 
in Chapter 4, and further analysis of function has been perfonned in Chapter 5. 
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Delineation of L-DC in relation 
to splenic dendritic and myeloid cell 
subsets 
CHAPTER4 
4.1 Introduction 
Multiple dendritic and myeloid subsets have been described in spleen. While 
splenic dendritic cell (DC) subsets have been very well defined and characterised in 
terms of phenotype and function, this is not the case for splenic 1nyeloid subsets. The 
term 'myeloid' has been used as an umbrella term describing both granulocytes and 
macrophages/monocytes which descend from a common myeloid progenitor (CMP) 
in bone marrow (Akashi et al. , 2000). Granulocytes comprise neutrophils, 
eosinophils, basophils and mast cells (Hickey and Kubes, 2009), while monocytes 
have been classified as distinct resident and inflammatory monocytes largely on the 
basis of n1onocyte subsets described in peripheral blood (Auffray et al. , 2007). The 
cun·ent classification system for splenic myeloid cells is based on cell surface 
phenotype. However, full phenotypic profiles are not available for these cells, and a 
benchmark phenotype is lacking in the field. Most studies have focused on specific 
subsets and do not compare one subset against another to ensure pure populations, or 
to gain a comprehensive picture of the relationship between subsets. Accurate 
identification of splenic myeloid cell types is essential for di~tinguishing specific 
subsets and their function, and to 1nake studies in the field comparable. 
Monocytes develop from a CMP in bone 1narrow and traverse into blood as 
1nature cells (Akashi et al. , 2000). Monocytes in blood have been categorised as both 
resident and inflamn1atory n1onocytes (Auffray et al. , 2007; Geiss1nann et al. , 2003). 
Resident n1onocytes have a longer half-life than inflammatory 1nonocytes and remain 
in blood for a longer period (Gordon and Taylor, 2005). In addition, resident 
monocytes are also thought to act as precursors of tissue resident 1nacrophages in the 
steady-state, hence the name ' resident' monocytes . They are identifiable as CC-
chemokine receptor 2 (CCR2Y and CX3-chemokine receptor 1 
(CX3CRliiLy6C+Ly6G- cells, while inflan1matory monocytes are distinct as 
CCR2+CX3CR1 10Ly6C 11iLy6G- cells (Auffray et al. , 2007; Geissmann et al. , 2003 ; 
-Nahrendorf et al. , 2007; Sunderkotter et al. , 2004; Tacke et al. , 2007). Unlike 
resident monocytes, inflan1matory n1onocytes are recruited from blood to sites of 
inflamn1ation and can act as precursors of TNF/iNOS-producing (Tip) DC and 
macrophages (Geissn1am1 et al. , 2008). Recent adoptive transfer studies (Drutn1an et 
al. , 2012; Varol et al. , 2007; Yrlid et al. , 2006) suggested that inflammatory 
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monocytes were precursors of resident monocytes, although this finding has since 
been disputed (Alder et al., 2008; Mildner et al., 2007). Inflammatory monocytes 
have also been described as cells which shuffle between bone marrow and blood 
(Varol et al., 2007), but these findings have also been debated. Further evidence for 
lineage distinction between these subsets comes from gene knockdown experiments 
involving the Kruppel-like factor 4 (Klf4) molecule, essential for differentiation of 
inflammatory monocytes (Alder et al. , 2008). Gene knockout induced a drop in the 
nu1nber of inflammatory monocytes but did not affect the number of resident 
1nonocytes (Alder et al. , 2008). In addition, selective depletion of inflammatory 
monocytes by knockout of Ccr 2 did not affect the nun1ber of resident monocytes 
(Mildner et al. , 2007). A direct lineage relationship between resident and 
inflammatory monocytes is therefore in doubt, and remains to be investigated further 
in terms of the lineage origin of each subset. It is important to address this issue in 
the context of defining the lineage relationship of an L-DC subset in spleen. 
Most studies on monocytes have involved blood as a source of cells, so that 
little is understood about splenic monocytes and their relaJjonship with blood 
1nonocytes. The studies of Swirski et al. (2009) demonstrated that splenic monocytes 
resembled their blood counterpart on the basis of phenotype, morphology and gene 
expression. Monocytes in blood and spleen were identified as lineage (Lin)10 cells, 
with a CD 11 b11 iCD 11 c10MHCII1°F 4/8010 phenotype. This population was further 
delineated into resident and infla1nmatory monocytes based on Ly6C expression. In 
addition, spleen was identified as a reservoir for monocytes, where the latter could be 
efficiently deployed to sites of inflammation during cardiac arrest (Swirski et al. , 
2009). 
N eutrophils in spleen have previously been delineated on the basis of the 
phenotype of their blood equivalent as a CDl 1 b +Ly6C+Ly6G+ subset (Galli et al. , 
2011 ), but have not been extensively characterised in spleen. Similarly, eosinophils 
have been described in blood, but a splenic subset has not been well characterised. 
Blood eosinophils are defined as a CD 11 b +Siglec-F+CCR3+F4/80+ subset 
(Voehringer et al. , 2007), which participates in defence against parasitic infections 
and allergy via antibody-dependent cell mediated cytotoxicity (Klion and Nutman, 
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2004; Masure et al. , 2013). The precise phenotype of splenic eosinophils relative to 
other splenic myeloid subsets is still not yet known. 
In the previous chapter, L-DC were broadly defined as a subset of cells in 
spleen with the CD 11 b11 iCD 11 c10MHCirCD8- phenotype. However, this population 
was found to be heterogeneous on the basis of gene profiling evidence. While L-DC 
resen1ble myeloid DC on the basis of CD 11 b expression, lack of MHCII expression 
has raised criticism that L-DC may 1nore resemble splenic n1onocytes/macrophages 
than DC. In addition, low expression of CD 11 c on L-DC has raised further questions 
in that so1ne myeloid DC and pDC have been described as CD 11 c10 cells (Asselin-
Paturel et al. , 2001; Bjorck, 2001; Nakano et al. , 2001). 
Cell surface phenotype has been widely accepted as a means to identify and 
distinguish cell subsets. For this reason, a staining protocol and gating strategy is 
developed here to n1ore accurately identify an L-DC candidate, and to distinguish it 
from other myeloid and cDC subsets in spleen. In this chapter, the delineation and 
identification of splenic DC, monocytes and myeloid Sl!bsets is addressed 
concurrently. The phenotype of splenic neutrophils and eosinophils is also 
characterised in relation to monocytes and DC. 
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4.2 Results 
4.2.1 Phenotypic characterisation of myeloid subsets in spleen 
The identification of known dendritic and myeloid subsets can be readily 
achieved based on accumulated flow cyto1netry data in the literature. In line with the 
co1nmonly used gating strategy, splenic myeloid subsets can be identified by their 
distinct Ly6C and Ly6G expression. The myeloid subset was gated as 
CDl 1 b 11 iCD1 lc-MHCir. These were further delineated as inflammatory monocytes, 
resident monocytes and neutrophils (Figure 4.1 ). Both inflammatory and resident 
n1onocytes express Ly6C, but not Ly6G. Infla1nmatory monocytes were 
distinguishable from resident n1onocytes by higher expression of Ly6C. Neutrophils 
can be distinguished fro1n 1nonocytes, since they express Ly6G, as well as Ly6C 
(Figure 4.1 ). In addition, these three myeloid subsets have distinct side scatter 
profiles (SSC). All three have low forward scatter (FSC10), but can be distinguished 
based on SSC, with inflammatory monocytes as SSC10, resident monocytes as sschi, 
and neutrophils as sscmid (Figure 4.1 ). Hence staining with a!!Jibodies specific for 
CD 11 b, CD 11 c, MHCII, Ly6C and Ly6G can distinguish these three myeloid subsets 
in spleen as described in the literature. 
4.2.2 Identification of a candidate L-DC subset in spleen 
L-DC resemble myeloid DC based on their CDl 1 b 11 i expression. To further 
explore the relationship between L-DC and known myeloid subsets in spleen, T and 
B cell depleted splenocytes were stained for CD 11 b, CD 11 c, MHCII, Ly6C and 
Ly6G. Initially CDl 1 b11iCD1 lc10MHCir cells were gated as the L-DC containing 
subset, and then fu1iher tested for Ly6C and Ly6G expression. Three distinct 
populations of cells were observed: Ly6C+Ly6G+ (21.3%), Ly6C+Ly6G- (32.2%) and 
Ly6C-Ly6G- ( 45.4%) (Figure 4.2). These were tern1ed 'L-DC candidates ', and 
further analyses were designed to assess their potential as 'L-DC' . The FSC and SSC 
profile of each subset was investigated. Both Ly6C+Ly6G+ and Ly6C+Ly6G- L-DC 
candidates have a FSC11iSSC111 id profile, while the Ly6C-Ly6G- subset has dominantly 
a FSC10SSC10 profile (Figure 4.2). 
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Figure 4.1 Flow cytometric identification of myeloid subsets in murine spleen. 
Spleen cells were prepared by red blood cell lysis prior to T and B cell depletion, and then stained with antibodies specific for CD 11 b (Ml /70, PE-
Cy7), CDl lc (N418 , APC), MHCII (MS/114.15.2, Pacific Blue), Ly6C (Al-21 , FITC) and Ly6G (1A8, PE). Prior to analysis, cells were stained with 
propidium iodide (PI, 1 µg/n1l) for gating live (Pr) cells. Myeloid cells were gated initially as CD 11b11 iCD11 c-MHCir cells. Further staining with Ly6C 
and Ly6G revealed 3 populations with distinct FSC and SSC as reported in the literature: inflarmnatory n1onocytes (Infl 1nono ), resident 1nonocytes 
(Resi mono) and neutrophils (Neutro ). Data are presented as dot plots. Gates were set based on fluorescence 1ninus one controls, and numbers in gates 
represent % specific binding. 
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Figure 4.2 Initial ex vivo identification of L-DC as CDllb 11 iCDllc 10MHCir cells. 
Spleen cells were prepared by red blood cell lysis prior to T and B cell depletion, and then stained with antibodies specific for CDI 1 b (Ml /70, PE-
y7) , CDl le (N418 , APC), MJ-ICII (25-9-17, Biotin), Ly6C (Al-21 , FITC) and Ly6G (1A8 , PE). Streptavidin (SA)-APC-Cy7 was used as a second 
stage reagent. Prior to analysis, cells were stained with propidiun1 iodide (PI, 1 ~Lghnl) for gating live (Pr) cells. L-DC were initially gated as 
Dl 1 b11 iCDl lc10MHClr cells. Further staining with Ly6C and Ly6G revealed 3 populations with overlapping FSC and SSC profiles: Ly6C+Ly6G+ 
yoc+Ly6G- and Ly6C-Ly6G-. Gates were set based on fluorescence n1inus one controls, and numbers in gates represent% specific binding. 
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Since Ly6C and Ly6G expression did not delineate a single subset, additional 
markers were needed to identify L-DC. To fully delineate the L-DC phenotype, it 
was also necessary to identify and characterise all known myeloid and DC subsets at 
the same time. Previously, it was reported that resident monocytes could be 
distinguished from infla1m11atory monocytes on the basis of their higher CD4 3 
expression (Sunderkotter et al., 2004). In addition eosinophils, which reside in spleen 
in the steady-state, are distinguishable from other myeloid cells by expression of 
Siglec-F (Voehringer et al., 2007). Cells were therefore stained for these markers 
along with CDl lc, CDl 1 b, Ly6C and Ly6G. Common myeloid and DC subsets were 
gated as in Figure 4.1, and L-DC candidates were gated as in Figure 4.2. 
Conventional DC were gated as CD1 lc11iLy6C-Ly6G- cells, and CD8+ cDC 
and CD8- cDC were then delineated as the CDI 1 b- and CDl 1 b + subsets, respectively 
(Figure 4.3 A). While these subsets did not express the Siglec-F marker of 
eosinophils, a 13.6% subset of CD8+ cDC and a 8.8% subset of CD8- cDC were 
CD43\ consistent with published results (Naik et al., 2006). Myeloid cells were 
gated as CD 11 c101- cells, and further delineated as CP 11 b11iCD 11 c10 and 
CDl 1 b11 iCD1 le- subsets (Figure 4.3 B). CDl 1 b11iCD1 le- cells were further delineated 
on the basis of Ly6C and Ly6G expression to give infla1nn1atory monocytes, resident 
1nonocytes and neutrophils (Figure 4.3 B). Ahnost 100% of these gated subsets 
expressed low levels of CD43. Resident monocytes however contained a distinct 
CD43 11 i subset (81.8%, Figure 4.3 B). When CDl 1 b11 iCD1 lc10 cells were gated on the 
basis of Ly6C and Ly6G expression to reveal 3 candidate L-DC subsets, 69.1 % of 
Ly6C-Ly6G-, 71 % of Ly6C+Ly6G+ and 60.6% of Ly6C+Ly6G- cells were CD43+. As 
with resident n1onocytes, the Ly6C+Ly6G- L-DC candidate also had a CD43 11i subset 
(36.7%, Figure 4.3 B). 
Previous studies on eosinophils in the spleen concentrated on their 
characterisation as a functional cell type and did not focus on their phenotype in 
relation to other known 1nyeloid subsets. It was therefore in1portant to map out the 
phenotype of eosinophils in relation to other DC and myeloid subsets under study 
here. Gated resident monocytes were found to contain a large subset of Siglec-F+ 
cells (87 .2% ), raising questions about the presence of eosinophils (Figure 4.3 B). In 
order to confinn the specificity of Siglec-F staining, a back-gating strategy was 
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Figure 4.3 Further phenotypic characterisation of splenic dendritic and myeloid 
subsets. 
Spleen cells were prepared by red blood cell lysis followed by T and B cell depletion, 
and then stained with antibodies specific for CDl lb (Ml/70), CDl lc (N41S, APC), 
Ly6C (AL-21 , Pacific Blue) , Ly6G (lAS, Bio), CD43 (IBII, Alexa488) and Siglec-F 
(ES0-2440, PE) , using streptavidin (SA)-i\PC-Cy7 as a second stage reagent. Prior to 
flow cyton1etry, cells were stained with propidiu1n iodide (PI, 1 µg/1111) to delineate live 
(Pr) cells. A) Conventional DC ( cDC) were initially gated on the basis of side scatter 
(SSC) and CD 11 c expression. CDS+ cDC were gated as Ly6C-Ly6G- cells which are 
also CD 11 b-, while CDS- cDC were gated as Ly6C-Ly6G- cells which are CD 11 b +_ 
Expression levels of CD43 and Siglec-F were determined. These are known markers of 
resident 1nonocytes and eosinophils. B) Myeloid cells and L-DC were initially divided 
as CD 11 c- and CD 11 c10 subsets, respectively , and further delineated on the basis of 
CD 11 b versus CD 11 c expression. Myeloid cells were gated as CD 11 bh iCD 11 c- cells 
and fu1iher delineated on the basis of Ly6C and Ly6G expression to reveal neutrophils 
eutro) as Ly6C+Ly6G+ cells, inflamn1atory n1onocytes (Infl 1110110) as Ly6ChiLy6G-
cells and resident 111onocytes (Resi 1110110) as L 6C+Ly6G- cells as described in the 
literature (Geiss1nann et al. , 2003). L-DC were gated as CD 11 bhiCD 11 c10 cells and then 
fu11her delineated to gi e 3 candidate subsets differing in Ly6C and L 6G expression. 
Expression of CD43 and Siglec-F \ ere dete1mined for all subsets. Gates were set based 
on fluorescence 1ninus one controls, and numbers in gates represent % specific binding. 
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applied to Siglec-F+ cells (Figure A. I). By this method, Siglec-F+ cells were found to 
be mainly CD 11 bhiCD 11 c-Ly6C+Ly6G-CD43+ cells, previously designated as 
resident monocytes in Figures 4.1 and 4.3. By contrast, the majority of inflammatory 
monocytes (~99%) and neutrophils (~97%) did not express Siglec-F (Figure 4.3 B). 
While the Ly6C-Ly6G- and Ly6C+Ly6G+ L-DC candidate subsets showed subsets of 
cells staining for Siglec-F (Figure 4.3 B), these subsets were s1nall (~10% and 
~ 11.7%, respectively). However, 19.2% of the Ly6C+Ly6G- L-DC candidate subset 
expressed Siglec-F (Figure 4.3 B). This staining pattern indicates possible eosinophil 
conta1nination amongst resident monocytes, and amongst the Ly6C+Ly6G- L-DC 
candidate subset. 
4.2.3 Further distinction of myeloid subsets in spleen 
To investigate the subsets further, the phenotype of designated resident 
1nonocytes was analysed in detail. CX3CR1 expression has been associated with the 
differentiation of macrophages and DC, and this lineage has been defined by a 
macrophage/dendritic progenitor (MDP) (Fogg et al. , 2006; __ Jung et al. , 2000; 
Palframan et al., 200 I). Resident monocytes and inflammatory monocytes have been 
described as CX3CRI hi and CX3CRI 10 cells, respectively (Auffray et al. , 2007; 
Geissn1ann et al. , 2003). CX3CRI transgenic n1ice tagged with green fluorescence 
protein (GFP) were therefore used to detern1ine if the designated resident 1nonocyte 
subset of CD 11 bhiCD I I c-Ly6C+Ly6G-Siglec-F+ cells expressed CX3 CR I , which is 
associated with the macrophage/dendritic lineage. In order to detect staining levels of 
CX3CRI , two gates were defined based on fluorescence minus one controls, namely, 
a CX3CRI 10 and a CX3CRI hi gate, reflecting cells expressing different levels of the 
n1arker. Experi1nental limitations reduced the nu1nber of n1arkers which could be 
studied concurrently, and so Ly6C was not included in the staining mix. 
Identification of myeloid subsets was therefore based on the SSC profile as described 
in Figure 4.1 , and on Ly6G staining. When designated resident 1nonocytes in spleen 
were gated as SSC 11iLy6G- cells, they showed few cells with CX3CRI staining 
(6.78%), again raising issues about the identity of cells as resident monocytes (Figure 
4.4). Inflanunatory 1nonocytes were gated as SSC10Ly6G- cells, and consistent with 
the literature (Geissn1am1 et al. , 2003), 87% of cells were CX3CRI 10 with 7.4% as 
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Figure 4.4 CX3CRl expression delineates splenic dendritic and myeloid subsets further. 
Spleens of Cx3Cr 1-GFP transgenic mice were prepared by RBC lysis and T/B cell depletion. Cells were stained with 2 distinct antibody cocktails. The 
first included antibodies to CDl 1 b (Ml /70, PE-Cy7), CDl lc (N418, APC) and Ly6G (1A8, PE), while the second contained antibodies to CDl 1 b 
(Ml /70, Pe-Cy7), CDl lc (N418, APC),· CD8 (53-6.7, PE) and MHC-II (25-9-17, Biotin). Streptavidin (SA)-APC-Cy7 was used as a second stage 
reagent. Prior to flow cytometry, cells were stained with propidium iodide (PI, 1 µg/ml) to delineate live (Pr) cells. Initial gating on the basis of CD 11 c 
and CDl 1 b expression allowed identification of myeloid cells as CDI 1 b11 iCD1 le-, L-DC candidates as CDl 1 b11 iCD1 lc10, and cDC as a CDl 1 b +CDl lc11 i 
subset. Myeloid cells were further delineated on the basis of SSC and Ly6G expression. Resident n1onocytes (Resi 1nono) were gated as SSC11 iLy6G-
cells, inflammatory monocytes (Infl mono) as SSC10Ly6G- cells and neutrophils (Neutro) as SSCinterLy6G+ cells, based on published data (Tan et al. , 
2011). Similarly, three L-DC candidate subsets were delineated on the basis of Ly6G expression and predicted Ly6C expression. cDC were separated 
into CD8+ cDC and CD8- cDC based on MHCII and CD8 expression. CX3CR1 expression was examined across all identified subsets. Gates were set 
based on fluorescence minus one controls, and numbers in gates represent % specific binding. 
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CX3CR1 hi (Figure 4.4). Neutrophils were gated as sscmidLy6G+ cells, and were 
sho\vn to be CX3CR1- (Figure 4.4). 
In this study, L-DC candidates were also divided into 3 populations based on 
SSC and Ly6G staining. The Ly6C expression on the L-DC candidates gated on the 
basis of SSC and Ly6G was verified in another staining (Figure A.2). Amongst the 
three L-DC candidate subsets, the Ly6C-Ly6G- subset contained 72% CX3CR1 10 cells 
with 26% CX3CR1 hi cells, whilst the Ly6C+Ly6G- subset contained 63% CX3CR1 hi 
cells with 25% CX3CR1 10 cells. The Ly6C+Ly6G+ subset contained 43% of 
CX3CR1 hi cells, and so was also heterogeneous. When CX3CR1 expression was 
exa1nined on cDC, 48% of gated CD8- cDC were CX3CR1 10, while 24% of gated 
CD8+ cDC were CX3CR1 10 (Figure 4.4). CX3CR1 is a clear 1narker expressed at low 
levels on subsets of cDC and inflammatory monocytes. However, here it was found 
that CX3CR1 was not expressed at high levels on the resident monocyte population 
as defined in the literature. It was, however, expressed at high levels on subsets of L-
DC candidates. 
Fu1iher atte1npts were therefore made to distinguish a true resident n1onocyte 
subset in spleen. Macrophage-colony stimulating factor receptor (M-CSFR/CD 115), 
was used previously to delineate monocytes/macrophages and other n1yeloid cells 
(Dai et al., 2002; Sasn1ono et al. , 2003), and was examined here as a possible 1narker 
for fu1iher delineation of splenic 1nyeloid and DC subsets. All designated resident 
1nonocytes were found to be CD 115+, while less than 10% of inflammatory 
1nonocytes expressed CD 115 (Figure 4.5). Neutrophils were CD 115-, consistent with 
the literature (Dunay et al. , 2010). Amongst the L-DC candidates, 63 % of the 
Ly6C+Ly6G- subset and 45% of the Ly6C+Ly6G+ subset expressed CDl 15. 
However, the Ly6C-Ly6G- L-DC candidate was clearly negative for CDl 15 
expression (Figure 4.5). In tenns of CD 115 expression, overlap exists between the 
designated resident n1onocytes and the Ly6C+Ly6G+ and Ly6C+Ly6G- subsets of L-
DC candidates. 
In order to eliminate possible contan1ination of neutrophils within gated L-
DC populations, staining for the 7 /4 neutrophi] marker was used to assess L-DC 
candidates. Figure 4.6 shows that 7 /4 stains almost 100% of gated neutrophils as a 
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Figure 4.5 ldentificatio~ of splenic monocytes on the basis of CDllS expression. 
Splenocytes were prepared by red blood cells lysis and T/B cell depletion and stained with antibodies specific for CDI lb (Ml /70, PE-Cy7), CDl lc 
(N418, APC), Ly6C (Al-21 , FITC), CDI 15 (AFS98, PE) and Ly6G (1A8, biotin). Streptavidin (SA)-APC-Cy7 was used as a second stage reagent. 
Prior to analysis, cells were stained with propidiu1n iodide (PI, 1 µg/ml) for gating live (Pr) cells. Myeloid subsets of inflamn1atory monocytes (Infl 
mono) , resident monocytes (Resi n10110) , neutrophils (Neutro) and L-DC candidates were gated as described in Figure 4.3. CDl 15 expression levels 
were determined on gated subsets. Gates vvere set based on fluorescence minus one controls, and nun1bers in gates represent % specific binding. 
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Figure 4.6 Further identification of splenic neutrophils. 
Splenocytes were prepared by red blood cell lysis and T/B cell depletion, and stained with antibodies specific for CD 11 b (Ml /70, PE-Cy7), CD 11 c 
(N418, APC), Ly6C (Al-21, FITC), Ly6G (1A8 , PE) and 7/4 (7/4, Biotin). Streptavidin (SA)-APC-Cy7 was used as a second stage reagent. Prior to 
analysis, cells were stained with propidiu1n iodide (PI, lµg /ml) for gating live (Pr) cells. Myeloid subsets and L-DC candidates were gated as 
described in Figure 4.3 , In1: inflanunatory n1onocytes, Rin: resident monocytes and Neu: neutrophils. While cDC were gated as CDl lb+CDl lc11 iLy6C-
Ly6G- cells. Expression of the 7 /4 marker of neutrophils was detennined on all subsets, and data are presented as overlaid dot plot displays. Gates were 
set based on fluorescence minus one controls, and nu1nbers in gates represent % specific binding. 
Myeloid subsets 
Im 
Rm o 
<.D 
>,. 
_J 
<{ 
I 0 I ·.• 
(I) 
(I) 
□ ■ □ 
Ly6G i 
99,3 
7/4 
Neutro (N) 
Intl mono (Im) 
Res i mono (Rm) 
.n 
..-
..-
0 
0 
0 
<.D 
>,. 
_J 
<{ 
I 
u 
(f) 
(I) 
Pl- live splenocytes 
29.6 17.8 
~,,, ., ,, 0 ,, TT,;; ·· ',"T , , .,/ ,, , , , " "" , , 0.037 I 11• 11 
' I 
□ ■ 
Ly6G l 
.i.i-'•,·}l\···•I ·.· .. · ,, .;.~·.i'~-
~ ~i: · .~ .. ~.if't~,A. ~-~)lU::(~;,, 
.]tf!J? 
99 .7 
7/4 
0 
<.D 
>,. 
_J 
<{ 
I 
u 
(I) 
(f) 
cDC 
Ly6G 
0.13 
7/4 
CHAPTER4 
positive control, while cDC served as appropriate negative controls (Figure 4.6). 
Most inflammatory n1onocytes (98%), but only a few resident monocytes (9.55%) 
showed 7/4 staining. The Ly6C+Ly6G+ L-DC candidate subset was uniformly 
positive for 7 /4, indicating that this subset is probably neutrophils. However 80% of 
the cells in the Ly6C+Ly6G- L-DC candidate subset were also positive, and since 
these cells were shown in Figure 4.3 to express Siglec-F, it is possible that they may 
be 1nostly eosinophils. The Ly6C-Ly6G- L-DC candidate subset was negative for 7/4. 
These data clearly delineate both the myeloid and L-DC candidate subsets further by 
identifying cells that express 7 /4. Since the presence of neutrophils and eosinophils 
can be readily confinned by morphology, histological analysis of all sorted subsets 
was then conducted. 
4.2.4 L-DC is morphologically distinct from splenic myeloid subsets 
Myeloid and DC subsets were stained with antibodies as described in Figure 
4.3 and then sorted flow cytometrically. Subsequently, sorted cells were prepared as 
cytospins and stained with Giemsa. Photomicroscopy was U§_ed to identify and 
quantitate cells on the basis of n1orphology. Gated CD 11b11iCD11 c-Ly6C+Ly6G+ 
myeloid cells ( also 7 /4+Siglec-F-) den1onstrated characteristic neutrophil morphology 
with a 1nulti-lobate nucleus and cytoplasm devoid of granules (Figure 4.7). All cells 
in this subset had this characteristic morphology (Table 4.1 ). Gien1sa staining of 
sorted infla1nmatory monocytes revealed a bi-lobate nucleus, and a cytoplasm devoid 
of granules typical of n1onocytes (Figure 4. 7). The majority of cells (>90%) had this 
morphology (Table 4.1 ). Gated CD 11 b11 iCD 11 c-Ly6C+Ly6G- cells, originally 
classified as resident n1onocytes, now appear to be clearly eosinophils. All cells 
demonstrated multi-lobate nuclei with the clear presence of orange granules in the 
cytoplasm. This morphology is very consistent with eosinophils, and 100% of this 
sorted subset had this similar fonn (Table 4.1). In contrast, the Ly6C+Ly6G- L-DC 
candidate subset revealed 1norphology resembling monocytes with a bi-lobate 
nucleus and a cytoplasn1 devoid of granules (Figure 4. 7). I-Iowever, this subset was 
also heterogeneous, con1prising only ,.__,65% mononuclear cells or monocytes (Table 
4.1). The Ly6C+Ly6G+ L-DC candidate subset was found to be a mixture comprising 
mainly neutrophils with ,.__, 10% monocytes ( data not shown). Both CD8+ cDC and 
cog- cDC displayed similar 1norphology and characteristics as DC. A majority (80-
63 
Figure 4. 7 Morphology of splenic dendritic and myeloid subsets. 
Splenocytes were prepared by red blood cell lysis and T/B cell depletion, and stained with antibodies specific for CDl lb (Ml /70, Pe-Cy7) , CDl lc 
(N418, APC), Ly6C (AL-21, Pacific Blue), Ly6G (1A8 , Bio), CD43 (IBII, Alexa488) and Siglec-F (ES0-2440, PE), using streptavidin (SA)-APC-Cy7 
as a second stage reagent. Prior to analysis, cells were stained with propidiu1n iodide (PI, 1 µg/inl) for gating live (Pr) cells. Myeloid subsets, cDC and 
L-DC candidates were gated as described in Figure 4.3 for sorting. CD43 and Siglec-F staining were also used to delineate subsets, but gating on these 
antibodies is not shown. Gates were set based on fluorescence minus one controls, and numbers in gates represent % specific binding. Sorted subsets 
were cytospun on to slides and fixed with absolute ethanol prior to Giemsa staining to elucidate n1orphology microscopically. Photo1nicroscopy of 
subsets was performed at 600X magnification, bar 1 0µm. 
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Table 4.1 Morphological characterisation of splenic dendritic and myeloid subsets. 
Subset Sorted subset . Expt* 
classification No. of cells 
CDl 1 bhiCDl lc-Ly6C+Ly6G-CD43 11iSiglec-F+ I 72 Eosinophils 
II 72 
CDl lb 11iCDl lc-Ly6C+Ly6G+ CD43+Siglec-F I 26 Neutrophils 
II 18 
CDl 1 b11iCDl lc-Ly6C 11iLy6G-CD43+Siglec-F Inflammatory I 72 
Monocytes II 68 
CDl 1 bhiCDl lc10Ly6C+Ly6G-CD43 +/hiSiglec-F- Resident I 76 
Monocytes II 80 
CDl lb 11iCD1 lc10Ly6C-Ly6G-CD43+Siglec-F I 78 L-DC 
II 84 
CDl 1 b-CDl lc 11iLy6C-Ly6G-CD43-Siglec-F I 41 CD8+ cDC 
II 34 
I 
CDl 1 b +CDl 1 c 11iLy6C-Ly6G-CD43-Siglec-F I 61 CD8- cDC 
II 59 
* Data are shown for 2 independent sorting experiments. 
+ Cells were cytospun and stained with Gie1nsa for 1nicroscopic classification. 
# Don1inant subsets are shown in bold. 
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90%) of cells displayed the morphology of 1nononuclear cells with vacuoles evident 
in the cytoplasm, and nuclei staining bluish instead of red (Table 4.1, Figure 4.7). 
In line with its proposed dendritic-like phenotype, the Ly6C-Ly6G- L-DC 
candidate subset contained a majority of cells with the same morphology as the cDC 
subsets, with 4 7% and 62% of cells being mononuclear cells with vacuoles evident in 
the cytoplasn1 across two experiments (Table 4.1, Figure 4. 7). This subset was 
therefore heterogeneous, containing 30-40% monocyte-like cells, and 5-10% 
eosinophils (Table 4.1 ). Overall, Giemsa staining served to distinguish the L-DC 
candidate subsets further, and to reveal the dendritic-like morphology of the majority 
of cells in the Ly6C-Ly6G- L-DC candidate subset. It also disputed the monocytic 
nature of the classified resident monocyte subset, which appears to represent a clear 
eosinophil subset in spleen. Resident 1nonocytes may instead represent the major 
subpopulation of cells present in the Ly6C+Ly6G- L-DC candidate subset. 
4.2.5 L-DC are distinct from splenic macrophages 
Macrophages have been historically characterised in spleen based on 
iimnunohistological analysis. However, while some n1acrophage-specific markers 
have been identified, 1nacrophage phenotypes have not been well characterised. In 
tenns of testing whether the L-DC candidate subsets were conta1ninated with 
1nacrophages, it was first essential to determine the full phenotype of known splenic 
n1acrophages and to co1npare this with L-DC and other described subsets. Expression 
of the 1nacrophage 1narkers MOMA- I , SIGNRl and CD68 was therefore 
investigated on splenocytes. MOMA-I is specifically expressed by marginal zone 
1netallophilic n1acrophages (MMM), SIGNRl is expressed by marginal zone 
n1acrophages (MZM), and CD68 is expressed by white pulp macrophages (WPM) 
(Elo1naa et al. , 1995; Kang et al. , 2003 ; Mebius and Kraal, 2005; Noel et al. , 2007). 
Spleen cells were stained for specific macrophage markers as well as CD 11 c, 
CDl 1 b, Ly6C and Ly6G, and then gated as described in Figure 4.7. For each of the 
three macrophage markers, marker positive cells were gated and found to display a 
majority phenotype (40-50%) as CDl lb+CDl lc-Ly6C+1-Ly6G- cells (Figure 4.8). 
This subset was tern1ed 'putative macrophages ', and served as a positive control for 
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Figure 4.8 Identification of splenic macrophages. 
Splenocytes were prepared by red blood cell lysis and T/B cell depletion and stained with antibodies specific for CD 11 b (Ml/70~ Pe-Cy7), CD 11 c 
(N418 , APC), Ly6C (AL-21 , FITC), Ly6G (1A8, PE), and specific n1acrophage n1arkers: A) CD68, B) MOMA-1 , and C) SIGNRl. Streptavidin (SA)-
APC-Cy7 was used as a second stage reagent. Ce lls positive for specific n1acrophage 1narkers were gated and further exainined on the basis of CD 11 b 
ai1d CDl lc expression. The 111ajority of gated cells were CDl lb+CDl le- 1nyeloid cells. Ly6C and Ly6G expression were then exa111ined on 
D 11 b +CD 11 c-111yeloid cells. Gates were set based on fluorescence n1inus one controls, and nun1bers in gates represent% specific binding. 
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comparison with other subsets. However, amongst the 1nacrophage marker positive 
cells, subsets of CD 11 c11 i cells which reflect cDC were found representing ~ 1 % of the 
total spleen cell population (Figure 4.8). Some CDl 1 b11iCD1 lc10 cells were also 
present which therefore justified more extensive analysis. 
In subsequence experitnents, myeloid subsets and L-DC candidates were 
gated as described in Figure 4. 7 and tested for expression of 1nacrophage markers. 
Figure 4.9 shows that CD68 did not stain the gated CDl 1 b 11 iCD1 lc-Ly6C 11iLy6G-
inflarmnatory monocytes, the CD 11 b11iCD 11 c-Ly6C10Ly6G- subset of cells 
categorised as eosinophils in Figure 4.7, nor did it stain the CDl 1 b 11iCD1 lc-
Ly6C+Ly6G+ subset of neutrophils. However, CD68 did stain about 20% of putative 
macrophages (Figure 4.9 A). Cells within the CD1 lc10 gate reflective of L-DC and 
resident monocytes did not express CD68, nor did the gated CD 11 c 11 i subsets of 
CD8+ cDC and CD8- cDC (Figure 4.9). Some CD68+ cells were evident a1nongst the 
CD1 lc10 subset, which expressed both Ly6C and Ly6G and resembled neutrophil-
like cells. However, sitnilar staining and analysis of spleen cells using MOMA-1 and 
SIGNRl revealed staining to be specific for only a subset (~20%) of putative 
n1acrophages (Figure 4.10 A and 4.11 A). No other cells, including L-DC, showed 
expression of MOMA-1 or SIGNRl specific for marginal zone metallophilic 
n1acrophages and n1arginal zone n1acrophages (Figure 4.10 B and 4.11 B). 
Splenic 1nacrophages can be divided into two populations based on their 
anatomical location, namely white pulp and red pulp n1acrophages. While antibodies 
against MOMA-1 , SIGNRl and CD68 can be used to detect subsets of marginal zone 
and white pulp macrophages, expression of F 4/80 can be used to detect the presence 
of red pulp 1nacrophages. Myeloid subsets and L-DC candidates were therefore gated 
as described above, and F 4/80 staining was detennined. Putative n1acrophages were 
gated as in Figure 4.8 , and served as a positive control. A subset (27%) of the 
putative n1acrophages was positive for F4/80 (Figure 4.12A). Aln1ost all of the 
inflanu11atory and resident monocytes were positive for F4/80, while only 21 % of 
neutrophils expressed F4/80 (Figure 4.12B). Si1nilarly, almost all of the Ly6C+Ly6G-
resident monocytes and Ly6C-Ly6G- L-DC subsets stained for F4/80, while 74% of 
the Ly6C+Ly6G+ L-DC candidate, reflective of neutrophil-like cells, stained for 
F4/80. To detennine the specificity of F4/80 staining, both subsets of cDC were 
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Figure 4.9 L-DC is distinct from splenic white pulp macrophages. 
Splenocytes were prepared by red blood cell lysis and T/B cell depletion, and stained 
with antibodies specific for CD 11 b (Ml /70, PE-Cy7), CD 11 c (N4 l 8, APC) , Ly6C (AL-
21 ~ FITC), Ly6G (1A8 , PE) and F4/80 (CI:A3- l , Biotin). Streptavidin (SA)-APC-Cy7 
was used as a second stage reagent. L-DC candidates, and myeloid and DC subsets 
were gated as described in Figure 4.3 , while putati e macrophages were gated as 
-L 
CD 11 b · CD 11 c-L 6C-Ly6G- cells. Specific antibod to CD68 was used to identify white 
pulp macrophages. A) Expression of CD68 on 111 eloid subsets and putati e 
111acrophages. B) E pression of CD68 on L-DC candidates and cDC subsets . Gates ere 
et based on fluore scence 111inus one controls, and numbers in gates represent % specific 
binding. 
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Figure 4.10 L-DC is distinct from splenic marginal-zone metallophilic 
macrophages. 
Splenocytes were prepared by red blood cell lysis and T /B cell depletion, and stained 
with antibodies specific for CDl lb (Ml/70, PE-Cy7), CD l le (N418, APC), Ly6C (AL-
21 , FITC), Ly6G (1A8, PE) and F4/80 (CI:A3-l, Biotin). Streptavidin (SA)-APC-Cy7 
was used as a second stage reagent. L-DC candidates, and 111yeloid and DC subsets, 
were gated as described in -legend to Figure 4.3, while putative 1nacrophages were gated 
as CD 11 b +CD 11 c-Ly6C-Ly6G- cells. Specific antibody to MOMA-1 was used to 
identify 111arginal-zone 111etallophilic 111acrophages. A) Expression of MOMA-1 on 
111yeloid subsets and putative macrophages. B) Expression of MOMA-1 on L-DC 
candidates and cDC subsets. Gates were set based on fluorescence 1ninus one controls, 
and numbers in gates represent % specific binding. 
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Figure 4.11 L-DC is distinct from spleen marginal zone macrophages. 
Splenocytes were prepared by red blood cell lysis and T /B cell depletion, and stained 
with antibodies specific for CDl 1 b (Ml /70, PE-Cy7), CDl lc (N418, APC), Ly6C (AL-
21 , FITC), Ly6G (1A8, PE) and F4/80 (CI:A3-1 , Biotin). Streptavidin (SA)-APC-Cy7 
was used as a second stage reagent. L-DC candidates, and 1nyeloid cells and DC subsets 
were gated as described in the legend to Figure 4.3 , while putative macrophages were 
gated as CD 11 b +CD 11 c-Ly6C-Ly6G- cells. Specific antibody to SIGNRl was used to 
identify 1narginal zone 1nacrophages. A) Expression of SIGNRl on 111yeloid subsets and 
putative macrophages. B) Expression of SIGNRl on L-DC candidates and cDC subsets . 
Gates were set based on fluorescence minus one controls and nu1nbers in gates 
represent % specific binding. 
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Figure 4.12 Identification of splenic red pulp macrophages. 
Splenocytes were prepared by red blood cell lysis and T/B cell depletion and stained 
ith antibodies specific for CDl lb (Ml /70, PE-Cy7), CDl lc 418 , APC), Ly6C (AL-
21 : FITC), Ly6G (1A8, PE) and F4/80 (CI:A3 -1 , Biotin). Streptavidin ( A)-APC-Cy7 
v.·as used as a second stage reagent. L-DC candidates myeloid cells and DC subsets 
were gated as described in the legend to Figure 4.3 , while putati e macrophages were 
gated as CD 11 b +CD 11 c-L 6C-L 6G- cells. A) Expression of F4/80 on m eloid subsets 
and putati e macrophages. B) Expression of F4/80 on L-DC candidates and cDC 
subsets. Gates ere set based on fluorescence minus one controls and numbers in gates 
represent % specific binding. 
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gated and expression of F 4/80 determined. Almost 100% of gated cDC were F 4/80\ 
indicating that F 4/80 can be expressed by both myeloid and DC subsets in spleen. 
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4.3 Discussion 
L-DC have been described as myeloid DC in that they express high levels of 
CD 11 b. It was therefore important to explore the relationship between L-DC and 
other known CD 11 b-expressing 1nyeloid subsets in spleen. In order to compare L-
DC with myeloid subsets, it was first essential to clearly identify all known myeloid 
subsets within spleen. Thus, a broad screen of cell surface marker expression and 
morphological analysis was perfonned to develop a staining and gating strategy for 
accurate identification of all myeloid and DC subsets. This was based on both 
existing infonnation in the literature, and our own· laboratory experience in splenic 
subset analysis. 
This analysis first distinguished the CD8+ cDC and cog- cDC subsets, which 
are already well defined in the literature. Identification of infla1nmatory monocytes 
and neutrophils was also straightforward according to published information. 
Resident 1nonocytes were more difficult to define and required broader comparative 
analysis. The L-DC subset was first identified in terms of three candidates, two of 
which were found to resemble resident monocytes and neutrophils, allowing 
delineation of the most likely L-DC candidate. 
Fron1 the experimental data shown here, cells in spleen with the phenotype of 
resident n1onocytes described in the literature, showed more resen1blance to 
eosinophils than to n1onocytes. This conclusion was based on both cell surface 
1narker expression of Siglec-F as well as cell 1norphology studies. Phenotypic 
analysis of CX3CR1 and CD43 expression, along with morphological analysis, also 
revealed that the Ly6C+Ly6G- L-DC candidate subset showed properties of resident 
1nonocytes similar to that described in the literature. We also showed on the basis of 
7/4 expression that the Ly6C+Ly6G+ L-DC candidate reflected neutrophils. Lastly, 
on the basis of phenotypic and n1orphological studies, the Ly6C-Ly6G- L-DC 
candidate was identified as the best match for an in vivo equivalent of LTC-DC. 
The current classification and na1n1ng of 1nyeloid subsets is based on 
accun1ulated flow cytometric data and various functional assays. Blood monocytes 
are the 1nost widely studied and characterised n1onocytes, although splenic 
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1nonocytes have been shown to closely resemble their blood counterparts in terms of 
phenotype, function and gene expression (Jung et al. , 2000; Voehringer et al. , 2007). 
Inflammatory blood monocytes were previously described as the Ly6C11i subset of 
CD 11 b11iCD 11 c-MHCirLy6G- cells, with resident blood monocytes as the Ly6C10 
equivalent subset (Auffray et al. , 2007; Geissmann et al. , 2003 ; Gordon and Taylor, 
2005; Sunderkotter et al. , 2004; Tacke et al. , 2007). In line with the literature, we 
atte1npted to define both splenic infla1mnatory and resident monocytes in spleen 
based on the phenotype of their blood counterpart (Figure 4.1 ). However, 1nultiple 
analyses revealed that the putative resident 1nonocyte subset in spleen having a 
CD 11 b11 iCD 11 c-MHCirLy6C10Ly6G- phenotype, differed from its blood resident 
monocyte counterpart. The splenic subset equivalent to resident monocytes in blood 
was instead enriched for eosinophils. Splenic neutrophils were easily identifiable as 
CD 11 b11 iCD 11 c-MHCirLy6C+Ly6G+ cells, as described in the literature (Fleming et 
al., 1993; Sun1agin et al. , 2010). We also showed that it is possible to further 
distinguish splenic 1nonocyte subsets from neutrophils by their distinct side scatter 
(SSC) and forward scatter (FSC) profiles (Figure 4.1 ). 
L-DC were thought to rese1nble 1nyeloid dendritic-like cells based on their 
CD 11 b11 iCD 11 c10MHCir phenotype. To distinguish these cells fron1 n1onocytes, and 
to avoid subset contan1ination, Ly6C and Ly6G expression were first en1ployed. L-
DC were gated as CD 11 b11 iCD 11 c10MHCir cells, and then fu1iher delineated on the 
basis of Ly6C and Ly6G expression (Figure 4.2). Three L-DC candidate populations 
were identified initially, na1nely Ly6C+Ly6G\ Ly6C+Ly6G- and Ly6C-Ly6G- cells 
(Figure 4.2). SSC and FSC profiles also served to distinguish these subsets. The 
Ly6C+Ly6G+ L-DC candidate displayed a SSCmidFSC11i profile, resembling 
neutrophils (Figures 4.1 and 4.2), while the Ly6C-Ly6G- L-DC candidate displayed a 
SSC1°FSC10 profile, distinct fron1 sschi infla1m11atory 1nonocytes (Figures 4.1 and 
4.2) . Lastly, the SSC/FSC profile of the Ly6C+Ly6G- L-DC candidate revealed a 
heterogeneous population that overlapped with the Ly6C+Ly6G+ and Ly6C-Ly6G- L-
DC candidate subsets (Figure 4.2). SSC profiles suggested some n1yeloid cell 
conta1nination within the L-DC candidate subsets. For this reason, 1nore myeloid 
n1arkers were en1ployed to delineate L-DC fu1iher. Those myeloid markers also 
served to better define other splenic n1yeloid subsets. 
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Both inflammatory and resident monocytes in blood are thought to derive 
from a CMP in bone marrow (Fogg et al. , 2006; van Furth et al. , 1972), and hence 
display similar markers and requirements for development. The expression of the 
CD43, CX3CR1 and Ly6C markers were therefore used to distinguish resident and 
inflammatory 1nonocytes. Previously, resident monocytes were characterised as 
Ly6C+CD43hiCX3CR1 hi cells, while inflammatory 1nonocytes are distinct as 
Ly6ChiCD43+CX3CRl 1° cells (Auffray et al. , 2007; Geissmann et al. , 2003 ; 
Sunderkotter et al. , 2004). In studies described here, all splenic myeloid subsets were 
found to express CD43 , although resident monocytes were evident as a distinct 
CD43hi sub-population (Figure 4.3). The Ly6C+Ly6G- L-DC candidate subset was 
also found to contain ~37% CD43hi cells, consistent with the presence of resident 
1nonocytes (Figure 4.3). Others have however distinguished resident monocytes as 
CD43+ cells, and inflanunatory monocytes as CD43- cells (Geissmann et al. , 2003 ; 
Sunderkotter et al. , 2004). Inconsistency between the literature and the results with 
CD43 staining described here could be attributable to the nature of the controls used 
to measure CD43 expression. Sunderkotter et al. (2004) used isotype controls, while 
fluorescence minus one controls were en1ployed here to delin~ate CD43 expression. 
In addition, Sunderkotter et al. (2004) only compared CD43 expression amongst 
blood n1onocytes. In staining experin1ents shown here, cDC as CD43- cells, were 
used as an internal biological control for CD43 staining (Figure 4.3 A). 
To directly test whether the Ly6C+Ly6G- L-DC candidate subset was 
conta1ninated with resident n1onocytes, several markers of monocytes including 
CX3CR1 were assessed for expression on 1nyeloid and DC subsets. Mice transgenic 
for CX3CR1 expression tagged with green fluorescence protein (GFP), allowed 
detection of cells that descend fro1n the macrophage/dendritic lineage (Fogg et al. , 
2006; Nahrendorf et al. , 2007; Swirski et al. , 2009). Auffray et al. (2007) defined 
resident 1nonocytes as CX3CR1 hi cells and inflainn1atory monocytes as CX3CR1 10 
cells. Contrary to the literature, staining experi1nents here revealed that the 
Ly6C+Ly6G-SSChi subset of ' apparent' resident monocytes in spleen lacked CX3CRl 
expression (Figure 4.4), while Ly6ChiLy6G-SSC10 inflammatory monocytes were 
CX3CR1 10 (Figure 4.4), consistent with the literature. As with inflammatory 
n1onocytes, the Ly6C-Ly6G- L-DC candidate was also CX3CRl 10• Since the 
Ly6C+Ly6G- L-DC candidate was found to contain a distinct CX3CRl hi subset of 
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cells (63%, Figure 4.4), these cells appear to more closely resemble resident 
monocytes. They are, however, a subset showing low expression of CD 11 c, 
consistent with studies reporting that monocytes and some macrophages do express 
low levels of CDl lc (Drutman et al. , 2012; Gower et al. , 2011; Soos et al. , 2006; 
Vallon-Eberhard et al. , 2006). Analysis of resident monocytes by Auffray et al. 
(2007) exa1nined only CDl 1 b, Ly6C and Ly6G expression, and not CDl lc 
expression on monocytes. The CX3CR1 hi subset of resident monocytes therefore 
resembles the Ly6C+Ly6G- L-DC candidate. If this subset is indeed ' resident 
monocytes' , then the identity of the literature described CD 11 b11 iCD 11 c-MHCir 
Ly6C+Ly6G- subset of resident monocytes in spleen needs to be revisited. 
, 
To further examine the identity of the CDl 1 b11 iCD1 lc-MHCirLy6C+Ly6G-
subset, several new cell surface 1narkers were analysed. Siglec-F, an inhibitory 
receptor expressed by murine eosinophils (Bochner, 2009; Guo et al. , 2007) proved 
definitive for subset identification (Figure 4.3 B). The CD 11 b11iCD 11 c-MHCir 
Ly6C+Ly6G- subset of reputed resident monocytes contained a major subpopulation 
of Siglec-F+ cells reflecting eosinophils (87%, Figure 4.3) _ while inflanunatory 
n1onocytes were Siglec-F- cells ( ~99%, Figure 4.3). The Ly6C+Ly6G- and Ly6C-
Ly6G- L-DC candidate subsets were mainly Siglec-F- cells. Overall, Siglec-F+ 
eosinophils were 1napped to the CD 11 b11 iCD 11 c-MHCirLy6C+Ly6G- population. 
Fron1 the above results, resident 1nonocytes formally described in the literature as 
CDl lc- cells reflect a population heavily contaminated with eosinophils, and resident 
n1onocytes in spleen appear to lie within the Ly6C+Ly6G- candidate L-DC 
population expressing CD 11 c10• 
To fuiiher test these findings, more myeloid markers like CD 115 were 
en1ployed (Dai et al. , 2002 ; Sasmono et al. , 2003 ; Wiktor-Jedrzejczak and Gordon, 
1996). The newly defined eosinophil subset of CDl 1 b11iCD1 lc-MHCirLy6C+Ly6G-
cells was found to express CD 115, while inflammatory monocytes were negative 
(Figure 4.5). In addition, cells of the newly defined CD 11 b11iCD 11 c10Ly6C+Ly6G-
subset were also CDl 15+ as was the Ly6C+Ly6G+ L-DC candidate (Figure 4.5). 
CDl 15 expression did not further delineate resident monocytes and the Ly6C+Ly6G-
L-DC candidate subset, suggesting an overlap between the two populations. The 
absence of CD 115 expression on inflammatory monocytes was unexpected, but 
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could be attributed to the use of a different antibody clone in these experiments, or to 
weaker expression of CD 115 on splenic monocytes as opposed to blood monocytes. 
The in:fla1nmation-associated 7 /4 antigen was also used to further delineate subsets of 
1nyeloid cells and L-DC candidates. In line with the literature, both neutrophils and 
inflammatory monocytes were positive for 7 /4 (Henderson et al. , 2003 ; Hirsch and 
Gordon, 1983; Taylor et al. , 2003 ). Interestingly, both the Ly6C+Ly6G+ and 
Ly6C+Ly6G- L-DC candidate subsets were also positive for 7/4, consistent with 
other evidence that both Ly6C+ L-DC candidate subsets are contaminated with 
neutrophils and/or in:flanunatory monocytes. 
Phenotypic studies were informative, but not definitive in identification of L-
DC and n1yeloid subsets. Thus, morphological characterisation by May-Grtinwald-
Gie1nsa staining was used to confi1m predictions. Blood monocytes have been 
described as cells with bi-lobate nuclei and minimal cytoplasm devoid of granules 
(Geissmann et al. , 2003 ; Sunderkotter et al. , 2004). Only inflammatory monocytes 
displayed this morphology in line with their blood counterparts (Swirski et al., 2009; 
Voehringer et al. , 2007). Giemsa staining confi1med that the sp]enic CD 11 bhiCD 11 c-
Ly6C+Ly6G- subset, newly categorised as eosinophils, had the characteristic multi-
lobate nucleus with orange granules in the cytoplasm, consistent with their 
phenotypic classification as Siglec-F+ eosinophils (Mori et al. , 2009). The 
Ly6C+Ly6G- L-DC candidate displayed morphology consistent with blood 
monocytes and in:flarmnatory monocytes, but not with DC. Cells had a bi-lobate 
nucleus with 1ninimal cytoplas1n lacking granules. On the basis of phenotypic and 
morphological studies, it was concluded that spleen resident monocytes must lie 
within the Ly6C+Ly6G- L-DC candidate population. 
The 1norphology of splenic DC was found to be quite distinct from described 
Langerhans cells which have long membrane projections (Silberberg, 1973). CDS+ 
cDC were found to be mononuclear cells with vacuoles evident in the cytoplasm. 
Both CDS- cDC and the majority of cells in the Ly6C-Ly6G- L-DC candidate subset 
also den1onstrated similar cDC morphology with vacuoles in the cytoplasm. By 
comparison, the Ly6C+Ly6G+ L-DC candidate population comprised mainly cells 
with multi-lobate nucleus resembling neutrophils, and this was confirmed by their 
7 /4 staining. On the basis of combined phenotypic and morphological studies, the 
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Ly6C-Ly6G- L-DC candidate subset of CD 11b11iCD11 c10MHCir cells is most 
consistent with an in vivo equivalent of LTC-DC. It is also distinct fro1n other splenic 
myeloid subsets and cDC based on phenotype, and consistent with a novel dendritic-
like cell subset in spleen. 
There have been at least four types of 1nacrophages described within the 
spleen, each distinguishable by their anaton1ical location. These have mainly been 
identified iinmunohistologically using specific antibodies, but not extensively 
characterised by flow cytometry. Here the phenotype of splenic macrophages was 
analysed in relation to the splenic myeloid and DC subsets under investigation here 
using four distinct 1narkers: CD68, MOMA-I , SIGNRl and F4/80. The 1najority of 
1narker positive cells had the phenotype of CDl 1 b +CD1 lc-Ly6C-Ly6G- cells (Figure 
4.8). Some 1nacrophages have been described as CD 11 c + cells, but CD 11 c 
expression appears to be an anato1nically location-specific marker, e.g. it is 
expressed by puln1onary macrophages in particular (Gonzalez-Juarrero et al. , 2003 ; 
Gower et al. , 2011; Soos et al. , 2006; Vallon-Eberhard et al. , 2006). L-DC 
phenotypically resemble 1nacrophages, since they lack MHCl~ expression and have 
high expression of CD 11 b. They have been shown here to be clearly distinct fron1 
splenic n1acrophages. Only low-level contamination (0 .5-5%) of marker positive 
splenic 1nacrophages was found a1nongst the n1yeloid, L-DC and cDC subsets under 
study here (Figures 4.9 - 4.12). Overall, L-DC lack expression of MOMA-I , 
SIGNRl and CD68, distinguishing then1 from 1narginal-zone n1etallophilic 
n1acrophages, marginal-zone n1acrophages and white pulp 1nacrophages. By contrast, 
F 4/80 staining which defines red pulp macrophages (Austyn and Gordon, 1981 ; 
McKnight and Gordon, 1998; Morris et al. , 1991), was expressed by cDC, L-DC and 
all myeloid subsets. Uniform expression of F 4/80 across many splenic subsets could 
in1plicate it as 1narker of splenic red pulp location rather than a specific subset 
n1arker. 
In conclusion, a novel dendritic-like cell type, L-DC, has been defined as a 
CDl 1 b11 iCD1 lc10Ly6C-Ly6G-MHCir subset resen1bling in vitro grown LTC-DC. L-
DC are distinct from cDC due to lack of MHCII expression, and also distinct from 
known myeloid cells due to the absence of specific myeloid n1arkers. In addition, 
splenic 1nyeloid subsets have been redefined here by employing further 1narkers and 
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morphological analysis. The CDI 1 bhiCDI lc-Ly6C+Ly6G- phenotype described in 
the literature for resident monocytes in blood was found to identify eosinophils in 
spleen, while an alternative resident monocyte subset in spleen has been defined as 
CDI 1 b 11iCDI lc10Ly6C+Ly6G-CD43+CX3CRI hiCDI 15+Siglec-F- cells. While 
phenotype analysis is useful in identification of cells, it should not be the only 
benchmark for delineation. Thus, a co1nbination of phenotypic, 1norphological, 
functional (Chapter 5) and genetic studies (Chapter 6) have been used to further 
identify subsets. 
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Functional characterisation of L-DC in 
relation to splenic dendfitic and 
myeloid cell subsets 
CHAPTERS 
5.1 Introduction 
Dendritic cells (DC) play an important role in the immune system by acting 
as a mediator between the innate and adaptive irmnune responses (Heath et al. , 
2004). Under steady-state conditions, DC process and present self antigen to T cells 
to maintain self-tolerance and to prevent autoimmunity (Heath et al., 2004; Shortman 
and Naik, 2007). However, during infection and inflammation, autoimmunity is also 
kept in check by regulatory T (Treg) cells (Sakaguchi et al. , 2008). During infectious 
states, DC become activated by danger signals and recruit other leukocytes to sites of 
infection leading to activation of the adaptive immune response (Shortman and Naik, 
2007). Most iinportantly, DC that acquire infectious agents activate T cells and 
mount an antigen-specific immune response against the pathogen (Heath et al. , 2004; 
Short1nan and Naik, 2007). Since multiple DC subsets have been described, it is 
important to characterise them in terms of their function, and to identify their 
interaction with other leukocytes for better understanding of their · role in the 
maintenance of tolerance and in inducing immune responses. 
Professional antigen presenting cells (APC) can process and present 
exogenous antigen to CD4+ T cells as peptides on MHCII molecules. However, some 
splenic DC have a unique ability to cross-present antigen to CDS+ T cells (Sho1iman 
and Heath, 20 I 0). Exogenous antigens are processed and presented as peptides 
bound to MHCI n1olecules for CDS+ T cell activation. Cross-presentation can occur 
by two pathways: the cytosolic and vacuolar pathways (Heath and Carbone, 200 I). 
The cytosolic pathway involves uptake of exogenous antigen by endosomes with 
subsequent release into the cytoplasm where it is degraded by proteasomes. Peptides 
are then transpo1ied into the endoplasmic reticulum (ER) by transporters associated 
with antigen processing, the TAP molecules (Heath and Carbone, 200 I) . 
Subsequently, peptides are loaded on to MHCI molecules which are then shuttled to 
the cell me1nbrane for presentation to CDS+ T cells. While this is the most likely 
mechanism for cross-presentation, there has been no direct evidence that the loading 
of peptides on to MHCI molecules occurs in the ER. However, TAP and the MHCI 
loading complex have been described in phagosomes and endosomes (Burgdorf et 
al. , 2008; Monu and Tro1nbetta, 2007), so that it is likely that the loading of peptide 
on to MHCI can occur in the cytoplasm. The vacuolar pathway is distinct from the 
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cytosolic pathway such that antigen processing occurs within endosomes (Heath and 
Carbone, 2001 ). These contain lysosomes that break antigen down into peptides. The 
loading of peptide on to MHCI occurs when vesicles carrying MHCI molecules fuse 
with peptide-rich endosomes. The use of these pathways by DC is still not well 
defined. However, it is possible that DC can use both pathways under different 
conditions, and there is evidence in the literature which supports this possibility 
(Joffre et al. , 2012). 
LTC-DC are capable of cross-presenting antigen to CD8+ T cells (O'Neill et 
al. , 2011; O'Neill et al. , 2004; Quah et al., 2004; Wilson et al. , 2000) (Chapter 3). 
Their cross-presenting ability, as well as their high endocytic capacity, can therefore 
be used as defining prope1iies in the identification of a similar cell type in vivo. In 
Chapter 3, the ability of a CDl 1 bhiCDl lc10MHCirCD8- L-DC subset to cross-prime 
CD8+ T cells was determined in an in vitro assay by pulsing the sorted L-DC subset 
with OVA prior to addition of labelled CD8+ T cells from OT-I TCR-tg (anti-
H2Kb/OV A257_264) n1ice. However, the assay outcome was limited by low numbers of 
available L-DC. Conventional( c) DC are rare cells representing about one percent of 
spleen, and L-DC have an even lower frequency in spleen than cDC (Griffiths et al., 
2013). In addition, antigen pulsing and washing steps used in in vitro assays also 
contribute to cell loss. To overco1ne the limitations of the in vitro assay for 
functional studies, Act1n-OV A transgenic mice were en1ployed here as a source of 
APC (Ehst et al. , 2003). These mice constitutively express membrane-bound OVA 
under the actin pro1noter. Cross-presentation of antigen occurs in vivo, when APC 
endocytose dead cells and cell debris. However, this 1nouse 1nodel expresses high 
levels of cell-associated OVA protein. It is therefore possible that so1ne OVA enters 
the endogenous antigen processing pathway within cells. For example, defective 
OVA could be tagged for ubiquitin destruction in the cytoplasm, entering 
proteason1es, and then be transpo1ied into the ER. For this reason, it was necessary to 
use control APC subsets which do not cross-present in order to gauge any 
background effect due to antigen overload. Since myeloid subsets have been 
described as unable to cross-prime CD8+ T cells, these were used as controls in 
cross-presentation assays involving APC derived from Actm-OV A mice. 
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This chapter focuses on the functional characteristics of cDC and other 
myeloid subsets identified in Chapter 4, as well as the ' candidate ' L-DC subsets 
under investigation. Five aspects of APC function have been investigated. These 
include the ability to uptake and retain antigen, to present antigen to CD4+ T cells, to 
cross-present antigen to CD8+ T cells, and to induce cytotoxic T lymphocytes. 
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5.2 Results 
5.2.1 Comparison of the endocytic capacity of L-DC, cDC and myeloid cells 
Spleen is a secondary lymphoid organ that is specialised in filtering blood-
borne antigens. It is anticipated therefore that some splenic dendritic and myeloid 
cells are readily able to endocytose antigen. In this study, pinocytosis and receptor-
mediated endocytosis of antigen were investigated. Previous studies showed that 
LTC-DC are highly endocytic (O'Neill et al., 2004; Tan et al. , 2011), and so this 
property was also used to distinguish L-DC candidates. Soluble OVA conjugated 
with FITC (OV A-FITC) was delivered intravenously to C57BL/6J mice at different 
times ( 1, 3 and 6 hours) prior to euthanasia. Spleens were collected for analysis and 
flow cyton1etric assessment of uptake of OV A-FITC in different splenic dendritic 
and myeloid subsets was performed as described in Section 2.5.1. Consistent with 
the literature, both CDS+ cDC and CDS- cDC demonstrated ability to endocytose and 
retain antigen over a 3 hour period (Figure 5.1 A). CDS+ cDC demonstrated some 
ability to retain antigen, since 11.2% of cells retained antigen_ after 6 hours (Figure 
5.1 A). 
Among the n1yeloid subsets, both resident and inflarmnatory 1nonocytes 
showed ability to endocytose and retain antigen, with resident monocytes the most 
potent. Only ~9% of neutrophils and eosinophils took up and retained antigens after 
6 hours. Their endocytic capacity was relatively weak compared with the monocyte 
and cDC subsets (Figure 5.1 A and B). L-DC displayed ability to endocytose antigen, 
but the level of uptake was relatively low compared with 1nonocytes (Figure 5 .1 A 
and B). Overall, resident n1onocytes showed the strongest ability to endocytose and 
retain antigen over a 6 hour period, followed by CDS+ cDC, CDS- cDC, 
infla1mnatory 1nonocytes, L-DC, then neutrophils and eosinophils (Figure 5.1 C). 
In tenns of receptor-mediated endocytosis, different cell types can have a 
unique combination of receptors on their cell me1nbrane to aid uptake of antigen in 
various fonns. Mannose receptor-mediated uptake of antigen in DC has been shown 
to play a role in cross-presentation of antigen to CDS+ T cells (Burgdorf et al. , 2007; 
Burgdorf et al. , 2006). Cross-presentation is a defining property of DC, especially 
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Figure 5.1 Endocytic ability of myeloid and DC subsets. 
The ability of cells to endocytose antigen was 111easured by uptake of FITC-conjugated 
ovalbun1in (OV A-FITC). C57BL/6J 1nice were given OV A-FITC intravenously (i.v.; 
11ng per mouse) at ti1nes of 1, 3 and 6 hours prior to euthanasia for spleen collection. 
Control n1ice were given PBS. Spleen cells were RBC lysed and enriched for dendritic 
and 111yeloid cells via T and B cell depletion. Cells were stained with 2 distinct antibody 
cocktails. The first included antibodies to CD 11 b (Ml /70, PE-Cy7), CD 11 c (N4 l 8, 
APC), Ly6C (Al-21, PE) and Ly6G (1A8, Biotin). The second contained antibodies to 
CDI lb (Ml /70, PE-Cy7), CDI lc (N418, APC), CD8 (53 -6.7, PE) and MHC-II (25-9-
17, Biotin). Streptavidin (SA)-APC-Cy7 was used as a second stage reagent. Prior to 
flow cyton1etry, cells were stained with propidium iodide (PI, 1 µg/inl) to delineate live 
(Pr) cells. A) cDC were gated as CD 11 b +/-CD 11 chi cells and further delineated to give 
CD8+ cDC (CD8+MHC-II+) and CD8- cDC (CD8-MHC-II+) for assess1nent of OVA-
FITC staining. B) Myeloid cells were gated as a CDI 1 bhiCDl lc- subset, and further 
delineated to give eosinophils (Eos : Ly6C+Ly6G-) , inflarmnatory n1onocytes (Infl mono 
: Ly6ChiLy6G-) and neutrophils (Neu : Ly6C+Ly6G+). Resident monocytes (Resi 1110110) 
were gated as CD 11 bhiCD 1 1 c10Ly6C+Ly6G- cells while L-DC were gated as 
CD1 lbhiCDllc10Ly6C-Ly6G- cells. Uptake of OVA-FITC was assessed as% FITC 
staining cells. Gates were set based on fluorescence 1ninus one controls. Nu1nbers in 
quadrants reflect % positive cells. C) Time course of OV A-FITC uptake by cells. 
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splenic CDS+ cDC (Heath et al. , 2004 ). In order to determine if L-DC and other 
myeloid subsets could endocytose antigen via mannose receptor as do CDS+ cDC, 
mannan-conjugated to FITC (mannan-FITC) was delivered intravenously to 
C57BL/6J mice and uptake 1nonitored over time. Consistent with the literature, both 
CDS+ cDC and CDS- cDC demonstrated strong ability to take up antigen via the 
mannose receptor. Over 50% of CD8- cDC took up mannan-FITC and retained it for 
6 hours, co1npared with ~40% of CD8+ cDC (Figure 5.2 A) . Interestingly, both 
resident and infla1n1natory 1nonocytes demonstrated the strongest ability to take up 
n1annan via 1nannose receptor. By 1 hour after antigen delivery, over 7 5% of resident 
1nonocytes had taken up and retained mannan. Even after 6 hours, over half of the 
resident 1nonocytes retained mannan (Figure 5.2 A). In contrast, inflan1matory 
monocytes displayed peak uptake (SS%) at 3 hours post delivery of n1a1man with 
retention of antigen for 6 hours by ~45% of cells (Figure 5.2 A). Delayed uptake 
could reflect lower accessibility to antigen in comparison with resident monocytes. 
About 3 5% of eosinophils showed ability to take up 1nannan at 3 hours post delivery, 
although the level of 1nannan diminished by 6 hours (Figure 5.2 A). Neutrophils did 
not endocytose mam1an-FITC. L-DC showed similar high a_~ility to take up and 
retain n1annan as did CDS+ cDC (Figure 5.2 A). In this in vivo assay, uptake of 
n1am1an reflects both cell ability for endocytosis and accessibility to blood-borne 
antigen. Resident monocytes took up and retained the 111ost 1na1man, followed by 
infla1nn1atory 1nonocytes (Figure 5.2 B). Each of CDS+ cDC, L-DC and CDS- cDC 
took up and retained 1nannan-FITC at similar levels (Figure 5.2 B). 
5.2.2 Cross-priming ability as a criterion for delineation of L-DC subsets in 
spleen 
L TC-DC are known to be capable of cross-priming CD8+ T cells (Tan et al. , 
2011 ). Therefore, cross-prin1ing ability was used as a selection criterion for 
delineation of the in vivo equivalent of L TC-DC. This assay was therefore employed 
to detem1ine if the Ly6C-Ly6G- L-DC candidate delineated in Chapter 4 is in fact an 
in vivo equivalent of L TC-DC in terms of cross-presentation capacity. Splenic 
dendritic and n1yeloid subsets were therefore sorted from 1nACT-OV A mice 
according to the sorting plan used in Figure 4.3. The cross-priming ability of L-DC 
and other 1nyeloid subsets for OT-I TCR-tg CD8+ T cells was assessed and compared 
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Figure 5.2 Role of mannose receptor in antigen uptake. 
Ability of dendritic and n1yeloid subsets to take up antigen via n1annose receptors was assessed in tenns of uptake of FITC-conjugated 1na1u1an 
(rhannan-FITC). This was given to C57BL/6J 1nice intravenously (i.v: 0.Sn1g per n1ouse) at 1, 3 and 6 hours before euthanasia for spleen collection. 
Control 1nice were given PBS. Spleen cells were prepared and stained for flow cyto1netry as described in the legend to Figure 5 .1. Prior to flow 
cyton1etry, cells were stained with propidiu1n iodide (PI, 1 ~tg/inl) to delineate live (Pr) cells. A) Myeloid cells were gated as CD 11 b11 iCD 11 c- cells and 
f-urther delineated to give eosinophils (Eos: Ly6C+Ly6G-), infla1m11atory n1onocytes (Infl n1ono: Ly6C 11 iLy6G-) and neutrophils (Neu: Ly6C+Ly6G+). 
Resident monocytes (Resi mono) were gated as CDl 1 b 11 iCD1 lc10Ly6C+Ly6G- cells, while L-DC were gated as CDl 1 b 11 iCDl lc10Ly6C-Ly6G- cells. 
Conventional DC were gated as CD 11 b +t-cD 11 c11 i cells, and flu-ther delineated to give CD8+ cDC (CD8+MHCII+) and CD8- cDC (CD8-MHCII+) 
subset. Uptake of 1nannan-FITC via n1annose receptors was assessed as % 1nannan-FITC positive cells. Gates were set based on fluorescence 1ninus 
one controls. Numbers in quadrants reflect % positive cells. B) Uptake of FITC-n1a1man by cells at over time. 
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with that of CD8+ cDC and CD8- cDC subsets, which serve as positive controls. The 
assay was performed in the presence and absence of lipopolysaccharide (LPS) which 
acts as a potent inflanunatory stimulus for some DC (Akira and Takeda, 2004). 
Across experiments I, II and III (Figure 5.3), both CD8+ cDC and CD8- cDC showed 
strong ability to cross-priine CD8+ OT-I T cells, with CD8- cDC marginally stronger 
than CD8+ cDC. L-DC demonstrated weaker ability to cross-pri1ne CD8+ OT-I T 
cells requiring ~30 fold 1nore L-DC to induce an equivalent response as CD8- cDC 
(Table 5 .1). N eutrophils in Experiment I, and resident monocytes in Experiment II, 
showed weaker ability to induce proliferation in CD8+ T cells than did L-DC (Figure 
5.3). 
The ratio of T cells/ APC required to induce 50% proliferation of CD8+ T 
cells was calculated in order to co1npare data across experiments (Table 5 .1 ). This 
collective data showed that isolated CD8- cDC demonstrated the strongest ability to 
cross-pri1ne CD8+ T cells, even above CD8+ cDC. This is contradictory to the 
literature which compares isolated antigen-pulsed CD8+ cDC and CD8- cDC (Den 
Haan et al. , 2000; Pooley et al. , 2001). CD8- cDC incll}ced 50% maxi1num 
proliferation of CD8+ T cells at 900 T cells/ APC (Table 5 .1 ). CD8+ cDC were the 
second best inducer of proliferation in CD8+ T cells, requiring 1nore APC at a ratio of 
~300:1 T cells/APC (Table 5.1). L-DC were required at a higher number and induced 
50% maxi1nun1 proliferation at ratios of 3 3 or 100 CD8+ T cells/L-DC (Table 5 .1 ). 
Both resident monocytes and neutrophils showed weaker ability to cross-prin1e CD8+ 
T cells than L-DC (Table 5.1). In addition, the presence of LPS added into co-
cultures in this protocol did not improve the outco1ne of T cell activation across 5 
experi1nents for all cell types tested (I to V) (Table 5 .1 ). 
The cross-presenting ability of myeloid subsets in relation to DC has been the 
subject of debate. Initial studies suggested that cross-presentation was restricted to 
DC (Shortman and Heath, 2010). However, some n1acrophages and neutrophils have 
been described as having cross-presenting ability under various conditions 
(Beauvillain et al. , 2007; Harding and Song, 1994; Kovacsovics-Bankowski et al. , 
1993; Norbury et al. , 1995 ; Pfeifer et al. , 1993). Splenic myeloid subsets so1ied from 
1nACT-OV A mice were therefore co1npared with the candidate L-DC subset for 
ability to cross-present OVA, with the aiin of further delineating the L-DC subset 
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Figure 5.3 Cross priming capability of dendritic and myeloid cell subsets. 
Splenocytes were harvested fro1n Act-n1OV A 1nice and prepared by red blood cell lysis 
and T /B cell depletion. In experiments I, II and III, e1u·iched splenocytes were stained 
with CDl 1 b (Ml/70, PE-Cy7), CDl le (N418, APC) , Ly6C (AL-21 , FITC), Ly6G 
(1A8, PE) and MHCII (25-9-17, Bio) , using streptavidin (SA)-APC-Cy7 as a second 
stage reagent. Cells were so1ied as described in Figure 3 .2. Conventional DC were gated 
as CD 11 c11 iMHCII+Ly6C-Ly6G- cells and further delineated to give CD8+ cDC and CD8-
cDC on the basis of CD 11 b expression. L-DC were gated as CD 11 b 11 iCD 11 c
10Ly6C-
Ly6G-MHCir cells. In experin1ent I, neutrophils (Neu) were gated as CDl 1 bhiCDl lc-
Ly6C+Ly6G+MHCir cells. In experi1nent II, resident monocytes (resi 1110110) were gated 
as CDl 1 b11 iCDl lc10Ly6C+Ly6G-MHCir cells. Diluting numbers of APC were plated 
followed by treatn1ent with or without lipopolysac·charide (LPS: 1 0ughnl) for 2 hours 
prior to the addition of 105 CFSE-labelled OT-I (TCR-tg) CD8+ T cells. The latter were 
purified fron1 OT-I 1nouse spleen through depletion of B cells, CD4+ T cells, DC and 
111yeloid cells using 1nagnetic bead protocols. In experiment III , OT-I CD8+ T cells were 
sorted fron1 OT-I 1nice as PrThyl.2+Va2+CD4- cells. Cells were cocultured with APC 
in T cell: APC ratios of 33 :1 , 100:1 , 300:1 and 900:1. After 72 hours, CD8+ OT-IT 
cells were gated as Pr CD 11 b -Thy l .2+V a2+ cells, and assessed flow cyto1netrically for 
CFSE dilution as an indicator of proliferation. OT-IT cells alone also served as -control 
( con). Graphs show % proliferation of OT-I cells . 
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Table 5.1 Ability of dendritic and myeloid subsets to activate COS+ T cells. 
Expt Condition T cell/ APC ratio giving 50% maximum proliferation of 
OT-IT cells 
. 
. cos- cOC CDS+ cOC L-OC Resi Monoa Neub 
I +LPS 900 300 33 
- 33 
-LPS 900 300 33 
- << 33 
II +LPS 900 300 33 ") ") .) .) 
-
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-
-
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-LPS > 900 141 100 42 -
V +LPS > 900 > 900 100 100 -
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' 
' 
- LPS > 900 > 900 100 100 -
a Resi mono : Resident 1nonocytes b Neu : N eutrophils 
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from myeloid cells. Both resident and inflammatory monocytes shovved some ability 
to cross-prime CDS+ T cells, although resident monocytes gave a stronger CDS+ OT-
I T cell response (Figure 5.4). The T cell/APC ratio which gave 50% maximum 
proliferation, was also tabulated for experiments VI - VIII (Table 5.2). The presence 
of LPS induced a marginal increase in cross-priming response for L-DC under this 
protocol, while other APC remained unaffected (Table 5 .2). While outcomes from 
different experiments varied slightly, there was an overall trend showing that L-DC 
were similar to the CD4 3 + subset of cDC, but were better APC than resident 
monocytes, infla1mnatory monocytes and neutrophils. 
5.2.3 The effect of cytochrome c on cross-presentation capacity 
Uptake of cytochro1ne c via endocytosis, and entry into the cytoplasm via 
cross-presentation, can lead to cell death (Ming et al., 2008). Since cytochro1ne c 
selectively kills CDS+ cDC, this suggests that the mechanisn1 for cross-presentation 
by CDS+ cDC involves the cytosolic pathway (Ming et al., 2008). L-DC were 
therefore tested to determine if cytochrome c treatment leads tQ_ cell death, indicative 
of cross-presentation via the cytosolic pathway. Cytochrome c was injected 
intravenously into C57BL/6J mice, and changes in the representation of all dendritic 
and n1yeloid subsets determined after 6 hours (Figure 5.5). No difference was found 
in the size of the treated populations compared with controls for CDS+ cDC, CD8-
cDC, L-DC, neutrophils or infla1mnatory monocytes (Student's t test: p < 0.01). 
Further analysis of treatn1ent on CDS- cDC involved the Wilcoxon test since the 
variance of the treated and control populations was different. This test again showed 
no significant difference at p < 0.05. A significant increase in the subset size of 
resident n1onocytes was observed (Student's t test: p < 0.01), while a significant 
decrease in% eosinophils was observed (Student's t test: p < 0.01). Since an increase 
in cell nun1ber is w1likely to be due to the direct effect of cytochro1ne c on cells, this 
change in resident n1onocytes could reflect a population change due to treatment in 
VlVO. 
To further dete1mine the effect of cytochrome c on the cross-presenting 
capacity of splenic APC, sorted cells from mACT-OV A mice were treated with 
cytochro1ne c prior to co-culture with CFSE-labelled OT-I CDS+ T cells for 
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Figure 5.4 Cross priming capability of L-DC compared with monocyte subsets. 
Splenocytes were harvested fron1 Act-111OV A 1nice and prepared by red blood cell lysis 
and T /B cell depletion. In experi1nents VI and VII, splenocytes were stained with 
CDllb (Ml/70, PE-Cy7), CDllc (N418, APC), CD43 (IBII, Alexa 488), Ly6C (AL-
21, Pacific Blue), Ly6G (1A8, PE) and MHCII (25 -9-17, Bio), using streptavidin (SA)-
APC-Cy7 as a second stage reagent. Cells were so1ied as described in Figure 4.3. L-DC 
were gated as CD 11 b11 iCD 11 c1°CD43+Ly6C-Ly6G-MHCir cells. Resident 1nonocytes 
(Resi 1110110) were gated as CDl 1 b 11 iCD1 lc1°CD43+Ly6C+Ly6G-MHCir cells, while 
inflan1111atory 111onocytes (Infl mono) were gated as CD 11 b11 iCD 11 c-
CD43 +Ly6C11iLy6G-MHCir cells. In experin1ent VI, CD43- cDC were gated as 
described in Figure 4.3 as CD 11b+I-CD11 c11 iCD43-MHCII+Ly6C-Ly6G- cells. In 
experin1ent VII , neutrophils (Neu) were gated as described in Figure 4.3 , 
CD 11 b11 iCD 11 c-CD43+Ly6C+Ly6G+MHCir cells. Sorted APC were used to activate 
OT-I cells as described in-Figure 5.3. OT-I T cells were sorted fro1n OT-I 111ice as Pr 
Thyl.2+Va2+CD4- cells. Cells were cocultured with APC in T cell:APC ratios of 33:1 , 
100:1 , 300:1 and 900:1. After 72 hours , CD8+ OT-IT cells were gated as PrCDllb-
Thy 1.2+V a2+ cells, and assessed flow cytometrically for CFSE dilution as an indicator 
of proliferation. OT-I T cells alone served as a control (Con). Graphs show % 
proliferation of OT-I cells. 
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Table 5.2 Ability of dendritic and myeloid subsets to activate CDS+ T cells. 
Expt Condition T cell/APC ratio giving 50% maximum proliferation of 
OT-IT cells 
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Figure 5.5 Effect of in vivo cytochrome c treatment on myeloid and DC subset representation. 
he in vivo killing effect of cytochro1ne c was investigated in C57BL/6J 1nice. Cytochro1ne c (5111g/111ouse) was delivered intravenously 6 hours prior 
to euthanasia for spleen collection. Contro l 111ice were given PBS. Spleen cells were prepared and stained for flow cyto1netry as described in the legend 
to Figure 5.3 , and gated as described in Figure 5.2. Gates were set based on fluorescence 111inus one controls. Prior to flow cyton1etry, cells were 
stained with propidiun1 iodide (PI, 1 ~Lg/n1l) to delineate live (Pr) cells. Individual 111ice were analysed. A bar is used to show 1nean values. A) Percent 
cDC relative to total dendritic and 1nyeloid cell population. B) Percent 1nyeloid subsets and L-DC relative to total dendritic and 1nyeloid cell 
population. Red boxes indicate a significant change relative to wild type using Student's t-test (p value < 0.01). 
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assessment of T cell proliferation. Consistent with the literature, a drop in the cross-
presenting ability of CD8+ cDC was observed when cells were treated with 
cytochrome c across multiple experiments (Figure 5.6). This effect was reflected by a 
weaker T cell proliferative response. Similarly, a drop in ability to cross-present was 
observed for cog- cDC. Cytochrome c did reduce L-DC ability to cross-present 
antigen to CD8+ T cells in one experiment, but this was not a consistent result and 
gave a 3-fold reduction in only one experi1nent (Figure 5.6 and Table 5.3). 
Cytochro1ne c treatment resulted in a consistent three-fold increase in the number of 
APC needed to give 50% n1aximum proliferation for both cog- cDC and CD8+ cDC 
(Table 5.3). While the cross-presentation capacity of CD8+ cDC and cog- cDC is 
clearly affected by cytochrome c treatment, the case for L-DC is less certain, with 
variable, s1nall effects. One interpretation is that the cytosolic pathway is not used 
exclusively by the L-DC subset for cross-presentation of antigen. 
Resident monocytes demonstrated weak ability to cross-prin1e CD8+ T cells 
(Figure 5.4), and their nu1nbers in vivo were not reduced by cytochro1ne c treatment 
of mice (Figure 5.5). Neutrophils showed little ability to cross_:-prime CD8+ T cells 
(Figures 5 .3 and 5. 7), and required more APC and a T cell/ APC ratio of less than 
33:1 to generate 1neasurable T cell proliferation (Table 5.4). Similarly, the T cell 
activating capacity of both resident and infla1mnatory 1nonocytes was unaffected by 
cytochro1ne c treat1nent (Figure 5. 7) , and also required more APC and a T cell/ APC 
ratio of less than 33: 1 to induce measurable T cell proliferation (Table 5.4). 
Consistent with data shown in Table 5.3 , cytochrome c treated L-DC in experiments 
VI and VII (Table 5.4) showed a n1inor and variable decrease in ability to cross-
prii11e CD8+ T cells following cytochrome c treatment. 
5.2.4 Ability of splenic dendritic and myeloid cells to activate CD4+ T cells 
Antigen presenting cells like DC and monocytes can take up exogenous 
antigen for processing and presentation on MHCII leading to activation of CD4+ T 
cells. cog- cDC have been described as the main APC for induction of CD4 + T cell 
activation (Kronin et al. , 2001). In contrast, LTC-DC have been described as MHCir 
cells which lack ability to present antigen on MHCII for CD4+ T cell activation (Tan 
et al. , 2011). Lack of MHCII expression and inability to activate CD4+ T cells can 
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Figure 5.6 Effect of cytochrome c on the cross-priming potential of isolated DC 
subsets. 
Splenocytes were harvested fron1 Act-1nOV A n1ice and prepared by red blood cells lysis 
and T /B cell depletion. In the two experiments shown, e1u·iched splenocytes were 
stained as described in the legend to Figure 5 .3. Cells were sorted as described in Figure 
4.3. In both experin1ents, L-DC were gated as CDl 1 b
11 iCD1 lc10Ly6C-Ly6G-MHCir 
cells. While CD8+ cDC were gated as CDl 1 b-CD1 lc11 iMHCII+Ly6C-Ly6G- cells and 
CD8- cDC as CD 11 b +CD 11 c11 iMHCII+Ly6C-Ly6G- cells. Diluting nun1bers of APC 
were plated followed by treatn1ent with or without cytochro1ne c (6 1ng/ml) for 2 hours 
prior to the addition of 105 CFSE-labelled OT-I (TCR-tg) CD8+ T cells, purified fro1n 
OT-I n1ouse spleen tlu·ough depletion of B cells, CD4+ T cells, DC and myeloid cells 
using n1agnetic bead protocols. Cells were cocultured with APC in T cell:APC ratios of 
33:1 , 100:1 , 300 :1 and 900:1. After 72 hours, CD8+ OT-IT cells were gated as Pr 
CD 11 b-Thy 1.2+Va2+ cells, and assessed flow cyton1etrically for CFSE dilution as an 
indicator of proliferation. OT-I T cells alone served as controls ( con). Graphs show % 
proliferation of OT-I cells. 
Expt II 
100 COS- cOC cos+ coc L-OC 
C 75 
·---- .... 0 .. 
.. :;:::; 
.. cu .. 
.. I.... 
... ~ \ 50 \ 
\ 0 \ I.... 
\ Q. 
~ 
' 
-;:R 
' 
0 
' 25 
' 
' 
' 
' 
' .... 
.... 
• 0 
~~ ~:t ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ o<::-':, ,~ ':,~ O:;~ ':, ,~ ':,~ O:;~ ':, ,~ ':,~ O:;~ CJ 
Expt Ill 
100 COS- cOC cos+ coc L-OC 
C 75 - Cyto C 0 .... , .... , 
-•- w/o Cyto C ' ....., ' ' ' ' cu 
' ' □ Control I.... ' ' ' ~ ' • 50 
' 
' 0 
' 
I.... 
• Q. 
' 
' ~ 
' 0 25 ' 
' 
' 
' 
□ 0 
r:s~ c;::,~ c;::,~ c;::,~ r:s~ .1\ .1\ c;::,~ r:s~ .1\ .1\ ~~ o<::-C) · C) · C) · C) · ':, "\) ':,\) 
~\) ':, "\) ':,\) 
~\) ':, "\) ':,\) 
~\) G 
T cell : APC ratio 
Table 5.3 Activation of COS+ T cells following cytochrome c treatment. 
Expt Condition · j T cell/APC ratio giving 50% maximum proliferation of OT-I 
T cells 
cos- cOC COS+ cOC L-OC Neua 
I + Cyto C 300 141 33 << 33 
- Cyto C 900 300 < 33 << 33 
II + Cyto C 300 423 33 
- Cyto C >> 900 423 100 
III + Cyto C 300 100 100 
- Cyto C >> 900 300 141 
IV + Cyto C 423 100 100 < 33 
- Cyto C 300 I 300 141 < 33 
a Neu : N eutrophils 
Figure 5.7 Effects of cytochrome c on L-DC and myeloid cell subsets. 
Splenocytes were harvested fro1n Act-1nOV A 1nice and prepared by red blood cell lysis 
and T/B cell depletion. E1u·iched splenocytes were stained with CD 11 b (Ml/70, PE-
Cy7), CD 11 c (N4 l 8, APC), CD43 (IBII, Alexa 488) , Ly6C (AL-21 , Pacific Blue), 
Ly6G (1A8, PE) and MHCII (25-9-17, Bio) , using streptavidin (SA)-APC-Cy7 as a 
second stage reagent. Cells were sorted as described in Figure 4.3. L-DC were gated as 
CDl 1 b11 iCDl lc1°CD43+Ly6C-Ly6G-MHCir cells, while neutrophils (Neu) were gated 
as CD 11 b11 iCD 11 c-CD43+Ly6C+Ly6G+MHCir cells. Resident monocytes (Resi mono) 
were gated as CD 11 b11 iCDl lc1°CD43+Ly6C+Ly6G-MHCir cells, while inflammatory 
111onocytes (Infl mono) were gated as CDl 1 bhiCDl lc-CD43+Ly6C 11 iLy6G-MHCir cells. 
In addition. cDC were gated as CD 11b+I-CD11 c11 iCD43-MHCII+Ly6C-Ly6G- cells. 
Cross-presenting capacity of subsets in the presence and absence of cytochrome c 
treatn1ent was assessed by ability to induce proliferation in OT-I CD8+ T cells as 
described in Figure 5.6. OT-I T cells served as controls (Con). Graphs sho % 
proliferation of OT-I cells. 
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Table 5.4 Activation of CD8+ T cells following cytochrome C treatment. 
Expt Condition T cell/APC ratio giving 50% maximum proliferation of OT-IT cells 
V 
VI 
+ Cyto C 
- Cyto C 
+ Cyto C 
- Cyto C 
L-DC 
100 
100 
141 
300 
a Resi mono : Resident 1nonocytes 
b Infl mono : Inflamn1atory monocytes 
c Neu : N eutrophils 
Resi monoa 
<< 33 
<< 33 
< 33 
< 33 
I 
I 
Intl monob 
< 33 
< 33 
Neuc 
< 33 
< 33 
CD43+cDC 
100 
300 
CHAPTER 5 
therefore be used as another criterion for identification of an in vivo equivalent of 
L TC-DC. APC subsets were sorted from the spleens of Actm-OV A mice and 
compared for capacity to induce proliferation in CD4 + T cells isolated from OT-II 
TCR-tg (anti IA b/OV A323_339) mice. 
Consistent with the literature, both CDS+ cDC and cos- cDC were shown to 
present antigen for activation of CD4+ T cells, with CD8- cDC as the stronger 
inducer (Pooley et al. , 2001) (Figure 5 .8). LPS had little effect as an activator of 
APC. L-DC induced no response in CD4+ T cells even in the presence of LPS 
(Figure 5.8). Resident monocytes did activate a s1nall proportion of CD4+ T cells 
(Figure 5.8), while eosinophils, neutrophils and inflammatory monocytes completely 
lacked ability to present antigen for activation of CD4+ T cells (Figure 5.8). 
5.2.5 Induction of effector T cells by L-DC 
The ability of APC to activate and induce proliferation in CDS+ T cells does 
not necessarily translate to their ability to induce effector functiQn. Experiments were 
therefore perfonned to con1pare the ability of L-DC, resident monocytes and CDS+ 
cDC to induce cytotoxic effector function in CDS+ T cells. An in vivo cytotoxic 
killing assay developed by Dr. Ben Quah (JCSMR, Canberra, ACT, Australia) was 
utilized here (Quah et al. , 2012). So1ied CDS+ OT-I (TCR-tg) T cells were delivered 
intravenously into 1nice one hour ahead of the delivery of APC sorted fro1n Actn1-
OV A n1ice (Figure 5.9 A). Three doses of so1ied APC were given to mice: 90,000, 
9,000 or 900 cells. Six days later, labelled peptide-pulsed splenocytes were delivered 
intravenously to these mice to act as target cells for cytotoxic effectors primed by 
so1ied APC (Figure 5.9 A). At one day after delivery of target cells, host splenocytes 
were harvested to quantitate % lysis of target cells (Figure 5 .9 A). Ahead of adoptive 
transfer, target splenocytes were labelled ,vith three different dyes used at four 
different concentrations. These were then pulsed with four different OVA peptides, 
-either SIIN, N 6, G4 or E 1 used at six different concentrations, so creating a 
multiplex assay. The peptides used are discussed in the legend to Figure 5.9. OT-IT 
cells can recognise the SIIN peptide but not the G4 and El peptides included as 
negative controls. The N6 peptide is a variant of SIIN peptide with phenylalanine 
and glutamic acid re1noved, which is also recognised by OT-I T cells. 
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Figure 5.8 Activation of CD4+ T cells by different splenic APC. 
Splenocytes were harvested fron1 Act-mOV A n1ice and prepared by red blood cell lysis and T/B cell depletion. In experi1nent I, T/B depleted 
splenocytes were stained as described in Figure 5.3. Cells were sorted as described in Figure 3.2, such that cDC were gated as CDl lc
11 iMHC-II+Ly6C-
Ly6G- cells and further delineated to give CD8+ cDC and CD8-cDC on the basis of CD 11 b expression. L-DC were gated as CD 11 b
11 iCD 11 c10Ly6C-
Ly6G-MHC-Ir cells, while resident 1nonocytes (Resi mono) were gated as CDl lb11 iCDl lc10Ly6C+Ly6G-MHC-Ir cells. In experiments II and III, 
splenocytes were stained with an additional antibody specific for Siglec-F. Dendritic and myeloid cell subsets were gated as described in Figure 4.3. 
Both CD8-cDC and L-DC were gated as described in experi1nent I but also as Siglec-F- cells. Eosinophils (Eos) were gated as CDl 1 b
11 iCDl lc-
Ly6C+Ly6G-Siglec-F+ cells, while neutrophils (Neu) were gated as CDl 1 bhiCDl lc-Ly6C+Ly6G+Siglec-F- cells. Resident monocytes were gated as 
CDl lb11 iCDl lc10Ly6C+Ly6G-Siglec-F- cells, while inflamn1atory monocytes (Infl mono) were gated as CDl lbhiCDl lc-Ly6C
11 iLy6G+Siglec-F- cells. 
Diluting numbers of APC were plated, followed by treat1nent with or without lipopolysaccharide (LPS: 1 0ug/ml) for 2 hours, prior to the addition of 
105 CFSE-labelled OT-II (TCR-tg) CD4+ T cells, sorted as PrThyl.2+Va2+CD8- cells. Cells were cocultured in T cell:APC ratios of33:l , 100:1 , 300:1 
and 900: 1. After 72 hours, CD4 + OT-II T cells were gated as Pr CD 11 b-Thy l.2+V a2+ cells, and assessed flow cytometrically for CFSE dilution as an 
indicator of proliferation. OT-II T cells alone served as controls (Con). Graphs show% proliferation of OT-II cells. 
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Figure 5.9 Ability of splenic APC subset to induce cytotoxic T lymphocytes. 
The ability of APC subsets to induce cytotoxic effector function in CD8+ T cells was assessed by n1easuring lysis of OVA peptide-pulsed target cells in 
a fluorescent target assay (FTA). A) The experimental procedure is shown as a timeline. On Day 0, CD8+ T cells fron1 OT-I TCR-Tg n1ice were 
prepared by RBC lysis of splenocytes and sorting for PrThyl.2+Va2+CD4- cells. OT-IT cells (3.5 x 10
6) were delivered intravenously (i.v.) into host 
rriice (C57BL/6). An hour later, several APC subsets sorted fro1n Actm-OV A n1ice were also delivered into host 1nice. These were sorted as described 
in Figure 4.3 , and three cell doses (90K, 9K or 0.9K) were given i.v .. In order to measure the effector function of activated CD8+ T cells after 7 days, 
B6.SJL splenocytes as targets were prepared and adoptively transfe1Ted i.v. on Day 6. Target cells were labelled with several concentrations of 3 
different dyes for later identification as described in Section 2.5 .3. Overall, labelled target cells were then pulsed with 6 different concentrations of 4 
distinct OVA peptides: SIINFEKL (SIIN), GLEQLESIINFEKL (N6), SIIGFEKL (G4) and EIINFEKL (El). Specific killing of the distinctly labelled, 
antigen-pulsed target cells was determined by flow cyto1netric analysis to determine the nu1nber of target cells remaining in the test mouse co1npared 
with the control mouse given OT-IT cells only. Calculation of target lysis involved the fonnula described in Section 2.5.3. B) % specific lysis of target 
cells pulsed with different concentrations of peptides by OT-I T cells prin1ed with three different APC types. Data is expressed as n1ean ± SE (n= 6). 
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CHAPTERS 
The APC subsets of L-DC, resident monocytes and CD8+ cDC each induced 
CTL which lysed target cells pulsed with SIIN and N6 peptides, but not target cells 
pulsed with the G4 or El peptides (Figure 5.9 B). In addition, the level of lysis of 
target cells reduced with decreasing concentration of peptides used to pulse APC, 
and the nun1bers of APC used to prin1e host mice (Figure 5.9 B). In order to directly 
compare APC subsets, the concentration of peptide required to prime CTL for 50% 
lysis of target cells was determined for each APC. With N6 peptide, CTL generated 
by priining with 9,000 resident 1nonocytes required 100 times more peptide to induce 
50% lysis of target cells, when compared with L-DC and CD8+ cDC. After priming 
with 90,000 APC, cytotoxic T ly1nphocytes generated with CD8+ cDC as APC, 
required 10 ti1nes more SIIN peptide to give 50% lysis of target cells by comparison 
with L-DC and resident 1nonocytes (Table 5.5). When the nu1nber of priming APC 
was reduced to 9,000, CTL generated by resident monocytes required a higher 
concentration of SIIN to induce 50% lysis of target cells when co1npared with L-DC 
and CD8+ cDC (Table 5.5). Overall, resident n1onocytes induced a weaker CTL 
response compared with L-DC and CD8+ cDC. The latter two APC appear to induce 
similar cytotoxic effector responses. 
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Table 5.5 Capacity of splenic subsets to induce cytotoxic T cells. 
Peptide No. APC from Actm-
OVA mice used for Concentration of peptide (uM) 
• • t + pr1m1ng -x required to activate CTL for 50% 
lysis of targets 
Targets: L-DC Resi Mono CD8+cDC 
SIIN 90K 0.1 0.1 1.0 
9K 10.0 >>10 10.0 
0.9K 0 0 0 
N6 90K 0.001 0.001 0.001 
9K 0.01 1.0 0.01 
0.9K 0 0 0 
-
G4 90K 0 0 0 
9K 0 0 0 
0.9K 0 0 0 
El 90K 0 0 0 
9K 0 0 0 
0.9K 0 0 0 
* Mice were also given sorted OT-I CD8+ T cells (3.5 x 106) prior to APC. 
+ APC were sorted from spleens of n1ACT-OV A 1nice. These included L-DC, resident 
monocytes (Resi mono) and CD8+ cDC. 
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5.3 Discussion 
There have been many reports suggesting that the route of antigen uptake can 
determine the processing and presentation pathway used for T cell activation 
(Burgdorf et al. , 2007; Burgdorf et al. , 2006; Burgdorf et al. , 2008). Burgdorf et al. 
(2006, 2007, 2008) demonstrated that soluble antigen uptake in DC via pinocytosis 
can lead to strikingly different outcomes in terms of activation of T cells compared 
with n1annose receptor-mediated uptake. They showed that uptake of antigen via the 
mannose receptor led exclusively to CD8+ T cell activation as evidence of cross-
presentation, while uptake via pinocytosis led to the activation of CD4+ T cells. 
However, their study did not distinguish the capacity of cDC, since they isolated 
CD 11 c + splenocytes via density centrifugation and micro bead technology rather than 
by sorting, and co1npared only the cross-priming ability of the heterogeneous 
population of CD 11 c + splenocytes, bone marrow-derived DC and bone marrow-
derived macrophages. The relationship between antigen uptake capacity and cross-
presentation capacity has been studied here using carefully sorted myeloid and 
dendritic subsets characterised in spleen. 
Here it is shown that splenic DC and myeloid subsets not only differ in 
phenotype, but also have distinct functional capacity. Aspects of immune function 
studied in this chapter help to distinguish these splenic subsets further. CD8+ cDC 
and CD8- cDC can be distinguished from 1nyeloid subsets by their high endocytic 
ability, their strong cross-priming ability, and their ability to induce both CD4 and 
CD8 T effector functions. By comparison with n1yeloid subsets, cDC subsets were 
capable of endocytosing soluble antigen, but showed weaker capacity for mannose 
receptor-mediated endocytosis. Amongst the myeloid subsets, monocytes, 
eosinophils and neutrophils lacked ability to activate CD4+ T cells, and only resident 
monocytes den1onstrated some ability to cross-prime CD8+ T cells. In te1ms of 
endocytic capacity, resident n1onocytes and inflammatory monocytes demonstrated 
superior ability to endocytose antigens via the mannose receptor, and resident 
monocytes showed the strongest ability to endocytose soluble antigen. The Ly6C-
Ly6G- L-DC candidate identified in Chapter 4 demonstrated strong mannose 
receptor-mediated uptake of antigen but weak capacity to endocytose soluble 
antigen. This L-DC candidate also displayed stronger ability than myeloid subsets to 
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cross-prime CD8+ T cells (Figure 5.3 and 5.4), and lacked ability to activate CD4+ T 
cells consistent with former evidence from L TC-DC. 
Previously, a functional mannose receptor was considered to be a marker of 
cross-presentation ability of splenic APC subsets (Burgdorf et al. , 2006; Burgdorf et 
al. , 2010). However, here we show that antigen uptake via mannose receptors is not 
related to cross-presentation capacity. Both resident and inflammatory monocytes 
demonstrate potent ability to take up mannan-FITC (Figure 5.2) but do not cross-
prime CD8+ T cells (Figure 5.2). At 3 hours post delivery of ma1man, close to 90% 
of infla1nmatory 1nonocytes and 75% of resident monocytes had taken up mannan-
FITC (Figure 5.3 and 5.4). By comparison, only 52% of CD8,+ cDC, 48.5% of L-DC 
and 34% of CD8- cDC had taken up mannan (Figure 5.2). Inflammatory and resident 
monocytes did not cross-present antigen at the level seen for CD8+ cDC, CD8- cDC 
and L-DC, although, L-DC and CD8+ cDC showed similar uptake of mannan-FITC, 
but variable cross-presenting ability. 
The hypothesis that antigen uptake via the mannose receptor is an indicator of 
cross-presentation ability is therefore disputed on the basis of data presented here. 
Previously, Segura et al. (2010) den1onstrated that gene knock-out of aminopeptidase 
IRAP, encoding an enzyme essential for proteolytic breakdown of antigen in the 
endoson1e, did not affect the cross-presenting ability of CD8+ cDC. Similarly, the 
knock down of 111annose receptor in CD8+ cDC did not impact on ability to cross-
present antigen (Segura et al. , 2009). However, gene knock down of IRAP and 
1na1u1ose receptor did adversely impact the ability of ex vivo isolated monocyte-
derived DC (1no-DC) to cross-prime (Segura et al. , 2009). One explanation for these 
discrepant findings could be that DC have n1ultiple receptors on the cell membrane 
which participate in the endocytosis of antigen, also consistent with their ability to 
clear apoptotic cells fro1n the environment (Savill et al. , 2002). Thus, for CD8+ cDC 
at least, receptors other than the mannose receptor must contribute to the uptake of 
antigens, and these must contribute to cross-priming of CD8+ T cells in mannose 
receptor and IRAP knockout mice. 
Early studies described the uptake of antigen via pinocytosis as an important 
element in the activation of CD4+ T cells (Burgdorf et al. , 2007). Both CD8+ cDC 
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and CD8- cDC demonstrate potent ability to take up antigen via pinocytosis and are 
both strong activators of CD4+ T cells (Figure 5.1 A) (Belz et al., 2005; Schnorrer et 
al., 2006). Resident monocytes were found to be the most pinocytic over a six hour 
time course (Figure 5.1 A), but these cells do not have the capacity to activate CD4+ 
T cells. Such activation capacity is due to a lack of MHCII expression rather than 
pinocytosis ability. One distinguishing trait of L-DC is their inability to activate 
CD4+ T cells. This is likely due to their absence of MHCII expression, rather than 
their weak pinocytic ability in comparison with monocytes (Figure 5 .1 C). 
hmnature DC have been described as highly endocytic until activation and 
1naturation, after which endocytic ability is reduced (Guermonprez et al. , 2002; 
Stei1u11an and Swanson, 1995; Wilson et al., 2004). This has been proposed as a 
possible mechanism for retaining antigen for cross-presentation (Savina and 
Amigorena, 2007). The in vitro studies on cross-presentation, involving pulsing APC 
with soluble OVA then measuring cross-presentation via proliferation of CD8+ T 
cells, are not reflective of the in vivo environment which allows multiple cell 
interactions (Burgdorf et al. , 2007; Burgdorf et al. , 2006; Buxgdorf et al. , 2008; 
Segura et al. , 2009). During the inflan1matory state, antigen in vivo could be both 
cell-associated and soluble in blood. Different APC could be needed to clear dead 
cells or cell debris, than are needed to take up soluble antigen from blood. Since each 
of the monocyte, L-DC and cDC subsets described here is able to take up soluble 
antigen as a spleen subset, they n1ay be well placed to clear blood-borne antigens in 
spleen. 
In order to gain an accurate picture of the ability of splenic subsets to cross-
present cell-associated antigen, subsets were sorted from Actm-O VA mice and their 
cross-priming ability investigated in vitro. Actm-OV A mice display constitutive 
expression of n1embrane-bound OVA. Antigen presenting cells in Act1n-OV A mice 
acquire OVA protein during clearance of dead cells and cell debris in tissues and 
blood. In tenns of experii11ents described here, no pulsing of APC with OVA was 
required, and the Actn1-O VA mouse system provided an excellent model for 
presentation of cell-associated antigen. One limitation of the model is that some level 
of OVA could be processed via the endogenous pathway and become loaded on to 
the MHCI molecule for presentation to CD8+ T cells. Cells which do not cross-
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present were therefore employed as negative controls. N eutrophils in the absence of 
LPS stimulation showed no ability to cross-prime cog+ T cells giving values close 
to zero and to T cell only controls (Figure 5.3), consistent with other reports in the 
literature (Savina and Amigorena, 2007). The amount of OVA being processed via 
the endogenous pathway is negligible in neutrophils, although LPS treated 
neutrophils showed very weak ability to cross-prime cog+ T cells (Figure 5.3). 
However, bone 1narrow and peritoneal neutrophils can cross-prime cog+ T cells 
under inflammatory although not steady-state conditions (Beauvillain et al. , 2007). In 
experiments described here, neutrophils without LPS stimulation were therefore used 
as control APC. 
In line with the literature, both cog+ cDC and cog- cDC showed superior 
ability to cross-prime cog+ T cells in co1nparison with neutrophils (Figure 5.3) 
(Heath et al. , 2004), while L-DC showed slightly weaker capacity (Figure 5.3). 
Under protocols used here, LPS stiinulation had no or little impact on L-DC cross-
priming ability, while both subsets of cDC induced a better response under LPS 
stimulation (Figure 5.3). Gene profiling in Chapters 3 and 6 _revealed that L-DC 
express both Tlr2 and Tlr4 , which encode TLR essential for signalling upon LPS 
activation. Gene expression levels of Tlr 2 and Tlr4 were comparable with the cDC 
(Good et al. , 2012; McCurdy et al. , 2001). In addition, L-DC also express Cdl4 
which encodes a co-receptor for TLR4 at levels comparable with cDC subsets. Thus, 
the lack of response towards LPS in L-DC is not due to the absence of receptors for 
LPS, but rather insensitivity towards LPS activation. Another possible explanation 
could be a lack of co-receptors of TLR, such as 1nonomeric recon1binant (MD-2) 
and/or LPS-binding protein in L-DC. 
A co1nparison of the ability of different APC subsets to cross-prime revealed 
that cog- cDC were consistently better than cog+ cDC. Cross-pri1ning ability had 
been previously described in CD8+ cDC, while CD8- cDC were found to be much 
weaker in those experiments (Den Haan et al. , 2000; Heath et al. , 2004; Rock et al. , 
1990). Those studies however used cultured cDC, involved ex vivo pulsing of 
antigen, or were performed in disease models (Belz et al. , 2005 ; Schnorrer et al. , 
2006). Studies here showed that CD8- cDC can endocytose and retain antigen, such 
that antigen capture is not a limiting factor in the ability of CD8- cDC to cross-prime 
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CD8+ T cells. Since CD8- cDC have been described as better inducers of CD4+ T cell 
activation (Dudziak et al., 2007; Maldonado-Lopez et al., 1999; Villadangos and 
Schnorrer, 2007), one hypothesis is that in normal mice, CD8- cDC have the 
n1achinery for cross-presentation, but may preferentially use the MHCII antigen 
processing pathway for CD4+ T cell activation. CD8- cDC so1ied from the Actm-
OVA n1ice would have been exposed to cell-associated OVA constantly which may 
predispose cells to cross-presentation. The cross-priming ability of APC in the Actm-
OV A ani1nal 1nodel n1ay therefore not be reflective of normal animals. 
Cross-prinung of CD8+ T cells is considered an exclusive property of DC 
(Belz et al. , 2005; Den Haan et al. , 2000; Schnon·er et al. , 2006; Shortn1an and 
Heath, 2010). However, there have been repo1is that macrophages can also cross-
present antigen (Harding and Song, 1994; Kovacsovics-Bankowski et al. , 1993 ; 
Norbury et al. , 1995; Pfeifer et al. , 1993). Resident monocytes, which are considered 
to be the precursors of macrophages, were investigated here for their ability to cross-
prime CD8+ T cells since there are no repo1is of the cross-presentation capacity of 
monocytes. Resident n1onocytes did demonstrate ability to cross:-prime CD8+ T cells 
in two out of four experiinents. However, their ability was very weak in comparison 
with cDC and L-DC. The addition of LPS did improve ability to cross-prime, 
suggesting that son1e resident monocytes 1nay have become activated upon LPS 
stimulation, and 1nay have even differentiated to give macrophages. 
Cytochro1ne c treatment can be used effectively to induce apoptosis 
specifically in cells with cross-presenting ability (Ming et al. , 2008). Cytochro1ne c is 
endocytosed by APC in the san1e way as antigen, and released into the cytoplasm for 
cross-presentation ia the cytoplasn1ic pathway. When cytochro1ne c enters the 
cytoplasm after uptake, it binds to apoptotic protease activating factor 1 (Apaf-1) to 
fom1 an apoptosome which then induces a caspase cascade resulting in cell death 
(Jiang and Wang, 2004). Contrary to previous repo1is (Ming et al. , 2008), we have 
shown here that cDC numbers in the animal are not reduced following intravenous 
delivery of cytochrome c (Figure 5.5). One problem could be the known variation 
amongst the batches of cytochrome c (personal communication with L.L.Ming, 
WEHJ, Melbomne, Australia). However when cytochrome c was used in vitro to 
treat CD8+ cDC and CD8- cDC, there vlas a 3 fold reduction in the capacity of cDC 
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to induce CD8+ T cell proliferation. By companson, cytochrome c treated L-DC 
showed only a 1.5 fold reduction in their ability to cross-prime CD8+ T cells. In vivo 
treatment with cytochrome c might require much higher concentrations to induce the 
same level of cell death as achieved in vitro. The i1npact of cytochrome c treatment 
on cDC subsets in vitro suggests that the cytosolic pathway 1nay be pri1narily 
e1nployed for cross-presentation by these cells. Effect of cytochrome c on L-DC is 
variable, thus L-DC 1night use both the cytosolic and vacuolar pathways for cross 
presentation. Cytochrome c treatment did not affect the numbers of neutrophils and 
monocytes present when given in vivo (Figure 5.5). Furthermore, when 1nyeloid 
subsets were isolated and tested in the cross-presentation assay after in vitro 
cytochrome c treatment, no inhibition of function was ob~erved for neutrophils 
(Figure 5.6 and 5.7). Resident monocytes did not induce CD8+ T cell proliferation in 
two out of three experin1ents performed. 
Both cDC and L-DC subsets showed strong capacity for cross-pnn11ng 
leading to activation of CD8+ T cells, which is essential in the generation of 
cytotoxic T lymphocytes (Barry and Bleackley, 2002). Cytotoxic__T lymphocytes play 
a dual role in 1naintaining self-tolerance by lysing self targets, and by lysing infected 
cells or cancerous cells. The ability of cytotoxic T lymphocytes generated in vitro by 
antigen-pulsed L-DC, CD8+ cDC and resident 1nonocytes was investigated using a 
fluorescent target array to detect lysis in vivo. This was developed by Dr Ben Quah 
(Quah et al. , 2012). Cytotoxic T ly1nphocytes generated by L-DC presentation of 
OVA, lysed target cells pulsed with the SIIN and N6 peptides of OVA, but not the 
G4 and E 1 peptides. This demonstrated that lysis of target cells was antigen-specific, 
since OT-I CD8+ T cells only recognise SIIN and N6 peptides in the context of 
MHCI. Si1nilarly, both CD8+ cDC and resident monocytes generated cytotoxic T 
lymphocytes which gave antigen-specific lysis of target cells. However, resident 
monocytes required a 1nuch higher concentration of peptide on target cells to give a 
sin1ilar level of lysis. Cytotoxic T lyn1phocytes generated by priming with 9000 
resident monocytes required 100 times more N 6 peptide on target cells than did L-
DC or CD8+ cDC to achieve the san1e level of target lysis (Table 5.5). Thus, resident 
monocytes are weaker inducers of cytotoxic T lymphocytes than L-DC and cDC, 
consistent with a lack of cross-presenting ability. In contrast, both CD8+ cDC and L-
DC de1nonstrate strong ability to generate a CTL response. 
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Activation of CD4+ T cells is essential in adaptive inununity to activate B 
cells and macrophages. CD8- cDC have been described as strong inducers of CD4 + T 
cell activation (Behrens et al., 2004). Consistent with the literature, CD8- cDC were 
found here to be the strongest inducers of CD4+ T cell proliferation, followed by 
CD8+ cDC (Figure 5.8). LTC-DC as MHCir cells lacked ability to activate CD4+ T 
cells (Tan et al. , 2011). L-DC defined here as an in vivo MHCir subset, did not 
induce proliferation of CD4+ T cells, while resident monocytes induced low level 
proliferation (Figure 5.8), and the level of response was n1uch lower than for cDC 
subsets. Lastly neutrophils, eosinophils and inflammatory monocytes, which lack 
MHCII expression, also failed to induce proliferation of CD4+ T cells. 
While both L-DC and resident monocytes share a similar phenotype ( Chapter 
4 ), they are shown here to be distinct in terms of function. Even though resident 
n1onocytes demonstrate strong ability to uptake and retain antigen, they lack ability 
to cross-prin1e CD8+ T cells. The relationship between L-DC and resident monocytes 
will be explored further in Chapter 6 by gene profiling these __ subsets, along with 
other splenic n1yeloid and cDC subsets studied here. 
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Molecular definition of splenic 
dendritic and myeloid celf subsets 
CHAPTER6 
6.1 Introduction 
In order to delineate the lineages of dendritic cells (DC) and tissue 
macrophages more completely, both Gautier et al. (2012) and Miller et al. (2012) 
employed transcriptome analysis to compare related subsets of cells isolated from 
different tissue sites. Gautier et al. (2012) identified and isolated many 1nacrophage 
subsets from different tissues and compared their gene expression profiles to identify 
a core 1nacrophage gene signature profile that could be used to delineate tissue 
macrophage subsets from DC. Similarly, Miller et al. (2012) identified various DC 
subsets in different tissue sites and compared their gene expression profiles to 
identify a core tissue DC profile that distinguishes cells of the dendritic lineage from 
tissue macrophages. In addition, Miller et al. (2012) also identified transcriptional 
regulators involved in the commitment of myeloid progenitor cells to the DC lineage. 
Transcriptome analysis has been undertaken here to analyse the relationship 
between splenic n1yeloid subsets including the newly identified L-DC in relation to 
cDC, and also with the myeloid subsets of inflammatory monocytes, resident 
monocytes and eosinophils. In an earlier transcripto1ne analysis performed in 
Chapter 3, it was concluded that the L-DC subset defined as CDl 1 bhiCD1 lc10MHCir 
CD8- cells, was a heterogeneous population with gene expression indicative of 
n1yeloid lineage cells, but with cells having antigen presenting function akin to the 
dendritic lineage of antigen presenting cells (APC). In addition, this subset of 
' candidate ' L-DC also expressed genes expressing inhibitory function towards T 
cells. With the new antibody staining and delineation protocols established in 
Chapter 4, and with confinnation of subset identities made in Chapters 4 and 5 
through both functional and morphological analysis, it is now possible to better 
define the L-DC, cDC and myeloid subsets. 
Putative CD 11 b11 iCD 11 c10MHCirCD8- L-DC identified in Chapter 3 were 
further delineated to give 3 candidates on the basis of Ly6C and Ly6G expression as 
described in Chapter 4. Morphological and phenotypic studies in Chapter 4 further 
defined the candidate L-DC as a CD 11 bhiCD 1 1c10Ly6C-Ly6G-CD43 +Siglec-F-
, subset. In addition, splenic resident 1nonocytes and eosinophils were redefined as 
CD1 lb11 iCD1 lc10Ly6C+Ly6G-CD43 11iSiglec-F- and CDl lb11iCD1 lc-Ly6C+Ly6G-
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CD43+Siglec-F+ cells, respectively. The identity of the candidate L-DC subset was 
confirmed via functional assays performed in Chapter 5. Despite new understanding 
about these splenic dendritic and myeloid subsets, the lineage relationship between 
L-DC and other dendritic and myeloid cell subsets in spleen remains unknown. To 
further analyse their relationship in terms of lineage, further gene profiling analyses 
have been undertaken. 
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6.2 Results 
6.2.1 Transcriptome analysis of splenic myeloid subsets 
Subsets of CDS+ cDC, CDS- cDC, resident monocytes, inflammatory 
monocytes, eosinophils and L-DC were sorted fro1n spleens of C57BL/6J mice 
according to the staining procedure used for subset identification in Figure 4.3, and 
sorted according to the strategy outlined in Figure 6.1. 
High purity RNA was extracted from sorted L-DC, CDS+ cDC, CDS- cDC, 
inflammatory monocytes, resident monocytes and eosinop~ils, using the RN easy 
minikit as described in Section 2.7.1. RNA of high purity and low degradation was 
converted to cDNA, biotin-labelled, and then hybridised to Murine Gene STl.0 
genechips (Affymetrix: Santa Clara, CA, USA). Duplicate genechips were analysed 
for each RNA preparation. Scanned images of labelled genechips were analysed 
using Partek (St. Louis, MO, USA) to give signal values and p values. The main aim 
of the study was to assess the association between the novel L:DC subset and well 
defined cells of the dendritic and 1nyeloid lineages. Initial data analysis involved 
ANOV A for selection of genes up- or down-regulated by at least 3-fold in pairwise 
comparison. Data mining was also used to assess the expression of genes linked to 
known functions in development, or associated with distinct cell lineages. 
Differences in overall gene expression between the subsets were revealed by 
Principal Component Analysis (PCA). This showed close grouping of resident 
monocytes, inflammatory monocytes, L-DC and cDC subsets in the first principal 
component, but separation of L-DC and monocyte subsets from cDC subsets in the 
second principal component (Figure 6.2). In addition, CDS+ cDC were clearly 
differentiated from CDS- cDC in the second principal component. Lastly, 
eosoinophils were distinct from other myeloid and cDC subsets on the basis of the 
first and second principal components. This analysis indicated more similarity 
between L-DC and monocyte subsets, and differentiated L-DC from eosinophils and 
cDC subsets. 
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Figure 6.1 Cell sorting strategy for isolation of dendritic and myeloid subsets and 
L-DC from spleen. 
Splenocytes were prepared by red blood cell lysis followed by T and B cell depletion. 
Cells were then stained with antibodies specific for CD 11 b (Ml/70, Pe-Cy7), CD 11 c 
(N41S, APC), CDSa (53-6.7, Alexa 700), Ly6C (AL-21 , Pacific Blue), Ly6G (lAS, 
Bio), CD43 (IBII, Alexa4SS) and Siglec-F (ES0-2440, PE), using streptavidin (SA)-
APC-Cy7 as a second stage reagent. Prior to flow cyto1netry, cells were stained with 
propidiun1 iodide (PI, 1 µg/1111) to delineate live (Pr) cells. Conventional DC ( cDC) were 
initially gated on the basis of side scatter (SSC) and CD 11 c expression. CDS+ cDC were 
gated as CD 11 b-CDS+Ly6C-Ly6G- cells, while CDS- cDC were gated as CD 11 b +CDS-
Ly6C-Ly6G- cells. Myeloid cells and L-DC were further delineated on the basis of 
CD 11 b versus CD 11 c expression. Myeloid cells were gated as CD 11 b
11 iCD 11 c- cells, 
and further delineated on the basis of Ly6C and Ly6G expression to reveal 
inflanunatory n1onocytes (IM) as Ly6C 11iLy6G- cells and eosinophils (Eos) as 
Ly6C+Ly6G-CD43+Siglec-F+ cells. Resident monocytes (RM) were gated as 
Ly6C+Ly6G-CD43+Siglec-F- cells, while L-DC were gated as Ly6C-Ly6G-
CD43+Siglec-F- cells. Gates were set based on fluorescence 111inus one controls, and 
nun1bers in gates represent% specific binding. 
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Figure 6.2 Variability in gene expression amongst dendritic and myeloid subsets. 
Transcriptome analysis was performed on subsets of cells sorted fro1n n1urine spleen as described in Figure 4.3. RNA was extracted and labelled for 
hybridisation to Murine Gene STl .0 genechips (Affymetrix). Following scanning to collect signal values, data were analysed using Partek and 
ANOV A by pairwise comparison. Principle Component Analysis (PCA) was used to detern1ine the variability in gene expression profile for each 
subset. Three principle co1nponents are shown for each subset prepared for analysis in duplicate. 
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The pairwise relationship between subsets was demonstrated on bivariate 
plots (Figure 6.3 A). A total of 35,556 genes was analysed for each subset. 
Consistent with PCA, bivariate analysis between L-DC and resident monocytes 
showed the least variance, indicating high similarity in overall gene expression with 
very few differentially expressed genes shown as outliers (Figure 6.3 A). This was 
followed by L-DC and inflammatory monocytes, having higher numbers of 
differentially expressed genes (Figure 6.3 A). By comparison, analyses involving L-
DC and cDC subsets showed more variation (Figure 6.3 A), and more differentially 
expressed genes. The resident and inflammatory n1onocyte subsets showed low 
variation in gene expression and very few differentially expressed genes, indicating a 
close relationship between these two n1onocyte subsets. The_ CD8+ cDC and CD8-
cDC subsets gave a tight bivariate plot indicating a close relationship, but a high 
number of genes differentially expressed between the subsets (Figure 6.3 A). 
Consistent with PCA, eosinophils showed greater differences when co1npared with 
L-DC and infla1nmatory n1onocytes (Figure 6.3). Indeed, the eosinophil subset is 
quite distinct from the other subsets. 
Hierarchical clustering was then used to map the relationship between subsets 
based on gene expression. Average signal values fro1n duplicate samples were used 
for clustering, and genes selected which showed expression in at least one subset 
(signal value > 100), giving a sample set of 8,508 genes. The analysis indicated a 
close relationship between L-DC and resident monocytes, and then between these 
two subsets and infla1mnatory monocytes. CD8+ cDC and CD8- cDC were more 
closely related with each other than with L-DC, resident monocytes or infla1nmatory 
monocytes. As predicted fro1n PCA analysis, eosinophils were shown to be quite 
distinct as a subset. 
6.2.2 Investigation of gene expression 
The lineage of cells in the different subsets was investigated by data mining, 
seeking the expression level of known genes related to the functional categories of 
'DC and APC', ' Che1nokines ', ' Cell surface markers ' and ' Inflammatory cytokines 
and receptors ' . Signal values were collected for sets of 84 genes utilised by 
SABiosciences (Frederick, MD USA) in their PCR arrays. Data are shown as 
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Figure 6.3 Relationship between splenic dendritic and myeloid subsets in terms of overall gene expression. 
Transcripto1ne analysis was perfon11ed on dendritic and 1nyeloid subsets sorted fro1n murine spleen. Signal value data from duplicate samples were 
obtained using PARTEK. A) Mean signal values for a total of 35,556 genes were plotted in pairwise comparisons. The darker blue inner polygon 
contains 50% of data points, while the pale blue outer polygon contains all other data points which are not outliers. Red outliers are plotted outside the 
polygons. The bivariate median is shovvn by the red asterisk at the centre of the polygon. B) Hierarchical clustering was used to analyse the relationship 
between subsets on the basis of gene expression. The dendrogram displays distance between subsets based on clustering 8,508 genes selected for 
analysis on the basis of signal value > 100 for any one subset. Average signal values from duplicate samples were also used for clustering. 
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heatmaps with dendrograms reflecting hierarchical clustering. Gene expression is 
only shown for those genes expressed by at least one subset based on signal value > 
100 (Figure 6.4). The CD8+ cDC and CD8- cDC subsets showed greatest similarity 
in gene expression, and this was reflected by dendrograms in all 4 analyses (Figure 
6.4 A-D). As also found in Chapter 3, these two so1ied subsets were reflective of the 
DC lineage by common high expression of genes encoding cell surface markers 
including Cd40, Cd74, Cd80, Cd83, Dpp4 and St6gall (Figure 6.4 A) (Edwards et 
al., 2003; Lechmann et al., 2002; Miller et al. , 2012; Prazma et al. , 2007). Genes 
upregulated by CD8+ cDC included Cd8a, Cd24 and Cd86, all of which encode 
known 1narkers of CD8+ cDC (Belz et al., 2002; Miller et al. , 2012; Vremec et al. , 
2000). CD8- cDC showed specific high expression of Cd7, Cd22, Cd72 and Klrdl , 
which are also known 1narkers of cog- cDC (Figure 6.4 A) (Edwards et al. , 2003 ; 
Miller et al. , 2012). 
In tenns of 'DC and APC' related gene expression, both cDC subsets showed 
high expression of Cd74, Flt3 , H2-Dma and Jca,nl , all encoding known n1arkers of 
the cDC lineage (Figure 3.7 B) (Edwards et al. , 2003; Karsunky et al. , 2003; Miller 
et al. , 2012). CD8+ cDC uniquely expressed Cd86 and Fcgrt, while cog- cDC 
showed expression of Cd209a, Tlr 1, Tnf and Mif. In terms of chemokine-related 
genes, both cDC subsets expressed Ccr7 and Tnf, which encode known chen1okines 
and chen1okine receptors expressed by DC (Allavena et al. , 2000; Ding et al. , 2011). 
CD8+ cDC were uniquely marked by expression of Xcr 1 as reported previously 
(Bachen1 et al. , 2010; Kroczek and He1u1, 2012; Yamazaki et al. , 2013), as well as 
expression of Cxcl9 (Kerschen et al. , 2010). CD8- cDC also specifically expressed 
Ltb (Figure 6.4 D). These data, and their concordance with descriptions of cDC gene 
expression in the literature, confinn the efficiency of the cell sorting procedures and 
gene profiling methodology developed here. 
A1nongst n1yeloid subsets, resident monocytes and inflammatory monocytes 
shared sin1ilar gene expression profiles for the functional categories of 'DC and 
APC ' and 'Chen1okines ' (Figure 6.4 B-C). Both n1onocyte subsets expressed Csflr 
which encodes the receptor for macrophage colony stimulating factor essential for 
monocyte development. In addition, they also expressed Ccr 2, which encodes an 
essential receptor for monocyte 1nigration (Auffray et al. , 2009; Geissmann et al. , 
95 
Figure 6.4 Pathway specific gene expression in dendritic and myeloid subsets. 
Data mining was applied to Affyn1etrix datasets collected fro1n L-DC, cDC and 1nyeloid subsets. Signal values for genes selected for inclusion in 
specific pathways or functions were collated as Excel files. For each of the subsets, log2 signal values were plotted as a heat map using R/Bioconductor 
software. The line chart (blue) overlaid on heat n1aps indicates log2 signal intensity changes about the mean ( dashed blue line). Genes were clustered 
by their level of expression as shown by row dendrogran1s. In addition, dendritic and n1yeloid subsets were clustered on the basis of gene expression as 
shown by coltunn dendrograms. Data mining involved sets of genes utilised by SABioscience for their PCR arrays. These reflected : A) Cell surface 
markers, B) DC and APC markers, C) Che1nokines, and D) Inflarmnatory cytokines and receptors. 
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2008). Resident monocytes specifically expressed Ccr5, Il2rb, Klrcl and Jfng, while 
inflammatory monocytes specifically expressed Fcgr 1, Fas, Tgfbl, Ccl2, Cxcl2, 
Cxcll O and Tlr2. Consistent with PCA (Figure 6.2), eosinophils were distinct from 
all other myeloid and DC subsets on the basis of gene expression profiles (Figure 6.3 
A-D). Eosinophils specifically expressed Krt8, Ccll 9 and Cxcll 3, as reported 
previously (Akuthota et al., 2013; Tani et al., 2014). Since eosinophils are shown 
here to be very distinct from cDC and other myeloid subsets, they have been 
disregarded in further analysis of gene expression directed at lineage determination 
for L-DC. 
The L-DC subset showed gene expression 1nore closely linked with resident 
monocytes than with any other subsets across the four functional categories studied. 
This is shown by dendrograms above heatmaps (Figure 6.4 A-D). In addition, 
inflaffilnatory 1nonocytes were closely clustered with both resident monocytes and L-
DC. This result is consistent with PCA and bivariate analysis, and aligns L-DC with 
monocytes more than cDC subsets. Genes conunonly expressed in high level across 
L-DC and n1onocyte subsets included Csflr, Itga,n, Jfng, -Cxcr4 and Cx3cr 1. 
Transcripton1e analysis in Chapter 3 also showed Itgam, Csfr 1 and Cxcr4 
upregulation in n1onocyte subsets. Itgam encodes CD 11 b, a common marker of 
n1yeloid cells which n1ediates the inflamn1atory response by regulating adhesion and 
n1igration of cells to sites of infection (Arnaout et al. , 1983; Solovjov et al. , 2005). 
Cx3cr 1 encodes a n1arker common to cells of the n1acrophage/dendritic lineage (Fogg 
et al., 2006; Jung et al. , 2000; Palfran1an et al. , 2001). L-DC also expressed Lrpl , 
Cd37 and Peca,nl at higher levels than seen in monocytes (Fig 6.4 A-D). LRPl has 
been described as a receptor important for endocytosis of multiple functionally 
distinct ligands, proteases and growth factors (Lillis et al. , 2008). Recent studies also 
showed that LRP 1 regulates the signalling and migration of monocytes and 
macrophages (Gorovoy et al. , 2010; Staudt et al. , 2013). It appears to play an 
inhibitory role since in Lrp1-1- 1nice recruitn1ent of monocytes into subcutaneous 
tumors is significantly increased, and Lrp 1-1- BM-derived macrophages express 
higher levels of inflammatory chemokines (Staudt et al. , 2013). CD37 plays a role in 
the regulation of cell-cell adhesion, signal transduction, and T and B cell activation 
(Hemler, 2001; Knobeloch et al., 2000; Van Spriel et al. , 2004). Dendritic cells fro1n 
Cd3 7 1- mice are compro1nised in migration, as well as integrin-mediated adhesion 
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and in vivo priming of adoptively transferred naYve T cells (Gartlan et al. , 2013 ; Van 
Spriel et al. , 2012). As with CD37, PECAMl (or CD31) is also involved in cell 
migration (Muller et al. , 1993; Newman and Newman, 2003; Piali et al. , 1995). The 
above data suggests a closer relationship between L-DC and the myeloid cell lineage 
than cDC lineage, although the data do not in any way establish lineage relationship. 
While L-DC appear more closely related to 1nonocytes than cDC in tenns of gene 
profile, data shown in Chapter 3 identified L-DC as having functional siinilarity with 
cDC. 
Recently, Gautier et al. (2012) analysed gene expression in different tissue 
1nacrophage subsets. They defined a core signature of 3 9 genes defining tissue 
n1acrophages (Gautiar et al. , 2012). Expression of these 39 genes was detennined by 
data 1nining. However, none of the subsets studied here expressed all 39 genes, and 
1nost expressed very few (Figure A.3). Furthennore, none of the subsets analysed 
appears to reflect or contain a subset of tissue macrophages. 
In order to test the relationship between L-DC, cDC and monocyte subsets 
fu1iher, core gene profiles for cDC and monocytes were sought. A list of genes 
co1mnon to both CDS+ cDC and cos- cDC was selected based on the criteria of 
signal value in both subsets > 100, and relative fold difference < 1.2. Any genes 
expressed by 1nonocytes under the sa1ne criteria were also re1noved. A sin1ilar 
dataset of genes expressed by 1nonocytes but not cDC was also produced. The 
expression of ' corm11on cDC genes ' and ' co1mnon monocyte genes ' by L-DC was 
then assessed. L-DC expressed 1nost of the co1nmon cDC genes, and their expression 
profile closely rese1nbled that of both cos-cDC and CDS+ cDC subsets (Figure 6.5). 
However, L-DC also expressed n1ost of the common monocyte genes, with very 
si1nilar expression profiles between L-DC and both the resident and inflammatory 
n1onocyte subsets (Figure 6.6). While L-DC appear to mirror both the monocyte and 
cDC lineages, clustering analysis showed a closer relationship between L-DC and 
1nonocytes, than between L-DC and the cDC subsets (Figures 6.5 and 6.6). 
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Figure 6.5 Genes expressed by cDC but not monocytes. 
Genes co1nn1only expressed by CD8+ cDC and CD8- cDC were selected as those with 
signal values > 100 in both subsets and fold change < 1.2. Genes then expressed by 
1nonocytes according to the same criteria were then removed. Expression of cDC 
specific genes is co1npared in L-DC and each of the cDC subsets. For each of the 
subsets, log2 signal values were plotted as a heat 111ap using R/Bioconductor software. 
The line cha1i (blue) overlaid on heat 111aps indicates signal intensity changes about the 
111ean (dashed blue line). The relationship between L-DC and cDC subsets was 
determined by clustering and is shown by coluinn dendrograms. 
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Figure 6.6 Genes expressed by monocytes but not cDC. 
Genes conunonly expressed by infla1mnatory and r'esident n1onocytes were selected as 
those with signal values > 100 in both subsets, and relative fold change < 1.2. Genes 
expressed by the cDC subsets according to the san1e criteria were then re1noved. L-DC 
expression is shown for genes co1111non to n1onocytes. Expression of monocyte genes is 
co1npared in L-DC and the two 1nonocyte subsets. For each of the subsets log2 signal 
values were plotted as heat maps using R/Bioconductor software. The line chart (blue) 
overlaid on heat maps indicates changes about the n1ean ( dashed blue line). The 
relationship between L-DC and 1nonocyte subsets was determined by clustering, and is 
shown b colu1nn dendrograins. 
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6.2.3 Genes upregulated in L-DC over the cDC subsets 
In order to advance understanding of the L-DC lineage, and to identify 
potential genes and markers which define these cells, analysis of genes specifically 
upregulated in L-DC, but not other subsets was conducted. ANOVA analysis was 
used to make pairwise co1nparison between subsets as described previously in 
Chapter 3. Data were then extracted for genes upregulated at least 3-fold in one 
subset only. The numbers of genes in each dataset was represented in a Venn 
diagram as a 1neasure of si1nilarity or overlap between the subsets (Figure 6. 7). 
Lowest variability was identified between the CD8+ cDC and cog- cDC subsets, 
while larger variability was observed between L-DC and each of the cDC subsets. A 
total of 24 genes were differentially expressed across L-DC, CD8+ cDC and CD8-
cDC (Figure 6. 7 A). Con1plete lists of these genes are shown in Tables A.1 , A.2 and 
A.3. 
In the comparison of L-DC with the two cDC subsets, genes upregulated in 
one but not the other two subsets were identified (Table 6.1 ). The CD8+ cDC subset 
was n1arked by specific upregulation of Xcr 1, Jji205 , Tlr 11, Btla, CD24a and Clec9a 
(Table 6.1 ). These genes have previously been reported as specific markers for CD8+ 
cDC, which identify the antigen presenting function of a DC (Caminschi et al. , 
2001a; Ca1ninschi et al. , 2008; del Hoyo et al. , 2002; Galibert et al. , 2005 ; Ghosh et 
al. , 2013 ; Kroczek and Henn, 2012; Watanabe et al. , 2003). Analysis in Chapter 3 
also showed that CD8+ cDC showed specific upregulation of Xcr 1 and Clec9a. 
XCRl has been shown to bind to XCL 1 secreted by T cells and aids the n1igration of 
DC to T cell areas within spleen, so promoting cross-prin1ing of CD8+ T cells for 
development of a cytotoxic T cell response (Dorner et al. , 2009; Kroczek and Henn, 
2012). Expression of CLEC9a is restricted to CD8+ cDC and pDC, and plays a 
specific role in the uptake of apoptotic cells via binding to the exposed actin 
filaments of damaged cells (Ca1ninschi et al. , 2008 ; Zhang et al. , 2012). Recently 
IFI205 was described as a receptor that regulates signalling via transcriptional 
regulation of the inflanu11asome adapter protein ASC (Ghosh et al. , 2013). BTLA has 
previously been described as an inhibitory receptor on DC that regulates T and B cell 
activation (Can·eno and Collins, 2003). BTLA can also induce CD8+ T cell tolerance 
in NOD mice, and acts as a regulator of DC homeostasis (De Trez et al. , 2008 ; Li et 
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Figure 6. 7 Differential gene expression. 
Diagran1s show nu1nbers of genes upregulated > 3-fold in one of two subsets assessed in pairwise con1parison. Infl n1ono: Inflan1n1atory n1onocytes· 
Resi 1110110: Resident n1onocytes. 
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Table 6.1 Genes upregulated in only one of three DC subsets. 
Subset No. of Genes upregulated + genes 
CD8+ cDC 9 CD24a, Jji205, Clec9a, Tlr 11, Xcr 1, Apol7c, Btla, A530099Jl 9Rik, 4930506M07Rik 
CD8- cDC 2 Ccndl , H2-Eb2 
L-DC 13 Tlr 7, Ctsd, Itgam, Clec4a3, Zeb2, Csflr, Emr4, Krt80, Cd300ld 
+ Genes were selected which showed > 3-fold difference in signal value across each of three subsets taken in pairwise comparison. Individual subsets are distinguished by specifically upregulated genes. 
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al. , 2011). Genes upregulated by cog- cDC included only Ccndl and H2-Eb2. 
CCNDl is involved in cell cycle progression, while H2-Eb2, also known as MHCII, 
is expressed by APC (Shin et al., 2006; Sun et al., 2008). 
By co1nparison with the cDC subsets, L-DC showed upregulation of genes 
which reflect both dendritic and myeloid lineage cells. Clec4a4, also known as 
Dcir2, encodes a C-type lectin previously described for cog- cDC. CLEC4a4 
participates in 1nultiple pathways depending on its i1nmunoreceptor (Dudziak et al. , 
2007; Idoyaga et al. , 2013). Emr4 encodes the epidermal growth factor receptor on 
cog- cDC, 1nonocytes and some macrophages (Caminschi et al. , 2001 b ). In addition, 
L-DC express higher levels of Zeb2 and Krt80, which are involved in adhesion and 
1nigration (Qi et al. , 2012; Windoffer et al., 2011), as well as myeloid cell n1arkers 
like Itga,n and Csfl r as found in Chapter 3. L-DC also upregulated Cd3 00ld in 
relation to cDC subsets. Cd300ld encodes a type I transmembrane protein with a 
short cytoplas1nic tail and a charged trans1nembrane residue (Borrego, 2013). 
CD300LD is expressed by granulocytes, 1nonocytes, macrophages, 1nonocyte-
derived DC (n10-DC) and pDC (Izawa et al. , 2007), and interacts with adaptor 
protein FcRy chain to transn1it an activation signal via LYN and SYK kinases (Izawa 
et al. , 2007). Upon binding to cells, CD300LD induces increased production of 
cytokines, particularly IL-6, and hista1nine release fro1n bone 1narrow-derived n1ast 
cells (Izawa et al. , 2007). The binding of CD300LD to ligands on n1acrophages and 
neutrophils also induces increased pro-inflammatory cytokine production (Nakano et 
al. , 2008). 
6.2.4 Genes upregulated in L-DC but not the monocyte subsets 
Datasets were extracted to identify genes upregulated at least 3-fold in either 
L-DC or the 2 monocytes subsets. L-DC and inflammatory 1nonocytes were found to 
be the most distinct subsets, while L-DC and resident monocytes were the 1nost 
closely related (Figure 6.5 B). These findings are consistent with previous PCA and 
clustering evidence (Figures 6.2-6.4). Only 4 genes were found to be conu11only up-
or down-regulated in L-DC compared with the two monocyte subsets. 
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In the comparison of gene expression between L-DC, resident monocytes and 
inflammatory monocytes, only L-DC and inflammatory monocytes were found to 
show upregulated genes. Resident monocytes therefore reflect a subset of both the L-
DC and inflammatory monocyte subsets (Table 6.2). Only small numbers of genes 
were upregulated. Fnl , Fl Jal , and Mmp8 identified inflammatory monocytes, and 
upregulation of CdJ00e identified L-DC. All of this evidence is consistent with 
previous data showing that resident monocytes are closely related to L-DC. It also 
predicts a close relationship between resident monocytes and inflammatory 
monocytes. Previously in Chapter 3, inflammatory monocytes were shown to 
upregulate FI Jal which encodes an alternate activation marker for macrophages 
(Table 3.4) (Ma1iinez et al., 2006; Muszbek et al., 1996). In ~ddition, inflammatory 
monocytes showed upregulation of Fnl which encodes fibronectinl, and Mn1p8 
which encodes matrix metalloproteinase-8. FNl is involved in cell adhesion, 
migration and growth, while MMP8 is a protease involved in breaking dovvn 
extracellular matrix. In addition, FNl, F13Al and MMP8 have also been previously 
described as specifically upregulated in inflammatory monocytes over resident 
1nonocytes by others (Ingersoll et al., 2010). 
L-DC upregulated only CdJ00e, as previously identified in Chapter 3. 
CD300E is a type I transn1en1brane protein with a short cytoplas1nic tail and a 
charged transn1e1nbrane residue which interacts with DAP12 (Borrego, 2013). It is 
expressed n1ainly by n1onocytes, mo-DC, and at lower levels by in vitro derived 
n1acrophages and DC (Bon·ego, 2013). Upon binding, CD300E induces activation 
signals, calcium 1nobilisation and release of reactive oxygen species by monocytes 
(Aguilar et al. , 2004; Brckalo et al. , 2010). In addition, CD300E binding also induces 
cytokine release by monocytes and promotes survival of monocytes and mo-DC 
(Aguilar et al. , 2004; Brckalo et al. , 2010). DC activated via CD300E have stronger 
capacity to sti1nulate T cells (Brckalo et al. , 2010). Overall, CD300E reflects a 
possible candidate marker for delineation of L-DC fro1n the two monocyte subsets. 
6.2.5 Identification of genes which distinguish L-DC from resident monocytes 
Both PCA and gene expression analyses revealed a close developmental 
relationship between resident n1onocytes as CD 11 b11 iCD 11 c +Ly6C+Ly6G-
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Table 6.2 Genes upregulated in only one of three myeloid subsets. 
Subset No. of 
genes Genes upregulated + 
Inflammatory 
3 Fnl , Fl3al , Mmp8 monocytes 
Resident 
0 nil monocytes 
L-DC 1 Cd300e 
+ Genes were selected which showed > 3-fold difference in signal value across each of three subsets taken in pairwise co1nparison. Individual subsets are distinguished by specifically upregulated genes. 
CHAPTER6 
CD43+Siglec-F- cells and L-DC which differ mainly by the low levels of CD43 and 
absence of Ly6C expression. To further investigate this relationship, genes 
specifically upregulated in either L-DC or resident monocytes were identified 
(Figure 6.8 A). In line with previous analyses (Table 6.2), Cd300e was found to be 
upregulated in L-DC over resident n1onocytes, along with Cd9, Dnahcl 2, Tg,n2 , 
Pecaml , Fabp4, Rabi 1, Serpinb6a, Abhd2 and Sash3. Both CD300E and CD9 
regulate the ability of DC to activate T cells (Aguilar et al. , 2004; Brckalo et al. , 
2010; Kobayashi et al., 2004). In addition, CD9 also n1odulates cell adhesion and 
migration (Lagaudriere-Gesbert et al. , 1997), and acts as a potent co-stimulatory 
n1olecule for T cells (Kobayashi et al. , 2004). DNAHC12 belongs to the dynein 
fa1nily , comprising proteins that convert energy in ATP into energy in n1ovement 
(Robe1is et al. , 2013), while FABP4 is involved in T cell priming via regulation of 
IFN-y production by CD8+ T cells (Elmasri et al. , 2009; Gorbenko et al. , 2006; 
Roberts et al. , 2013). TGM2 is involved in multiple processes including apoptosis 
and signal transduction (Rebe et al., 2009). RAB 1 lB has been found to participate in 
both endocytic and exocytic pathways involving Fe receptors to transport 
intracellular antigens (Schlierf et al. , 2000; Ward et al. , 2905). SERPINB6A is 
essential for protecting CD8+ T cytotoxic lymphocytes against the action of its ' own 
cytotoxic granules (Zhang et al. , 2006). SASH3 , also known as SL Yl , participates in 
the regulation of n1arginal zone B cell develop1nent via the Notch signalling pathway 
(Scheikl et al. , 2009). All of these genes reflect the function of antigen presenting 
cells, consistent with the defined functional role of L-DC in CD8+ T cell activation in 
Chapter 5. 
Consistent with reports in the literature, resident monocytes expressed gene 
encoding the known 1narkers of L Y6Cl , L Y6C2, and CCR2 (Figure 6.8) (Auffray et 
al. , 2009; Geissn1ann et al. , 2008). Expression of Ly6Cl /2 reflects the adopted 
sorting strategy used to separate resident 1nonocytes from L-DC on the basis of this 
n1arker (Figure 4.7). In addition, resident monocytes also showed upregulation of 
genes expressed by n1acrophages including Chi3l3 , Ifi205 , Msr 1, An1wap and 
Cd209a (Figure 6.8 A) (Gundra et al. , 2014; Ingersoll et al. , 2010; Nio et al. , 2012; 
Platt and Gordon, 2001). Chi3l3 is clearly upregulated by resident monocytes (Figure 
6.8). Expression of Ifi205 has been described for both DC and n1acrophages, where it 
regulates the inflaimnasome adapter protein ASC (Ghosh et al. , 2013 ; Inglis et al. , 
101 
Figure 6.8 Genes upregulated or specifically expressed between L-DC and resident 
monocytes. 
ANOV A analysis was used to 111ake pairwise co1nparisons of gene expression between 
san1ples and to calculate relative fold changes. A) Genes upregulated in either L-DC or 
resident 111onocytes were selected as those for which the signal value in one subset was 
> 50, and the signal value in the second subset was > 125. Data shown reflect genes 
with > 2.5 fold difference in signal value. B) Genes specifically expressed in either L-
DC or resident 111onocytes were selected as those for which the signal value in one 
subset was < 50 and the signal value in the second subset was > 125. This gave a 
dataset of 7 genes, with none specifically expressed by L-DC. 
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201 0; Orlova et al., 2006). Msr 1 is expressed by both macrophages and DC, and is 
involved in the endocytosis of double stranded RNA, transportation to endoson1es, 
and interaction with TLR3 for triggering IFN responses (Dansako et al. , 2013 ; 
Herber et al. , 2010). As with MSRl and IFI205 , CD209a is also expressed on both 
n1acrophages and DC (Cheong et al. , 201 0; Taylor et al. , 2005). CD209a recognises 
and binds mannose-type carbohydrates found on viruses, bacteria and fungi , and 
induces phagocytosis of pathogens by macrophages (McGreal et al. , 2005). AMW AP 
is expressed by tissue macrophages, microglia and retinal cells, and regulates 
proinflammatory microglia and macrophage activation (Karlstetter et al. , 2010). The 
list of genes described above confirms that the sorted resident monocyte population 
isolated here accurately reflects the subset described in the literature. 
Since very few genes were identified as upregulated by L-DC over resident 
monocytes, an analysis of specifically expressed genes was conducted. Genes 
specifically expressed in either L-DC or resident n1onocytes were selected according 
to the criteria of signal value > 125 in one subset and < 50 in the other. This gave a 
subset of 7 genes specific to resident monocytes, but none for L:-DC. Amongst genes 
specifically expressed by resident monocytes, Ngp, SJ 00a8 and SJ 00a9 are known to 
encode n1onocyte and macrophage markers (Ehrchen et al. , 2009; Schiopu and Cotoi, 
2013 ). NGP regulates n1onocyte functions of activation and recruitn1ent into sites of 
infection (Soehnlein et al. , 2009). Both S 1 00A8 and S 1 00A9 have been described as 
activators of endogenous TLR4, so promoting proinflam1natory responses (Ehrchen 
et al. , 2009; Schiopu and Cotoi, 2013). LCN2 is expressed by neutrophils and limits 
bacterial growth via sequestration of bacterial siderophores containing iron (Flo et 
al. , 2004). Lastly, both Fnl and Fl 3al are upregulated in inflaminatory 1nonocytes 
over resident monocytes (Table 6.2). Resident n1onocytes have higher expression of 
these markers over L-DC, but lower expression co1npared with infla1nn1atory 
monocytes. 
Gene expression analysis has therefore enabled further distinction between 
resident monocytes and L-DC. Overall, L-DC show upregulation of 1nany genes with 
functional roles in antigen processing and presentation to T cells, while resident 
n1onocytes show upregulation of genes previously described in relation to monocyte 
and 1nacrophage function. This evidence supports previous studies showing 
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distinction in terms of marker expression, morphology and capacity to activate T 
cells. 
6.2.6 Further attempts to identify specific markers of L-DC 
The co1nbination of phenotypic, functional and genomic evidence suggests 
that L-DC reflect a myeloid lineage DC. To further investigate the relationship 
between L-DC and cDC, specifically expressed genes in either L-DC or each of the 
cDC subsets were identified. In pairwise comparison between L-DC and CD8+ cDC, 
L-DC were found to specifically express 1nultiple genes related to myeloid cells 
(Figure 6.9). In line with the literature, L-DC expressed Itga,n (CD 11 b) which is not 
expressed by CD8+ cDC (Tan et al., 2011). In addition, L-DC express Klra2 also 
known as Ly49b, which is expressed by monocytes, 1nacrophages, NK cells and DC 
(Gays et al., 2006; Yan1ada and Tsuchida, 2014). Ly49B interacts with SHP-1 , SHP-
2, and SHIP to regulate signalling events (Gays et al. , 2006). In addition, Ly49B 
regulates T cell differentiation via recognition of MHCI molecules on T cells 
(Yamada and Tsuchida, 2014). L-DC also specifically expres?ed the Pilra, Pilr/Jl 
and Pilr/J2 genes which encode proteins that regulate SHP signalling. SHP plays a 
central role in 1nultiple cell signalling pathways via dephosphory lation of tyrosine 
residues. The balance of PILRa-mediated inhibitory signals and PILR~-n1ediated 
activation signals regulates signalling via SHP, although the exact functions of 
PILRa and PILR~ are unknown. PILRa was previously shown to be in1portant for 
neutrophil recruitinent during inflammation (Wang et al. , 2013), while PILR~ 
n1ediates an inflan1matory response via production of IL-2 7 by antigen presenting 
cells and IL-10 by effector T cells (Tato et al. , 2012). L-DC also specifically 
expressed genes related to n1acrophages including E,nr4, Emr 1 and Csfl r (Figure 
6.9) (Corbett et al. , 2005; Geissmann et al. , 2008; Stacey et al. , 2002). L-DC also 
showed specific expression of Nkg7 and Gz,naA (Figure 6.9). Both genes encode 
granzyn1es involved in the induction of apoptosis. In addition, expression of NKG7 
has been described for neutrophils and NK cells (Shimane et al. , 1999). 
L-DC also specifically expressed multiple genes related to DC although not 
CD8+ cDC, including Clec4a3 , Clec4al , Clec4e , Ace , Fabp4 and CD300ld (Figure 
6.9). CLEC4 represents a family of trans1nembrane C type lectin receptors involved 
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Figure 6.9 Genes specifically expressed in either CDS+ cDC or L-DC. 
ANOV A analysis was used to n1ake pairwise comparisons of gene expression between the CD8+ cDC and L-DC subsets. Genes specifically expressed 
in either CD8+ cDC or L-DC were selected based on the criteria of signal value in one subset < 50, and signal value in the other > 150. This gave a 
dataset of 139 genes (See Table A.4). Only those showing > 15 fold difference in signal value are shown. 
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in diverse functions, including cell adhesion, signalling and inflammation. L-DC 
expressed 2 isoforms of CLEC4A, described for cog- cDC (Dudziak et al. , 2007; 
Idoyaga et al., 2013). CLEC4E functions in antigen presentation and initiation of 
inflammatory responses after cell death (Barr et al. , 2007; Osorio and Reis e Sousa, 
2011). Necrotic cells release SAP-130 which binds to CLEC4E, initiating caspase 
recruitment leading to the production of pro-infla1nmatory cytokines and 
chemokines, and the recruitment of phagocytes to inflammatory sites (Y an1asaki et 
al. , 2008). Expression of Ace was also observed in L-DC and was identified in 
Chapter 3 (Figure 6.9 and Table 3.5). CD300LD is a me1nber of the CD300 immune 
receptor family , and has been described on human 1nyeloid lineage DC (Comas-
Casellas et al. , 2012; Gasiorowski et al., 2013). When cross-linked, CD300 
n1olecules regulate leukocyte function by transmitting activating and/or inhibitory 
signals. The exact function of CD300LD remains unknown, however, it has been 
hypothesised that CD300LD may regulate the expression of CD300F, and the level 
of other CD300 1nolecules on the cell surface (Comas-Casellas et al., 2012). 
Si1nilarly, F ABP4 has also been described for hu1nan 1no-DC. It is involved in 
production of IL-12 and TNF, and T cell pritning (Rolph et al._, 2006). In line with 
evidence obtained in Chapter 3, analysis of specific gene expression in relation to 
CDS+ cDC reveals that L-DC rese1nble myeloid type DC. 
Further investigation between L-DC and cog- cDC revealed multiple genes 
specifically expressed by L-DC including Clec4e , Pilrb2, Fabp4, Plaur, Dnahcl 2, 
Fgd4, Xdh and S,npdl3b , which were also observed in the comparison of L-DC and 
CDS+ cDC (Figures 6.9 and 6.10). In addition, L-DC specifically expressed Ms4a4a, 
Zfyve9 and Lilra5 over CDS- cDC (Figure 6.10). LILRA5 is expressed by 
1nacrophages and induces production of proinflammatory cytokines and IL-10 in a 
rheun1atoid arthritis model (Mitchell et al. , 2008). ZFYVE9 participates in TGF-~ 
signalling by recruiting and interacting with SMAD2 and SMAD3 proteins (Tang et 
al. , 2010). Lastly, MS4A4A is a novel protein which is pa1i of a signalling complex. 
In su1mnary, L-DC specifically express multiple genes involved in signalling 
pathways which are distinct from CDS- cDC. 
Sorted CDS+ cDC and cos- cDC were also found to express 1nany genes 
specific to each subset (Figure 6.11 ). CDS+ cDC showed upregulation of Clec9a, 
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Figure 6.10 Genes specifically expressed in either ens- cDC or L-DC. 
ANOV A analysis was used to make pairwise comparisons of gene expression between the ens- cne and L-ne subset. Genes specifically expressed in 
either ens- cne or L-ne were selected based on the criteria of signal value in one subset < 50, and signal value in the other > 150. This gave a dataset 
of 71 genes (see Table A.5 ). Only those showing > S fold difference in signal value are shown. 
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Figure 6.11 Genes specifically expressed in either CDS+ cDC or CDS- cDC. 
ANOV A analysis was used to n1ake pairwise comparisons of gene expression between the CDS+ cDC and CDS- cDC subsets. Genes specifically 
expressed in either CDS+ cDC or CDS- cDC subsets were selected based on the criteria of signal value in one subset < 50, and signal value in the other 
> 150. This gave a dataset of 35 genes (shown). 
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Cd8, Anpep, Tlr 11 and 5430435g22Rik, while CDS- cDC showed upregulation of 
H2-Eb2, Cd4, Dscam and St8sia6 (Miller et al., 2012; Short1nan and Heath, 2010) 
(Table A.1 ). In addition, pairwise comparison between CDS+ cDC and CDs- cDC to 
identify specifically expressed genes revealed multiple known DC genes. CDS+ cDC 
specifically expressed Hepacam2 and Itgae , while CDS- cDC specifically expressed 
En1r 1, E1nr4, Clec4a4a, Clec4al, Clec4a3, Gn19733, Dscam, Itga1n and Apobecl 
(Figure 6.11 ). The above analyses confirm that the sorted cDC subsets were 
accurately identified and sorted in line with cDC subsets described in the literature. 
6.2. 7 Identification of markers which distinguish resident and inflammatory 
monocyte subsets 
Both resident n1onocytes and inflammatory monocytes have been shown here 
to be closely related in tenns of origin and phenotype. Previously, blood-derived 
inflanu11atory 1nonocytes were described as precursors of resident monocytes 
(Sunderkotter et al., 2004; Varol et al., 2007), although their relationship is still 
under discussion. To fu1iher distinguish these two n1onocyte s~~sets in spleen, genes 
specifically expressed by either resident or inflarmnatory 1nonocytes were identified 
by pairwise comparison. However, only genes specific to resident monocytes could 
be identified, suggesting that inflarmnatory n1onocytes are closely related to resident 
1nonocytes in spleen in terms of function or lineage. A111ongst the small nun1ber of 
genes identified as specifically expressed by resident 1nonocytes, half are expressed 
by natural killer cells ( data not shown). This suggests that sorted resident monocytes 
n1ay be contan1inated with a subset of natural killer cells. These genes were therefore 
not identified a1nongst genes upregulated in resident monocytes over infla1mnatory 
n1onocytes or L-DC. This was also seen in Chapter 3. 
In a comparison of resident and inflarm11atory 1nonocytes, resident monocytes 
upregulated genes encoding known markers like Ccl5, Itgax , Cd300e , Duspl 6, Cd36, 
H2-Abl and Fabp4, while inflanunatory n1onocytes upregulated M1np8, F13al , 
Vcan , Cdl 4 and Fnl (Figure 6.12). These findings were in line with the literature 
that compared gene expression profiles of 1nurine blood monocyte subsets (Ingersoll 
et al., 2010). In line with the staining and gating strategy used, resident 1nonocytes 
showed upregulation of Itgax also know as CDl lc. Upregulation of H2-Abl and H2-
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Figure 6.12 Genes upregulated in either resident monocytes or inflammatory monocytes. 
ANOV A analysis was used to make pairwise con1parisons between gene expression in infla1n1natory and resident 1nonocytes. Genes were selected 
which showed > 4 fold change in signal value in either resident n1onocytes (Resi 1nono) or infla1nn1atory 1nonocytes (Infl mono) and signal value in the 
both subsets > 50. This gave a dataset of 37 genes (shown). 
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Aa could indicate the potential for resident monocytes to express MHCII upon 
activation. DUSP 16 is a dual-specificity phosphatase that can regulate mitogen-
activated protein kinase involved in transduction of extracellular signals to the 
nucleus for gene transcription (Masuda et al. , 2001 ). It has also been described to 
selectively regulate cytokine production by 1nyeloid cells (Niedzielska et al. , 2014 ). 
CCL5 is a chemokine involved in the recruitment of leukocytes to sites of 
inflammation, and has been described to promote recruitment and survival of hu1nan 
1nacrophages (Keophiphath et al. , 2010). Inflammatory monocytes showed 
upregulation of Capg which participates in control of actin-based motility in 
macrophages (Dabiri et al. , 1992; Pellieux et al. , 2003). In line with the literature, 
inflammatory 1nonocytes showed upregulation of CD 14, a marker on hun1an 
inflarmnatory 1nonocytes which acts as a co-receptor for TLR4 signalling 
( Geissn1ann et al. , 2003 ; Zanoni et al. , 2011 ). 
6.2.8 Gene expression unique to L-DC but not other subsets 
Eff 01is were made to identify a delineating phenotype f o_~ L-DC in Chapters 3 
and 4 using available antibodies. These markers have proven helpful in delineating a 
candidate L-DC subset separate fro1n other dendritic and 1nyeloid subsets. However, 
in the absence of a specific L-DC n1arker, 1nore definitive gene expression analysis 
was needed to identify L-DC. Genes expressed by L-DC, but not any other sorted 
DC or 1nyeloid subset prepared in this study, were therefore identified. Genes were 
selected with signal values > 150, and with a relative fold difference between signal 
values for L-DC and all other subsets of at least 2-fold (Figure 6.13). In line with 
previous analyses, L-DC specifically upregulated Cd300e at > 3-fold over all other 
dendritic and 1nyeloid subsets. CD300E is important for activation of n1onocytes and 
for cytokine production. CD300E-prin1ed DC also induce stronger T cell activation 
(Brckalo et al. , 2010). L-DC also showed specific upregulation of Cd300ld, 
Serpinb6a and Dnahcl 2 at > 2.5-fold levels (Figure 6.13). Genes upregulated > 2-
fold in L-DC over other subsets were mainly proteases, adhesion proteins and 
transn1embrane proteins which are more con1monly expressed genes. In summary, 
markers discovered here which n1ay delineate L-DC amongst other splenic DC and 
myeloid subsets include CD300E, CD300LD, CD9 and SERPINB6A. 
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Figure 6.13 Genes specifically expressed by L-DC and not other dendritic and myeloid subsets. 
Genes were selected based on the criteria of signal value in L-DC > 150, with fold difference between L-DC and the lowest expressing subset > 2 fold. 
Genes showing > 2.0 fold,> 2.5 fold and > 3 fold upregulation in L-DC are listed. 
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6.3 Discussion 
Gene profiling studies have been used to identify the L-DC lineage and to 
identify new 1narkers which distinguish the L-DC subset from other splenic dendritic 
and myeloid subsets. Potential new markers of interest include CD300E, CD300LD 
and CD9. While CD9 is 1nore commonly expressed by leukocytes and endothelial 
cells (Ba1Teiro et al., 2008), CD300E and CD300LD have more restricted expression 
by DC subsets (Gasiorowski et al. , 2013). Unfortunately, the only antibodies 
available for CD300E are specific for hu1nan and do not crossreact with 1nurine 
1nolecules ( data not shown). The studies described here also identify a close 
relationship in terms of gene expression between L-DC and the CD 11 c10 resident 
111onocyte subset in spleen. The resident monocyte population is quite distinct fron1 
inflamn1atory 1nonocytes in spleen despite evidence for common function. Both 
CD8+ cDC and CD8- cDC gene profiles were found to be consistent with the 
literature indicating that the staining and sorting protocols established in Chapter 4 
are accurate for delineation of these subsets. Lastly, the gene profile of eosinophils 
was quite distinct fro1n the other dendritic and myeloid subsets isolated, suggesting a 
distinct lineage origin for these cells. This result is consistent with evidence that the 
eosinophil develops fron1 a granulocyte/inacrophage progenitor instead of 
1nacrophage/dendritic cell progenitors (Iwasaki and Akashi, 2007; McNagny and 
Graf, 2002; Weissn1an et al. , 2001 ). 
In ten11s of overall gene expression of isolated splenic subsets, PCA analysis 
indicated a close relationship between L-DC, resident monocytes and inflanunatory 
n1onocytes. Both CD8+ cDC and CD8- cDC were 1nore closely associated. Despite 
their conu11on origin fro1n the CDP, CD8+ cDC and CD8- cDC develop quite distinct 
functions (Figure 6.2). Gene expression between eosinophils and L-DC, and 
eosinophils and infla1m11atory 1nonocytes, showed the largest variation, while L-DC 
and resident 1nonocytes, and L-DC and inflammatory monocytes showed the least 
variation in gene expression. Hierarchical clustering identified L-DC as closely 
related to resident n1onocytes, and CD8+ cDC and CD8- cDC subsets were also 
closely related. The close relationship between gene profiles for L-DC and resident 
monocytes raises questions about a possible common lineage origin. It is yet to be 
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determined whether one is a precursor of the other, or whether they reflect 
functionally distinct progeny of a common progenitor endogenous to spleen. 
Gene expression profiles obtained for resident monocytes compared with 
inflammatory monocytes were consistent with gene expression described in the 
literature for monocytes. Both monocyte subsets expressed Csflr and Ccr2 which 
encode receptors essential for monocyte development and migration, respectively 
(Figure 6.4 A-D) (Auffray et al. , 2009; Geissmann et al., 2008). Resident monocytes 
did not show specific gene expression distinct from inflammatory monocytes, 
although a nun1ber of genes were upregulated in expression. Resident monocytes 
upregulated expression of Cc/5, Duspl 6, Cd36, Fabp4 and H2-Abl, while 
infla1mnatory monocytes upregulated Fnl, Fl 3al , Mmp8, Vcan and Cdl 4 expression 
(Figure 6.12). The gene expression profiles of both resident and inflammatory 
1nonocytes were very similar, 1naking it difficult to identify 1narkers specific for each 
subset. Similarity in gene profile could be attributed to their develop1nent and a 
common lineage origin, or a common progenitor (Fogg et al. , 2006). For example, 
previously it was reported that Ly6Chi inflarmnatory monocytes are a precursor of 
Ly6C 10 resident monocytes, although that study involved peripheral blood rather than 
splenic n1onocytes (Sunderkotter et al., 2004). 
When gene profiles of L-DC were co1npared with those of the cDC subsets, 
L-DC was shown to upregulate genes encoding both dendritic and 1nyeloid cell 
markers like Clec4a4, En1r4, Zeb 2, Krt80, Itga,n and Csfr 1 (Can1inschi et al. , 2001a; 
Dudziak et al. , 2007; Idoyaga et al. , 2013 ; Qi et al. , 2012; Windoffer et al. , 2011) 
(Table 6.1). When the L-DC gene profile was compared with that of the two 
n1onocyte subsets, it was found that L-DC upregulated Cd300e and Cd9 (Table 6.2-
6.3). Both CD300E and CD9 regulate the function of DC, monocytes, mo-DC and T 
cells (Aguilar et al. , 2004; Bo1Tego, 2013 ; Brckalo et al. , 2010). These results are 
consistent with Chapter 3 findings in that L-DC were found to express multiple · 
n1arkers that regulate T cell function. In addition to CD3 00E and CD9, data mining 
to identify new markers for L-DC revealed CD300LD, SERPINB6A and DNAHC12 
as further 1narkers of interest (Figure 6.13). CD300LD belongs to the same fa1nily as 
CD300E, and participates in signal transduction and production of pro-inflammatory 
cytokines (Con1as-Casellas et al. , 2012; Gasiorowski et al. , 2013). Serpinb6a 
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encodes a protein essential for protection against cytotoxic granules (Zhang et al. , 
2006), while Dnahcl 2 encodes a protein that forms part of dynein (Robe1is et al. , 
2013). 
Overall, the L-DC subset of CDl 1 b11iCD1 lc10Ly6C-Ly6G-CD43+Siglec-F-
cells has a gene profile showing a close lineage relationship with that of resident 
monocytes. However, L-DC express many genes in common to cells of the dendritic 
lineage, which are not expressed by resident 1nonocytes. Overall, L-DC represent a 
novel cell type with a gene expression profile resembling both the cDC and 
monocyte lineages. To fu1iher analyse the relationship between L-DC, and other 
dendritic and n1yeloid subsets in spleen, mutant mouse models with a mutation in 
genes encoding growth factors , cytokines or receptors were investigated to detennine 
how specific n1utation affected the development of each of the subsets described 
here. 
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L-DC development is distinct from 
splenic dendritic and myeloid cell 
subsets 
CHAPTER 7 
7.1 Introduction 
In the steady-state, spleen contains multiple subsets of dendritic cells (DC) 
and myeloid cells. The average half-life of conventional ( c) DC is about three days, 
while 1nonocytes have a half-life of 1 day (Karnath et al. , 2002; van Furth and Cohn, 
1968). Thus, splenic cDC and monocytes need to be constantly replenished from 
precursors. He1natopoiesis occurs within bone marrow where hematopoietic stem 
cells (HSC) give rise to multipotent progenitors (MPP), which in turn generate 
common lymphoid progenitors (CLP) and common myeloid progenitors (CMP). 
CMP give rise to the macrophage/dendritic cell progenitors (MDP) (Fogg et al. , 
2006) which generate co1nmon dendritic progenitors (CDP) (Liu et al., 2009; Onai et 
, 
al. , 2007). MDP generate cDC and monocytes, which develop to become 
1nacrophages in tissues, whilst CDP exclusively generate cDC and pDC (Liu et al. , 
2009). Monocytes and plasmacytoid (p) DC exit bone ma1Tow as mature cells and 
pre-pDC, but cDC leave bone 1narrow as pre-cDC that further differentiate and 
divide in spleen (Naik et al., 2006; Naik et al., 2007). The lineages of cDC and 
n1yeloid cells have been extensively studied, but many questions remain to be 
answered. 
Our understanding of L-DC developn1ent is still inco1nplete, although L-DC 
are thought to originate fron1 HSC or hematopoietic progenitor cells (HPC) that seed 
spleen during e1nbryogenesis (Petvises and O'Neill, 2014). Other examples of tissue-
specific DC development have been reported including Langerhans cells, which 
derive from a local pool of self-renewing HPC in the epiden11is (Merad et al. , 2004; 
Merad et al. , 2002). Recent studies on neonatal spleen showed that L-DC could be 
detected as early as embryonic day (E) 18.5 , while cDC were detected later at 4 days 
after birth (Petvises and O 'Neill, 2014). This suggests that L-DC are distinct fro1n 
the cDC lineage, and could develop independently of hematopoiesis in bone marrow. 
In addition, culturing sorted CDP or MDP over supporting stromal cells failed to · 
induce L-DC production (Petvises and O'Neill, 2014). These findings suggest that L-
DC are distinct from both the cDC and monocyte lineage. Recent studies have 
described a lineage of macrophages that develops independently of hematopoiesis in 
bone 1narrow, arising from yolk-sac HSC or HPC (Schulz et al. , 2012). These cells 
are phenotypically distinct fron1 bone 1narrow-derived macrophages, although their 
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functional capacity still remains to be investigated (Schulz et al. , 2012). In addition, 
the relative contribution of yolk sac-derived macrophages verses bone marrow-
derived macrophages to tissue sites still remains to be investigated fully. Recent 
studies have however confirmed that c-Myb is essential in the development of bone 
marrow-derived but not yolk sac-derived myeloid cells, and in c-Myb mutant mice, 
these subset changes can be identified (Schulz et al., 2012). 
Here the development of L-DC has been investigated in a number of 1nutant 
mouse models known to i1npact the develop1nent of DC and 1nyeloid subsets. The 
GM-CSP and PLT3 ligand (PLT3L) growth factors are known to be important in the 
differentiation of DC subsets (Xu et al., 2007). In order to investigate L-DC 
development in relation to cDC, splenic DC and myeloid subsets were investigated 
in GM-CSF1- and Flt3L_1_ 1nutant mice. The BATP3 transcription factor was recently 
described as essential for CD8+ cDC develop1nent (Jaiswal et al., 2013; Tussiwand et 
al. , 2012), and the in1portance of this factor in L-DC development has therefore been 
investigated by analysis of the DC subset composition of Batf-3_1_ n1ouse spleen. 
One consideration in L-DC development is whether these cells which are 
found only in spleen develop in response to infla1nn1atory signals. Such a 1nodel n1ay 
preclude their development in the steady-state. In tenns of their ability to respond to 
enviro1unental signals, both dendritic and 1nyeloid cells express Toll like receptors 
(TLR) on their cell surface that recognise pathogen-associated n1olecule patterns 
(P AMP) \\rhich activate innate iirununity. Signalling through a range of TLR 
n1olecules is 1nediated by either MYD88 or TRIP (Takeda et al. , 2003 ; West et al. , 
2006). To investigate the role of TLR signalling in L-DC develop1nent, MyD88_1_ or 
Trif1- n1ice have been analysed for the presence of DC subsets in spleen. Studies on 
L-DC in this chapter, also encompass an analysis of resident monocytes, sii1ce this 
subset has been found in Chapters 4 and 6 to rese1nble L-DC in terms of their 
phenotype and gene expression. 
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7.2 Results 
7.2.1 L-DC development occurs independently of growth factors which 
regulate cDC development 
Fms-like tyrosine kinase 3 (FLT3) signalling has been described as essential 
for cDC development in the spleen in the steady-state (McKenna et al., 2000). 
Adminstration of FLT3L during in vitro and in vivo cell develop1nent leads to an 
increase in the number of splenic cDC and pDC (Maraskovsky et al. , 1996; 
Pulendran et al., 1997; Shurin et al., 1997). Similarly, knockdown of Flt3L in mice 
leads to a two- to three- fold drop in the nu1nbers of splenic cDC and pDC in adult 
mice (McKenna et al., 2000). To investigate if L-DC develop1nent is equally 
dependent on FLT3L, the representation of cDC and L-DC was analysed relative to 
DC and myeloid subsets in adult wild type and Flt3L_1_ 1nice. Myeloid cells were 
assessed as control subsets. 
CD8+ cDC were gated as CD 11 b-co 11 chiMHCII+ cells, while CD8- cDC 
were gated as CDl 1 b +CDl lc11iMHCII+ cells (Figure 7.1 A). In line with the literature 
(Beaudin et al. , 2014; Karsunky et al., 2003), a six-fold drop in percent CD1 lc11i cells 
was observed in Flt3L_1_ n1ice co1npared with wild type 1nice. However, the relative 
proportion of CD8+ cDC and CD8- cDC was unaffected (Figure 7.1 A). A significant 
5 .5-fold drop in percent CD8- cDC amongst total dendritic and n1yeloid cells, and a 
significant 2-fold drop in percentage of CDS+ cDC were observed in multiple Flt3L_1_ 
mice co1npared with wild type n1ice (Figure 7.1 B). There was also a significant drop 
in the percentages of inflammatory and resident n1onocytes in Flt3L_1_ mice (Figure 
7 .1 C). In contrast, neither L-DC nor eosinophils were affected by loss of Flt3L 
expression. Lastly, the percentage of neutrophils increased in Flt3L_1_ 1nice. These 
results predict a role for FL T3L in the development of cDC, inflamn1atory and 
resident n1onocytes, but not L-DC and eosinophils. The increase in neutrophils could · 
reflect infla1mnation in a mouse model with reduced immune capacity. 
During infla1mnation, inflammatory monocytes can give nse to DC that 
produce TNF-a and inducible NO synthase. These are called Tip-DC (Auffray et al. , 
2009; Geissn1ann et al. , 2003; Serbina et al. , 2008). Granulocyte-1nacrophage 
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Figure 7.1 L-DC development occurs independently of Flt3 ligand. 
Splenocytes were harvested from C57BL/6J-Flt3L 1111 ll111x (Flt3-ligand KO) and C57BL/6J 
( wild type) mice, and red blood cells lysed prior to T and B cell depletion. Cells were 
stained with antibodies specific for CD 11 b (Ml /70, Pe-Cy7), CD 11 c (N4 l 8, APC), 
MHC-II (MS/114.15.2, Pacific Blue), Ly6C (Al-21 , FITC) and Ly6G (1A8, PE). Prior 
to analysis, cells were stained with propidium iodide (PI, 1 µg/ml) for gating live (Pr) 
cells. A) Gating strategy to distinguish myeloid and DC subsets. Myeloid cells were 
initially gated as CD 11 b11 iCD 11 c- cells, and further divided to give inflammatory 
1nonocytes (Infl mono: Ly6C 11 iLy6G- cells) , eosinophils (Eos: Ly6C+Ly6G- cells) and 
neutrophils (Neu: Ly6C+Ly6G+ cells). L-DC were gated as CD 11 b11 iCD 11 c10Ly6C-
Ly6G- cells, while resident n1onocytes were gated as CD 11 bhiCD 11 c10Ly6C+Ly6G-
cells. Conventional dendritic cells ( cDC) were gated as CD 11 chiCD 11 b +/- cells and 
fu11her delineated as CD8+ cDC (MHCII+CD 11 b-) and CD8- cDC (MHCII+CD 11 b +) 
subsets . Gates were set based on fluorescence minus one controls, and numbers in gates 
represent % specific binding. Individual mice were analysed. B) Percent cDC subsets 
are shown relati e to the total dendritic and myeloid cell population. C) Percent myeloid 
cells and L-DC are shown relati e to the total dendritic and myeloid cell population. A 
bar is used to sho mean alues. Red boxes indicate a significant change relati e to 
·ild type using tudenf st-test (p alue < 0.01). 
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colony-stimulating factor (GM-CSF) has been shown to induce the formation of 
inflammatory type DC after addition to cultures of BM progenitors (Berthier et al. , 
2000; Inaba et al., 1993; Xu et al. , 2007). In order to investigate a role for GM-CSF 
in the development of splenic dendritic and myeloid subsets, changes in the 
population representation of cDC, L-DC and 1nyeloid subsets was investigated in 
G M-CSF1- 1nice. Previous studies have reported no reduction in the proportion of 
pDC and cDC in GM-CSF1- mice (Kingston et al. , 2009; Vremec et al. , 1997). In this 
study however, both CD8+ cDC and CD8- cDC were found to be present in 
significantly higher percentage in GM-CSF1- n1ice (Figure 7 .2 B), while both 
resident and inflammatory monocytes demonstrated a significant drop in percent in 
GM-CSF1- 1nice (Figure 7.2 C). The percentage of eosinophils in GM-CSF1- mice 
was significantly increased, while the percentage of L-DC and neutrophils was 
unaffected. 
L-DC development appears to occur independently of both FLT3L and GM-
CSF, while the developn1ent of 1nonocyte subsets is dependent on both factors 
(Figure 7.2). While cDC subsets are dependent on FLT3L for development, they are 
not dependent on GM-CSF. In fact, in the absence of GM-CSF, there appears to be a 
con1pensatory increase in the develop1nent of cDC as well as eosinophils (Figure 
7.2). These results distinguish L-DC from both cDC and 1nyeloid subsets, in that L-
DC develop1nent occurs independently of both FLT3L and GM-CSF. 
7.2.2 L-DC development occurs independently of inflammatory signals 
During inflammation, the engagement of pathogen molecules to TLR on HSC 
can trigger their differentiation (Boiko and Borghesi, 2012; Nagai et al. , 2006). TLR 
signalling mainly involves two adaptor proteins: MYD88 and TRIP (Takeda et al. , 
2003 ; West et al. , 2006). MYD88 is required for all signalling through all TLR 
except TLR3 (Takeda et al. , 2003 ; West et al. , 2006). TLR3 uses TRIP for signal · 
transduction, while TLR4 uses MYD88 or TRIP in association with Toll-interleukin 
1 receptor don1ain-containing adapter protein (TIRAP) or Trif-related adaptor 
molecule (TRAM), respectively (Takeda et al. , 2003; West et al. , 2006). 
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Figure 7.2 L-DC development occurs independently of GM-CSF. 
Splenocytes were harvested from C57BL/6J-Csj211111 Ard (GM-CSF KO) and C57BL/6J 
( wild type) n1ice, and red blood cells lysed prior to T and B cell depletion. A) Cells 
were stained and gated as described in the legend to Figure 7 .1. Gates were set based on 
fluorescence 1ninus one controls, and numbers in gates represent % specific binding. B) 
Percent cDC subsets are shown relative to the total dendritic and myeloid cell 
population. C) Percent rnyeloid cells and L-DC are shown relative to the total dendritic 
and 1nyeloid cell population. A bar is used to show mean values. Red boxes indicate a 
significant change rel a ti e to wild type using Student's t-test (p value < 0.01). 
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CHAPTER 7 
Analysis of L-DC development in MyD88_1_ and Trif1- mice therefore 
represents a test of whether inflarmnatory signals are essential for the develop1nent of 
L-DC from HSC. To determine if TLR signalling plays a role in L-DC development, 
the percentage of L-DC amongst total dendritic and myeloid cells was analysed in 
MyD88-1-, Trif1- and MyD88_1_/Trif1- 1nice compared with wild type control n1ice. In 
addition, the representation of splenic DC and myeloid subsets was analysed 
concurrently to determine if knockout of TLR affects their develop1nent. In MyD88_1_ 
mice, a significant 2.5-fold increase in the percentage of CDS- cDC was seen 
co1npared with wild type mice (Figure 7 .3 B). On the other hand, eosinophils showed 
a significant, but small decrease in percentage (Figure 7 .3 C). The populations of 
inflammatory monocytes, resident n1onocytes, L-DC and neutrophils were not 
significantly different in MyD88_1_ mice compared with wild type mice (Figure 7 .3 
C). These results emphasise how development of L-DC and most other subsets 
occurs independently of inflammatory signals, with the exception of eosinophils. The 
increased nun1ber of CDS- cDC in mutant 1nice could be related to the presence of 
inflammatory or Tip DC a1nongst the CDS- cDC subset since these cells have a 
similar phenotype to CDS- cDC. The development of TipJ?C is likely to be 
dependent on TLR signalling. 
TLR3 is involved in recognition of double stranded RNA associated with 
viral infection (Alexopoulou et al. , 2001). To investigate a possible role for TLR3 in 
the development of n1urine L-DC and cDC, the require1nent for the TLR3 adaptor 
protein TRIF was investigated using Trif1- 1nice. Consistent with the literature, a 
significant reduction in the percentage of both CDS+ cDC and CDS- cDC was 
observed in Trif1- mice co1npared with wild type mice, and associated with TLR3 
signalling (Figure 7.4 B). Amongst the myeloid subsets, only resident monocytes 
showed a significant but small decrease in nu1nbers con1pared with wild type 1nice, 
while neutrophils de1nonstrated a significant increase. The percentage of L-DC 
re1nained constant in Trif1- mice con1pared with wild type mice (Figure 7.4 C). These · 
data reveal dependency for TLR3 signalling for developn1ent of cDC and resident 
1nonocytes. The increase in neutrophils could reflect the higher infection status of 
these 1nutant mice, or a con1pensatory effect. 
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Figure 7.3 L-DC development occurs independently of MyD88 signalling. 
Splenocytes were harvested from C57BL/6J MyD88_1_ (MyD88 KO) and C57BL/6J (wild type) n1ice, and red blood cells lysed prior to T and B cell 
depletion. Cells were stained with 2 distinct antibody cocktails. The first cocktail included antibodies to CD 11 b (Ml /70, Pe-Cy7), CD 11 c (N418 , 
APC), Ly6C (Al-21 , FITC) and Ly6G (1A8, PE), while the second contained CDl lb (Ml /70, Pe-Cy7), CDl lc (N418, APC), MHCII (AF6-120.1 , 
FITC) and CD8 (53-6.7, PE). Prior to analysis, cells were stained with propidium iodide (PI, lµghnl) for gating live (Pr) cells. A) Gating strategy to 
distinguish dendritic and myeloid subsets. Myeloid cells were initially gated as CD 11 b11 iCD 11 c- cells and further delineated into inflan1n1atory 
1nonocytes (Infl mono: Ly6C11 iLy6G- cells), eosinophils (Eos: Ly6C+Ly6G- cells) and neutrophils (Neu: Ly6C+Ly6G+ cells). L-DC were gated as 
CDl 1 b11 iCD1 lc10Ly6C-Ly6G- cells, while resident monocytes were gated as CDl 1 bhiCD1 lc10Ly6C+Ly6G- cells. CD8+ cDC were gated as CDl 1 b-
CD1 lc11iMHCII+CD8+ cells, while CD8- cDC were gated as CDl 1 b +CD1 lchiMHCII+CD8- cells. Gates were set based on fluorescence n1inus one 
controls, and numbers in gates represent % specific binding. Individual 1nice were analysed. A bar is used to show 1nean values. B) Percent cDC is 
shown relative to the total dendritic and myeloid cell population. C) Percent 1nyeloid subsets and L-DC shown relative to the total dendritic and 
myeloid cell population. Red boxes indicate a significant change relative to wild type using Student's t-test (p value < 0.01). Blue boxes indicate a 
significant change relative to wild type using Student's t-test (p value < 0.05). 
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Figure 7.4 L-DC development occurs independently of TRIF signalling. 
Splenocytes were harvested fro1n C57BL/6J Trif1- (TRIF KO) mice and C57BL/6J (wild type) 1nice, and red blood cells lysed prior to T and B cell 
depletion. Cells were stained with 2 distinct antibody cocktails as described in Figure 7.3. A) The gating strategy described in Figure 7.3 was also used. 
Data are presented as dot plots. Gates were set based on fluorescence minus one controls, and numbers in gates represent % specific binding. 
Individual mice were analysed. A bar is used to show mean values. B) Percent cDC is shown relative to the total dendritic and n1yeloid cell population. 
C) Percent myeloid cells and L-DC are shown relative to the total dendritic and n1yeloid population. Red boxes indicate a significant change relative to 
wild type using Student's t-test (p value < 0.01). 
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CHAPTER 7 
MyD88_1_ /Trif1- double knockout mice were also investigated to confirm the 
importance of TLR signalling in splenic dendritic and myeloid cell develop1nent, 
MyD88_1_/Trif1- mice lack all TLR. The representation of each individual subset was 
assessed relative to the total dendritic and myeloid cell population in wild type 1nice. 
CD8- cDC showed a significant drop in percentage, while there was no change in 
percent of CD8+ cDC in MyD88_1_/Trif1- 1nice (Figure 7.5 B). In addition, resident 
n1onocytes and eosinophils showed a significant drop in percentage, while 
inflarmnatory 1nonocytes and L-DC were unaffected (Figure 7.5 C). As with Trif1-
1nice, neutrophils showed a significant increase in percentage in MyD88_1_/Trif1- over 
wild type n1ice, a result which could reflect the infection or inflammatory status of 
these mice (Figure 7.5 C). 
From con1bined studies on the three MyD88-1- , Trif1- and MyD88_1_/Trif1-
mutants, one can conclude that there is a role for TLR signalling in the development 
of cog- cDC, CD8+ cDC, eosinophils and resident 1nonocytes. However, the 
develop1nent of L-DC and inflarmnatory 1nonocytes appears to have occu1Ted 
independently of TLR signalling. The latter two subsets must d~velop in steady-state 
spleen without TLR signalling. It is important to consider that our protocol for 
delineation of the cog- cDC subset could also capture inflarmnatory or monocyte-
derived Tip DC whose developn1ent would be lost in Tlr_1_ mice. Again, L-DC 
develop1nent occurs independently of inflanunatory signals, and this serves to 
distinguish these cells as a subset distinct fro1n resident monocytes. 
7.2.3 The lineage origin of L-DC is distinct from cDC 
The above studies suggest that L-DC development occurs independently of 
growth factors and envirorunental factors that drive cDC development. However, it is 
still not known whether L-DC and cDC derive from a conunon lineage progenitor. 
To finiher distinguish L-DC developn1ent from cDC, their prevalence was · 
investigated in Batf3_1_ mice which have a mutation in a transcription factor 
expressed by cells of the cDC lineage. Batf3 expression has been described in pre-
cDC, CD8+ cDC and cog- cDC, with peak expression in differentiated cDC (Hildner 
et al. , 2008 ; Murphy et al. , 2013 ; Satpathy et al. , 2012). Batf3_1_ 1nice have been 
shown to contain decreased numbers of CD8+ cDC, but not cog- cDC (Hildner et 
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Figure 7.5 L-DC development occurs independently of TLR signalling. 
Splenocytes were harvested fron1 C57BL/6J MyD88-1-TRJF1- (MyD88/Trif KO) n1ice and C57BL/6J (wild type) 1nice, and red blood cells lysed prior to 
T and B cell depletion. Cells were stained with 2 distinct antibody cocktails as described in Figure 7 .3. A) The gating strategy described in Figure 7 .3 
was also used. Gates were set based on fluorescence minus one controls, and nu1nbers in gates represent % specific binding. Individual 1nice were 
analysed. A bar is used to show n1ean values. B) Percent cDC subsets are shown relative to the total dendritic and n1yeloid cell population. C) Percent 
myeloid cells and L-DC are shown relative to the total dendritic and myeloid population. Red boxes indicate a significant change relative to wild type 
using Student' s t-test (p value < 0.01). Blue boxes indicate a significant change relative to wild type using Student's t-test (p value < 0.05). 
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al. , 2008), and Batf3 appears to be essential for CD8+ cDC development from pre-
cDC (Hildner et al. , 2008). Batf3 may co-operate with another factor to induce the 
final differentiation of pre-cDC to CD8+ cDC, while CD8- cDC differentiation may 
occur independently ofBatf3 (Murphy et al. , 2013). 
Consistent with the literature, a significant drop in the percent of CD8+ cDC 
was observed compared with wild type mice (Figure 7.6 C). The percentage of 
infla1runatory monocytes also dropped significantly in Batf3_1_ mice (Figure 7 .6 D). 
However, the percentage of CD8- cDC in Batf3_1_ varied with four of the ten Batf 3-1-
mice studied displaying an increase in percentage of CD8- cDC, while another four 
mice showed a lower percentage of CD8- cDC compared with controls. The 
, 
variability in CD8- cDC percentage could suggest either multiple interaction effects 
leading to highly variable nu1nbers, or heterogeneity amongst the CD8- cDC subset 
delineated here. Both L-DC and resident monocytes displayed no changes in 
percentage due to the Batf3 n1utation. Eosinophils were the only cells that displayed 
an increase in percentage in Batf3_1_ mice. The increase in eosinophils would be 
consistent with increased inflarmnation in these mice. 
7.2.4 Investigation of the role of c-Myb in L-DC development 
HSC can give nse to all blood cells, including cells of myeloid and 
lyn1phocyte lineages. Conventional DC develop fro1n pre-cDC that derive from CDP 
in bone 1na1Tow, while monocytes develop from CMP in BM which traverse into 
blood as monocytes. Once 1nonocytes enter tissues, they differentiate to give 
n1acrophages. Recent studies report a separate lineage of macrophages derived from 
yolk sac progenitors, and distinct from bone man·ow-derived macrophages (Schulz et 
al. , 2012). This lineage of macrophages is dependent on the P U J transcription 
factor , while n1acrophages arising from HSC progenitors in bone marrow are 
dependent on the c-lvfyb transcription factor (Schulz et al. , 2012). To investigate the · 
relationship between L-DC and macrophages, a c-Myb mutant 1nouse model, 
Booreana (c-MybE308G), was analysed (Papathanasiou et al. , 2010). While most 
mutations of c-Myb are embryonically lethal, this single nucleotide mutation c-
MybEJOSG allows mice to survive several weeks post birth (Papathanasiou et al. , 
2010). They do, however, have multiple changes a1nongst the hen1atopoetic cell 
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Figure 7.6 L-DC development occurs independently of Batf-3 signalling. 
Splenocytes were harvested fron1 B6. l29S(C)-Batf3'1711 ·1Kmm (Batf-3 KO) and C57BL/6J (wild type) n1ice, and red blood cells lysed prior to T and B cell 
depletion. Cells were stained with 2 distinct antibody cocktails. The first included antibodies to CD 11 b (Ml/70, Pe-Cy7), CD 11 c (N4 l 8, APC), Ly6C 
(Al-21 , PB), Ly6G (1A8, PE), MHC-II (25-9-17, Biotin) and CD8 (53-6.7, FITC). The second contained antibodies to CDllb (Ml /70, Pe-Cy7), 
CDl le (N418, APC), Ly6C (Al-21 , PB) , Ly6G (1A8, Bio), CD43 (IBII, FITC) and Siglec-F (E50-2440, PE). Prior to analysis, cells were stained with 
propidilu11 iodide (PI, 1 ~tg/ml) for gating live (Pr) cells. A) The gating strategy to distinguish myeloid and DC subsets is shown. Myeloid cells were 
initially gated as CDl 1 b11 iCDl le- cells, and further delineated into inflammatory monocytes (Infl 1110110: Ly6C11 iLy6G-CD43+Siglec-F- cells), 
eosinophils (Eos: Ly6C+Ly6G-CD43+Siglec-F11 i cells) and neutrophils (Neu: Ly6C+Ly6G+CD43+Siglec-F- cells). L-DC were gated as 
CDl 1 b11 iCDl lc10Ly6C-Ly6G-CD43+Siglec-F- cells, while resident monocytes were gated as CDl 1 b11 iCDl lc10Ly6C+Ly6G-CD43 11 iSiglec-F- cells. Both 
CD43 and Siglec-F staining vvere not shown. CD8+ cDC were gated as CDl 1 b-CDl lc11 iMHCII+CD8+Ly6C-Ly6G- cells, while CD8-cDC were gated as 
CD 11b+CD11 c11 iMHCII+CD8-Ly6C-Ly6G- cells. Gates were set based on fluorescence 1ninus one controls, and numbers in gates represent % specific 
binding. Individual mice were analysed. A bar is used ·10 show mean values. B) Percent cDC subsets are shown relative to the total dendritic and 
n1yeloid cell population. C) Percent 1nyeloid subsets and L-DC are shown relative to the total dendritic and 111yeloid cell population. Red boxes indicate 
a significant change relative to wild type using Student's t-test (p value < 0.01). 
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compartment, including an increase in the number of HSC (Papathanasiou et al. , 
2010). 
Mutation in c-Myb resulted in a significant drop in the percentage of CD8-
cDC, infla1mnatory 1nonocytes and neutrophils in Booreana n1ice over wild type 
mice (Figure 7.7B). L-DC, resident monocytes and eosinophils were not affected by 
the c-Myb n1utation. The explanation for this result could depend on the role of c-
Myb in developn1ent of 1nyeloid cells and DC from bone 1na1Tow-derived 
progenitors. The possibility that L-DC and resident monocytes do not derive from 
bone 1na1Tow progenitors but from progenitors laid down during embryogenesis, 
1nust be considered. However, an alternative explanation is needed for results 
observed for CDS+ cDC and eosinophil developn1ent. 
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Figure 7.7 L-DC development occurs independently of c-Myb signalling. 
Splenocytes were harvested from CS7BL/6Jc-MybE3080 (Booreana) mice and C57BL/6J (wild type) n1ice, respectively, and red blood cells lysed prior 
to T and B cell depletion. Cells were stained with 2 distinct antibody cocktails as described in Figure 7.3. A) The gating strategy in Figure 7.3 was also 
used. Gates were set based on fluorescence minus one controls, and nu1nbers in gates represent % specific binding. Individual mice were analysed. A 
bar is used to show n1ean values. B) Percent cDC relative to live cells is shown. C) Percent 1nyeloid cells and L-DC are shown relative to live cells. 
Red boxes indicate a significant change relative to wild type using Student' s t-test (p value < 0.01). 
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7.3 Discussion 
None of the mutant mice studied here are embryonically lethal, and none of 
the genes mutated are crucial for survival. For this reason, these strains could provide 
important infonnation about the development of L-DC in relation to other splenic 
dendritic and myeloid subsets. L-DC development occurs independently of factors 
that regulate cDC and n1onocyte development, including FL T3L and GM-CSF. In 
addition, L-DC develop1nent occurs in the steady-state, independently of TLR 
signalling. Lastly, there is also evidence suggesting that L-DC may arise from yolk 
sac-derived c-Myb-independent progenitors in spleen, rather than from bone ma1Tow-
derived progenitors. All of these data separate L-DC from cDC as a separate lineage 
, 
of cells, and identifies them as distinct fron1 splenic monocyte subsets. 
The binding of FL T3 L to FL T3 triggers the development of cDC from pre-
cDC (Kingston et al. , 2009; Waskow et al., 2008; Xu et al. , 2007). Thus, knockout of 
either Flt3 and Flt3L adversely affects cDC development (Kingston et al. , 2009; 
Waskow et al. , 2008). Consistent with this, a significant drop in the percentage of 
-
splenic CDS+ cDC and CDS- cDC was observed in Flt3L_1_ mice (Kingston et al. , 
2009; Xu et al. , 2007). FL T3 is also a 1narker of CLP and CMP (Karsunky et al. , 
2003), such that the delivery of additional FLT3L to mice can lead to an expansion 
of the n1onocyte pool as well as cDC (Beaudin et al. , 2014; Karsunky et al. , 2003). 
Expression of the FL T3 receptor on n1onocytes, and the expansion of 1nonocytes 
following FLT3L sti1nulation, suggest that FLT3 receptor tyrosine kinase signalling 
plays a role in 1nonocyte development. In agree1nent with this, Waskow et al. (2008) 
showed an increase in the numbers of MDP which give rise to CDP and 1nonocytes 
following FLT3L stin1ulation in vivo and in vitro. A drop in the nu1nber of resident 
and inflan1111atory n1onocytes in Flt3L_1_ mice shown here therefore supports a role 
for FL T3 signalling in n1onocyte develop1nent. Since L-DC development is not 
con1pro1nised in Flt3L_1_ mice, L-DC is distinguishable in terms of develop1nent and 
lineage fro1n both cDC subsets, as well as from resident and infla1nmatory 
1nonocytes in spleen. 
Both FL T3L and GM-CSF have been used in different culture syste1ns to 
generate DC in vitro. Previously, it was shown that the culture of BM precursors 
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with FLT3L generated cDC and pDC, while GM-CSF addition generated 
inflammatory type DC (Berthier et al. , 2000; Kingston et al. , 2009). GM-CSF1- mice 
were employed here to determine any role for GM-CSF in the development of L-DC. 
Deficiency in GM-CSF production did not affect the development of L-DC, 
suggesting that L-DC are not likely to be inflammatory type DC dependent on GM-
CSF signalling. By comparison, the percentage of both resident and inflammatory 
monocytes was reduced, consistent with their development in response to GM-CSF, 
and probably inflanm1ation. However, this evidence does not necessarily mean they 
derive fron1 a co1mnon progenitor. The percentage of inflanunatory n1onocytes 
dropped by 4-fold in GM-CSF1- n1ice, while resident monocytes showed a smaller, 
but significant 1.4-fold drop. Previous studies in GM-CSF1- mice showed no 
, 
significant changes in peripheral blood myeloid subsets, although alveolar 
n1acrophages were defective (Stanley et al. , 1994). However, that study did not 
investigate splenic n1yeloid subsets in the same detail as used here. 
GM-CSF is secreted in response to inflammation and can induce 
infla1mnatory DC or Tip DC (Be1ihier et al. , 2000; Inaba et al. , 1993 ; Xu et al. , 
2007). In contrast, cDC are generated in the steady-state, and their developn1ent 
occurs independently of GM-CSF (Kingston et al. , 2009). Here, however, the 
percentage of CD8+ cDC and CD8- cDC was found to be significantly increased in 
GM-CSF1- 1nice (Kingston et al. , 2009). An increase in cDC could occur as a 
compensatory change in spleen due to a reduction in the nun1ber of monocytes. 
Lastly, eosinophils displayed increased nu1nbers in GM-CSF1- mice suggesting that 
the developn1ent of eosinophils occurs independently of GM-CSF. An increase in 
nU111bers of eosinophils could also reflect an inflarmnatory and/or allergic state in 
GM-CSF1- mice. 
Inflaimnatory signalling induced by interferons or TLR signalling can drive 
HSC proliferation and differentiation (Boiko and Borghesi, 2012; Nagai et al. , 2006). 
MUI·ine HSC have been repo1ied to express TLR on their cell surface and can 
recognise pathogen-associated molecular patte1ns (P AMP) (Nagai et al. , 2006; 
Zhang et al. , 2005 ; Zhao et al. , 2013). Stin1ulation of HSC with LPS in vivo leads to 
an increase in HSC cycling, evident by increased colony fanning units in spleen, 
blood and BM (Zhai1g et al. , 2005). The expression of TLR on HSC could reflect a 
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mechanism whereby HSC can detect infection directly, and respond by increased 
hematopoiesis. In order to investigate whether TLR signalling plays a role in L-DC 
development, the three MyD88-1-, Trif1-and MyD88_1_/Trif1- mutant mice were studied. 
The combined results showed no significant change in the percentage of L-DC across 
all three mutants, confirming that L-DC development occurs independently of TLR 
signalling. In contrast, cDC subsets were reduced in TLR mutants. CDS+ cDC and 
CDS- cDC development and homeostasis are clearly dependent on Trif signalling 
evident by a drop in the numbers of cells in Trif1- and MyD88-1/ Trif1- mice. TRIP 
acts as an adaptor protein for TLR3 signal transduction, an essential pathway for DC 
recognition of virus (West et al. , 2006). Hence, lack of Trif expression would affect 
cDC ability to activate T cells. 
Resident monocytes also showed reduced numbers in Trif1- and MyD88_1_ 
/Trif1- mice, suggesting that their development is also dependent on TLR3 signalling. 
Despite distinct lineage origins, both cDC and resident 1nonocytes share the same 
require1nent for TLR3 signalling. However, numbers of inflammatory monocytes, 
which are also precursors of Tip DC (Geissn1ann et al. , 2008), were not affected in 
any of the TLR mutants. The conversion of inflammatory monocytes to immature 
Tip DC during parasitic infection has been shown to occur independently of IFN-y 
and MYD88, while the activation of i1nmature Tip DC is dependent on both 
signalling pathways (Bosschae1is et al. , 2010). Since inflammatory monocyte 
numbers are unchanged in TLR n1utant n1ice, it would appear that all mice under 
study here reflect steady-state conditions, and without conversion of inflammatory 
1nonocytes to Tip DC. These studies therefore highlight how resident monocytes and 
inflan1111atory n1onocytes have distinct require1nents for TLR signalling. 
Out of all the subsets studied in TLR mutant n1ice, only eosinophils showed a 
drop in numbers in MyD88_1_ mice. Eosinophils are essential for activation of i1111ate 
i1mnunity against parasite infections and allergic responses through engage1nent of · 
TLR7 (Nagase et al. , 2003). MYD88 is required for all TLR signalling except TLR3 , 
thus lack of MYD88 signalling could adversely affect eosinophils. Lastly, one 
interpretation for the increased proportion of neutrophils observed in Trif1- and 
MyD88_1_/Trif1- n1ice could be that there is a con1pensatory increase due to reduced 
numbers of resident n1onocytes and cDC observed in these mice. 
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L-DC development occurs independently of FLT3L, GM-CSF and TLR 
signalling. Previously, this lab published evidence that L-DC could arise fro1n 
progenitors in BM, in particular L T-HSC and MPP when co-cultured over splenic 
stromal lines (Hinton and O'Neill, 2012; Petvises and O'Neill, 2014). These findings 
support 1nounting evidence that L-DC arise from a progenitor distinct fron1 CDP. 
Data shown here are consistent, and serve to further delineate the L-DC lineage from 
the cDC lineage. BA TF-3 is a transcription factor essential for the differentiation of 
CDP or pre-cDC to give CD8+ cDC (Hildner et al. , 2008). In Batf-3_1_ mice, a 
significant drop in CD8+ cDC development was observed consistent with the 
literature (Hildner et al. , 2008). However, the percentage of L-DC was unaffecte·d in 
Batf-3_1_ n1ice, suggesting that L-DC have a distinct lineage origin from cDC, 
although a significant drop in the percentage of inflammatory monocytes was 
observed. Recent studies in Batf-3_1_ mice showing a defect in the differentiation of 
CD4 T helper cells into T helper 17 (Thl 7) cells (Kurachi et al. , 2014; Schran1l et al. , 
2009) which are essential in conducting inflammatory responses against pathogens 
and in autoi1mnunity (Bettelli et al. , 2006; Brilstle et al. , 2007). It is interesting to 
speculate that inflammatory 1nonocytes may be important n1ediators of Th 1 7 cell 
developn1ent. 
It is well known that a distinct lineage of n1acrophages arises fro1n yolk sac-
derived hen1atopoietic progenitors or HSC (Schulz et al. , 2012). The study used 
CX3CRl gfpl + 1nice, where one copy of the gene encoding CX3CR1 was replaced with 
green fluorescent protein (GFP) reporter cDNA, to track of the developn1ent of 
1nacrophages during e1nbryogenesis. Two populations of macrophages were 
observed in CX3CR1 gfpl + n1ice. CD 11 b1°F4/8011 iCX3CR1 11i cells were first detected in 
the en1bryo between E9.5 and El0.5 , while CDllb11iF4/801°CX3CR1 10 cells were 
observed after E12.5. The lineage origin of these 1nacrophages was confinned using 
PU T 1- and c-Myb_1_ 1nutant mice (Schulz et al. , 2012). PU.1 is an essential 
transcription factor for n1acrophage developn1ent, but dispensable for HSC 
developn1ent (Dakic et al. , 2005), while C-MYB is an essential transcription factor 
for he1natopoietic development, but is dispensable for macrophage develop1nent 
(Mucenski et al. , 1991 ; Mukouyan1a et al. , 1999; Sumner et al. , 2000). 
CD1 lb1°F4/8011iCX3CR1 11i cells were present in c-lvfyb-1- n1ice, but absent in PU T 1-
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mice, indicative of a yolk sac origin. In contrast, CD 11 bhip 4/801°CX3CR1 10 cells were 
present PU 1-1- mice, but absent in c-Myb-1-mice, indicative of a bone marrow origin 
(Schulz et al., 2012). This study raises the question of whether other cell types also 
derive from yolk sac-derived progenitors. Previous evidence indicates that L-DC 
derive fro1n HPC which are endogenous to spleen, which seed spleen during 
embryogenesis (O'Neill et al., 2014). 
In order to investigate the lineage origin of L-DC as either bone n1arrow- or 
yolk sac- derived, Booreana 1nice (c-MybE3osGIE3osG) were employed (Papathanasiou 
et al. , 2010). Increased numbers of HSC, MPP, CLP and CMP and a drop in GMP 
and MEP numbers have been recorded in Booreana bone marrow (Papathanasiou et 
al., 2010). These changes are also reflected in progeny cells in blood, and significant 
reduction in the numbers of neutrophils and red blood cells were also observed. Here 
it was shown that spleens of Booreana mice carry reduced numbers of CD8- cDC, 
inflanm1atory 1nonocytes and neutrophils, consistent with their origin from bone 
marrow progenitors, and consistent with decreased nun1bers of CMP and GMP in 
Booreana bone n1arrow (Petvises and O'Neill, unpublished data). However, resident 
1nonocytes and L-DC were present in si1nilar numbers in Booreana and wild type 
1nice, suggesting that both resident 1nonocyte and L-DC develop1nent occur 
independently of c-Myb. These findings support the possibility that L-DC and 
resident n1onocytes in spleen arise fron1 endogenous yolk sac-derived he1natopoietic 
progenitors. Whether they are related in tern1s of lineage is not yet known. 
None of the n1utants studied here showed any effect on L-DC develop1nent. 
Clearly the developn1en of L-DC is distinct fron1 cDC, 1nonocytes, eosinophils and 
neutrophils. In contrast, cDC develop1nent and homeostasis was affected by 
signalling dependent on Flt3, Batf-3 and TLR3 signalling. The development and 
homeostasis of both resident monocytes and infla1mnatory 1nonocytes were 
adversely affected by 1nutations affecting Flt3 and GM-CSF signalling. In addition, · 
the production of inflanu11atory 1nonocytes was shown to be dependent on Batf-3 and 
c-Myb signalling, while resident monocytes were dependent on Trif signalling. 
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General discussion 
CHAPTERS 
8.1 Identification of L-DC in relation to other splenic dendritic and myeloid 
cell subsets 
In general terms, this thesis has made a number of contributions towards 
better understanding of the dendritic and 1nyeloid subsets present in murine spleen. 
In particular, the novel dendritic-like subset 'L-DC' has been further characterised in 
relation to other known dendritic cell (DC) subsets as well as monocytes. New 
procedures used for characterisation of subsets have been verified, in that the CDS+ 
cDC and CDS- cDC subsets can be clearly identified, and are shown here to resemble 
the cDC subsets described by others. L-DC are shown as clearly distinct from cDC 
subsets. Full and complete analysis of splenic subsets has required that the 1nonocyte 
subsets be redefined, with the outco1ne that infla1nmatory monocytes are now clearly 
distinguishable as a separate lineage from resident monocytes, and are also distinct 
from L-DC. The resident monocyte subset defined here as a subset of spleen has 
been shown to be clearly distinct fron1 described resident monocytes present in 
murine blood. Resident monocytes are also shown to be distinct as a subset from L-
DC, although there is clear evidence that these subsets are si1nilar, and probably 
derived from a common progenitor or lineage. L-DC are -therefore defined as a 
separate novel dendritic-like subset in spleen as previously hypothesised (O'Neill et 
al. , 2014). 
This study has used flow cytometry extensively to better identify the cell 
surface marker phenotype of subsets (Chapters 3 and 4). L-DC is now best 
distinguished as a CDl 1 b11 iCD1 lc10MHCirLy6C-Ly6G- subset of cells, which are 
also CX3CR1 1°CD43 10Siglec-F-. They are distinct from eosinophils on the basis of 
CD1 lc10 expression and lack of Ly6C and Siglec-F expression. In tenns of their 
relationship to monocyte subsets, L-DC are distinct from resident monocytes on the 
basis of their CX3CR1 10Ly6C-CD 115- phenotype, while resident monocytes are 
CX3CR1 11 iLy6C1°CD115+ cells. L-DC are also distinct from inflarmnatory 1nonocytes 
on the basis of CD 11 c10Ly6C- expression, while inflammatory monocytes are CD 11 c-
Ly6C11i cells. They are clearly distinct fro1n cDC in that they lack MHCII expression, 
and also on the basis of CD43 and CX3CR1 expression. Further tests of L-DC 
function, gene expression and lineage have therefore been based on a new set of 
distinguishing 1narkers (Chapter 5). Functional assays used to distinguish the splenic 
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dendritic and myeloid subsets have been limited by low cell yields achieved after cell 
sorting, and by the low representation of DC subsets in spleen. In terms of 
characterising L-DC as an in vivo equivalent of LTC-DC, ability to cross-present 
antigen was investigated primarily. Initially, the endocytic ability of L-DC for 
soluble antigen and receptor-mediated antigen uptake was confirmed. L-DC 
demonstrated similar ability as CD8+ cDC to take up antigen via mannose receptors, 
and weaker ability to endocytose soluble OVA compared with the cDC subsets. 
Initially, several protocols for assess1nent of cross-presentation were tested, 
including in vitro pulsing of DC with antigen and in vivo priming. However, cell 
numbers recovered were too low and this con1promised experin1entation ( data not 
shown). For this reason, mACT-OVA mice were employed which express cell 
surface antigen (OVA) constitutively. These experiments confinned the cross-
presentation ability of CD8+ cDC and CD8- cDC, but not of neutrophils, resident and 
inflamn1atory monocytes, as shown previously by others. An established 
experimental procedure was therefore proven reliable in identifying cross-
presentation as a property of the more clearly characterised L-DC subset. L-DC 
showed weaker ability in cross-presentation than cDC, but regularly showed cross-
presentation ability across multiple experiments. 
Mutant n1ice were utilised to confin11 the development and lineage origin of 
L-DC as distinct from cDC and n1onocyte subsets (Chapter 7). The developn1ent of 
L-DC occurred independently of growth factors like FLT3L and GM-CSF, known to 
be essential for cDC and 1nonocyte/macrophage development, respectively. L-DC 
also develop independently of BATF3, a transcription factor required for CD8+ cDC 
development. The developn1ent of L-DC also occurs independently of infla1nmatory 
signals, consistent with a subset resident in spleen under steady-state conditions. L-
DC develop independently of TLR signalling, and this was also shown to be true for 
inflanunatory monocytes. In contrast, the splenic cDC and resident monocytes were 
found to be dependent on TLR3 and TLR4 signalling, consistent with inflammation 
as a factor in the development of at least son1e cells in these subsets. 
In tenns of their restricted develop1nent in only spleen, the question of L-DC 
ong1n from a spleen versus a bone marrow progenitor was addressed. The 
development of dendritic and n1yeloid subsets fro1n bone ma1Tow progenitors has 
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been shown to be critically dependent on c-Myb. The development of L-DC was 
therefore analysed in c-MybE308O mutant mice which show reduced hematopoiesis in 
bone marrow with subsequent changes in blood leukocyte numbers. Mice containing 
the non-lethal c-MybE308O mutation showed reduced production of neutrophils, 
infla1nmatory monocytes and CD8- cDC in spleen. The production of resident 
monocytes and L-DC was however unaffected by this mutation, consistent with L-
DC and resident monocytes having a developmental origin distinct from bone 
marrow progenitors. The possibility that they derive from a spleen endogenous 
progenitor laid down during embryo genesis, and perhaps of yolk sac origin, has been 
considered. These data also support a common lineage relationship and progenitor 
origin for L-DC and resident monocytes in spleen, despite their clear phenotypic and 
functional differences. 
Transcripton1e analysis was used initially to investigate the incompletely 
characterised L-DC subset in relation to other well defined subsets of cDC and 
granulocytes (Chapter 3). This initial study identified L-DC as functionally similar to 
DC, but also bearing myeloid characteristics. L-DC wer~ clearly distinguishable 
fro1n cDC. This initial study also identified contaminant cell populations and 
contributed to the development of optimised procedures for delineation of subsets on 
the basis of 1narker analysis. A subsequent transcriptome analysis in Chapter 6 
involved the more fully defined subsets identified in Chapter 4. This allowed cDC 
subsets, inflan1matory monocytes and eosinophils to be clearly distinguished as pure 
subsets and distinct from L-DC. This study showed clearly that a newly defined 
resident monocyte subset was very similar to L-DC. However, both subsets showed 
clear differences in their function as cross-presenting cells, with only L-DC and not 
resident 1nonocytes effective in cross-presentation and in activation of CD8+ T cells 
in response to antigen. L-DC and resident monocytes were also clearly distinct in 
te1n1s of their development. Numbers of resident monocytes but not L-DC were 
compromised in Trif1-, Flt3L_1_ and G,n-cs/1- mice, consistent with a role for 
inflan1mation in the fo1mation of resident monocytes but not L-DC. In terms of their 
transcripto1ne, L-DC reflect a distinct novel dendritic-like cell type, showing 
expression of genes which drive antigen presentation as well as activation and 
regulation of T cells, consistent with a dendritic antigen presenting cell phenotype. 
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However, L-DC also express genes reflective of the myeloid lineage which are 
commonly expressed by both the resident and inflammatory monocyte subsets. 
8.2 Redefining the splenic myeloid subsets 
While it has been known for a long time that the spleen contains multiple 
dendritic and myeloid subsets, with different subsets distinguishable on the basis of 
phenotype, function or anatomical location, the relationship between subsets has not 
been clearly defined. As a result of recent intensive flow cytometric analysis, splenic 
DC subsets are now better characterised than the myeloid subsets. These remain in 
need of better delineation. For the myeloid subsets, the literature contains multiple 
descriptions of different phenotype and function. The history of this work led to 
confusion in the identification of splenic dendritic subsets for some time, and now 
remains a problem for the definition of myeloid subsets. Indeed, the same cell type 
could be named differently on the basis on function versus phenotype. For example, 
in the gut, multiple DC subsets can be identified based on CD 11 b, CDS, CD 103 and 
CX3CR1 expression (Iwasaki and Kelsall, 2001; Johansson-Lindbom et al. , 2005 ; 
Scott et al. , 2011; Varol et al. , 2009). The CD103+CX3CRi- and CD103-CX3CR1 + 
DC subsets in lanuna propria induce tolerogenic and pro-inflammatory responses, 
respectively (Atarashi et al. , 2008 ; Denning et al. , 2007). The CD103-CX3CR1 + DC 
subset has however been described as a macrophage on the basis of developmental 
origin (Bain and Movlat, 2014), but as a DC on the basis of CDl lc and MHCII 
expression (Scott et al. , 2011 · Varol et al. , 2009). In order to address these issues, a 
recent paper suggested a unified nomenclature for DC, monocytes and macrophages 
based primarily on ontogen , and secondly in terms of location, function and 
phenotype (Guilliams et al. , 2014). This study defined subsets in terms of their 
anatomical location as \Veil as their phenotype. A case in point in this thesis has been 
the delineation of resident monocytes in spleen on the basis of the published 
pheno pe and function of resident monocytes in blood. This study revealed that the 
spleen equi alent subset \Nas not a resident monocyte but instead a subset of 
eosinophils. Further anal sis \Vas needed to identify a candidate resident monocyte 
cell pe in spleen. Indeed, the phenotype of subsets can ary from tissue to tissue, 
emphasising ho\ important it is to identify subsets on the basis of multiple criteria 
and to have a unified nomenclature for dendritic and m eloid subsets. 
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In order to better define L-DC in relation to splenic myeloid subsets, it was 
necessary to identify myeloid and DC subsets concurrently. Historically, splenic 
monocytes have been classified as resident and inflammatory monocytes with the 
splenic subsets identified on the basis of the original blood subset phenotypes. Since 
different n1arkers were used previously to identify blood monocytes, a combination 
of all known markers was incorporated into the staining protocol. Monocytes have 
been described previously as CD 11 b11iCD 11 c-MHCir cells, and then further 
delineated into inflammatory or resident monocyte subsets (Geissmann et al. , 2008; 
Geissmann et al. , 2003). Inflamn1atory monocytes are commonly gated as 
CX3CR1 10Ly6C11iLy6G- cells, while resident monocytes are gated as 
CX3CRl hiLy6C+Ly6G- cells (Geissmann et al., 2008; Geissmann et al. , 2003). 
However, in Chapter 4, it was found that gating according to this practice revealed 
resident n1onocytes as a CD 11 c- subset which did not express CX3CR1 . Instead, high 
levels of CX3CRl co1mnon to resident monocytes were expressed by a subset of 
CD 11 c10 cells, and restricted also to a Ly6C+Ly6G- subset. 
The expression of CD 11 c on monocytes has been a debatable issue, with 
son1e investigators describing cells as CD 11 c- while others as CD 11 c10 cells. More 
comprehensive staining for myeloid n1arkers revealed that an apparent subset of 
CD 11 c - resident 1nonocytes stained positive for Siglec-F, which is a delineating 
n1arker for eosinophils, and not resident monocytes. In addition, n1orphological 
studies in Chapter 4 confinned the identity of CDl lb 11iCD1 lc-MHCirLy6C10Ly6G-
cells as eosinophils. In the sa1ne study, phenotypic and morphological analysis 
identified CD 11 b 11iCD 11 c10MHCirLy6C+Ly6G- cells as resident monocytes, 
distinguishing the1n from previously defined subsets. This newly defined resident 
monocyte subset, as well as a subset of inflammatory 1nonocytes, showed si1nilar 
functional characteristics as 1nonocytes in that they expressed co1mnon markers like 
CCR2, CSFlR, CD44, CD209 and F13Al (Chapters 3 and 6) (Ingersoll et al. , 2010; 
Swirski et al. , 2009). In addition, the full development of both n1onocyte subsets in 
spleen was found to be inhibited in Flt3_1_ and Gm-cfs r_1_ mice. These genes encode 
Flt3 and GM-CSFR which are impo1iant in the development of myeloid subsets 
(Beaudin et al. , 2014; Karsunky et al. , 2003 ; Xu et al. , 2007). This study has 
highlighted the con1plexity and confusion in the no1nenclature used to define DC and 
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myeloid subsets. Phenotype alone is insufficient to correctly identify a subset, and a 
combination of morphology, function and gene expression are therefore required to 
confirm subset identify. 
8.3 L-DC as a novel dendritic-like subset 
Antibody staining and flow cytometric analysis were used pri1narily to 
distinguish L-DC fro1n other splenic dendritic and myeloid subsets. Initial studies 
identified L-DC as CDl 1 bhiCDl lc10MHCirCD8-B220- cells, distinct from cDC on 
the basis of phenotype (Chapter 3). Further phenotypic and morphologic studies 
revealed that a candidate L-DC subset is distinct from n1acrophages, inflammatory 
monocytes, resident monocytes, neutrophils and eosinophils. L-DC are distinct fro1n 
CD8+ cDC primarily by lack of MHCII and CD40 expression but also since they 
express CDl 1 b, CD43 and CX3CR1 (Chapters 3 and 4). MHCII expression is 
associated with APC and presentation of antigen to CD4+ T cells, and CD40 is an 
essential co-stimulatory molecule expressed on APC for activation of T helper cells 
(Pooley et al. , 2001; Van Essen et al. , 1995). Lack ofMHCII and CD40 expression is 
consistent with L-DC inability to present antigen to CD4 + T cells and to induce a T 
helper response (Chapter 5). In contrast, L-DC showed resemblance with CDS- cDC 
in terms of expression of CDl 1 b, CX3CR1 and F4/80 (Chapters 3 and 4). However, 
transcripton1e analysis also showed L-DC to be distinct from cDC on the basis of 
overall gene expression and clustering analysis. Despite these differences, L-DC 
rese1nble cDC 1norphologically, and can function in cross-presentation with ability to 
cross-pri1ne CDS+ T cells (Chapters 4 and 5). Indeed, L-DC reflect dendritic-like 
cells, showing si1nilar ability to take up and retain 1nannan as CD8+ cDC. Cross-
presentation is a hallmark of DC, and distinguishes DC from other myeloid subsets. 
A previous study showed that CD8+ cDC mainly utilised the TAP pathway for 
processing antigen for cross-presentation to CD8+ T cells (Ming et al. , 2008). 
However, L-DC appear to use a TAP-independent pathway, since cytochrome · c 
treatn1ent of cells does not inhibit their cross-presentation capacity. It is possible that 
L-DC could utilise both TAP-dependent and TAP-independent pathways for 
processing of antigen for cross-presentation under different conditions. L-DC also 
showed similar ability as CDS+ cDC to induce cytotoxic T cells through specific 
lysis of target cells. 
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The possibility that L-DC reflect a macrophage subset on the basis of lack of 
MHCII expression and low level CD 11 c expression was considered, but refuted. It 
was first important to better define macrophages in spleen on the basis of phenotype 
since most studies have used irrununocytochemistry to identify macrophages. Here, 
splenic macrophages were identified as CD 11 b1°CD 11 c-Ly6c-1+Ly6G- cells through a 
series of staining and backgating strategies (Chapter 4). Further staining for markers 
which define particular splenic macrophage subsets, including SIGNRl , MOMA-I 
and CD68, confirn1ed that L-DC is a distinct subset. L-DC has also shown to be 
distinct fro1n neutrophils, eosinophils and infla1nmatory monocytes in tenns of 
phenotype, morphology and gene expression. L-DC can be delineated from 
neutrophils by lack of Ly6G and 7 /4 expression (Galli et al. , 2011; Rosas et al. , 
2010). L-DC could be also distinguished from eosinophils by lack of Siglec-F 
expression (Chapter 4) (Bochner, 2009; Guo et al., 2007), and from inflammatory 
monocytes by absence of Ly6C expression. 
Our working hypothesis is that L-DC represent an A~C subset appropriately 
localised in spleen to present blood-borne antigen for activation of CD8+ T cells. 
This hypothesis is suppo1ied by evidence for the high endocytic and cross-
presentation ability of L-DC. Identification of gene expression unique to L-DC has 
revealed 3 specific 1narkers related to antigen presentation including CD300E, 
CD300LD and CD9 (Chapter 6). Both CD300E and CD300LD are members of the 
CD300 fa1nily , which regulates the immune response via paired activating and 
inhibitory receptors (Borrego, 2013 ; Izawa et al. , 2007). In addition, CD300 
molecules have been described to bind to lipids, like phosphatidy lserine and 
phosphatidy lethanolamine, which are exposed on the plasma membrane of apoptotic 
and activated cells (Borrego, 2013). CD300E also participates in T cell activation via 
regulation of transcription factor expression (Brckalo et al. , 2012), and in n1onocyte 
and mo-DC activation (Brckalo et al. , 2010). It induces the release of reactive 
oxygen in monocytes, as well as cytokine release and expression of activation 
n1arkers upon binding (Brckalo et al. , 2010). CD300E-primed DC show stronger 
ability to activate T cells, while CD300LD induces cytokine production in 
neutrophils and 1nacrophages (Izawa et al. , 2007). CD9 can act as a costin1ulatory 
molecule on DC to activate T cells, and facilitates the uptake of exosomes by APC 
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(Kobayashi et al., 2004; Lagaudriere-Gesbert et al., 1997). These unique markers 
support the hypothesis that L-DC function as an APC with distinct ability to present 
antigen and activate T cells. Here, L-DC are identified as a novel subset of dendritic-
like cells with many characteristics of 1nyeloid lineage cells, but with antigen 
presenting function reflecting a subset of DC unique to spleen. 
8.4 Relationship between L-DC and resident monocytes 
Data presented here identify L-DC as closely related to splenic resident 
monocytes in terms of phenotype and gene expression profile, but distinct in terms of 
function, morphology and develop1nent. Both L-DC and resident monocytes were 
gated as CD 11 b11iCD 11 c10MHCirCD8-Ly6G- cells, then further distinguished on the 
basis of Ly6C, CX3CR1 and CDl 15 expression (Chapters 3 and 4). L-DC were 
further identified as Ly6C-CX3CR1 1°CD115- cells, while resident monocytes were 
Ly6C+CX3CR1 11 iCD115+ cells (Chapters 3 and 4). The gene expression profiles of L-
DC and resident monocytes were found to be very similar, suggesting that the two 
subsets could be derived from a common progenitor. Despit~ their similarity, L-DC 
can be distinguished fro1n resident monocytes by cross-presentation ability and 
distinct n1orphology. Develop1nental studies in Chapter 7 also highlighted how 
resident 1nonocytes in spleen are dependent on GM-CSP, FL T3 , TRIP and 
TRIP /MYD88 for development, while L-DC are not. However, linkage between L-
DC and resident monocytes was indicated by evidence of a possible comn1on lineage 
origin since the development of both subsets remained unaffected in Booreana n1ice 
which contain a non lethal 1nutation in c-Myb. Hematopoiesis fro1n bone man·ow 
progenitors depends on c-Myb expression, so the hypothesis that L-DC and resident 
monocytes develop in spleen from an endogenous progenitor laid down during 
embryogenesis, and perhaps a yolk sac-derived progenitor, should be considered 
(O'Neill et al. , 2014). During primitive hen1atopoiesis, yolk sac-derived progenitors 
are laid down in tissues and then generate tissue-specific macrophages after birth 
(Ginhoux and Jung, 2014). Recent studies have shown that microglia and 
Langerhans cells are derived fron1 yolk sac-derived progenitors seeded into tissues 
during e1nbryogenesis (Ginhoux et al. , 201 O; Merad et al. , 2004; Merad et al. , 2002). 
Yolk sac-derived n1acrophages can be distinguished from bone marrow-derived 
n1acrophages on the basis of phenotype, transcription factor expression and 
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differentiation pattern (Schulz et al. , 2012). Yolk sac-derived macrophages develop 
independently of c-Myb but are dependent on PU 1, while bone marrow-derived 
macrophages are dependent on c-Myb but not PU 1 (Schulz et al. , 2012). An 
alternative hypothesis for the developmental relationship between L-DC and resident 
monocytes is that they both derive fro1n a common progenitor in spleen which is 
yolk sac-derived. However, they would need to diverge at so1ne later point in 
developn1ent, acquiring function and properties reflective of a resident n1onocyte and 
a resident DC subset. Further experimental work could investigate the precursor-
progeny relationship between these 2 subsets, for example whether one develops 
fro1n the other, or whether they diverge fron1 a cormnon progenitor. 
The possibility that L-DC reflect 1nonocyte-derived DC (n10-DC) was also 
considered. Mo-DC have been characterised mainly in mouse models of infection. 
Ly6C 11 i inflarmnatory 1nonocytes give rise to mo-DC like TNFa and iNOS-producing 
DC (Tip-DC) in tissues during infla1nn1ation, while resident monocytes give rise to 
alternative activated M2 1nacrophages in tissues during the steady-state (Auffray et 
al. , 2007; Auffray et al. , 2009). Tip-DC has also been 4escribed as classically 
activated Ml macrophages (Geissmann et al., 2010; Hume, 2012; Serbina et al. , 
2003). It is notable that L-DC development occurs independently of inflarmnatory 
signals (Chapter 7), essential for generation of Tip-DC. In addition, the L-DC 
phenotype is distinct fro1n Tip-DC by lack of Ly6C and MHCII expression (Chapters 
3 and 4), and lack of nitric oxide production (data not shown). These findings show 
that L-DC are clearly distinct fron11no-DC. 
Blood resident monocytes have been described as precursors of macrophages 
in the steady-state (Geiss1nann et al. , 2010), although it is unlikely that they are 
precursors of yolk sac-derived splenic n1acrophages since these are thought to 
develop without a n1onocytic stage (Takahashi et al. , 1989). A contradictory study 
has shown that splenic 1nacrophages are largely derived from bone 1narrow-derived 
n1onocytes, with none or little contribution from yolk sac-derived progenitors 
(Ginhoux et al. , 2010). In the light of an absence of inforn1ation on the relationship 
between splenic 1nacrophages and monocyte subsets, it is i1npossible at this stage to 
n1ake predictions about a possible role for the newly defined splenic resident 
n1onocyte subset described here. A previous study identified a reservoir of 
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1nonocytes in spleen including inflammatory and resident monocytes, both of which 
were rapidly deployed to sites of inflammation upon induction of n1yocardial 
infarction (Swirski et al., 2009). After myocardial infarction, both monocyte subsets 
exited the spleen and entered the circulation. However, only inflammatory 
monocytes lodged in heart tissue, while resident monocytes were thought to be 
distributed into other tissues. That paper identified splenic monocytes as 
CD 11b+CD11c1°CD115+F4/8010Ly6G- cells which were further delineated on the 
basis of Ly6C expression (Swirski et al. 2009). According to analyses described 
here, however, the resident monocyte subset in that study is likely to be 
contan1inated with eosinophils. That study however failed to address the origin of 
splenic 1nonocytes, whether they were blood 1nonocytes which had lodged in spleen 
or whether they developed from splenic progenitors. 
In terms of the lineage relationship between L-DC and resident monocytes 
described here, it is possible that these two subsets derive from the same endogenous 
progenitor in spleen, but acquire specific functions as they develop under the 
influence of the spleen microenvironment. L-DC could re:t1ect an endogenous DC 
population with specific function in cross-presentation of blood-borne antigen to 
CD8+ T cells, while splenic resident monocytes could reflect a population of 
n1onocytes specialised in clearance of blood-borne antigens evidenced by their 
ability to endocytose both soluble and particulate 1nolecules. 
8.5 Relationship between inflammatory monocytes and resident monocytes 
Blood monocytes develop fro1n a co1nmon myeloid progenitor (CMP) in 
bone ma1Tow and enter circulation as mature cells. Recently, an immediate precursor 
of n1onocytes, the corm11on monocyte progenitor (CMoP) was also described in 
blood (Hettinger et al. , 2013). CMoP were found to give rise to inflammatory and 
resident monocytes, and to macrophages following macrophage deletion or 
infla1nmation, but they did not give rise to DC (Hettinger et al. , 2013). While that 
study has defined an impo1iant progenitor subset, it remains to be investigated 
whether spleen resident n1onocytes and inflarmnatory monocytes described here arise 
directly fro1n CMoP. 
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The resident monocyte and inflammatory monocyte subsets identified here in 
spleen appear to be closely related in terms of gene expression (Chapter 6). 
Clustering analysis has shown that both subsets share similar gene expression 
profiles, although they are not as closely related as are resident monocytes with L-
DC subset. Co1nparison between L-DC, infla1nmatory monocytes and resident 
monocytes led to the identification of Fnl , Fl Jal and Mmp8 as genes encoding 
specific n1arkers of inflammatory monocytes. Inflammatory monocytes were also 
distinguished from resident monocytes by upregulated expression of M1np8, F] Jal , 
Vcan , Cdl 4 and Fnl , while resident 1nonocytes were characterised by upregulation 
of Ccl5, Duspl 6, CdJ6, H2-Abl and Fabp4 genes. 
Both n1onocyte subsets appear to develop independently. Inflammatory 
1nonocytes but not resident monocytes depend on FL T3L and GM-CSF for 
development in spleen. Resident monocytes are dependent on TLR3 and TLR4 
signalling, while inflamn1atory monocyte develop in the absence of inflarm11ation 
and are dependent on the BATF3 and C-MYB transcription factors. Further 
investigation of the lineage origin of resident 1nonocy_tes and inflarmnatory 
1nonocytes, and their relation to L-DC lineage will be essential for fiuiher 
understanding their functional role in spleen. 
8.6 Conclusions and future work 
This study has identified three specific markers which could be potential 
identifiers of the L-DC subset in spleen. These include CD300E, CD300LD and 
CD9. Available antibodies for CD300E and CD300LD are however specific for 
hu1nan and not 1nurine 1nolecules, and did not show staining of murine splenocytes 
( data not shown). Fwiher experi1nental work will be dependent on production of 
antibodies specific for the murine CD300E and CD300LD 1nolecules. A CDJ00e_1_ 
knockout mouse strain has been developed by Georgina Clark (University of Sydney, 
NSW, Australia) which will also be impo1iant in further studies in order to assess the 
developn1ent and function of L-DC in murine spleen. Lastly, it will be important to 
translate this 111urine study into the human n1odel, and to identify a human 
counterpa1i of L-DC, and to establish hu1nan splenic longte1m cultures which 
produce LTC-DC. 
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In conclusion, L-DC represent a novel subset of antigen presenting cells that 
have not previously been described in spleen. They have distinct potential in cross-
presentation and could play an important role in immunity to blood-bo1ne infections 
and to cancer. In addition, the availability of a culture systen1 that generates large 
numbers of cells equivalent to L-DC could have potential therapeutic value in 
personalised medicine. 
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Figure A.1 Identification of eosinophil phenotype. 
Spleen cells were prepared by red blood cell lysis followed by T and B cell 
depletion, and then stained with antibodies specific for CD 11 b (Ml /70, PE-Cy7), 
CDl le (N418, APC), Ly6C (AL-21 , Pacific Blue), Ly6G (1A8, Bio), CD43 (IBII, 
Alexa488) and Siglec-F (ES0-2440, PE) , using streptavidin (SA)-APC-Cy7 as a 
second stage reagent. Prior to flow cytometry, cells were stained with propidium 
iodide (PI , 1 µg/ml) to delineate live (Pr) cells. Siglec-F+ cells were gated and further 
delineated on the basis of CDl 1 b, CD l lc, Ly6C, Ly6G and CD43 expression. The 
1najority of the Siglec-F+ cells expressed the phenotype of CD 11 bhiLy6C+CD43 11 i 
cells. Gates were set based on fluorescence minus one controls and numbers in gates 
represent % specific binding. 
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Figure A.2 Expression of Ly6C and Ly6G on L-DC candidates. 
Splenocytes were prepared and depleted of T and B cells as described in the legend 
to Figure 3.2. Cells were then stained with antibodies specific for CDl 1 b (M l /70 
PE-Cy7), CDl lc (N418 , APC), MHCII (25-9-17, Biotin), Ly6C (Al-21 , FITC) and 
Ly6G (1A8 , PE) , along with propidium iodide (PI lµg/ml) for gating live (Pr) cells. 
L-DC were gated as CD 11 b11 iCD 11 c10MHCir cells, then delineated on the basis of 
SSC and Ly6G expression. Three candidate L-DC subsets have been identified as 
SSC10Ly6G- SSC 11 iLy6G- and sscmidLy6G+ cells. Expression of L 6C on these 
subsets was identified. Gates were set based on fluorescence minus one controls and 
nu1n bers in gates represent % specific gating. 
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Figure A.3 Relationship between sorted dendritic and myeloid subsets and 
tissue macrophages. 
A set of genes uniquely expressed by tissue macrophages was identified by Gautier 
et al. (20 12). The expression of these genes is shown for each of the L-DC cDC and 
myeloid subsets. For each of the subsets, signal values were plotted as a heat 1nap 
using R/Bioconductor software. The line chart (blue) o erlaid on heat maps indicates 
signal intensity changes about the n1ean ( dashed blue line). 
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Table A.1 Genes upregulated between COS+ cOC and cos- cOC. 
Fold-Change CDS+ cDC CDS- cDC 
Gene Symbol (CDS+ cDC vs. Mean* Standard Mean* Standard CDS- cDC) + Error Error 
Cd8a 27.760 2195.601 1.674 80.206 13.316 
Leprell 18.700 980.770 41.569 52.682 5.428 
Clec9a 11.996 3392.192 5.644 285.108 36.356 
F6301 l JLJ0Rik 11.788 631.032 28.134 53.497 1.357 
Xcrl 10.811 1868.014 75.846 172.892 · 9.038 
Cxcl9 8.523 846.279 6.207 99.470 5.929 
Cadml 8.3 89 649.668 6.609 77.474 2.497 
Cd36 8.135 1277.064 30.626 158.133 19 .431 
A530099JJ 9Rik 7.745 2044.525 61.354 266.319 36.026 
Ppap2a 7.671 394.075 20.952 51.451 3.940 
5430435G22Rik 7.332 714.641 55.541 97.175 0.063 
lr/8 7.213 520.587 61.997 71.740 3.470 
Gclc 6.979 839.291 69.400 120.956 16.279 
Zc3hl2c 6.957 629.493 17 .648 91.751 15.419 
P2ryl4 6.883 722.152 27.864 10,5.120 7.736 
Pdia5 6.205 360.117 40.376 57.807 3.982 
Serpinb6b 6.093 757.433 28.334 125.936 20.695 
Tlrl 1 5.970 866.195 13.192 147.310 25.528 
Zc3hl2c 5.856 539.440 8.477 93.220 14.333 
Cacnal e 5.843 461.562 27.567 78.868 1.165 
Ly75 5.827 603.775 10.825 103.809 6.585 
Mpegl 5.729 1856.619 31.853 324.460 17.125 
Naaa 5.448 1520.239 34.984 279.251 12.111 
Tlr3 5.431 452.356 2.728 83.351 3.261 
Slc24a6 5.343 357.848 21.183 66.928 3.052 
Pygl -5.007 51.034 11.070 252.082 36.260 
Tlrl -5.011 145.418 10.188 727.615 32.956 
Ffar2 -5.066 51.473 3.337 261.555 26.392 
Ccr/2 -5.117 76.939 4.528 394.462 33.476 
Apl s2 -5.593 56.170 1.089 315.051 24 .636 
Ms4a6c -5.642 156.529 21.362 875.087 17.948 
Manla -6.100 91.439 1.285 559.336 42 .041 
B4galt6 -6.126 54 .736 7.457 333.803 32.710 
Klri2 -6.488 52.744 0.753 346.550 54.901 
Lair] 
-6 .836 80.834 7.688 558.137 94.371 
Fgr -6 .849 62.017 0.315 427.433 47.658 
St8sia6 -6.876 56.681 4.728 391.098 46.106 
Cyp4fl6 -7.390 139.444 8.088 1028.779 9.949 
Cd300lf -7.466 58.307 7.648 431.599 2.847 
Abeb la -7.508 54.137 9.155 401.695 29.625 
Pgapl -7.552 82.519 0.523 628.003 78.002 
Fcerlg -7.734 122.952 0.040 951.812 41. 73 8 
Cybb -7.785 240.468 1.650 1872.053 5.191 
Ptgs2 -7.804 111.339 3.020 868.571 0.638 
Cd209a -7 .915 90.135 15 .468 706.500 71.983 
Gprl41 -7 .930 51.999 2.702 411.941 10.842 
Sirpa -7.943 104.930 0.800 833.676 18.321 
Ccl3 -8.048 184.994 4.515 1488 .726 31.009 
Rgll -8.109 68.415 4.020 555.152 38.649 
Ms4a6b -8 .132 83.506 4.574 678.064 4.506 
Arap2 -8 .267 81.273 5.637 671.226 36.532 
Gml966 -8.405 132.006 9.473 1109.452 79.698 
Klrdl -8.650 166.452 28.5 36 1418.506 4.376 
Cd7 -8.708 120.259 15.711 1039 .292 46.182 
Sl00a4 -9.890 95.820 14.184 940.997 84.081 
Mmpl2 
-11.009 50.726 1.200 559.861 41.845 
Ms4a4c -12.251 79.293 8.637 965.636 0.177 
Emb 
-14.906 50.480 6.721 747.515 51.220 
Sirpbl b -14.911 76.957 7.361 1142.435 21.104 
Sirpbla 
-15.369 107.658 12.318 1643.742 8.262 
Sirpbl a -16.575 91.904 10.731 1513.692 48.988 
Sirpbl b -17.607 89.728 10.088 1570.473 46.530 
+ Genes were selected which showed 2: 5 fold change in signal value in either CDS+ cDC or CD8-
cDC assessed in pairwise comparison. 
* Data represent mean of duplicate samples (n=2). 
Table A.3 Genes upregulated between L-DC and ens- cDC. 
Fold-Change L-nc ens- enc 
Gene Symbol (L-nc vs. ens- Mean* Standard Mean* Standard cnC) + 
Error Error 
Klra2 26.329 1450.602 110.356 56.154 11.631 
Pilra 23.659 1160.911 58.620 50.588 12.555 
Cd300e 16.170 1421.362 12.809 88.025 4.742 
Ceacaml 14.725 1321.885 70.953 89.675 2.437 
Fcgr4 14.092 1084.527 0.263 76.960 0.015 
Ace 13.357 989.627 73.881 73.984 3.797 
Emr4 12.281 2439.648 139.380 198.545 9.187 
Cd36 11.903 1881.042 220.923 158.133 19 .431 
Cd300ld 11.635 1120.164 83.248 96.918 13.244 
Cpd 10.867 548.903 12.224 50.622 3.543 
Pilrbl 9.652 806.360 60.236 83.536 6.164 
Rasa3 9.302 491.216 18.542 53.035 5.284 
CJ 8.317 425.896 13.786 51.240 2.417 
Nuprl 7.538 481.366 36.486 63.685 1.325 
Slcl 1 al 7.523 389.184 9.197 51.735 1.265 
Smpdl3a 7.471 1163.378 90.269 155.623 10.940 
Csflr 7.3 88 1335.560 100.913 181.666 22.4 70 
Ly 6i 7.330 414.900 43.280 57.882 13.457 
Ccl6 7.267 743.856 8.929 102.348 0.479 
Grk5 7.062 417.621 13.741 59.721 8.576 
Plin2 7.040 819.562 65.949 117.l 09 15.807 
Cx3crl 6.947 637.558 46.178 92.441 12.915 
Llcam 6.882 448.746 22.570 65.447 6.506 
Gsr 6.844 659.658 44.670 96.472 7.621 
E430024C06Rik 6.758 1568.881 44.092 23L069 3.002 
Trend 6.660 357.258 13.473 53.603 0.252 
Hpgd 6.636 2346.482 46.518 354.083 19.447 
Jtgal 6.626 1244.192 117.344 187.209 l 0.115 
Cfh 6.528 559.477 20.458 85.863 6.024 
Apoe 6.504 526.683 49.335 80.640 1.650 
Hegl 6.404 466.517 9.132 72.966 4.383 
Treml4 6.357 2158.616 126.754 339.569 19.967 
Lrpl 6.310 375.113 16.648 59.407 1.334 
Ldlrad3 6.141 388.563 14.701 63.290 2.838 
Tmem38b 6.095 369.920 13.911 60.656 0.946 
Spn 5.967 536.108 0.126 89.851 0.915 
Gmll 711 5.951 939.789 148.111 156.649 14.680 
Clec4a3 5.852 2663 .629 105.292 458.377 56.846 
Gml 1711 5.793 862 .056 168.664 146.209 9.082 
Gzmb 5.755 451.871 24.728 80.416 17.915 
lkz/3 5.732 290.713 35.031 50.415 2.588 
Mppl 5.724 545.943 83.878 95.434 15 .059 
Duspl6 5.715 877.419 64.334 153 .858 15.115 
Sepxl 5.638 296 .277 6.127 52.605 2.590 
Rras 5.559 496.804 51.089 88.937 2.818 
ldhl 5.559 301.556 55.509 53.422 3.349 
Rbpms 5.465 288.010 12.871 52.652 0.388 
Seppl 5.448 326.572 47.610 59.464 4.3 16 
Slpr5 5.352 303.395 4.288 56.686 0.514 
Cyth3 5.276 309.885 27.349 5 8.531 1.589 
Atpla3 5.008 528.196 5.192 105 .459 0.591 
Rogdi -5.094 50.934 1.188 259.663 11.643 
Top2a -5 .111 88.695 3.295 456 .700 57.831 
Egr2 
-5.111 56.160 4.636 286.071 2.981 
Anxa3 
-5 .111 78.507 1.400 403.640 44.751 
Cd22 
-5.117 62.146 2.741 31 8.066 15.864 
Tspan2 
-5.125 64.412 3.474 330.478 24.040 
Gprl83 
-5 .129 96.407 1.247 494.547 9.969 
Slc44al 
-5.151 158.358 6.449 815.594 29.149 
Cd74 -5.174 495.887 33.751 2561.664 102.945 
CdJ00lf 
-5 .206 83.051 5.041 431.599 2.847 
P2ry10 
-5.238 87.687 5.633 459 .248 29.021 
H2-Abl 
-5.530 673.974 30.767 3723.520 53.946 
Kifll -5.547 50.132 0.942 278 .399 14.182 
Mdh2 
-5.847 33 1.933 14.718 1940.908 87.468 
lfi205 
-5.983 112.100 11.276 667.351 10.170 
Abeb la -6 .208 64.531 0.865 401.695 29.625 
Cd7 
-6.403 162.687 13.288 1039.292 46 .182 
Cd80 -6.417 54.467 1.371 350.752 30.798 
Dpp4 
-6.429 197 .603 16.634 1265.903 10.619 
Chn2 -6.465 59.894 1.464 388.241 30.106 
H2-Ebl 
-6 .591 331.002 10.861 2182.665 100.326 
Tlrl 
-6.706 108.3 88 0.201 727.615 32.956 
Tfrc 
-7.028 67.921 4.917 477.326 34.672 
Nedd4 -7.484 72.524 0.1 72 543.586 30.297 
Rgsl -7.876 337.758 42.980 2638.609 10.701 
Apol7c -8 .206 129.958 51.582 979.190 26.671 
Arap2 -8.283 80.973 2.949 671.226 36.532 
Kynu -8.337 129.013 17.380 1066.387 35.841 
R!;ll -8.460 65.465 0.460 555.152 38.649 
Rras2 -8 .852 86.797 0.272 768 .375 9.774 
Flt3 
-9.274 107.580 12.807 990.702 16.190 
Rnd3 
-9 .561 99.003 8.929 945.627 73.852 
Clec4a4 -9.672 63.153 5.598 610.519 50.632 
Plxncl -10.177 146.779 1.462 1493-.675 12.529 
Mmpl2 -10.510 53.148 1.701 559.861 41.845 
Klril -12.391 60.717 1.657 752 .187 13.788 
Pt!;S2 -12 .623 69 .661 10.852 868.571 0.638 
Ccndl -12 .824 70.079 2.545 899 .306 46.231 
H2-Ob -15 .3 87 65.471 3.630 1008.020 66.006 
H2-DMb2 -16.814 67.368 3.166 1132.532 49.628 
Dnasel 13 -18.035 56.513 3.214 1018.803 49.799 
Adam23 -24.250 62.837 5.703 1517.628 18.095 
+ Genes were selected which showed ~ 5 fold change in signal value in either L-DC or CD8- cDC 
assessed in pairwise comparison. 
* Data represent mean of duplicate samples (n=2). 
Table A.2 Genes upregulated between L-DC and CDS+ cDC. 
Fold-Change L-DC CD8+ cDC 
Gene Symbol (L-DC vs. Mean* Standard Mean* Standard CD8+ cDC) + 
Error Error 
Sirpbl b 20.229 1817.123 220.432 89.728 10.088 
Hp~d 18.954 2346.482 46.518 123.921 6.043 
Cybb 18.442 4461.392 487.951 240.468 1.650 
Ear2 18.372 3381.838 125.371 183.967 2.385 
P~lyrpl 17.279 1049.278 117.991 60.495 4.309 
Emb 16.666 842.257 118.940 50.480 6.721 
Sirpbl b 16.652 1283.321 140.667 76.957 7.361 
Lair] 16.436 1322.610 7.289 80.834 7.688 
Cd300e 15.779 1421.362 12.809 90.094 1.662 
Fcerl~ 15.199 1872.824 122.647 122.952 0.040 
Sirpbla 14.649 1573.238 142.862 107.658 12.318 
Fgr 14.323 888.436 18.826 62.017 0.315 
Sirpb l a 14.278 1304.114 48.662 91.904 10.731 
Gngt2 14.107 718.670 31.025 50.928 1.766 
Ear JO 13.892 1884.006 46.422 135.584 1.707 
StklO 13.758 817.522 63.934 59.738 7.702 
Earl 13.525 1465.111 47.061 108.343 3.871 
Py~l 13.078 651.837 19.608 51.034 11.070 
Gprl41 12.734 663.209 51.012 51.999 2.702 
Apls2 12.508 702.750 20.242 56.170 1.089 
Cx3crl 11.532 637.558 46.178 55.147 0.959 
Ear JO 10.956 1306.305 31.735 119.219 2.629 
Ctsd 10.442 627.410 12.664 60.518 7.339 
KlralO 10.156 619.711 4.363 61.109 3.378 
Klra9 9.815 521.935 6.31 7 53.22.9 2.408 
Serpinb 10-ps 9.815 1174.014 240.742 117.333 7.893 
Gmll711 9.746 939.789 148.111 95.224 0.298 
Ssh2 9.490 1615.582 73.366 170.142 5.252 
Gml 1711 9.219 862.056 168.664 91.700 0.796 
Ccl3 8.631 1598.800 92.611 184.994 4.515 
Ccl6 8.493 743.856 8.929 87.586 1.229 
Nc/2 8.445 451.472 9.861 53.477 1.683 
Mppl 8.226 545.943 83 .878 65.610 2.027 
Smpdl3a 8.164 1163.378 90.269 144.203 24.696 
Dram2 7.986 619.554 82 .119 77.477 9.491 
Slcl 2a2 7.979 1866.628 281.744 231.534 11.198 
Ms4a6b 7.788 650.514 38.3 15 83.506 4.574 
Sirpa 7.760 815.666 47.589 104.930 0.800 
Ly 6i 7.691 414.900 43.280 53 .701 2.291 
Stapl 7.678 2172.126 78.495 283.002 12.806 
Spn 7.674 536.108 0.126 69.880 1.582 
Ms4a6c 7.531 1168.381 36.276 156.529 21.362 
Gm1966 7.475 984.371 18.079 132.006 9.473 
Ptpnl2 7.430 1341.571 16.368 180.944 12.069 
Jfitm3 7.059 5280.975 38.623 748.077 3.257 
Faml J Ja 7.011 741.106 22.347 106.131 9.938 
Add3 6.853 522.108 54.546 76.290 8.863 
lfitm2 6.765 864.336 9.847 127.846 4.588 
Ldlrad3 6.709 388 .563 14.701 57 .881 0.633 
Cfh 6.613 559.477 20.45 8 84.722 5.395 
E430024C06Rik 6.553 1568.881 44.092 239.414 7.163 
E430024C06Rik 6.553 l 568.881 44.092 239.414 7.163 
Ms4a4c 6.463 509.466 1.648 79.293 8.637 
G6pdx 6.457 669.443 46.765 103.935 10.276 
lt~al 6.451 1244.192 117.344 194. l 06 28.443 
Tnfr~fl b 6.363 729.939 17.751 114.757 4.333 
Lyz2 6.336 5511.231 372.900 868.677 38.348 
Lpcat2 6.202 462.187 27.825 74.585 5.423 
Rras 6.152 496.804 51.089 80.552 6.033 
ll1 7ra 6.137 442.363 32.134 72.008 4.190 
Sepxl 5.946 296.277 6.127 50.268 6.690 
Tmem38b 5.909 369.920 13.911 62 .620 2.688 
Cd300a 5.875 1186.579 36.758 202.246 12.185 
Msn 5.764 2989.141 245.111 517.242 20.514 
Nadk 5.747 649.019 39.027 114.709 21.258 
Dusp16 5.740 877.419 64.334 153.463 17.710 
Nfe2l2 5.677 1293.088 222.153 228.891 45.185 
U~c~ 5.671 608.982 10.292 108.164 13 .079 
Nr4al 5.665 989.626 0.254 175 .483 16.710 
Casp4 5.655 389.013 24.212 69.542 11.092 
Bin2 5.651 354.086 38.551 62.357 2.946 
Slc44a2 5.623 632.895 24.218 113.100 11.936 
Gsr 5.594 659.658 44.670 117.690 2.687 
Klri2 5.592 295.497 18.183 52.744 0.753 
lfitml 5.580 432.218 17.171 77.397 0.617 
Caspl 5.511 599.420 74.556 107.938 2.119 
Tf!.(brl 5.474 710.148 36.679 129.721 6.712 
Jfitml 5.465 283.918 19.475 52.051 4.798 
Acot9 5.452 484.332 14.049 88.851 2.988 
Emp3 5.418 607.557 88.653 111.639 12.422 
Cpd 5.360 548.903 12.224 103.941 17.956 
Sh3kbpl 5.353 702.446 2.364 131.409 7.059 
Gm885 5.314 324.725 21.441 61.164 4.845 
Smc6 5.3 12 1014.524 80.477 190.495 6.000 
Mettl7al 5.192 318.346 11.740 61.41.0 4.075 
Eno] 5.174 435.383 7.718 84.935 11.634 
Klra3 5.109 375.137 6.290 73.500 3.450 
J~s/6 5.062 1790.305 71.141 353.625 12.118 
Rasa3 5.037 491.216 18.542 97.564 4.592 
Apoe 5.021 526.683 49.335 104.436 0.645 
Mlec -5.022 75.511 8.497 379.691 46 .827 
Slamf8 -5.093 54.877 2.822 279.847 20.152 
Klril -5 .155 60.717 1.657 312.952 7.292 
Cd81 -5.176 166.837 9.362 871.281 125.849 
Etv3 -5.178 66.731 3.967 344.928 2.060 
Tspan3 -5 .210 103.509 3.667 539.128 13.661 
Dpp4 
-5 .319 197.603 16.634 1047.465 14.413 
Slco3al -5 .345 59.599 7.297 316.613 16.614 
Cd74 -5.408 495.887 33.751 2686.703 244.990 
A430084P05Rik -5 .491 67.071 10.032 364.384 13.358 
Cpne2 -5 .535 63.129 4.825 350.438 37.882 
Strbp -5.540 71.880 5.453 398.445 33 .160 
Gclc -5 .5 87 150.240 12.684 839.291 69.400 
Myo9a -5.611 78.107 8.604 435.580 2.807 
Tbcld9 -5 .724 83.569 4.165 477.986 13.879 
Myo9a -5.774 137.488 22.361 791.678 114.617 
Lrrc18 -5.845 60 .960 5.492 355.076 12.291 
Pptl -5.853 634.664 70.073 3694.216 119.302 
Fnbpl -5.856 191.828 2.490 1127.571 98.748 
Pakl -5 .861 103 .911 1.060 610.027 34.972 
Slc9a9 -5.868 154.842 1.085 908.673 15 .612 
Pik3cb -5.901 120.383 8.550 712.350 73.358 
H2-Abl 
-6 .001 673.974 30.767 4051.319 296.617 
Gramd3 
-6 .005 56.670 8.137 336.807 3.139 
Zc3hl2c -6.184 87.452 6.271 539.440 8.477 
Myo9a 
-6.330 116.261 15.350 730.233 32.075 
H2-Ebl 
-6.390 331.002 10.861 2116.498 106.068 
Atpifl 
-6.468 170.249 5.469 1100.543 0.305 
Anxa3 -6.580 78.507 1.400 516.923 20.808 
Myo9a -6.658 91.101 12.687 600.683 5.719 
Zfp366 
-6.796 54.359 3.008 368.882 5.398 
Wdfy4 
-6.940 170.770 22.100 1175.192 7.617 
Ppap2a 
-7.093 55.491 1.091 394.075 20.952 
Nedd4 -7.188 72.524 0.172 521.334 1.146 
Map2k6 -7.200 54.172 5.738 388.136 15.413 
]1~/8 -7.350 70.327 0.248 520.587 61.997 
Fchsd2 
-7.496 86.324 1.179 647.033 2.550 
Naaa -7.574 200.658 1.640 1520.239 34.984 
Cxxlc -7.700 62.578 0.293 492.805 103.302 
My o9a -7.899 82.853 8.502 653.389 55.378 
Wdfy4 -8.322 54.694 1.326 456.649 38.620 
Zc3hl2c -8.339 75.474 1.321 629.493 17.648 
H2-DMb2 -8.561 67.368 3.166 579.615 63.513 
Cd86 -8.666 84.368 1.793 731.713 33.724 
Myo9a -9.705 109.991 9.023 1063.907 3.061 
P2ryl4 -10.457 69.319 6.587 722.152 27.864 
Cadml -10.620 61.179 1.103 649.668 6.609 
Fmnl2 -11.584 116.254 11.221 1340.514 17.331 
Btla -12.166 74.001 1.301 900.149 0.431 
Flt3 -13.114 107.580 12.807 1400.773 12.4 78 
H2-Ob -13.854 65.471 3.630 905.658 5.029 
Cd24a -13.964 91.100 7.591 1267.695 9.623 
Jfi205 -20.415 112.100 11.276 2276.985 8.050 
Adam23 -22.447 62.837 5.703 1404.960 26.830 
A530099Jl9Rik -29.922 68.309 1.155 2044.525 61.354 
Apol7c -30.727 129.958 51.582 3666.202 83.096 
Dnasel l3 -32.876 56.513 3.214 1855 .880 59.356 
Xcrl -36.979 50.499 1.581 1868.014 75.846 
+ Genes were selected which showed 2: 5 fold change in signal value in either L-DC or CD8+ cDC 
assessed in pairwise comparison . 
* Data represent mean of duplicate samples (n=2). 
Table A.4 Genes specifically expressed between L-DC and CDS+ cDC. 
Fold-Change L-DC CD8+ cDC 
Gene Symbol (L-DC vs. Mean* Standard Mean* Standard CD8- cD) + 
Error Error 
Zeb2 14.837 548.052 67.119 36.668 0.693 
lfitm6 14.407 646.978 112.504 44.228 0.583 
Gm9733 14.262 508.325 16.090 35.626 0.282 
Gzm.b 13.854 451.871 24.728 33.097 5.901 
Ms4a4a 13.817 511.336 80.421 36.838 4.618 
Atpia3 13.665 528.196 5.192 38.733 2.487 
Licam 13 .556 448.746 22.570 33.109 1.794 
Gda 12.573 385.173 7.133 30.667 1.525 
Sqrdl 12.326 328.967 23.265 27.184 5.500 
Pltp 12.081 485.865 58.788 39.922 0.244 
Lrpi 11.975 375.113 16.648 31.303 0.711 
Lilra5 11.826 442.285 10.181 37.485 2.662 
Neri 11.540 393.951 22.797 34.091 0.864 
CJ 11.306 425.896 13.786 37.653 0.302 
Pla2R7 11.213 510.647 32.392 45,.452 0.237 
Tlr8 11.029 361.373 32.602 32.676 1.666 
Abcd2 10.848 260.523 7.352 24.036 1.217 
Nupri 10.4 78 481.366 36.486 45.904 2.918 
Hgf 10.139 278.901 5.863 27.518 0.972 
lkzf3 9.856 290.713 35.031 29.362 2.181 
Fam46a 9.784 378.418 16.911 38.660 1.309 
Krt80 9.635 423.455 0.465 43.950 0.235 
Seppi 9.454 326.572 47.610 34.184 0.839 
Gm5i50 9.449 367.228 82.481 37.895 1.292 
A630033H20Rik 9.332 320.050 30.498 34.168 1.417 
lrak3 9.060 264.136 8.938 29.259 2.663 
Pparf{ 8.974 421.427 17.184 46.938 1.276 
Abca9 8.492 234.244 11.094 27.566 0.790 
Klra8 8.341 236.170 3.963 28.324 0.895 
Fc[;r3 8.200 300.711 28.094 36.512 0.215 
Zfyve9 8.196 308.588 0.476 37.663 0.892 
Fam55d 8.157 251.301 1.203 30.864 1.892 
Arhf{e/3 7.919 387.354 66.081 48.211 1.141 
Me;sti 7.917 166.937 11.405 21.039 0.326 
Sipr5 7.904 303.395 4.288 38.477 2.729 
Plxnb2 7.784 287.536 21.735 36.948 2.883 
Mdmi 7.713 260.629 0.366 33.795 0.634 
Cc/9 7.643 328.078 28.768 42 .763 0.557 
Gimap4 7.342 289.814 26.903 39.306 0.373 
Svil 7.290 256.716 10.133 35.245 2.054 
Trem3 7.262 357.258 13.4 73 49.163 0.101 
Cd300lb 7.242 218.947 2.567 30.237 0.582 
Ccdcl25 6.898 197 .052 2.197 28.629 1.895 
Treml 6.609 211.974 11.743 32.028 0.462 
Gstml 6.574 212.010 26.095 32.115 2.644 
Rhoq 6.467 256.344 4.777 39.630 0.193 
Tm.em26 6.400 244.988 24.831 38.142 2.108 
Xyltl 6.398 273.414 24.012 42.585 1.186 
Rtp4 6.380 197.046 9.031 30.881 1.326 
Pros] 6.351 179.988 24.135 28.108 1.130 
Apoc2 6.340 240.037 11 .321 37.820 0.295 
Hp 6.313 182.405 43 .577 28.123 1.913 
Tmem 71 6.311 151.394 20.686 23.769 0.444 
Fprl 6.308 169.278 2.425 26.835 0.312 
Thbd 6.226 211.722 25.817 33.902 3.149 
SJ00a6 6.167 219.687 25.302 35.415 1.409 
Cd84 6.158 228.672 10.700 37.366 4.491 
Rbpms 6.026 288.010 12.871 48.001 4.910 
Tbcld2b 5.971 191.380 0.900 32.084 1.493 
Csj3r 5.969 163.212 1.153 27.365 1.077 
Map3kl5 5.930 247.350 7.442 41.866 3.836 
B4f.{alt5 5.804 270.397 21.621 46.762 5.476 
Cyp4fl8 5.798 195.922 7.464 33.830 2.110 
Abi3 5.691 188.720 13.844 33.098 1.328 
Gcnt2 5.659 201.374 9.994 35.548 0.638 
Ms4a6d 5.547 158.618 7.103 28.609 1.567 
Raplf.{ap2 5.470 212.381 9.855 38.794 0.906 
6430548M08Rik 5.397 215.089 13.036 39.859 2.514 
Pdliml 5.343 244.698 2.334 45.881 2.751 
Alox5 5.338 176.833 3.283 33.130 0.641 
Ttc39a -5 .281 41.159 1.918 217.696 15.663 
Amica] 
-5.347 38.433 1.812 206.023 17.717 
Trpm2 -5 .403 44.730 0.361 244.203 35.127 
Frmd4b -5.486 43.374 2.417 237.666 6.732 
Gca -5 .498 45.694 2.830 252.937 33.173 
Faml49a -5.810 27.369 1.392 159.397 13.597 
Fnip2 -6.095 42.679 5.517 259.547 28.938 
Actnl -6.103 34.869 2.537 212.299 5.480 
Met -6.298 35.512 2.706 223.965 20.668 
Cxcll6 -6.382 42.028 0.692 268.406 11.225 
Ppef2 
-6.640 32.921 0.067 218.863 10.681 
Fndc 7 -6.643 29.337 0.427 194.899 4.072 
Nek6 -6.724 34.587 2.361 232.055 4.099 
H2-Oa -6.780 32.437 0.130 221.097 22.887 
Cdon -6.952 41.034 2.449 284.776 0.732 
Rab30 -7.135 42.721 0.268 304.795 0.546 
Clecla -7.266 29.651 0.328 215.436 2.336 
ltf.{ae 
-7.569 29.068 0.032 221.400 24.737 
Rnfl44b -7.821 33.829 4.037 264.515 31.007 
Ecel 
-7.880 47 .285 0.344 374.364 36.515 
Plekha5 -8.317 42.413 6.056 349.171 6.188 
Fam40b -8.470 30.717 1.708 262.130 35 .061 
Ciita -8.991 43.440 2.971 391.061 33.038 
Gatm -9 .527 32.792 2.301 311.982 14.869 
Kmo -10.016 47.450 3.216 474.173 1.057 
Adaml9 -10.264 40.698 1.667 418.164 25.395 
Gcet2 -10 .314 30.685 0.161 316.697 11.734 
Pdia5 -10.391 34.510 2.207 360.117 40.376 
Adam8 -10 .538 45.131 0.709 476.002 21.794 
Hepacam2 -11.851 23.649 1.339 280.052 11.621 
Kit -12.288 45.381 3.567 556.738 30.154 
Cacnale -13.444 34.281 0.870 461.562 27.567 
Ly75 -13.465 44.834 0.452 603.775 10.825 
Tlr3 -14.975 30.232 1.223 452.356 2.728 
+ Genes were selected which showed between 5 to 15 fold change in signal value where one subset 
has signal value :'.S 50 and the comparison subset has a signal value 2: 150, in either L-DC or CD8+ 
cDC assessed in pairwise comparison . 
* Data represent mean of duplicate samples (n=2) . 
Table A.5 Genes specifically expressed L-DC and ens-cDC. 
Fold-Change L-nC ens- enc 
Gene Symbol (L-nc vs. ens- Mean* Standard Mean* Standard cnct Error Error 
Gml0673 7.387 272.591 56.193 36.702 7.355 
Fcgr3 7.119 300.711 40.598 42. 165 3.019 
Jrak3 6.566 264.136 22.644 40.625 5.823 
Map3kl5 6.537 247.350 9.595 37.823 0.491 
Hp 6.532 182.405 36.805 27.146 1.271 
Tmem26 6.344 244.988 38.620 38.677 4.480 
Mdml 6.070 260.629 15.696 43.076 3.419 
Apoc2 6.045 240.037 10.652 39.798 3.288 
Fprl 5.936 169.278 11.785 28.583 2.002 
Thbd 5.904 211.722 22.901 35.616 1.195 
Xyltl 5.803 273.414 32.386 46.949 1.091 
Cd300lb 5.783 218.947 26.248 38.000 3.319 
Svil 5.765 256.716 16.560 44.520 1.425 
Tre,nl 5.757 211.974 20.345 36.820 2.085 
Pros] 5.710 179.988 20.266 31.242 0.695 
Ccdcl25 5.227 197.052 15.631 37.781 2.532 
Gstml 5.092 212.010 16.306 41.796 6.312 
Lrrcl6a -5.055 35.121 73.789 177.984 16.044 
Ptpn3 
-5.076 30.921 2.082 157.520 13.583 
Ptpn3 -5 .165 47.759 7.073 246.474 10.867 
Dennd3 -5 .320 37.311 4.596 199.139 16.767 
Ctnnd2 -5.372 33.902 1.754 182.360 12.929 
Flnb -5.546 48.463 6.019 270.441 29.982 
Buhl -5.601 34.466 5.957 195 .833 36.781 
Card] 1 
-5 .850 36.686 2.685 214..530 18.356 
Tnsl -6.049 32.084 2.670 194.485 12.789 
Mical3 -6 .091 46.421 5.960 282.759 12.329 
Clec9a -6 .333 45.057 3.686 285.108 36.356 
Gpm6b -6.405 34.712 5.485 223.304 21.3 83 
Tbcld4 -6.438 42.156 3.074 272 .840 28.020 
Si5<lec5< -6 .908 49.420 4.720 338.777 11.596 
St8sial -7.381 29.334 8.984 217.773 23.448 
B45<alt6 -7.506 44.314 6.252 333.803 32.710 
Cdon -7 .539 41.034 2.337 309.066 12.666 
Ciita -7 .679 43.440 2.430 332 .968 10.191 
Ptpn3 
-7 .950 33.400 4.627 266.634 30.051 
l 300002K09Rik -7 .991 41.162 3.429 329.781 24 .192 
+ Genes were se lected which showed between 5 to 8 fold change in signal value where one 
subset has signal value :S 50 and the comparison subset has a signal value 2: 150, in either L-DC 
or CD8- cDC assessed in pairwise comparison. 
* Data represent mean of duplicate samples (n=2) . 
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